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' My son, there is something else to watch out for. 
There is no end to the writing of books,
and too much study will wear you out ....
God is going to judge everything we do,
whether good or bad, even the things done in secret.'
Ecclesiastes Chapter 12,Verses 12 & 14*
SUMMARY.
Research has been carried out into the mechanisms of 
activation of chemical carcinogens, using the Ames mutagenicity 
test as an indication of this parameter.
As the mixed-function oxidase system has been the major 
enzyme system investigated, initial studies were carried out to 
evaluate the specificity of assays for the two major forms of the 
terminal oxygenase, cytochromes P-450 and P-448. A combined use of 
inducers, inhibitors and purified enzymes confirmed the specificity 
of the ethoxyresorufin O-deethylation assay for cytochrome P-448, and 
further detailed studies emphasised the advantages of this activity 
over biphenyl 2-hydroxylase and aryl hydrocarbon hydroxylase. In 
addition, 9-hydroxyellipticine was found to be a specific inhibitor 
and inducer of cytochrome P-448.,. and, provided a useful tool for both 
in vivo and in vitro investigations. Furthermore, a detailed study of 
the spectral interactions of substrates with cytochromes P-450 and P-448 
indicated that these two cytochromes have distinctly different substrate 
binding sites, which could be related to their disparate metabolic 
specificities and contrasting roles in activation and detoxification 
of xenobiotics.
The role of cytochromes P-450 and P-448, as well as other 
oxidative enzymes (i.e. the FAD-monooxygenase or Ziegler enzyme, and 
monoamine oxidase) in the activation of three major groups of carcin­
ogens (nitrosamines, aromatic amines and polycyclic aromatic hydro­
carbons) has been studied. An excellent positive correlation was observed 
between the activation of benzo(a)pyrene to mutagens and the O-deethyl­
ation of ethoxyresorufin, indicating that these are catalysed by the 
same form of cytochrome P-448. No similar clear-cut correlations could 
be obtained for dimethylnitrosamine and 2-acetylaminofluorene, and indeed, 
activation of dimethylnitrosamine could also not be related to its 
demethylation.
In addition, a comprehensive study of species and sex 
differences in the activation of these three groups of carcinogens
revealed that the rat (both male and female) was generally poor at 
activation,• while in contrast, the hamster consistently provided a 
good activating system, especially in the case of the nitrosamines.
Finally, preliminary studies have been carried out on the 
metabolic capacity of cytochrome P-450 in yeast and plant cells, and 
on the ability of iron-based chemical systems and haemoglobin to mimic 
the activity of cytochrome P-450. The cytochrome P-450 models were 
able to hydroxylate aniline and demethylate dimethylnitrosamine, while 
the yeast and plant preparations were most efficient at hydroxylating 
benzo(a)pyrene.
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ABBREVIATIONS.
The use of abbreviations in the text has been kept to a 
minimum. The following may be found (predominantly in Tables & Figures):-
AHH - aryl hydrocarbon hydroxylase
AMP - adenosine 5'-monophosphate
AN - aniline
ATP - adenosine 5'-triphosphate
Bio - biotin
DLPC - dilauroyl phosphatidylcholine
DMF - dimethylformamide
DMSO - dimethylsulphoxide
DNA - deoxyribonucleic acid
EDTA - ethylenediaminetetraacetic acid
EH - epoxide hydrolase
FAB - flavin adenine dinucleotide
FMN - flavin mononucleotide
GSH - reduced glutathione
Hb - haemoglobin
his - L-histidine
HPLC - high-pressure liquid chrbmatography
LOO" - lipid peroxide
IK2 - liver microsomal cytochrome P-450 from.phenobarbitone-induced rabbit
LM4 - H ” " P-448 m -naphthof lavone " '*
MAO - monoamine oxidase
5-MC - 5-methylcholanthrene
MFO mixed-function oxidase
NAD(p)- nicotinamide adenine dinucleotide (phosphate)
9-OHE - 9-hydroxyellipticine
P-450/P-448 - the forms of the terminal oxygenase of the mixed-function 
oxidase system
P-420 - breakdown product of cytochromes P-450
PB - phenobarbitone
PAP - para-aminophenol
PES - prostaglandin endoperoxide synthetase 
RBC - red blood cell 
RNA - ribonucleic acid 
mRNA - messenger ribonucleic acid 
(s) - inorganic sulphate
S9 - 9>000g supernatant
SDS - sodium dodecyl sulphate 
UDP - uridine 5*-diphosphate
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C H A P T E R
CHAPTER 1. GENERAL INTRODUCTION.
Mutagens and Carcinogens.
The incidence of human cancer is governed by both environmental 
(exogenous) and endogenous or genetic factors. This implies that a 
major reduction in cancer incidence may be accomplished by the 
identification of specific carcinogens and subsequent modification 
of the human environment to avoid unnecessary contact (Doll, 1977; 
Epstein, 1974; Weinstein, 1981a). It is generally considered that 
chemicals are the most important cause of human cancer, with estimates 
ranging between 60-90% (Bridges, 1976* Miller, 1978), although there 
is some evidence for the involvement of (and possible interaction 
with) oncogenic viruses and irradiation (Epstein, 1974; Weinstein, 
1981a). These conclusions were originally drawn from epidemiological 
studies (e.g. Doll, 1977t Epstein, 1974), particularly those showing 
the great variation in the types of cancer found in different 
communities and in different parts of the world. Although there is 
some genetic variation, this has been shown not to be the principle 
cause of cancer incidence range, as demonstrated by migrant groups 
who take on the new cancer profile of the area to which they have 
moved. Exposure to such carcinogenic chemicals may be from 
occupational, medicinal or dietary sources, e.g. vinyl chloride, 
synthetic steroids and nitrosamines (Epstein, 1974; Weinstein, ■
1981a). This must include the industrial pollution of our environ­
ment, either accidentally or through the deliberate use of pesticides. 
Similarly, chemical carcinogens and modifiers of the neoplastic 
process may be naturally present in our food, are often added 
during processing (in the form of flavours, colours, antioxidants, 
pyrrolysis products etc.-) or may accidentally contaminate it, such 
as fungal toxins, pesticide residues or plastic monomers from the 
packaging (Austwick and Mattocks, 1979; Sugimura, 1982). Human 
carcinogen exposure may also be categorized as voluntary (e.g. 
cigarette smoking) or involuntary (e.g. dieldrin in food)
(Epstein, 1974).
The epidemiological evidence for chemical carcinogens has been 
backed up by the use of long-term animal carcinogenicity studies, 
which at present are considered the most reliable laboratory 
method for determining carcinogenicity. However, both these methods 
lack sensitivity, are expensive and time-consuming (Epstein, 1974;’ 
Purchase, 1980), and hence it would not be possible to test the 
many thousands of chemicals which have been, and continue to be 
added to man's environment (Weinstein, 1981a), for their potential 
carcinogenicity. This has led to the development of various short­
term, generally in vitro tests as rapid screens for carcinogenic 
potential (Purchase, 1982; Purchase et al, 1976** 1978). These 
tests, in common with the long-term animal carcinogenicity tests, 
suffer from the problem of extrapolation to man (Weinstein, 1981a)-. 
This can be alleviated by more basic research on the comparative 
biology, metabolism and toxicity of various classes of carcinogens 
in different species. Some work of this nature is presented in 
chapters 5, 6 and 7 with respect to aromatic amines, polycyclic 
aromatic hydrocarbons and nitrosamines.
The end point of many of these short-term tests is DNA damage 
as demonstrated by clastogenic (chromosomal) effects, mutation, 
DNA-adduct formation or DNA repair (Purchase, 1979; Purchase, 1982, 
Stoltz et al, 1974). To understand the reasoning behind such 
assays it is necessary to review the Current state of knowledge 
on the basic mechanisms of mutagenesis and carcinogenesis.
Mutations are the stable, heritable modifications of the 
genetic information, which is held within the DNA structure, 
ubiquitous to all cells which have the potential to replicate. 
Mutations may occur spontaneously, or by the actions of chemicals 
or radiation., and result in a change in the number or types of 
nucleotide bases that constitute a normal gene. Using the broadest 
definition, the kind of damage may range from an alteration of a 
single base on the DNA molecule to the removal or rearrangement 
of large portions of the chromosomes, or even altered numbers of
chromosomes. Mutations may occur within germ or somatic cells
and the importance of a mutation at a particular position will
depend on whether it results in an amino acid alteration on a
critical part of a protein or causes premature termination of
template function (Lieberman, 1982). Chemicals tend to cause
fairly characteristic types of DNA damage, according to their
structure, as will be considered in more detail for aromatic
amines, nitrosamines and polycyclic aromatic hydrocarbons within
the appropriate chapters. Point mutations may arise from base-
mispairing, resulting from, for example, the deamination of
6
cytosine to uracil or through the 0 -alkylation of guanine 
(Lieberman, 1982). Frameshift mutations, which are generally 
more deleterious, may result from the intercalation of a planar 
structure of molecular dimensions comparable to that of a normal 
base-pair (e.g. acridines) into the DNA helix. Alternatively, 
the binding of a bulky moiety (such as 2-acetylaminofluorene) 
tends to cause displacement of the DNA bases and stabilization 
of a 'looped-out1 configuration, again resulting in frameshift 
mutation (Green, 1979). Chemicals may also cause mutations by 
altering the availability of components for, and the fidelity 
of DNA replication and repair, which may result in chromosome 
breakage (Stott et; al, 1981). Additionally, alteration in 
spindle function would result in unequal partitioning of chromatids 
and subsequent anomalies in chromosome number.
It is believed that greater than 10% of human pathological 
conditions have a genetic component and that genetic damage 
contributes substantially to early foetal death and congenital 
malformations (Purchase, 1979)- The major dominant and sex-linked 
genetic diseases (e.g. Huntingdon's chorea, muscular dystrophy) 
and the recessive disorders.(e.g. cystic fibrosis), in addition to 
those syndromes resulting from gross alteration in genetic material 
(e.g. Down’s syndfome) together form a significant health burden 
(Bridges, 1979). Although it is difficult to demonstrate unequivocally
that germ-cell mutation in man is caused by chemicals (Ames, 1979; 
Bridges, 1976), the possibility that recessive mutagenic disease 
may be passed on to future generations by the presence of excessive 
amounts of mutagens added to the environment, should not be ignored.
More emphasis has been placed on the effects of mutations within 
somatic cells. Much evidence (discussed below) has accumulated to 
suggest that cancer may result from somatic mutations. In addition 
it has been postulated that the processes of neuronal deterioration, 
diabetes and ageing may result from the accumulation of DNA damage, 
and the clonal origin of atherosclerotic plaques indicate that these 
may arise from somatic mutations within the vascular tissue (Ames,
1979; Bridges, 1976, 1979; Purchase, 1979; Sorsa, 1980).
Cancer is really a collective term for a group of diseases 
characterised by the unrestrained proliferation of somatic cells.
The currently popular somatic mutation theory of carcinogenesis 
suggests that cell transformation and subsequent tumour formation 
arises from DNA damage, which may in turn have occurred spontaneously 
(Lieberman, 1982) or through the action of radiation, viruses or 
chemical carcinogens, or combination of these (Weinstein, 1981b).
In addition to gene mutation, chromosomal structural rearrangements, 
activation of latent oncogenic viral genomes (Weinstein, -1981b) and 
transmissible alterations in gene regulation (Stott et al, 1981) 
may also be involved (see also Bridges 1976, 1979; Rubin, 1976; Sneider, 
1974). It has been argued (Weinstein, 1981b) that initiation of the 
carcinogenic process is unlikely to involve random point mutations, 
but to be due to the induction of gene rearrangements and/or alterations 
in the state of methylation of specific genes. This may result in the 
amplification of certain genes or the loss of various regulatory genes.
Table 1.1 contains evidence which has been advanced to support 
the somatic mutation theory, and the possible mechanisms of chemical 
carcinogenesis are summarized in Figure 1.1. This multistep process 
has arbitrarily been divided into several phases, initiation, 
promotion and progression (Pitot, Goldsworthy and Moran, 1981).
TABLE 1.1. EVIDENCE FOR THE SOMATIC MUTATION THEORY OF CANCER,
Detailed discussion of these points may be found in reviews by
Ames, 1976; Bridges, 1976, 1979; Miller, 1970; Miller and Miller,
19-81; Sneider, 1974; Sorsa, 1980.
1. MUTATION MAY ALTER CELL REGULATION, a characteristic of 
cancer cells.
2. MONOCLONAL ORIGIN OF MOST CANCERS, heritability and 
irreversibility of the defect.
3. LOW FREQUENCY OF OCCURRENCE of both mutagenicity and 
carcinogenicity.
4. NON-RANDOM CHROMOSOMAL CHANGES FREQUENTLY FOUND IN TUMOURS 
e.g. Philadelphia chromosome in chronic myeloid leukaemia.
3. THE ACTIVE FORMS OF MANY CARCINOGENS AND MUTAGENS ARE STRONG 
ELECTROPHILES capable of reacting with DNA.
6. CHEMICAL CARCINOGENS PRODUCE LESIONS IN DNA AND CHROMOSOMAL 
ABERRATIONS.
7. MOST CHEMICAL CARCINOGENS ARE MUTAGENS - there is a high 
correlation between the ability of chemicals to induce 
mutations and tumours.
8 . INDIVIDUALS/ORGANS WITH A LOW DNA REPAIR CAPACITY SHOW AN 
INCREASED CANCER INCIDENCE e.g. Xeroderma pigmentosum 
patients.
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FIGURE 1.1. POSSIBLE MECHANISMS OF CHEMICAL CARCINOGENESIS.
(Adapted from Lutz, 1979; Miller, 1970; Miller and Miller, 1981; 
and Stott et al 1981.
Initiation is a rapid and irreversible process, involving DNA 
damage and is without an apparent threshold, and furthermore 
the effects of initiating chemicals are additive. It appears 
that the persistence of chemically altered bases in the DNA 
and the fixation of errors by erroneous repair/replication of 
DNA are critical to the initiating process, hence its close 
relationship with somatic mutation. It is only during replication 
that DNA damage has serious consequences (Lieberman, 1982) and so 
the rate of cell division is extremely important in the fixation 
of mutations and subsequent cell transformation (Roberts, 1981). 
Promotion is an epigenetic event, providing favourable conditions 
for the selection and propagation of transformed cells, until they 
progress to a stage of being independent of normal cell control 
mechanisms (Miller and Miller, 1981). Promotion generally occurs 
over a long period of time and is largely reversible in the early 
stages, with an apparent threshold and maximum effect value (Pitot, 
Goldsv/orthy and Moran, 1981). The primary effect of most promoters 
is an alteration of cell surface membrane structure and function 
(V/einstein, 1981b), and particularly in the communication between 
cells, breaking down the regulation of neoplastic cells by 
surrounding normal cells (Williams, 1981) followed by a subsequent 
increase in mitotic*rate. Hyperplasia appears to be critical to 
promotional effects (Miller and Miller, 1981) and may explain 
the apparent carcinogenicity of hormones and irritants (Williams,
1981). It has been suggested that the hyperplastic response to 
recurrent cytotoxicity oould enhance the spontaneous mutation 
rate (Stott et ad., 1981). Promoters, such as the phorbol esters 
may be involved.in gene de-repression, especially of ’transforming 
genes', and can induce in normal cells the expression of several 
phenotypic traits characteristic of tumour cells, especially 
inhibition of terminal differentiation (Weinstein, 1981b). Damage 
to the endoplasmic reticulum may also be an important promoting 
factor, due to resultant effects on glycoprotein synthesis 
(Bridges, 1978; Parke and Ioannides, 1982). Progression of neoplasia 
is characterised by karyotypic alterations, which are associated
with increased growth, invasiveness , metastases and alterations 
in biochemical and morphological characteristics (Pitot, Goldsworthy 
and Moran, 1981). In these later stages, immune surveillance is 
an important protective measure against the establishment of a clone 
of malignantly transformed cells (Stoltz et al, 197*0.
Many chemicals are inert and must be metabolized to exert 
their effect (Guenther and Oesch, 1981), and so organ and species 
differences in carcinogenicity depend on the balance between 
activation and detoxification (Autrup, 1982; Parke and Ioannides,
1982). Chemicals of diverse structures can be metabolized to 
electrophilic reactive intermediates, the 'ultimate carcinogens’ 
(Miller, 1978; Miller and Miller, 1981), which can then bind to 
key nucleophilic macromolecules at the sites illustrated in Table 1.2. 
DNA is the most extensively bound and is likely to be the target of 
prime importance (Roberts, 1980), but this does not preclude the 
involvement of protein or RNA. However, chromosomal and nuclear 
proteins may to some extent protect the DNA, and the non-coding 
regions of DNA may effectively 'dilute' the result, although 
some DNA-DNA and DNA-protein cross-linking may occur in the 
presence of some chemicals (Green, 1979)* The binding of an 
electrophile to DNA occurs in competition with other nucleophilic 
sites, especially such scavenger molecules as glutathione.
Guanine is the most readily attacked DNA base (Lieberman, 1982) 
and more specifically, the alkylation of 0^ atoms of guanine 
may be critical to tumour initiation by alkylating agents (Miller 
and Miller, 1981; Roberts, 1981).
DNA repair processes are crucial in the modulation of 
mutagenic or carcinogenic effects, as enzymes may remove the 
chemically induced 'lesion' before (excision repair) or after 
(post-replication repair) DNA replication (i.e. before the lesion 
is fixed as a mutation) (Stott ejt al, 1981). It also appears 
that errors in this repair, possibly by an inducible error-prone 
DNA-repair enzyme system analogous to SOS repair observed in 
bacteria, may be responsible for the mutation rather than the 
initial chemically-induced mispairing of bases. These enzymes
Table 1.2. NUCLEOPHILIC SITES IN PROTEINS AND NUCLEIC ACIDS
(from DePierre and Ernster, 1978) 
Group Located in
S • methionine
S t  cysteine
Hi
histidine (N-1, N~3) 
guanine (N-7) 
adenine (N-1, N-3) 
cytidine (N-3)
tyrosine (C-3) 
guanine (C-8)
0*0 guanine (0-6)
repair most damaged bases, but occasionally insert incorrect base 
sequences at or near the sites of damage. However, the importance 
of these repair mechanisms may be inferred from the susceptibility 
of individuals, lacking one or another repair mechanism, to damage- 
induced cell-death, mutagenesis and neoplasia (Lieberman, 1981).
In addition, the susceptibility of different tissues to chemical 
carcinogens reflect their capacity to repair DNA. A fuller account 
of mammalian DNA repair mechanisms may be found elsewhere (Green,
1979; Lieberman, 1982; Roberts, 1980 and Sneider, 197*0.
Although the precise contribution of DNA damage to the 
complex process of neoplasia is not yet known, this index is still 
useful in providing tools to identify those chemicals with a potential 
of increasing cancer incidence. As such, short-term tests based on 
this endpoint have a place, not only in general safety evaluation 
but also in basic research into chemical activation.
The Ames Test 9
Uses and limitations.
The Ames test is the best established short-term test for 
carcinogenicity and there are now results for over 5>000 chemicals 
published (Maron and Ames, 1983? Purchase, 1982). It is a 
sensitive and simple assay, which utilises specially constructed 
strains of Salmonella typhimurium, which may be reverted specifically 
from a histidine requirement back to prototrophy by a wide variety 
of mutagens (both frameshift and base-pair substitution). Details 
of the mutations within these strains (Ames, McCann and Yamasaki, 
1973; Maron and Ames, 1983) and their properties are discussed 
in Chapter 2. The test is performed in Petri dishes, where the 
chemical, bacteria and usually an activating system (i.e. liver 
microsomes plus an NADPH-generating mechanism) are incubated 
together in a semi-solid agar medium, at 37°C. After two days, 
the number of colonies (revertants) on both test and control 
plates are counted. The inclusion of a trace amount of histidine 
in the agar allows the growth of a background confluent lawn of 
bacteria, as several divisions are often needed for mutagenesis 
to become evident (especially with frameshift mutagens) and also 
allows for any cytotoxic effects to be noted.
The Ames test provides a rapid and economical screen for 
potentially dangerous chemicals from both industrial and 
environmental sources (Purchase jet al, 1976). It is especially 
useful in the study of complex mixtures, such as cigarette smoke 
condensates (Kier, Yamasaki and Ames, 197*0, hair dyes (Ames,
Kammen and Yamasaki, 1975) and metabolites in the urine or faeces 
(Commoner, Vithayathil and Henry, 197*fj Durston and Ames, 197*0.
The Ames test is also useful as a tool towards understanding 
the mechanisms of activation of carcinogens and their reaction 
with DNA (Purchase, 1982). Some of the advantages that a 
bacterial detection system for mutagenicity offers include
(Ames ejt al, 1973)
(1) Prokaryotes have the same basic structure and function of 
their DNA as eukaryotes, although the latter is associated with 
histone proteins and is arranged in chromosomes.
(2) Bacteria are haploid, and so mutations will be expressed
(3) Bacteria have small genomes, so that fine genetic mapping
and biochemical analysis is possible.
(^ f) A large number of organisms may be exposed to a chemical
g
at one time (i.e. 3 x 10 bacteria on a single plate)
(5) Bacteria have a short generation time, allowing rapid 
detection of mutants.
(6 ) Some of the Ames tester strains lack excision repair 
mechanisms, which increase their sensitivity to most mutagens 
(McCann, Spingarn et, al, 1973)-
These points help to ensure that even if a mutagen acts
randomly it is likely to cause a measurable number of revertants, 
although these may only be a small fraction of the total mutants. 
Bacterial tests thus avoid the statistical problems associated 
with the use of a limited number of animals.
However, the mutagenicity of a chemical which is toxic to 
bacteria at low concentrations cannot be assessed. Similarly 
mutagens may be missed if they act at sites which are not 
represented in the series of tester-strain mutants used (Skopek 
et al, 1978). Framshift mutagens, in particular, seem to show 
preference for certain specific nucleotide sequences (Freese,
1971? Both, 197*0 and the tertiary structure of the DNA may also 
be important (Sneider, 197*+)- Chemicals acting at the chromosome 
level (affecting number or morphology), or those causing cancer 
by non-mutagenic mechanisms, especially those within the promoter 
bracket, cannot be identified in the Ames test (Stott et al, 1981).
For a short-term test for carcinogenicity to be useful, 
it must be able to detect a high proportion of carcinogens 
(sensitivity), whilst at the same time creating as few false 
positive results as possible (specificity), and, in addition, 
the limitations of classes of carcinogens that the test is 
able to identify must be well defined. These properties have 
been discussed in detail elsev/here (e.g. Bartsch jet al, 1980; 
Purchase, 1979 > 1980, 1982; Purchase et al, 1978). The Ames 
test has been extensively evaluated, and various studies have 
shown it to achieve between 70% and 93% accuracy in the 
prediction of carcinogenicity, or otherwise, of chemicals 
tested from a wide range of structures (e.g. Bartsch jet al,
1980; Maron and Ames, 1983; McCann and Ames, 1978; Purchase 
et al, 1978; Sugimura, 1982). The correlation between 
mutagenicity in the Ames test and carcinogenicity is largely 
dependent upon the choice of chemicals used in the comparison 
(Bartsch et_ al, 1980; Purchase, 1982) and also on variations 
in the details of the testing protocol (Purchase, 1980). There 
are certain groups of chemicals (e.g. polychlorinated pesticides) 
that the Ames test consistently fails to detect (Maron and Ames,
1983).
Ames (1978) suggests that these results indicate that most 
carcinogens are indeed mutagens, including known human carcinogens 
and that almost all mutagens which have been adequately tested 
are also carcinogens (Ames, McCann and Sawyer, 1978). It is 
possible to distinguish between closely related carcinogen/ 
non-carcinogen pairs, such as CC- andy# -naphthylamine, and 2- and
4-acetylaminofluorene, using the Ames test (McCann and Ames, 1976; 
Purchase, 1980; Purchase et al, 1976, 1978). Preliminary work 
has shown a reasonable quantitative correlation between mutagenici 
and carcinogenicity (Ames, 1979; Ames and Hooper, 1978), with 
both showing over 100 million fold range in chemical potency 
(Bartsch et al, 1980; McCann and Ames, 1977). However, although 
a qualitative relationship seems to be justified, this attempt at 
quantification has been critipised (Ashby and Styles, 1978a,b) on
the grounds of there being too many variables involved. Many studies 
have been carried out to establish the optimum conditions for the 
Ames test and some of these variables have been discussed (Bartsch 
et al, 1980; Belser et; al, 1981; Booth, Welch and Garner, 1980;
Grafe, Mattern and Green, 1981).
The Ames test will always produce a finite level of false 
positives and negatives, because of differences in enzyme levels and- 
activities, biological absorption and distribution, DNA and immuno­
logical repair mechanisms and so on, between the test system and the 
whole animal (Bridges, 1976; McCann and Ames, 1977; Purchase, 1980). 
Comparison with the“presently available animal data itself causes 
problems, as these are subject to considerable variation, not in the 
least being the quality of the experimental design. The definition 
of a non-carcinogen or weak carcinogen is very difficult with a 
limited number of animals, and extrapolation to m.an is hampered 
by the paucity of data produced by epidemiology (Bartsch ejt al, 1980). 
One of the variables, mentioned above, v/hich lends itself to further 
characterisation is a comparison of both qualitative and quantitative 
aspects of metabolic activation in vivo and in vitro, in a variety 
of species.
The activating system.
The most common activating system used in the Ames test is the 
9,000 g supernatant of a rat liver homogenate. This (generally known 
as the ’S9’ fraction) is buffered with appropriate salts and an 
NADPH-generating system in the ’ S9 mix’, which is then incorporated 
into the top agar with the bacteria and the chemical to be tested 
(Ames, McCann and Yamasaki, 1973)* Generally the animal is pretreated 
with Aroclor1254 to increase the levels of the mixed-function oxidase 
system (Maron and Ames, 1983)? although it has been suggested that 
a combined treatment of phenobarbitone and 3-^ethylcholanthrene is 
just as suitable in enhancing metabolic activation (Ong jet al, 1980). 
Alternative tissues of different animal species with various modes 
of pretreatment may be used as a source of S9, thus enabling a 
correlation to be expressed between their ability to activate and 
their susceptibility to a particular carcinogen (Ames and Hooper,
1978; Miller et_ al, 1980). The hamster, for example is far 
superior to the rat in activating nitrosamines (Bartsch ejt al,
1980). The S9 fractions to be used in Ames tests are stable to 
long-term storage at -80°C (Maron and Ames, 1983) and also once 
the S9 mix is incorporated into the test plates it remains 
active for at least two, and up to nine hours, due to the stabilizing 
influence of the agar (Ames, 1979)- Also, different carcinogens 
need different optimal amounts of S9 within the S9 mix (Bartsch 
et al, 1980). However, it is very rare, in general Ames mutagen­
icity testing, that the metabolic capacity of the S9 mix is 
measured and seldom thatjnore than one species is used. In 
chapters 3i 6 and 7? the activating system has been investigated 
in some detail with respect to species and sex differences and 
the effects of various inducers on the activation of armmatic 
amines, nitrosamines and polycyclic aromatic hydrocarbons.
The S9 fraction comprises both cytosolic and microsomal 
enzymes, and those which have been released from other components 
during cell disruption (e.g. lysosomes) and also from cells other 
than hepatocytes. The presence of high, non-physiological levels 
of NADPH in an oxygenated system tends to select for phase 1 
metabolism by the mixed-function oxidase system (discussed below).
A number of drug metabolizing enzymes, especially those responsible 
for Phase 2 (or conjugation) reactions, are unable to function due 
to lack of essential cofactors, whilst in vivo these may activate 
or detoxify the primary metabolites (Fry and Bridges, 1979). 
Conjugation reactions may result in further metabolic activation, 
such as the sulphation, acetylation, glucuronylation and 
glutathione conjugation of hydroxylamines and other compounds 
(Reichert, 1981). The S9 mix is generally weak at dehalogenation 
and demethylation reactions (McCann and Ames, 1976) and the test 
conditions do not normally allow for activation by reductive 
pathways, v/hich may occur, in vivo, in areas of low oxygen tension 
(Bridges, 1976; Fry and Bridges, 1979; Sweeney, 1981). However,
some effort has been made recently (Maron and Ames, 1983) to 
provide cofactors for Phase 2 reactions, such as sulphation, 
and also to incorporate riboflavin or FMN to support the reduction 
of azo bonds.
The Salmonella t.yphimurium strains themselves have no 
identifiable mixed-function oxidase system, but do have the ability 
to both enzymically and non-enzymically conjugate with glutathione 
(Meijer, DePierre and Pannug, 1980). They do, however, contain 
nitroreductases (Howard and Beland, 1982; Rosenkranz et al, 1982) 
which are important in the metabolic activation of nitro-containing 
compounds. For the metabolic activation of the majority of carcino­
gens in the Ames test, the mixed-function oxidase system is of 
prime importance and so this is now considered in some detail.
The Mixed-Function Oxidase System.
The metabolism of xenobiotic and endogenous compounds.
The mixed-function oxidase system has been subject to many 
recent, comprehensive reviews, to which the reader is referred 
for the more historical aspects of the discovery of its existence 
and functioning (e.g. Conney, 1982; Coon, 1981; Lu and West, 1978, 
1980; Paine, 1981).
The mixed-function oxidase system is well distributed within 
the phylogenetic tree, being found in bacteria, fungi, plants.,,., 
and all the different divisions of the animal kingdom so far 
studied (Testa, Jenner and Di Carlo, 1981). The mammalian 
system is of prime interest to this thesis and will be the subject 
of the principle discussions. However, in Chapter 8 , the mixed- 
function oxidase of plants and fungi will also be considered. It is 
a membrane-bound, multicomponent electron transport system found 
predominantly in the endoplasmic reticulum of the liver, which is 
where lipophilic compounds would tend to accumulate. It is also 
present in various extrahepatic tissues, especially the skin, 
gastrointestinal tract and lung (all of which interface with the 
environment) and the kidney, where differences have been found 
in the components of the mixed-function oxidase among the various 
tissues (Lu and West, 1978). Within the liver itself there is a 
heterogeneity in the distribution of the mixed-function oxidase, 
as indeed there is also with the oxygen tension and the activities 
of various conjugating enzymes (Redick et al, 1980; Sweeney, 1981). 
This probably contributes to the marked centrilobular necrosis 
associated with the intake of many toxic drugs (Ji, Lemasters 
and Thurman, 1981), and most of the mixed-function oxidase activity 
of the liver is associated with the parenchymal cells (DePierre and 
Ernster, 1978). In addition to the microsomes, the mixed-function 
oxidase system may also be found, to a lesser extent, in nuclear 
membranes (DePierre and Ernster, 1978; Patton _et al, 1980), nucleoli 
(Bresnick jet al, 1980) and mitochondrial membrane fractions (Jenner, 
Testa and DiCarlo, 1981; Pedick et al, 1980). The activity
in these subcellular compartments may contribute substantially 
to DNA damage (both nuclear and mitochondrial) due to the close 
proximity of production and reaction of active metabolites (Patton 
et al, 1980; Sum and Kasper, 1982).
The general reaction of the mixed-function oxidase system 
is the insertion of one atom of the oxygen into the substrate, 
while the other atom is reduced to produce water as expressed by 
the equation:-
NADPH + H+ + RCH^ + 02 ^  RCH20H + NADP+ + H20
As such, this enzyme system has a number of physiological 
functions (Conney, 1982; Lu and West, 1978). It is involved 
in the metabolism of steroids (Meijer and DePierre, 1981;
Pasleau jet al? 1981), thyroxine, biogenic - amides and indoles 
(Nebert jet al, 1981), lipid soluble vitamins (Jenner, Testa and 
DiCarlo, 1981), and the C O  and Go-1 hydroxylations of prostaglandins 
(Kupfer et_ al, 1980) and other fatty acids (Orton and Parker, 1982), 
and in the biosynthesis and metabolism of bile acids (Bostrom 
and Wikvall, 1982). The mixed-function oxidase system also 
metabolizes those lipid soluble components of the diet which are 
not required nutritionally and would otherwise accumulate to toxic 
levels v/ithin the fat deposits of the body. The substrate specificity 
of this enzyme system needs to be high v/ith respect to endobiotic 
metabolism, whilst for the metabolism of a wide variety of xeno- 
biotics to more polar derivatives, there needs to be a low 
substrate selectivity (Jenner, Testa and DiCarlo, 1981). This is 
achieved through the multiplicity of forms of the terminal 
oxygenase of the system, as described in more detail below. It 
is believed that the metabolism of endogenous compounds is achieved 
mainly by a form of the oxygenase called cytochrome P-448, especially 
when metabolism is in conformationally-hindered positions, as v/ith 
the steroids. It is probably fortuitous that this form also 
metabolizes such compounds as polycyclic aromatic hydrocarbons.
However (an) alternative isoenzyme(s), cytochrome(s) P-430, is/are 
believed to be involved mainly in the metabolism of xenobiotics,
and it is believed that this function may have developed from- 
endobiotic metabolism on an evolutionary scale (Jenner, Testa 
and DiCarlo, 1981).
Chemicals undergo biotransformation, (Phase 1) reactions, 
v/hich generally result in the introduction of groups v/hich make 
them available for the Phase 2 (conjugation) reactions. The 
products of the latter are usually more water soluble and 
readily excretable and include conjugates with glucuronide, 
sulphate, acetate, glycine, glutathione and methyl groups 
(Reichert, 1981). The types of biotransformation reactions 
catalysed by the mixed-function oxidase system (Nebert and Jensen, 
1979; Paine, 1981) include aliphatic oxidation, aromatic hydroxy- 
lation, N-, S- and O-dealkylation, oxidative deamination, 
epoxidation, sulphoxidation, desulphuration, dehalogenation 
and N-hydroxylation and oxidation. Reductive reactions may also 
be catalysed under the appropriate conditions. The pathway of 
metabolism will depend both on the chemical structure and on 
the isoenzyme of the terminal oxygenase of the system. Although 
such metabolic routes generally lead to detoxification, occasionally 
activation to a more toxic product occurs. Epoxidation, N-hydroxyl- 
ation and oxidative dealkylation are the pathv/ays v/hich most 
frequently yield highly reactive intermediates such as epoxides, 
hydroxylamines, quinone-imines, carbenes, free radicals etc.
These derivatives may be further metabolized, for example epoxides 
may be conjugated v/ith glutathione, or converted to dihydrodiols 
by epoxide hydratase, or they may bind to components of the 
metabolizing system itself, or to other macromolecules in the 
cell. Conjugation reactions also occasionally lead to activation 
(e.g. sulphation or glucuronylation of hydroxylamines; Reichert,
1981), and the balance betv/een the activation and detoxification 
reactions is essential to the toxicity of a chemical.
The components of the mixed-function oxidase system ♦
The study of the components and reaction mechanisms of the 
mixed-function oxidase system has mainly been achieved through 
the use of purified, reconstituted systems, which are described 
in some detail in Chapter 3*
The mixed-function oxidase system consists of NADPH-cytochrome 
P-430 reductase (a flavoprotein) and cytochrome P-430 (a haemo- 
protein), with dilauroyl phosphatidylcholine, cytochrome b,_ and 
NADH-cytochrome b^ reductase playing secondary roles in electron 
transport. In the mitochondrial, but not the microsomal system, 
an iron-sulphur protein, adrenodoxin and its reductase are also 
involved in the transfer of electrons between cytochrome P-430 
reductase and the haemoprotein (Lu and West, 1978; Masters jet al, 
1973). Cytochrome P-430 is a very hydrophobic protein (Waxman 
and Welch, 1982), and is normally deeply embedded within the 
membrane, while its reductase,has both hydrophobic regions 
v/ithin the membrane and hydrophilic areas on the cytoplasmic 
surface (Nebert et al 1981). The properties of the mixed-function 
oxidase system are altered by properties of lipids and proteins 
in the membrane, and especially by the composition and packing 
of the unsaturated fats. The fatty acid composition in the regions 
of cytochrome P-430 and its reductase tend to be unique within the 
membrane structure, and may also effect the solubility of the 
substrates (Gander and Mannering, 1980). The lipid (principally 
phosphatidylcholine) does not act as an electron carrier, but is 
involved in the interaction of the hydrophobic tail of the reductase 
with the cytochrome in such a way as to bring the haem and the 
reduced flavin into proper orientation near the surface of the 
membrane. This allows interaction with the NADPH and also for the 
substrate to gain access to the cytochrome P-430 via a hydrophobic 
pocket (Szutowski, 1980). Small changes in the association of the 
phospholipids and cytochrome P-430 could be evoked by diet, diurnal 
status and exposure to inducing chemicals etc.
Cytochrome b,_ also interacts with cytochrome P-430 via a 
hydrophobic tail region (Bendzko et al, 1982), and is not an 
obligatory component of the mixed function oxidase system. It 
does, however, have a synergistic effect on the metabolism of 
certain substrates and is believed to be involved in the donation 
of the second electron (see Figure 1.2), thus releasing more 
of the cytochrome P-430 reductase for the first electron transfer 
step. The NADH/b^/reductase system is involved in fatty acid 
desaturation (Bonfils, Balny and Maurel, 1981; Paine, 1981) as is 
also indicated in Figure 1.2.
The substrate specificity of the mixed-function oxidase 
system resides in the terminal oxygenase, cytochrome P-430. This 
haemoprotein has a tetrapyrrole prosthetic group, containing 
iron which is able to cycle between the ferrous and ferric state 
and may exist in a low or high spin configuration. Both the haem 
and the substrate binding site are at or near the surface of the 
protein (Dus, 1982a) and both are considered in Chapter 4.
Cytochrome P-430 has a vital role in both substrate binding and 
oxygen activation (see Figure 1.2), although the source of the 
reductase may have some influence on the overall rate of activity 
(Lu and West, 1978; Lu et al, 1972). NADPH-cytochrome P-430 
reductase is an unusual flavoprotein, which contains one molecule 
each of FAD (which accepts electrons from the NADPH) and FMN (which 
is involved in the electron transfer to cytochrome P-430) and there 
is rapid electron transfer between the two flavins (Oprian and 
Coon, 1982; Vermillion and Coon, 1974; Vermillion et al, 1981). 
Oxidized, partially reduced and fully reduced forms of both FAD 
and FMN exist in an equilibrium, which is dependent on the redox 
potential of the system and on the concentration of NADPH (Guengerich, 
1983).
The components of the mixed-function oxidase system have 
restricted mobility within the microsomal membrane, and there are 
10-20 molecules of cytochrome P-430 per reductase (Kamataki et al, 
1980), which may limit the maximum rate of electron transfer.
There could also be different interactions between the multiple 
forms of cytochrome P-430 and the reductase. The electrons may 
be transferred from the reductase to the haemoprotein via the 
porphyrin ring or through the hydrophobic pocket to the ligand 
on the haem iron (Gander and Mannering, 1980). The rate of 
interaction is a function of the concentration of the ferri- 
cytochrome P-430-substrate complex, the concentrations of the 
various reduced forms of the reductase and the mobilities of each 
of these within the membrane. Diffusion tends to be slow and 
the reductase is never saturated with its substrate (the 
ferricytochrome P-430-substrate complex) and also binds to other 
intermediate forms of the cytochrome P-430-substrate complex 
which arise during the overall cycle. Kinetic interpretation 
of the cycle is further complicated by the fact that the two 
electrons required in the overall reaction may be donated by not 
only the fully reduced, but also by one or more of the partially 
reduced forms of the reductase. Reduction of the ferricytochrome 
P-430-substrate complex is more rapid when the fully reduced 
FMN rather than the FMN semiquinone is the electron donor.
Kinetic interpretation of the mixed-function oxidase cycle has 
been comprehensively discussed by Gander and Mannering, 1980 
and it may'be concluded that it is probably not meaningful to 
try to assign a single rate-limiting step.
A proposed cytochrome P-430 cycle is shown in Figure 1.2 
and has been formulated from several reviews (see legend to 
figure). The precise nature of all the intermediates is not 
known and it is not clear exactly when the protons are taken 
up (White and Coon, '1980). The active form of oxygen involved 
in substrate oxygenation may be an oxenoid species or other 
resonance structure involving higher oxidation states of iron 
(Nebert and Jensen, 1979). The porphyrin n electron system 
and the thiolate ligand on the iron may be important in 
stabilization of the activated oxygen (White and Coon, 1980). 
These mechanistic details are discussed further in Chapter 8 , 
where they are compared to chemical models for cytochrome P-430.
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Hydroxylation (oxygenase function) and hydrogen peroxide production 
(oxidase function) are known to compete, and various substrates 
which affect the efficacy of the transfer of the second electron 
are known to enhance production (Paine, 1981). The cytochrome
P-4.50 cycle can catalyse the production of a variety of active 
oxygen species, including superoxide (CLy ) and hydrogen peroxide 
(HpO^), and also hydroxyl species (OH* and OH ) and singlet 
oxygen ('0^) derived from the interaction of these two inter­
mediates (Paine, 1981). Superoxide may also arise from an inter­
action of the reduced reductase and oxygen. It has been suggested 
(Archakov et al, 1980)_ that this reductase-generated 0^* could 
reduce cytochromes P~^ -50> b,_ and c in an alternative mechanism 
to direct electron transfer. Cytochrome P-A^O-catalysed hydroxy­
lation reactions can also be supported by a variety of peroxy 
compounds (e.g. cumene hydroperoxide)., which is known as its 
peroxygenase function (Coon, 1981; White and Coon, 1980). This 
can occur in the absence of NADPH and reductase, although it is not 
certain whether peroxides would act as oxygen donors under physio­
logical conditions.
Multiple forms of cytochrome P~^50»
The rate of metabolism of chemicals by the mixed-function 
oxidase system depends on many factors. These include the 
species and strain, the age, sex and conditions of pretreatment 
of the animal, and the tissue from which the metabolizing system 
is derived. Diet and nutritional status (i.e. vitamin or 
protein deficiency, the levels of unsaturated fatty acids and 
non-nutrients such as flavones) all affect the activity (Basu 
and Dickerson, 197^; Conney, 1982; Ioannides and Parke, 1979;
Paine, 1981). Cytochrome P-A^O levels can also be affected by 
various disease states, such as hyperthyroidism (Leakey e_fc al,
1982), viral infection and subsequent interferon production 
(Singh and Denton, 1981), and as a result of altered rates of 
haem synthesis and breakdown as occurs in diabetic and tumour- 
bearing animals (Berk, Dedmon and Ouellette, 1982). The
developmental changes in the mixed-function oxidase system have 
been well-studied, and cytochrome P-AjjO levels tend to be low in 
foetal and neonatal livers and activities toward different 
substrates peak at different ages (Paine, 1981; Pasleau et al,
1981; Rikans and Notley, 1982). All activities tend to decrease 
in old age (Schmucker and V/ang, 1982). Differences in the 
components of the mixed-function oxidase system (particularly 
in the cytochromes P-V?0) have been demonstrated in different 
tissues from the same animal (Lu and West, 1978) and in different 
strains and species (Guengerich, 1979; Guengerich _et al, 1982) 
due to their range of substrate specificity and most particularly 
as a result of purification and reconstitution of the components.
In addition, various species and tissues respond differently to 
inducing chemicals (Paine, 1981), and inducibility is also 
dependent upon age and sex (Gontovnick and Bellward, 1980;
Schmucker and Wang, 1982). Many studies in rats have shown 
considerable sex differences in metabolism by this species 
(Kremers et al, 1981). This is believed to depend upon the 
balance of male and female sex hormones, with some involvement 
of the hypothalamo-pituitary axis and cortisone (Paine, 1981;
Pasleau et_ al, 1981; Vodicnik et, al, 1981). The adult male 
rat generally has a higher ability to metabolize most substrates 
than the female, but this sex difference is not so clear-cut in 
other species. There are differences in both phospholipid 
metabolism (Rikans and Notley, 1982) and also slight variations 
in the electron transport from the reductase (Kitada et; al,
1980) between male and female rats. However, it appears that 
the major difference can be accounted for by the presence of 
electrophoretically,'immunologically, catalytically and spectrally 
distinguishable cytochromes P-A50 in the two sexes (Kato and Kamataki, 
1982; Chao and Chung, 1982; Kamataki ejt al, 1982).
Many studies, such as these and others (as reviewed by Conney,
1980, 1982; Guengerich, 1979; Guengerich _et al, 1982; Lu and West,
1980; Ryan et al, 1982) have suggested that multiple forms of
cytochrome P-A^O exist with differing but overlapping substrate
specificities (Paine, 1981). The evidence which has been put 
forward to substantiate this claim is summarized in Table 1.3* 
Although the initial studies involved the metabolism of various 
substrates by microsomal preparations, clarification of the 
heterogeneity was dependent on the purification and characterization 
of the constituent cytochromes P-VpO. These retained their 
substrate specificity and other properties on reconstitution 
with reductase and lipid (Lu and West, 1980). Although substrate 
specificity and spectral changes could be accounted for to some 
extent, by conformational changes or ligand binding, these cannot 
explain the large differences in molecular weight shown on SDS- 
polyacrylamide gel electrophoresis, or the marked diversity in 
amino acid composition between the various forms. The immunological 
differences also cannot be accounted for by variations in carbo­
hydrate moieties, which in addition to the previous two points 
indicate that the multiple forms of cytochrome P-A30 are indeed iso­
enzymes arising as separate gene products. There is also some 
evidence for post-translational modifications, for example in the 
microheterogeneity of the cytochromes P-A50 from phenobarbitone- 
induced rats (Waxman and Walch, 1982), which may be due to glyco- 
sylation and/or phosphorylation (Ryan et al, 1982). There are 
also believed to be multiple forms of cytochrome P-AA8 (Thorgeirsson. 
et al, 1979) from both/3 -naphthoflavone- (Lau and Strobel, 1982) and 
3-methylcholanthrene- (Wolf and Oesch, 1983) induced animals, 
although there is some identity between the cytochromes P-A48 
induced by both chemicals (Lau et al, 1982).
Studies with purified cytochromes P-A30 have indicated not 
only multiple forms v/ithin a particular species, but also very 
little cross-reactivity between the different forms in different 
species (Dus, 1982b; Guengerich, 1979; Lu and V/est, 1980).
Nebert's group (Nebert and Negishi, 1982; Nebert et al, 1981) 
have drawn up comparisons of the various cytochromes P-A50 from 
both control and induced animals and have shown some equivalence 
between certain forms. It is difficult to estimate exactly 
how many forms of cytochrome P-A30 there are, because of the lack
TABLE 1.5. EVIDENCE BOR MULTIPLE FORMS OF CYTOCHROME P-45Q.
Drawn from reviews by Conney,l980, 1982; Guengerich,1979j Guengerich
et al. 1982; Lu and West,1980; Ryan et al.1982.
1. MULTIPHASIC KINETIC PLOTS FOR SOME SUBSTRATES, suggesting the 
involvement of several cytochromes of different affinities.
2. DEVELOPMENT OF DIFFERENT ACTIVITIES DURING MATURATION.
3. DIFFERENTIAL EFFECTS OE INDUCERS AND INHIBITORS on. various 
substrates, and the regio- and stereo- specificity of hydrox- 
ylation.
4. " VARIATIONS 'IN THE ETHYLISOCYANIDE AND REDUCED - CO SPECTRA,
distinguish cytochromes from different sources.
5. MULTIPLE BANDS ON SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS 
i.e. different molecular weights and isoelectric points.*
6. IMMUNOLOGICAL DIFFERENCES i.e. differences in .cross-react­
ivity with antibodies.
7. DIVERSITY OF AMINO ACID COMPOSITION AND TERMINAL SEQUENCES 
and differences in peptide mapping after limited proteolytic 
or chemical digestion.
* Recent developments in HP10 have allowed separation of cytochromes 
P-450 of similar molecular weights, but different net charges (Ban- 
sal, Love and Gurtoo, 1983).
of a uniform system of nomenclature and the alternative methods of pur­
ification. Also, although the major forms from induced animals have 
"been well studied (Lu ejt al, 1980), relatively few of the species from 
control animals have been investigated in detail (Lu and West, 1980; 
Picket et al, 1981). It has been suggested (Nebert and Negishi, 1982) 
that.the multiplicity of the cytochrome P-450 system may be similar to 
that of the immunoglobulins, where variable and constant regions are 
recombined. There is some evidence to support this suggestion in studies 
on the mRNA's coding for two phenobarbitone - induced cytochromes P-450 
in the rat (Fujii-Kuriyama et al, 1982). However, peptide mapping has 
suggested greater differences in the isoenzymes, although techniques 
are not yet sensitive enough to detect minor alterations (Lu and West,
1980). Certain regions of the protein, such as the haem and substrate 
binding sites are likely to be conserved (Dus, 1982). Final clarification 
awaits further research at both the gene and the protein level and 
studies on both mRNA and protein processing.
Induction and inhibition of cytochrome P-450.
In the previous section it was mentioned that multiple forms of 
cytochrome P-450 are induced by different chemicals. There are two class­
ical groups of mixed-function oxidase inducers, those slowly metabolized 
drugs of diverse structure (Conney, 1982) which increase the levels of 
(a) low spin form(s) of the cytochrome (P-450 in rats, LM2 in rabbits), 
and the polycyclic aromatic hydrocarbons which induce (a) high spin 
form(s) of the cytochrome (P-448 or LM^) (Lu and West, 1978). The disti­
nction between these two major groups is considered in some detail in 
Chapters 3 and 4» with respect to substrate binding and specificity, 
and spectral properties. Cytochrome P-450 inducers (such as phenobarb- 
itone) tend to increase the levels of other enzymes, particularly the 
NADPH-cytochrome P-450 reductase, while cytochrome P-448 inducers are 
more selective in their effect, with only marginal effects on microsomal 
proteins and liver weight (Paine,1981). Both types of inducer have been 
shown to change the lipid content of the microsomes, which may be imp­
ortant in the expression of enzyme activity (Davison- & Wills,1974? Stern
Originally, there was some controversy over the nature of 
cytochrome P-AA8, with some believing it to be simply cytochrome 
P-4-.50, with the inducer bound at the type 1 substrate site (Hashimoto 
and Imai, 1976). There has been some contradictory evidence as 
to whether cytochrome P-AA8 can be produced in the absence of 
protein synthesis. A conversion of cytochrome P-A50 to P-AA8 
has been shown to occur very rapidly in vivo even in the presence 
of protein synthesis inhibitors and also in vitro, suggesting 
that membrane alteration, activation or other post-translational 
mechanisms could be responsible for the change in spectral and 
catalytic properties (Lu and West, 198O; Parke, 1975; Stern 
et al, 1975). However, de novo synthesis has been demonstrated 
by the blocking of the increase in cytochrome P-AA8 after 
3-methylcholanthrene administration by the transcription 
inhibitor, actinomycin D (Alvares, Bickers and Kappas, 1973)• 
Additionally, as the simultaneous administration of phenobarbitone 
and 3-methylcholanthrene has an additive effect on enzyme activity 
(Bidleman and Mannering, 1970), this suggests an independent 
control of the synthesis of cytochromes P-A50 and P-448. Indeed, 
studies on the mechanisms of induction have shown that these 
cytochromes are under completely different genetic control, and 
both involve DNA-dependent RNA synthesis and protein synthesis 
(Paine, 1981).
Nebert's group have studied the polycyclic aromatic 
hydrocarbon-inducibility in some detail, using responsive and 
non-responsive strains of mice. The ability of these mice to 
respond to this type of induction depends very much on a 
single autosomal dominant trait at the Ah locus (Nebert, 1979)*
This requires the presence of a cytosolic receptor, which 
interacts with high affinity to the inducing chemical (particularly 
planar polycycles such as 3-methylcholanthrene). The receptor- 
inducer complex subsequently interacts v/ith nuclear components, 
possibly at a sensor gene which then releases an activator 
message v/hich interacts with acceptor sites on the structural 
genes (Gonzalez and Kasper, 1982; Nebert et al, 1981). This
results in an increased transcription of messenger RNA's for as 
many as 15 distinct forms of cytochrome (Lu and West, 1980) and 
for at least 24- different activities (Nebert et al, 1981). This 
is illustrated in Figure 1.3i and it is believed that temporal 
genes are involved in the developmental changes in inducibility 
of various activities, possibly through the blocking of acceptor 
sites (Nebert and Jensen, 1979; Nebert et. al 1981). There is 
evidence for a similar cytosolic ’Ah' receptor in rats (Nebert 
et al, 1981) and some evidence for a heritable variation in one 
of the induced activities (aryl hydrocarbon hydroxylase) in man 
(Nebert and Jensen, 1979).
However, even in the absence of such receptors, mice are able 
to respond to the drug-type inducers. No receptor for phenobarbital 
has yet been described (Lechner et al, 1982), but administration 
of this chemical leads to general liver hypertrophy and an increase 
in the messenger RNA's for cytochrome P-A50, NADPH-cytochrome 
P-450 reductase and epoxide hydratase. The gene remains transcrip­
tionally active for far longer for the haemoprotein, compared to 
*
the other two enzymes which are transcribed by a single burst of 
activity of the RNA polymerase (Hardwick, Gonzalez and Kasper,
1983). There is also an increased ribosomal RNA synthesis in 
response to phenobarbitone administration (Parke, 1975). There 
is some evidence (Lechner et al, 1982) that the increase in mRNA 
synthesis only occurs after chronic administration of phenobarbitone, 
and that the effects of more acute administration are at the post- 
transcriptional level. There is certainly a stabilization of mRNA 
through lowered ribonuclease activity, an increased pre-mRNA 
processing and a more rapid movement of mRNA from ribonucleoprotein 
stores to bound polysomes (Lechner et al, 1982; Parke, 1975). 
Certainly, after phenobarbitone treatment, the endoplasmic reticulum 
membranes bind polysomes better, probably due to the altered 
phospholipid : cholesterol ratios (Lechner et al, 1982; Parke, 1975), 
and the general protein synthetic capacity of the cell is enhanced 
(Phillips et al, 1981). It is believed that the increase .in cyto-
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chrome P-4-50 reductase activity in response to phenobarbitone is 
due to a combination of increased synthesis and decreased breakdown 
(Paine, 1981). It is not known how many diverse chemical structures 
can induce cytochrome P-4-30 and it has been suggested that a common 
endogenous inducer could be involved. One such theory is that in­
ducers are poor acceptors of the active oxygen from the cytochrome 
and thus, through uncoupling the cycle, lead to the release of 
active oxygen forms such as *0^. This then results in the peroxi­
dation of lipids, whose levels are maintained as the inducer 
competes with their metabolism, and it is these lipid peroxides 
that are believed to be the endogenous inducer (Paine, 1978). The 
main properties of cytochrome P-4-50 inducers are that they bind to 
this haemoprotein and are slowly eliminated (ioannides and Parke, 
1979)- Compounds which form stable ligand complexes with 
cytochrome P-4-50 (such as safrole) are also good inducers, and 
there is often an inhibitory phase before induction occurs (Parke,
1979).
The raised levels of mRNA after administration of polycyclic 
aromatic hydrocarbons (e.g. 3-methylcholanthrene) are more clearly 
due to increased hepatic nuclear RNA polymerase activity, due 
to increased chromatin template activity (Parke, 1973)- It is 
the raised levels of mRNA which can account for the induced levels 
of protein for both cytochrome P-4-48 and glutathione transferase B 
in response to 3-methylcholanthrene (Picket et al, 1982). Indeed, 
this inducer has been shown to raise the levels of cytochrome 
P-448 mRNA for up to 48 hours after a single administration 
(Bresnick et al, 1981) and then continued protein synthesis is 
required to maintain.induction (De Pierre and Ernster, 1978).
Many different tissues respond to the polycyclic aromatic hydro­
carbon-type inducers with raised cytochrome P-448 levels, while 
phenobarbitone-induction occurs more specifically in the liver 
(Paine, 1981)•
As cytochromes P-4-50 and P-448 are haemoproteins, protein 
synthesis must be accompanied by raised haem synthesis in the 
mitochondria for the haloenzyme to be produced. The rate-limiting 
step of haem biosynthesis (6 -aminolaevulinic acid synthetase) is 
induced at an earlier stage to the appearance of raised cytochrome 
P-4-50 levels, and it is believed that haem biosynthesis is 
not the rate-limiting step in the synthesis of this haemoprotein 
(Paine, 1981). However, as more cytochrome P-4-50 can be measured 
immunologically than spectrally, it is possible the insertion of 
the haem into the apoenzyme is the slowest process (Guengerich _et al,
1982). Cytochrome P-4-50 is synthesised_ on the rough endoplasmic 
reticulum, possibly that in association with the mitochondria 
(which would facilitate haem insertion) and then travels to the 
Golgi body where it is probably glycosylated (Cooper et. al, 1981).
The cytochrome may diffuse in the endoplasmic reticulum membrane 
or within the cisternae, and some of the haemoprotein is transferred 
back to the nuclear membrane. This latter process appears to be
more extensive for cytochrome P-448 than P-450, as phenobarbitone
does not result in significant induction in nuclear envelopes 
(Gonzalez and Kasper, 1981). After phenobarbitone induction,
activities return to control values at about 5 days, and this
involves the degradation of large pieGes of endoplasmic reticulum 
by autophagic vacuoles. Conversely, after 3-roethylcholanthrene 
administration, where there has not been a general hypertrophy 
of the endoplasmic reticulum, only specific proteins are removed 
from the membrane and it takes much longer for the activity to 
return to normal (DePierre, Lundqvist and Ernster, 1982).
It is clear that much further work is needed to clarify 
the mechanisms of induction of the various forms of cytochrome 
P-450 and the following points need to be considered (Guengerich 
et al, 1982): (1) a single inducer may induce more than one form 
of the cytochrome; (2) the same isoenzyme can be induced by 
different chemicals; and (3 ) induction of one form may be 
associated v/ith repression of another. It should also be 
remembered that the forms of induced cytochrome, discussed above, 
only represent a small percentage of the cytochromes found in a
control liver, although cytochrome P-4-50 in phenobarbitone-induced 
animals represents about 60% and cytochrome P-448 (3-methylchol- 
anthrene-induced) about 9CP/o of the total cytochromes P-450 in the 
appropriate liver preparations. The differential effect of 
inducers in different tissues, with regard to both the organ 
specificity and the time-course of effect do suggest that there 
are different control mechanisms, especially as extrahepatic 
tissues are not very responsive to phenobarbitone (Kluwe and Hook,
1981).
Another group of inducers are the polychlorinated biphenyls 
(for example, Aroclor 1254-, which is a mixture of 18 congeners), 
and these have a similar effect to combined phenobarbitone and 
3-methylcholanthrene administration (Alvares, Bickers and Kappas, 
1973). When the polychlorinated biphenyls are resolved into their 
constituent isomers, some are shown to have cytochrome P-4-50- and 
others cytochrome P-448-inducing effect (Goldstein et al, 1981). 
This is dependent on their structure and the 3-methylcholanthrene~ 
type isomers bind to the cytosolic ’Ah' receptor and are 
planar, rectangular structures. The potency of the phenobarbitone- 
type inducers, on the other hand, is inversely related to their 
rate of metabolism, and so this group includes the more highly 
chlorinated derivatives (Goldstein et_ al, 1981). Some of the 
asymmetrical isomers may be true mixed inducers, while others 
appear to have no inductive effect at all (Parkinson _et al,
1980). Aroclor 1254- alters DNA, RNA and protein synthesis and 
also induces glutathione S-transferase and UDP-glucuronyl 
transferase (Ecobichon and Comeau , 1974-). This type of induction 
is commonly used when preparing S9 fractions from rats to be 
used in general mutagenesis screening in the Ames test (Ames,
McCann and Yamasaki, 1975)* This is believed to be a useful 
preparation for the metabolism of a wide variety of substrates, 
although it provides a complicated mixture of activating and 
detoxifying pathways through the different isoenzymes induced.
Although Aroclor-induced S9 has been used in some of the studies 
presented in this thesis, as a comparison, generally the more 
specific inducers, phenobarbitone and 3“methylcholanthrene have 
been used to investigate the involvement of cytochromes P-4-50 
and P-448 in the activation of carcinogens. In addition, 
specific inhibitors of these cytochromes have been used to 
minimize the contamination of the preparations with alternative 
isoenzymes (see Chapters 5i 6 and 7)-
Mixed-function oxidase inhibitors have been discussed in some 
detail in the comprehensive review by Testa and Jenner, 1981. They 
may act directly or indirectly and may be reversible or 
irreversible, i.e. they can compete with the substrate and/or 
interfere v/ith reduction of the cytochrome or the transfer of 
active oxygen to the substrate, while other compounds result; 
in complete destruction of the haemoprotein (Pedemonte ejt al,
1981). Many chemicals have a biphasic effect in that the inhibitory 
phase is followed by an inductive phase, and most compounds are 
very specific for the isoenzymes they inhibit and may even activate 
an alternative form (Pedemonte et al, 1981; Testa and Jenner, 1981). 
Inhibition of cytochrome P-448 by nitrogen heterocycles depends on 
the polycyclic size of the chemical, v/hile, conversely, the 
inhibition of cytochrome P-450 is dependent upon the hydrophobicity 
which suggests that their catalytic sites are structurally 
different (Little and Ryan, 1982). Further, discussion of these 
points may be found in Chapters 5 and 4, and particularly with 
regard to the cytochrome P-448 inhibitor, 9-hydroxyellipticine.
Activation of carcinogens by other enzymes.
Although the mixed-function oxidase is of prime importance in 
the activation of carcinogens, other enzymes may also be involved.
As has already been mentioned in previous sections, the Phase 2 
conjugation reactions may also lead to further activation 
(Reichert, 1981), and many of these enzymes are also subject to
induction. Epoxide hydr.olase, glucur-onyl transferase and 
glutathione transferase are all induced by phenobarbitone in 
microsomes, but not in nuclear envelopes, and the latter two 
enzymes may also be induced by 3-niethylcholanthrene (^e Pierre 
and Ernster, 1978; Gonzalez and Kasper, 1982; Lilienblum, V/alli 
and Bock, 1982). Epoxide hydrolase is found not only in microsomes, 
where it interacts with cytochrome P-448 to a greater extent than 
cytochrome P-450, but is also present in a cytosolic form 
(Guengerich and Davidson, 1982). Also, many structurally 
diverse carcinogens tend to raise the levels of epoxide hydrolase, 
which was initially known as the 'preneoplastic._. antigen’
(Dent and Graichen, 1982). Glutathione transferases not only 
have an important function in trapping strong electrophiles 
and making them more v/ater soluble, but also bind other ligands 
and so have a transport function (Grover, 1982).
Other enzymes and haemoproteins beside cytochrome P-450 have 
been shown to metabolize xenobiotics in the presence of NADPH,
H^O^ and organic peroxides (as reviewed by Mason and Chignall,
1982). Examples include ferredoxin reductase (Belvedore et al,
1982), horseradish peroxidase (Griffin et al, 198O; Sinha, 1981), 
catalase (Mason and Chignall, 1982), xanthine oxidase (Howard and 
Beland, 1982) and prostaglandin endoperoxide synthetase (Eling et 
al, 1983). In the absence of oxygen, xanthine oxidase can act 
as a nitroreductase and thus could activate nitro-aromatic compounds 
(Howard and Beland, 1982). Free radical mechanisms (reviewed by 
Mason et al, 1982) are important in the metabolic activation 
of chemicals by many of the enzymes mentioned above. Furthermore, 
one electron transfer may occur from NADPH-cytochrome P-450 reductase 
to quinones, resulting in semiquinone formation from, for example, 
antineoplastic drugs (Kharasch and Novak, 1981). In fact, DNA 
damage may result from the active oxygen species produced by the 
redox cycling of radicals arising from certain carcinogens, such as 
the nitroxide radicals formed from aromatic amines (Stier et al, 
1980).
It is clearly too simplistic only to consider the mixed-function 
oxidase system in the activation of carcinogens, and so in the 
appropriate chapters other enzymes (and non-enzymic activating 
systems) have also been investigated.
C H A P T E R
CHAPTER 2. MATERIALS AND METHODS .
This chapter encompasses all the methods generally used through­
out this project, and will continually be used as a source of reference 
for future chapters. However, where specific methods, or variations 
of these methods are used in conjunction with a particular experiment, 
these are detailed in the appropriate chapter.
MATERIALS .
All reagents, with the exception of those specifically noted 
below, including substrates, cofactors, standards etc. were 
purchased from Sigma, Poole, Dorset. The cytochrome c was from 
horse heart (Type III) and the glucose-6-phosphate dehydrogenase 
was from Bakers Yeast (Type VII). The following chemicals were 
supplied by alternative sources
Phenobarbitone, hexobarbitone, aniline hydrochloride, p-amino- 
phenol, biphenyl and its hydroxy derivatives and organic solvents 
were purchased from BDH, Poole, Dorset; perhydrofluorene, 1-phenyl 
hexane (Aldrich Chemical Co., Milwaukee, V/I, USA); resorufin and 
ethoxyresorufin (Pierce Chemicals, Rockford, I.L, USA); acetylacetone 
(Fisons Scientific Apparatus, Loughborough, Leics.); safrole 
(Hopkin and Williams, Chadwell Heath, Essex); actinomycin D 
(Boehringer Mannheim GmbH, FRG); ethylmorphine (May and Baker,
Dagenham, Essex).
The Chemical Repository, National Cancer Institute, Bethesda,
MD, USA kindly supplied the 3**hydroxybenzo(a)pyrene, while the 
9-hydroxyellipticine was kindly donated by Dr. P. Lesca, Iaboratoire 
de Pharmacologie et de Toxicologie, Fondementale du CNRS, Toulouse, 
France. Benzphetamine and Aroclor 125^ - were the generous gifts of 
Upjohn Co., Kalamazoo,-MI, USA and Monsanto Co., St. Louis, MD,
USA, respectively.
The carcinogens were purchased from the following suppliers:-
Benzo(a)pyrene, dibenzo(a,i)pyrene, benz(a)anthracene, aibenz(a,c)- 
anthracene, dibenz(a,h)anthracene, 7,12-dimethylbenzanthracene, 
3-methylcholanthrene, 2-naphthylamine, A-aminobiphenyl, benzidine and 
all the nitrosamine derivatives (Sigma, Poole, Dorset); 9j10-dimethyl- 
anthracene, 2-acetylaminofluorene, 2-aminoanthracene (Ralph N. Emanuel 
Ltd., V/embley); 2-aminofluorene, k-aminoazobenzene (Aldrich Chemical 
Co. Ltd., Gillingham, Dorset) and dimethyl,A-aminoazobenzene 
(BDH, Poole, Dorset).
Plastic disposable tubes (Sterilin, Teddington, Middlesex) and 
ready-poured agar plates (Vogel-Bonner ’ E* plates from Gibco Biocult, 
Paisley, Scotland were regularly used in the Ames test. This was 
always carried out in the confines of an Intermed Microflow Pathfinder 
air-flow chamber and plastic disposable (Microtouch) gloves were worn 
for handling bacteria/carcinogens. Oxoid No. 2 nutrient broth was 
used for culturing and diluting the Salmonella strains, while Difco- 
Bacto nutrient agar was used in the top agar. Filter sterilization 
of solutions was achieved through Millipore Swinnex filters with 
OUjyU. pore).
ANIMALS.
In general male animals have been used, unless specifically stated 
otherwise. Wistar albino rats (l$0-200g) and CD1 mice (30-A0g) were 
supplied by the Animal Breeding Unit, University of Surrey and 
Golden Syrian hamsters were supplied by Wrights of Essex.
The animals v/ere kept in constant environmental conditions of 
50% humidity, at 21°C with an automatic 12 hour light/dark cycle.
They were allowed water and food (Spratts Laboratory Animal Diet 
No. 1, Lillico, l/onham Mill, Surrey) ad libitum.
Freshly slaughtered pig liver was obtained from a local abattoir, 
while frozen samples of human liver v/ere supplied by Dr. Ph. Baune, 
Faculte de Medicine, Hopital Necker-Enfants Malades, Paris, France.
The human liver samples were examined histologically and found 
to be free from overt signs of hepatitis,but were still handled with 
extreme care to minimize the risk of infection by latent hepatitis • 
viruses.
METHODS.
Pretreatment of Animals.
Induction of liver microsomal enzymes was achieved by intra- 
peritoneal administration of either phenobarbitone (So mg/kg body 
weight in 0.9% saline), 3-methylcholanthrene (20 mg/kg body weight 
in corn oil) or Aroclor 1254 (500 mg/kg in oil) daily for 3 days. 
Animals v/ere killed 24 hours after the last administration.
Inhibition 111 vivo of cytochrome P-448 activity v/as achieved 
by dosing the animals (i.p) v/ith 9-hydroxyellipticine (20 mg As 
body weight in corn oil) 1 hour before death.
In all cases control animals received an equivalent volume of 
vehicle by the same route.
Preparation of the S9 Fraction and Microsomes.
All the solutions and glassv/are were sterile and pre-chilled 
to 4°C. Care was taken to minimize contamination at all stages 
when preparing subcellular fractions for use in the Ames test.
The laboratory animals v/ere killed by cervical dislocation, 
and swabbed v/ith alcohol before mid-line abdominal scission. Livers 
v/ere excised into 1.15/6 KC1, rinsed of blood, blotted dry and trans­
ferred to preweighed beakers containing a suitable volume of '1.15% KC1. 
They were, scissor-minced and then homogenized using three complete 
strokes in a Potter-Elvehjem homogenizer (size C, Arthur H. Thomas 
Co., PA, USA). The fibrous nature of pig and human liver necessitated 
the use of a Polytron homogenizer. The human liver was processed 
within the confines of a closed cabinet in a restricted laboratory, 
because of the hazard of virus-contaminated aerosol, and all equipment 
which came in contact with the human tissue was afterwards soaked in 
5% hypochlorite for at least 12 hours.
The homogenate volume was adjusted v/ith 1.15% KC1 to give 4 ml 
per g liver (wet weight) and was centrifuged at 9?000 g for 10 minutes 
in a refrigerated MSE18 centrifuge. The post-mitochondrial supernatant 
(S9) was either used fresh (within a few hours, kept on ice) or 
distributed into 2 ml aliquots, frozen and stored at -80°C. As stored 
S9 samples were required, they v/ere thawed on ice, and any unused 
portion discarded at the end of the day.
Microsomes were prepared from the S9 fractions by centrifuging 
aliquots for a further 45 min. at 105,000 g in a Beckman L5-65 
refrigerated ultracentrifuge. For the study of spectral interactions, 
microsomes were v/ashed by resuspending them in a stabilizing buffer 
(50 mM phosphate, pH 7.4, containing 20% glycerol and 1 mM EDTA) 
and they were centrifuged again as before in order to eliminate 
haemoglobin contamination.
The microsomal pellet was either resuspended immediately, or 
after overnight storage in a refrigerator, by a single stroke of 
a Potter homogenizer (size B) in the original volume of 1.15% KC1.
Once resuspended in this medium, the microsomes were used immediately, 
as their activity deteriorated rapidly. Most of the enzyme activities 
stored well as S9 (at -80°C), while certain activities (e.g. 
biphenyl hydroxylation) kept better if stored as 10096 microsomes 
(i.e. 1 ml per g liver) in the stabilizing buffer, mentioned above 
(Dr. P. M. M. Godden, personal communication).
Enzyme Assays.
All the assays . were carried out at least in duplicate. 
Protein determination.
The protein concentrations of suitably diluted samples of 
both the 25% S9 (dil. 1 : 500) and microsomal (dil. 1 : 100) 
preparations were estimated by the method of Lowry e_t al, 1951-
The principles and practical technique for this assay have 
been fully documented elsewhere (C. E. Phillipson, M.Sc. Thesis, 
1980).
Spectral assays for cytochromes P-450 and b^ «
These assays are based on the observations of Omura and Sato, 
1964. The cytochrome b^ content of microsomes can be estimated 
from the difference spectrum (peak at 426 nm, trough at 410 nm) 
produced by reducing the cytochrome b,_ only in the sample cuvette 
v/ith NADH in aerobic conditions. Cytochrome P-450 is reduced by 
dithionite and the CO-compound of the reduced cytochrome has 
an intense absorption land at 450 nm and thus can readily be 
detected by difference spectrophotometry. It shows no other peaks, 
but may exhibit a shoulder at 420 nm due to the breakdown product, 
cytochrome P-420.
Freshly prepared microsomal suspensions (25%) were further 
diluted betv/een 1 : 3 and 1 : 10 v/ith 0.1 M phosphate buffer, 
pH 7*4, to give a final protein concentration in the range of 
1 -3 mg/ml. Difference spectra were recorded between 390 nm and 
500 nm using a Varian Cary double-beam spectrophotometer, equipped 
with an automatic base-line correction. The spectrum obtained by 
adding 0.1 ml NADH (1 mg/ml) to the sample cuvette could be used
to calculate the cytochrome bc content of the microsomes, using
5 o
the extinction coefficient, A-10nm =  ^ cm ^°r
difference in optical density between VlO nm and kz6 nm. Cytochrome 
P-^30 was estimated by first gently bubbling CO into the sample 
cuvette for 30 sec., followed by reducing both sample and reference 
cuvettes v/ith a few grains of sodium dithionite. This had a dual 
role, as the oxidized-CO spectrum gives an estimation of the haemo­
globin contamination of the microsomes (by a peak at k20 nm), and 
also oxidized cytochrome P-^ +30 is more stable than the reduced form, 
so this method attempts to minimize cytochrome P-^30 loss during 
the assay. It is difficult to distinguish spectrally between 
cytochromes P-^-pO and P-kkQ in microsomal preparations, as there 
is generally a broad absorption peak in the range kA8-k52 nm. This 
assay therefore estimates the total concentration of several 
isoenzymes of cytochrome P~^30, using the extinction coefficient,
0-490nm = 51 I#i cm *
Assay of M-demethylation reactions .
The demethylation of ethylmorphine, benzphetamine and dimethyl- 
nitrosarnine were all determined by an adaptation of the method of 
Holtzman et al, 1968, using the S9 fraction.
The hydroxylation of the methyl group of any of these substrates 
results in the formation of an unstable aminocarbinol intermediate, 
which breaks down to release formaldehyde (Prough and Ziegler, 1977)• 
Semicarbazide is required to trap the ECHO in biological material, 
although it tends to inhibit the subsequent colour development in 
the Nash reaction (Kleeberg and Klinger, 1982*, Nash, 1993). These 
pathways and reactions are represented in Figure 2.1. It should be 
noted that there are various technical difficulties associated v/ith 
the Nash estimation of formaldehyde, as nascent ECHO may be lost 
through the formation of Schiff bases with amino acids and also by 
metabolism by aldehyde dehydrogenases. Additionally, high blank
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Figure 2.1: The production of formaldehyde by demethylation reactions
and its subsequent trapping and reaction with acetylacetonek
values may result from impurities in the acetylacetone or in the 
tris buffer (Kleeberg and Klinger, 1982).
The incubation mixture consisted of:-
Tris-HCl buffer (0.3M), pH 7.6 0.9 ml
MgCl (0.1M) 0.1 ml
Semicarbazide HC1 (2%), neutralized 0.2 ml
Glucose-6-phosphate (0.03M) 0.3 ml
NADP+ (2.3 mM) 0.3 ml
Microsomal supernatant, S9, (23%) 0.3 ml
The reaction was started by the addition of substrate (0.25 ml) 
to give a total volume of 2.55 ml and the tubes v/ere incubated over 
various time'intervals in a shaking water bath at 37°C. The final 
concentrations of ethylmorphine and benzphetamine in the reaction 
mixture (6 mM and 1 mK respectively), did not limit the rate of 
reaction even the presence of the most active preparations (i.e. 0.5 ml 
of 25% S9 from phenobarbitone-pretreated animals), and so these 
concentrations were routinely used. On the other hand, dimethyl­
nitrosamine demethylation showed a biphasic response v/ith respect 
to substrate concentration, v/hich is considered in more detail in 
Chapter 7- For all three substrates, the reaction was still linear 
at 10 min. and so was terminated at this point by the addition of 
15% ZnSGj- (1 ml), followed by a 2 : 1 mixture of saturated solutions 
of Ba(0Ii)2 and (1ml). Precipitated protein was removed by
centrifugation in a Mistral 6L centrifuge (2,000 rpm, 10 min.) 
and aliquots of the supernatant (2.0 ml) were added to 2.0 ml of 
freshly prepared Nash reagent (A M ammonium acetate, containing
acetylacetone per ml). It is important that the supernatant 
is clear, as various tissue components can interfere v/ith the Nash 
reaction (Kleeberg and Klinger, 1982). The mixture was incubated 
for AO min in a shaking water bath at 37°C and the absorbance v/as 
measured at A-12 nm in a Cecil CE 272 linear readout spectrophotometer. 
Suitable blanks(substrate added after protein precipitation) and
formaldehyde standards were carried through the same procedure.
The Nash reaction was found to be linear in the range 0 - 0 . 8  pmol 
HCHO, and so generally a single standard of O.Ayumol HCHO was used.
Assay for NADPH-cytochrome c reductase.
The NADPH-dependent reduction of cytochrome c was measured (in 
25% microsomal suspensions) by the method of Williams and Kamin 
(1962). Cytochrome c is used as an alternative substrate to 
cytochrome P-A50, as its reduction is easily followed by an increase 
in absorbance at 550 urn. The two reductase activities are in many 
ways indistinguishable (Masters e_t al, 1975? Vermilion and Coon,
197^), although the reduction of cytochrome c is believed to involve 
a hydrophilic site and cytochrome P-A50 a hydrophobic site on the 
reductase (Guenthner, Kahl and"Nebert, 1980).
The following were pipetted into two cuvettes:-
Sample
Potassium phosphate buffer 1.75 ml
(0.05 M), pH 7.6, containing 1 mM KCN
Cytochrome c (0.1 mil) 1.00 ml
Microsomal suspension (25%) 0.20 ml
After recording the baseline, the reaction (at 37°C) was 
started by adding 50 /*•! of NADPH (50 mM), mixing and following the 
rapid increase in absorbance at 550 nm, until this became non-linear 
(approximately 1 min) on a Varian Cary double-beam spectrophotometer.
The reaction rate levels off due to rapid depletion of the substrate
4*
and also because one of the products of the reaction (NADP ) tends
to inhibit the enzyme (Williams and Kamin, 1962). The initial rate
of reduction of cytochrome c can be calculated frpm the gradient,
—1 —1using the extinction coefficient, E,.,-- = 18.5 mM cm
550 nm
Previous work in this department has shown the above concentrations 
of substrates to be saturating for microsomal suspensions from a
Deference 
1.80 ml
1.00 ml 
0.20 ml
variety of sources.
Assay to measure the Q-deethylation of ethoxyresorufin.
Ethoxyresorufin O-deethylation was measured (in 25f% microsomes) 
by the method of Burke and Mayer, 197^ -? including those improvements 
outlined in a later paper (Burke, Prough and Mayer, 1977)•
Ethoxyresorufin is O-deethylated to yield resorufin as the only 
metabolite:-
ETHOXYRESORUFIN 
Fluorescence A = 4^6 nm
RESORUFIN
Fluorescence A = 5^0 nm ex
V = 586 nm
The production of resorufin can therefore be followed fluori-
metrically at the excitation wavelength (X _) of 510 nm (to minimize
light scatter due to the turbidity of the microsomes) and emission
wavelength (A. ) of 586 nm. There is no interference from amino em
acids or NADPH at these wavelengths.
The following reaction mixture was prepared in -a fluorirneter 
cuvette
Tris-HCl buffer (0.1 M), pH 7.8 
Microsomal suspension (25%) 
Ethoxyresorufin (50 jjM in methanol)
2.00 ml 
0.02 ml 
0.01 ml
The baseline fluorescence was recorded in a Perkin-Elmer
MPF-3 fluorescence spectrophotometer (A = 310 nm,A = 386 nm,
ex •. em
slit width = 3-5 nm). A 10yuJL aliquot of NADPH (30 mM) was stirred 
into the cuvette to start the reaction and a progressive increase 
in fluorescence was recorded over several minutes at 37°C.
The fluorimeter was always calibrated before use with a freshly 
diluted sample of quinine sulphate (1 ^ tg/ml in 0.03 M H^SO^), and 
the reaction quantified by means of multiples of 10 jx 1 of resorufin 
standard (0.01 mM in ethanol). The fluorescence of resorufin is 
proportional to its concentration in the range 0.3 - -^00 nM 
(Burke and Mayer, 197^) and the reaction may be followed in the 
range of 0.02 - 1.00 mg microsomal protein per ml in the cuvette. 
Therefore, in the case of microsomes from control or phenobarbitone- 
induced animals, where the activity is generally low, an increased 
volume of microsomes (30julL) was used’. In no case, even after 
cytochrome P-Vf8 induction was the NADPH concentration rate-limiting.
Care was taken not to unnecessarily expose resorufin or ethoxy­
resorufin to light or heat, as they are both unstable, particularly 
when in aqueous solutions.
Assay for the hydroxylation of biphenyl .
The hydroxylation of biphenyl was followed using the fluorimetric 
method of Creaven et al, 1963? optimized for microsomal rather than 
59 fractions (Dr. P. M. M. Godden, personal communication).
The major route of biphenyl metabolism is the ^-hydroxylation, 
with 2-hydroxylation being a minor pathv/ay, and together these account 
for about 90% of the metabolites formed (Burke and Bridges, 1973;
Burke and Mayer, 1973)* However, the exact contribution made by 
these two pathways and also by the 3-hydroxylation of biphenyl depends 
very much on the source of the microsomes, such as the species and 
type of induction used (Billings and McMahon, 1978; Burke and Prough, 
1977). The routes of biphenyl metabolism are depicted in Figure 2.2.
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Figure 2.2: The pathway of biphenyl metabolism
Although this method does not distinguish between the 2- and 
3-hydroxy derivatives as these both exhibit excited -state ionization, 
the l~hydroxybiphenyl does not show this property and so can be 
determined fluorimetrically in the same preparation (Bridges e_t al,
1965).
The incubation mixture consited of:-
Phosphate buffer (0.1 M), pH 7.k containing 
0.1M glucose-6-phosphate
MgCl (0.03 M)
KC1 (1.13% w/v)
NADP+ (0.006 M)
Glucose-6-phosphate dehydrogenase 
23% microsomal suspension
Biphenyl, recrystallized (0.012 M in k% Tv/een 80)
0.30 ml
0.20 ml 
0.30 nil 
0.23 ml 
2 units 
0.30 ml 
0.23 ml
TOTAL 2.00 ml
The reaction was started by the addition of substrate (absent 
in blanks and standards) and the tubes v/ere shaken in a water bath 
for 10 min. at 37°C. The reaction was terminated by the addition 
of 2 M HC1 (0.3 ml) in ice. Substrate was then added to the blanks, 
and the standards (6 yug 2-hydroxybiphenyl or 30 yu.g ^--hydroxybiphenyl 
dissolved in 3% ethanol) v/ere added to the appropriate tubes.
N-Hepta.ne, containing 1.3% isoamylalcohol (7 ml) was added to 
extract biphenyl and its metabolites on a rotary shaker for 3 minutes.
The phases were separated by centrifugation (2,000 rpm, 10 min) and 
heptane aliquots (2 ml) v/ere further extracted v/ith 0.1 M NaOH (7 ml) 
and centrifuged as before. Finally, aliquots (2 ml) of the aqueous 
layer (containing the hydroxy derivatives) v/ere placed in a 
fluorimeter cuvette, to which v/as added 0.5 M succinic acid (0.5 ml) 
to adjust the pH to 5-5- Fluorescence v/as measured at 338 nm and -^15 am, 
with excitation at 275 am and 295 am respectively, using a Perkin-Elmer 
MPF-3 fluorescence spectrophotometer. Readings were taken immediately,
as 2-hydroxybiphenyl is unstable in its exciting wavelengths and 
decomposes at the rate of about 1%/min (Bridges et al, 19&3)-
The concentration of 4-hydroxybiphenyl can be calculated from
the fluorescence reading at 338 nm (A. = 273 nm), as the 2 isomer
ex
does not interfere at this wavelength. From the reading at 413 nm 
(ADX = 293 nm) the amount of 2-hydroxybiphenyl can be determined 
after allowing for the contribution by the 4-isomer (Creaven et, al, 
1963). The fluorescence response v/as found to be linear in the 
concentration range 0 - 8jmg 2-hydroxybiphenyl and 0 - 3 0  /Ag 4-hydroxy- 
biphenyl (C. Ioannides, Ph.D. Thesis, 1973) and the hydroxylation 
reactions were linear over a 30 min time course.
The biphenyl concentration used must.be saturating for both 
the 2- and 4-hydroxylation pathways, and it should also be noted 
that the Tween 80 (required as a substrate solubilizer) also 
inhibits the reaction to a certain extent (Burke and Bridges,
1973)- Furthermore, the pH optimum of the assay depends not only 
on the pathway of metabolism, but also on the species used as the 
source of microsomes (Burke and Bridges, 1973; Creaven et al, 19^5)-
Assay for the hydroxylation of benzo(a)pyrene (aryl hydrocarbon 
hydroxylase).
Benzo(a)pyrene hydroxylation was assayed essentially by the 
method of Dehnen et al, 1973» but v/ith those alterations in the 
fluorescence measurement as outlined by Dr. D. J. King (Ph.D.
Thesis, 1983). This assay detects phenolic metabolites (primarily 
the 3~bydroxy derivative) of benzo(a)pyrene without the need for 
their separation by extraction in organic solvents.
The formation of fluorescent oxygenated products from benzo(a)- 
pyrene was increased with time in microsomes from both control and 
3-ruethylcholanthrene-induced animals, the latter having the higher 
rate (Figure 2.3-B). This v/as also dependent on substrate concen­
tration, saturation being achieved at a benzo(a)pyrene concentration 
of about 30/u.M (for microsomes from control animals) and 120yu,M (for 
microsomes from 3~methylcholanthrene-induced rats), as shown in 
Figure 2.3D* Benzo(a)pyrene was used at a concentration near to the 
limit of its solubility in the system (l60ymM) and was saturating 
up to approximately 1 mg/ml microsomal protein (from both control and
3-methylcholanthrene-induced rats) as shown in Figure 2.3C.
The following incubation mixture was used:-
Tris-HCl buffer (0.1 M), pH 7-2, containing 6 mM MgCl^.  0.4-00 ml
Buffered solution containing 1 mM NADP and 0.300 ml
10 mM glucose-6-phosphate
Glucose-6-phosphate dehydrogenase 1 unit
*23% microsomal suspension 0.100 ml
Benzo(a)pyrene (2 mg/ml in dimethylformamide) 0.013 ml
TOTAL 1.013 ml
The reaction v/as inititated by addition of the substrate (final 
concentration 120ju>0 and incubated for 20 min .at 37°C in a shaking 
water bath. Ice-cold acetone (1 ml) v/as added to terminate the 
reaction and the denatured protein removed by centrifugation at 
2,300 rpm for 10 min. Aliquots of the supernatant (0.6 ml) were 
transferred to tubes containing 1.4 ml of triethylamine (8.3% v/v 
in H^O) and again centrifuged to clarify, if necessary.
Blanks were run by adding the substrate after protein precipitation, 
and it was noted that the benzo(a)pyrene gave very little interfering 
fluorescence in the presence of the quencher (triethylamine).
Standards v/ere run by adding 43 pmol 3~hydroxybenzo(a)pyrene to 
tubes set up as for blanks. However, incubation of 3-bydroxybenzo(a)- 
pyrene with, microsomes and an NADPH-generating system resulted in a 
tirne-dependent decrease in fluorescence, which was greater when 
microsomes from 3-methylcholanthrene-pretreated male rats were used 
(Figure 2.3A). This suggests further metabolism to a derivative
Figure 2.3* Characteristics of ar.yl hydrocarbon hydroxylase
(A) 3-Hydroxybenzo(a)pyrene (43 pmol) was incubated with male rat 
liver microsomal preparation (O.65 mg of protein), NADP (0.3/umol), 
glucose 6-phosphate (3 yUmol), glucose 6~phosphate dehydrogenase (1 unit) 
in a total volume of 1.0 ml. (B) Benzo(a)pyrene (16O//.M) was incubated 
v/ith control (1.2 mg of protein) and 3-methylcholanthrene-treated rat 
microsomes (O.96 mg of protein) and the same NADPH-generating 
system. (C) Microsomes of control and 3-methylcholanthrene-treated 
animals were incubated with benzo(a)pyrene (l60yu.M) and the NADPH- 
generating system for 10 minutes. (D) Microsomes (O.63 mg of protein) 
v/ere incubated v/ith various concentrations of benzo(a)pyrene and the 
NADPH-generating system for 10 minutes.
( A ) Control microsomes; ( & ) 3~methylcholanthrene-treated microsomes.
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v/hich v/as not fluorescent at the wavelengths set. The fluorescent 
properties of the metabolites are not affected by the presence 
of coenzymes or proteins, but there is a limit in the linearity 
of the fluorescence of 3-hydroxybenzo(a)pyrene at higher concen­
trations of this metabolite (Dehnen jet al, 1973)* 11 has also been 
suggested that there is a lack of linearity at very low concen­
trations of 3-hydroxybenzo(a)pyrene, due to difficulties in 
extracting it completely from the tissue (Nebert, 1978).
Fluorescence was measured using a Perkin-Elmer MPF-3 fluorescence 
spectrophotometer against quinine sulphate (1yitg/ml in 0.05'M.H SO^) 
at the excitation wavelength of 467 nm, with the emission scanned 
from 300-560 nm. It is necessary to compare the 3-hydroxybenzo(a)- 
pyrene fluorescence, v/hich gives a peak at about 520 nm, with 
quinine sulphate as it is difficult to store authentic 3-hydroxy- 
benzo(a)pyrene (Nebert, 1978). Peaks at 5^0 nm suggest the presence 
of other metabolites.
Assay to measure aniline hydroxylation .
The hydroxylation of aniline v/as estimated (in S9 fractions) by 
an adaptation of the method of Guarino ejt al, 1969•
Aniline may be hydroxylated to give a mixture of p~, m- and o- 
substituted aminophenols. The predominant product formed by micro­
somes is p-aminophenol, v/hich may be extracted into ether.and 
subsequently into alkaline phenol. It reacts with the latter to 
give a blue phenol-indophenol complex, v/hich may be measured by its 
absorbance at 620 nm.
The incubation mixture consisted of:-
0.5 ml 
0.1 ml 
0.2 ml 
0.5 ml 
0.5 ml
Tris-HCl buffer (0.3 M), pH 7-6 
MgCl2 (0.1 M)
NADP+ (0.01 M)/glucose-6-phosphate (0.1 M) 
25% microsomal supernatant (S9)
Aniline hydrochloride (0.04 M) neutralized
TOTAL 1.8 ml
The reaction was started by the addition of substrate and
o
incubated for 15 min. in a shaking water bath at 37 C. It was
terminated by the addition of approximately 1 g NaCl, in ice. 
Peroxide-free ether, containing 1.5% (v/v) isoamyl alcohol (12 ml) 
was added, and the p-aminophenol extracted on a rotary shaker for 
20 min. Ether aliquots (10 ml) were subsequently added to k.O ml 
alkali phenol (0.5 M tripotassium orthophosphate, containing 1% 
w/v phenol) and extracted on a rotary shaker for 30 min. The 
ether layer v/as then aspirated, and the blue colour of the aqueous 
phase measured at 620 nm in a Cecil CE272 linear readout spectro­
photometer. _
Blanks (v/ith the aniline added at the end of the incubation 
period) and standards (O.lyumol p-aminophenol in 0.1 M HCl) were 
carried through the same procedure. The rate of p-aminophenol 
formation could therefore be estimated, taking account of the 
efficiency of its extraction.
Enzyme activity v/as linear with time and protein concentration 
under these conditions.
Assay for monoamine oxidase (MAO) activity.
The monoamine oxidase activity of the microsomal supernatants 
(S9 fractions) v/as measured using the rapid, microfluorimetric assay 
of Krajl, 1965. The metabolism of kynuramine can be monitored 
fluorimetrically by the appearance of A—hydroxyquinoline, v/hich 
arises from the spontaneous cyclization of the intermediate 
aldehyde formed by the oxidative deamination of this substrate 
(V/eissbach et al, 1960):-
0 0 0
I I I I
MAO ^
enzym:
non-
Kynuramine T-hydroxyauinoline
The assay was optimized with respect to substrate and protein 
concentrations and incubation time, using S9 preparations from 
control hamster liver, and v/as found to be linear over 60 min 
incubation. There v/as no advantage in using microsomal preparations 
compared to the S9 fraction. The reaction was linear up to 0.5 ml 
25% S9 fraction (i.e. 12.5 mg protein) per assay, using lOO^M-g 
kynuramine dihydrobromide in a total volume of 3*0 ml (data not 
shown).
The following incubation conditions v/ere adopted:-
Phosphate buffer (0.5 M), pH 1.25 ml
25% microsomal suspension (S9) 0.25 ml
Kynuramine dihydrobromide 0.50 ml
(200 yuLg/ml in buffer)
Distilled v/ater 1.00 ml
TOTAL 3.00 ml
The reaction was started by the addition of substrate and 
incubated for 30 min. in a shaking v/ater bath, at 37°C. It v/as 
terminated by the addition of 10% trichloroacetic acid (2 ml) 
and the precipitated proteins v/ere centrifuged down at 2,500 rpm 
for 10 min. Aliquots (1 ml) of the supernatant v/ere added to 
1 M NaOH (2.0 ml) and the fluorescence of the k— hydroxyquinoline 
read at 380 nm (excitation at 315 nm) in a Perkin-Elmer MPF-3 
fluorescence spectrophotometer, standardized v/ith quinine sulphate 
(l^Ug/ml in 0.05 M H^SO^). Blanks (substrate added after protein 
precipitation) and standards (5-30 nmol ^-hydroxyquinoline in 
0.1 M NaOH) were carried through the same procedure. There was 
very little interference by kynuramine at these wavelengths and . 
the standards were linear in this range despite fluorescence 
quenching by trichloroacetic acid.
Assay for the mixed function amine oxidase (FAD-monooxygenase 
or Ziegler enzyme).
The N-demethylation and M-oxidation of N, N-dimethylaniline 
v/ere measured (in the 25% S9 fractions) by an adaptation of the 
method of Ziegler and Pettit, 196^ f.
The reactions were carried out at tv/o different pH's, 7*6 
and 8.A-, as these v/ere the optima for N-demethylation and N-oxidation 
respectively (Das and Ziegler, 1970). The formaldehyde, produced 
as a result of oxidative demethylation, v/as assayed as previously 
described (p - . The N-oxide was estimated after its quantitative
reduction (at pH 2.5) by nitrous acid to N,N-dimethylaniline, which 
then readily formed the yellow p-nitroso derivative.
A final concentration of 5 mM N,N-dimethylaniline v/as found 
to be the limit of its solubility in this system, but v/as not 
limiting for either pathway of metabolism in the presence of up to 
*f0 mg protein from pig S9 fractions (i.e. 1 ml of 25% supernatant). 
The N-demethylation reaction (at pH 7*6) was linear over 20 min, 
but the N-oxidation reaction (at pH 8.^) was. only linear for 10 min 
(data not shown).
The following incubation conditions were used:-
Tris-HCl buffer (0.3 M) pH 7.6 or 8 A 
MgCl2 (0.1 M) 0.10 ml
1.20 ml
Semicarbazide HC1 (2 %), neutralized 
NADP+ (5 mM)/glucose-6~phosphate (0.06 M) 
25% microsomal supernatant (S9) 
N,N-dimethylaniline (1.25 M in methanol)
0.20 ml 
0.-50 ml 
0.50 ml 
0.01 ml
TOTAL 2.51 ml
The reaction was started by the addition of substrate, with 
thorough mixing, and was incubated for 5 min. in a shaking v/ater bath 
at 37°C. It was terminated by the addition of 1.5% ZnSO^ (1 ml), 
followed by a 2 : 1 mixture of saturated solutions of BaCOH)^ and 
NaPB, 0 (1 ml). Precipitated protein v/as removed by centrifugation
(2,000 rpm, 10 min) and an aliquot of the supernatant (1 ml) was 
assayed for formaldehyde with the Nash reagent (see p45). A 
further 2 ml aliquot v/as adjusted to pH 9-A with 0.5 ml glycine 
(0.5 M, pH = 10). Unmetabolized N,N-dimethylaniline was removed 
by extraction (10 min) with diethylether ( 3 x ?  ml). To 2.5 ml 
of the aqueous phase v/as added 0.2 ml trichloroacetic acid (3-0 M), 
to adjust the pH to 2.5, followed by 0.3 ml of freshly made NaNO^
(100 mM). The tubes were then incubated at 60°C for 10 min., 
cooled and the yellow colour estimated at 420 nm in an LKB ultra­
spectrophotometer.
Blanks for both reactions involved adding substrate after
protein precipitation, and a formaldehyde standard (0.4^junol) v/as
used to quantify the demethylation reaction as previously described.
The blanks for the Nash reaction v/ere higher than with other substrates
(e.g. benzphetamine), suggesting that the N,N-dimethylaniline may
interfere v/ith the colour reaction or may be non-enzyir&cally
demethylated. The reason for this remains to be elucidated. However,
the blanks for the N-oxidation pathway were always very low, suggesting
efficient extraction of the unmetabolized substrate into the diethyl
ether. The N-oxidation pathv/ay was quantified using the published
-1 -1
extinction coefficient for the p-nitroso derivative of 8.2 mM cm 
(Ziegler and Pettit, 1964).
The Ames Test.
The principles behind the Ames mutagenicity test have already 
been considered in Chapter 1, and all the procedures used are 
essentially those recommended by Ames, McCann and Yamasaki, 1975.
General information .
All glassv/are and heat-stable solutions were autoclaved, 
while other solutions including the ’S9 mix' were filter sterilized 
through a 0.45/^pore. Top agar consisted of 0.6% nutrient agar 
and 0.5% NaCl (w/v in H^G) which v/as always made up fresh, auto­
claved and then maintained at 45°C before use. Nutrient broth v/as 
used to culture and dilute the Salmonella strains. Stock L-histidine 
and biotin solutions were made up in two different strengths-and 
kept at 0 - 4°C. The * assay his/bio1 solution contained 0.5 mM 
L-histidine and 0.5 mM biotin, while the "test his/bio* solution 
contained 0.1 M L-histidine and 0.5 mM biotin. The former would only 
allow bacterial colonies to grow from those Salmonella which had 
reverted to histidine prototrophy, whilst the ’test* solution 
contained sufficient histidine for the auxotrophic strains also to 
grow.
Maintenance of bacterial tester strains .
The bacterial tester strains were supplied by Professor B. Bridges 
(MRC Cell Mutation Unit, University of Sussex), but came originally 
from the laboratories of Professor Bruce Ames (University of California, 
Berkeley, CA, USA).
Stock cultures were stored at -80°C in nutrient broth (0.8 ml) 
containing dimethylsulphoxide (0.07 ml), in tightly capped glass 
vials. Fresh cultures v/ere obtained by scraping a sterile needle over 
the surface of the frozen culture and inoculating 5 ml of nutrient 
broth. This was incubated overnight (16 hours) in a shaking water 
bath, at 37°C, and the resultant cultures kept at 0-4°C for up 
to a week.
Testing of-strain properties .
The standard tester strains contain different types of 
histidine mutations, with TA 1535 able to detect mutagens causing
base-pair substitution and TA 1537 and TA 1538 able to detect 
different kinds of frameshift mutagens. In addition each tester 
strain has two other mutations, v/hich greatly increase their 
sensitivity to mutagens. These are the loss of the excision repair 
system (Auvr B) and the inability to synthesise the lipopolysacc- 
haride cell wall (rfa). These allow the entry of large carcinogen 
molecules into the bacteria, and increase the chances of mutations 
being expressed. The sensitivity is further increased by the 
addition of a plasmid (pKMIOl), which confers both ampicillin 
resistance and an error-prone repair system to the bacteria 
(McCann, Spingarn et al, 1975)* Thus, strains TA 100 and TA 98 
arise from the strains TA 1535 and TA 1538 respectively, through 
the introduction of this R-factor.
Each new bacterial culture was tested for viability and 
spontaneous mutation rate. Cultures were also tested intermittently 
to ensure that all strain characteristics were maintained. All 
strain tests were carried out in duplicate.
Test for histidine requirement: A 0.1 ml sample of the ’test his/bio’ 
solution was spread onto the surface of a minimal ag&r plate and 
allowed to dry. The growth of bacterial cultures, cross-streaked 
onto these plates, was compared to any growth observed on unsupple­
mented minimal agar plates, after overnight incubation at 37°C.
If the bacteria have retained their histidine mutation, they 
should only be able to grov; on supplemented plates.
Test for defective cell wall (rfa mutation): An aliquot of the 
bacterial suspension (0.1 ml) was added to 2.0 ml of ’top' agar, 
containing 0.2 ml of the ’assay his/bio’ solution, and immediately 
mixed and poured onto minimal agar plates. When the agar had 
solidified, a sterile filter paper disc (1 cm in diameter) 
containing crystal violet (100 of a 1 mg/ml solution) was placed
on the centre of the plate, and incubated overnight at 37°C. A 
clear zone of inhibition around the disc indicated the presence 
of the rfa mutation, the bacteria being unable to exclude this 
high molecular weight dye which inhibits growth.
Test for the ampicillin resistance factor: The previous method 
was used, but substituting 100 fx1 of ampicillin (8 mg/ml in 0.02M 
NaOH) for the crystal violet on the filter paper disc.
A zone of inhibition was observed with all those strains which 
did not possess the R-factor plasmid (TA 1535» TA 1537 5 T A 1538). 
However, strains TA 100 and TA 98 are resistant to ampicillin, and 
an inability of these strains to grow to the edge of the disc 
suggests loss of the plasmid. This is usually associated with a 
decrease in the number of spontaneous revertants (see below).
Test for bacterial viability: The viability of the overnight 
bacterial cultures was assessed by colony growth on agar supplemented 
with L-histidine. The bacteria were serially diluted three times in 
nutrient broth to give a final dilution factor of 10 . Aliquots 
(0.1 ml) of the final dilution were transferred to 2 ml of nutrient 
agar (fortified with 0.2 ml of the ’test his/bio’ solution), mixed 
and poured onto minimal agar plates. These were allowed to set and 
incubated at 37°C for 2k hours, after which the total number of 
colonies were counted and the number of bacteria per ml. of the original 
culture calculated.
Test for spontaneous mutation rate: Although plates v/ere alv/ays run 
to estimate the background or spontaneous mutation rate concurrently 
with each mutagenicity test, this property was alv/ays checked in 
new cultures. Each strain gives a characteristic number of 
spontaneous revertants (80 - 150 for TA 100, 30 - 50 for strain 
TA 98 and 5 - 2 0  for those strains which do not possess the R-factor 
plasmid), so contamination or alteration of the traits of a particular 
strain could be rapidly detected using this test before embarking on
a large assay. The number of spontaneous revertant colonies v/ere 
generally slightly higher in the presence of the S9 mix (see below).
To 2 ml of nutrient 'top1 agar, containing 0.2 ml of the ’assay 
his/bio’ solution, was added 0.1 ml of the bacterial culture, 
mixed and poured onto minimal agar plates. These were allowed 
to set and were incubated for 48 hours, after which the number of 
revertant colonies were counted.
Mutagenesis assays.
These .were alv/ays carried out in triplicate.
Preparation of the S9 mix; The S9 mix is a buffered system 
containing the 25% S9 fractions (prepared as described earlier, 
p 41 ) and the cofactor and ion requirements for mixed-function 
oxidase-linked metabolism. Generally, the volume of S9 mix 
required for a particular day was calculated and made up in the 
following proportions:-
KHoP0, - NaOH buffer (0.2 M) pH 7*4 10 mlC. Lr
KOI (0.33 M) 2 ml
MgCl2 (0.08 M) 2 ml
Cofactor solution* 4 ml
S9 fraction (25%) 2 ml
TOTAL 20 ml
* The cofactor solution contained NADP (20yyjnol/rnl) and glucose- 
6-phosphate (25 ^ umol/ml)
Occasionally the proportions of S9 within the S9 mix were 
altered and these are outlined next to the relevant experiments.
Preparation of the carcinogens: The more polar carcinogens v/ere
dissolved in sterile distilled water, otherwise dimethylsulphoxide
(DMSO) was used as the solvent. The appropriate concentration 
ranges for each carcinogen v/ere chosen either from published 
reports or from previous experience v/ithin this laboratory;- 
occasionally a dose-ranging preliminary study was undertaken.
The carcinogens v/ere dissolved sufficiently concentrated so that 
the maximum volume added to each plate v/as 100 yul.
Most of the aromatic amines had to be freshly dissolved, 
with the exception of 2-acetylaminofluorene which could be stored 
for several weeks frozen in DMSO without altering' its mutagenic 
properties. The nitrosamines v/ere always used within 2 weeks 
when dissolved (as suggested in the IARC Monographs, 1978), 
while the polycyclic aromatic hydrocarbons v/ere relatively stable 
to storage in DMSO at *f°C, as long as they were protected from 
light.
The standard plate test: To 2 ml of ’top’ agar, containing 0.2 ml
of the .’assay his/bio' solution v/ere added 0.1 ml of the bacterial
9culture (approximately 10 bacteria/ml) together v/ith the 
appropriate volume of carcinogen (or the top volume of solvent 
for the blank). Finally, the S9 mix (0.5 ml) v/as added and the 
tube, v/as rapidly mixed and the contents poured on to a minimal 
agar plate, so that the enzyme preparation v/as not maintained at 
the temperature of the molten agar for more than a few seconds.
The plates were tilted and rotated to distribute the agar uniformly 
before it had started to harden. The agar v/as then allowed to 
solidify before incubating the plates in the dark at 37°C for
4-8 hours. ' After this time period the revertant colonies were 
counted and the presence of a light background lawn of bacterial 
growth confirmed. A sparse background grov/th of bacteria, giving 
the impression of thousands of minute colonies, would be due to 
extensive killing of the bacteria, which allows those remaining 
to grow on the available histidine.
Preincubation in liquid suspension; This method is essentially 
the same as the plate assay, but involves adding the components 
in a different order to allow short-lived reactive intermediates 
to reach the bacteria without being mopped up by the nucleophilic 
moieties in the agar.
The S9 mix (0.5 ml) was incubated with the bacteria (0.1 ml) 
and the carcinogen or solvent (0.1 ml) in a shaking water bath 
at 37°C, for various time intervals. At the end of the incubation 
period, 2 ml of the top agar (containing 0.2 ml ’assay his/bio’) 
was added, rapidly mixed and poured onto minimal agar plates.
These were allowed to set and v/ere incubated and evaluated as 
above.
This variant of the Ames test v/as particularly useful when 
the activating system used v/as not a conventional ’S9 mix’
(e.g. the chemical systems and purified yeast preparations of 
Chapter 8 ), as the viability of the bacteria could be concurrently 
assessed. This was performed by taking 100jx1 samples from the 
incubation mixtures and diluting and plating them as described 
for the viability test.
The results for both variants of the Ames test were expressed 
after subtracting the spontaneous mutation rate, which varied 
according to the bacterial strain and the source of the S9 in the 
S9 mix.
Statistical Analysis .
Comparisons betv/een sets of data v/ere performed using a 
Student's t-test program on an Olivetti microcomputer, which 
utilised the means and standard deviations (n - 1). The statistical 
significance v/as calculated using (n^ + n0 - 2) degrees of freedom, 
where n^ and n^ are the number of samples in each group.
Correlation coefficients (r) v/ere calculated on an Olivetti 
microcomputer using a simple linear regression analysis program.
C H A P T E R
CHAPTER 5. AN EVALUATION OF THE
ASSAYS FOR CYTOCHROME P-A-pO AND P-¥f8.
INTRODUCTION .
General .
Cytochrome P-A-50 exists in many forms (isoenzymes) which differ 
from each other in structure, physicochemical and immunological 
properties, substrate specificity and their reaction mechanisms and 
kinetics (Guengerich, 1979; Guengerich at al, 1982; Lu and West,
1980; and Ryan et_ al, 1982). These criteria have arisen from studies 
using microsomes from induced animals, purified reconstituted 
systems and inhibitors specific to certain forms.
The two major groups of the cytochrome considered in this thesis 
are the forrn(s) induced by polycyclic aromatic hydrocarbons, certain 
other carcinogens and/??-napthoflavone (i.e. cytochrome P-V+8), and 
the form(s) induced by slowly metabolized substrates(exemplified 
by phenobarbitone) known as cytochrome P-V50* These forms are • 
probably the best studied and have the least overlap in their substrat 
specificities (Lu and West, 1978). Evidence is accumulating that 
cytochrome P-Vf8 may be responsible for the activation of many 
chemicals to toxic and/or carcinogenic intermediates (e.g. paracetamol 
Steele e_t al, 1983; 2-aminoanthracene, Norman, Muller-Eberhard and 
Johnson, 1982; 2-acetylaminofluorene, Johnson et al, 1980). This 
form of the cytochrome is able to metabolise chemicals in sterically 
hindered positions (e.g. biphenyl 2-hydroxylation, Bridges et; al,
19o5; and benzo(a)pyrene bay region epoxidation, Levin et al, 1977)? 
thus rendering them less available for Phase 2 (detoxifying) 
metabolism. It is possible that cytochrome P—1T8 metabolizes 
chemicals by a different molecular mechanism, either by activating 
the bound oxygen and releasing superoxide or hydroxyl radicals, 
which may activate substrates non-enzymically (Cohen and Gederbaum, 
1979; Winston and Cederbaum, 19o2), or alternatively, cytochrome 
P-Zk8 may become decoupled from the reductase, which may then act
as an oxygen radical generator (Bosterling and Trudell, 1981; lai, 
Grover and Piette, 1979)• Indeed, a free hydroxyl radical 
mechanism of oxygenation has been demonstrated in an alcohol- 
inducible form of the cytochrome, during its metabolism of 
benzene, aniline and ethanol (Ingelman-Sundberg and Habjork, 1982).
In contrast, the phenobarbital-inducible form of cytochrome 
tends to direct metabolism., towards detoxification (e.g. hexobarbitone, 
Quin, Axelrod and Brodie, 1958; warfarin and strychnine, Conney 1980, 
1982). However, the opposite is true for bromobenzene toxicity and 
zoxazolamine paralysis, where cytochrome P-W3 is more proficient 
at detoxification (Conney, 1982). The differences in substrate 
specificity and interaction with the reductase is most probably 
a reflection of alterations in the apoprotein structure, as the 
haem environment and its ability to fix and activate oxygen have 
been shov/n to be very similar in all cytochromes P-^ -50 so far studied 
(Dus, 1982b).
A consequence of this diversity in substrate specificity and 
position of metabolism is that the response of a tissue to toxic 
chemicals may be influenced by the types of cytochromes present, 
and most particularly by the ratio of cytochromes P-^50 : P-kko. 
Therefore, determination of cytochrome P-^-50 and activities
v/ould give an indication of susceptibility to carcinogens and toxic 
chemicals. This is of great importance when considering the number 
of different enzyme inducers (drugs, environmental contaminants, 
anutrients etc.) to which man is exposed.
Purified, Reconstituted Systems .
Different isoenzymes of cytochrome P-T50 have now been purified 
from various animal species in different states of induction. This 
has been recently comprehensively reviewed (Guengerich, 1979; 
Guengerich et al, 1982; Lu and West, 1Q78, 1980; Ryan et al, •
1982).
The main phenobarhitone-inducible form from rabbit liver micro- 
somes has been purified and designated the code LTi2* has been shown 
to preferentially metabolize benzphetamine and ethylmorphine. The y5-naph- 
thoflavone-inducible form from rabbit liver (LM4) has also been purified 
to electrophoretic homogeneity in Coon’s laboratory. This cytochrome 
can metabolize many substrates at a low rate, but the proximate carcin­
ogen, 7»8-dihydro-7,8-dihydroxybenzo(a)pyrene is metabolized rapidly.
The rabbit IM4 preparation can also be distinguished from IM2 by differ­
ences in its amino acid composition and molecular weight, and there is 
very little immunological cross-reactivity ^ betwuen the two types(Dus,1982a), 
although they are both glycoproteins with thejsame apparent carbo­
hydrate content (Paine, 1981). It has been suggested that there 
are, in fact, multiple forms of LM;,, which are electrophoretically 
homogeneous and of similar molecular weight and peptide mapping 
(Bostrom and V/ikvall, 1982) but having different activities towards 
benzo(a)pyrene, benzphetamine and dimethylnitrosamine (Lu et al,
1980). Amino-terminal sequencing has also suggested the presence 
of four closely related peptides (Guengerich, 1979)? although it 
is possible that partial proteolysis has occurred during isolation 
(Paine, 1981)-
Purified, reconstituted mixed-function oxidase systems have 
the advantage of providing a clearly defined system for study.
It is through the use of such systems that the substrate specificity 
v/as found to reside in the cytochrome, as opposed to the other 
components (Lu et al, 1972). Hov/ever, results must be considered 
with a certain amount of caution, as artefacts may arise from the 
non-physiological situation. Methods of reconstitution also vary 
amongst laboratories, and requirements may be different for preparations 
from various sources. Usually, purified cytochrome P-VpO and its 
reductase are reconstituted with a lipid (v/hich acts as a hydro- 
phobic force, facilitating the interaction between these proteins), 
and the system is supplied v/ith substrate and a source of NADPH.
The cytochrome P-A-50 itself is normally deeply embedded in the 
microsomal membrane and must be solubilized v/ith detergents, 
without its concomitant breakdown to P-l-20 (Nebert et al, 1981).
The most commonly used lipid added to reconstituted systems is 
dilaurpyLphosphatidylcholine (DLPC), which forms small micelles 
containing a high concentration of protein (Szutowski, 1980), and 
acts similarly to detergents to disperse protein aggregates 
(Ingelman-Sundberg, Haaparanta and Rystrbm, 1981). Up to a 
critical micelle concentration, DLPC increases the rate of 
metabolism, without changing the K , suggesting that it affects 
cytochrome P-VijO-neductase interaction, without altering the 
mechanism of catalysis (Miwa and Lu, 1981). Activities in 
reconstituted systems depend not only on the isoenzyme of 
cytochrome P-V?0 used and the substrate, but also on the ratios 
of the various proteins and lipids, and v/hether cytochrome b,_ is 
also incorporated into the system (Bosterling et al, 1982). Also, 
if a high concentration of lipid soluble substrate is used, this may 
further perturb the phospholipid-protein interactions. Normally, 
in the microsomes there is 10-20 times more cytochrome P-V?0 present 
than its reductase, and different isoenzymes are preferentially 
reduced, depending on the substrate (Kamakaki et_ al, 1980). As an 
example, the reductase has a higher affinity for ILL, in the presence 
of benzphetamine than it has for other forms (Coon, 1981). In a 
reconstituted system, the reductase is no longer limiting, and the 
substrate, lipid factors and the reductase are all mutually beneficial 
in the formation of a functional cytochrome P-V?0 complex (Coon, 1981). 
When the mixea-function oxidase activity is reconstituted in a mem­
braneous system (lipid bilayers or liposomes), the actual phospho­
lipids present are very important and may even alter substrate 
specificity. Generally, a more negatively charged system facilitates 
the interaction between the reductase and cytochrome P-V?0 , but 
this is very dependent on the isoenzyme used (Ingelman-Sundberg, 
Haaparanta and Pystrom, 1981).
However, substrate specificity generally is -retained on 
purification of the cytochrome from microsomes, and is not highly 
sensitive to the presence of other proteins and the lipid composition. 
These factors can contribute to the rates of metabolism of all
substrates. It seems that there is some overlap in substrate 
specificity among the different forms (Guengerich, 1979'j Guengerich 
et al, 1982).
Substrate Specificity.
Although the initial nomenclature (i.e. cytochrome P-VpO vs.
P-448) for the different forms arises from the differing peak 
maxima of their reduced-CO spectra, this is one of the more minor 
differences between the isoenzymes. • It is not a useful criterion 
for satisfactorily distinguishing between the forms in microsomal 
preparations. A better method for estimating the relative 
concentrations of different cytochromes P-^30 within microsomes, 
without resorting to the laborious technique of purification, is 
to assay their ability to metabolize different substrates. However, 
as there is considerable overlapping of substrate specificity 
between different forms, the search continues for more and more 
specific substrates for the various isoenzymes.
Benzphetamine: The N-demethylation of benzphetamine is specifically
induced by phenobarbitone, as has been demonstrated both in microsomes 
and purified reconstituted systems (Haugen, 1981; Lu e_t al, 1972), 
but in the latter it can be inhibited by various lipid fractions, 
including phosphatidylcholine (Warner and Neims, 1979)* It is a 
more specific substrate for cytochrome P-^30 than ethylmorphine
”1973)1 although both these assays suffer from a disadvantage 
in that a competing N-oxidation pathway exists, catalysed by the mixed- 
function amine oxidase enzyme (Fok and Ziegler, 1970; Prough and 
Ziegler, 1977)» A minor route of benzphetamine metabolism, 
through several sequential oxidations, produces a metabolite which 
binds to cytochrome P-A30 to give a peak at ^33 nm (Jefcoate, 1978). 
Also, both benzphetamine and ethylmorphine stimulate hydrogen peroxide 
production from microsomes during their metabolism. These observations 
may help to explain why the ratio of NADPH utilization, to formaldehyde 
production is in the region of 2 : 1 for the metabolism of these
substrates (Werringloer, 1978). Furthermore, this assay does 
present some technical difficulties, as outlined in Chapter 2.
Biphenyl: Biphenyl is a substrate which can be metabolized by
several routes (see Chapter 2) and different isoenzymes of 
cytochrome P-A30 appear to be involved in the different positions 
of hydroxylation. In control animals, the A-hydroxylation pathway 
predominates, with very little 2- and 3-hydroxylation occuring 
(Haugen, 1981), apart from the mouse and hamster (Burke and 
Bridges, 1973)» and the immature rat and rabbit (Billings and 
McMahon, 1978; Creaven et al, 1983)- Phenobarbital preferentially 
induces the 4-hydroxylation (Burke and Mayer, 1973)1 although there 
seems to be another form of the cytochrome in these preparations 
which can catalyse the production of 3-hydroxybiphenyl (Billings 
and McMahon, 1978; Haugen, 1981). Induction by 3-niethylcholanthrene 
on the other hand, induces the 2- and 3-hydroxylation of biphenyl 
(Billings and McMahon, 1978; Burke and Prough, 1977) 1 although 
the A-hydroxylation is also enhanced (Burke and Mayer, 1973)* It 
must be noted that 2- and 3-hydroxybiphenyl cannot be satisfactorily 
distinguished by the generally-used fluorescence method, but only 
when HPLC is performed. The increase in 2-hydroxylation, following 
benzo(a)pyrene administration may be due to an initial activation 
(at 2 hours), and later (at 2 -^ hours) due to a true inductive 
process (McPherson afc al, 1978). The 2- and A-hydroxylation 
pathways have different pH profiles and different specificities 
towards NADPH/NADH requirements (Burke and Bridges, 1973)* In 
partially purified, reconstituted systems it has been shown that 
P-¥f8 is able to catalyse 2- and A-hydroxylation, while P-A30 
specifically catalysed the second pathway (Burke and Mayer, 1973)- 
Metabolism at the 2 position involves hydroxylation in a sterically- 
hindered, 'bay region' part of the molecule. It has also been 
shown that the relatively specific cytochrome P-^30 inhibitors 
(metyrapone and SKF 323A) preferentially inhibited the A-hydroxylation 
pathway (Burke and Bridges, 1973)* Additionally, it has been
suggested that k-chlorobiphenyl may be a more specific cytochrome 
P-W3 substrate, in that its 4 1-hydroxylation is induced by 
3-methylcholanthrene, but not by phenobarbitone (Parkinson and 
Safe, 1982).
Ethoxyresorufin: The O-deethylation of ethoxyresorufin is an 
alternative assay, v/hich appears to be specific for cytochrome 
P-AA8. It is induced byyS-napthoflavone (Warner and Neims, 1979)1 
and 3~methylcholanthrene, but not by phenobarbitone (Burke, Prough 
and Mayer, 1977)- Ethoxyresorufin binds to the protein substrate 
site and is metabolized to a single product, resorufin, and this 
is competitively inhibited by benzo(a)pyrene (Burke, Prough and 
Mayer, 1977)- Solubilized, partially purified preparations of 
cytochromes P-430 and P-A-A8 have allowed a demonstration of the 
specificity of the latter to deethylate ethoxyresorufin, whether 
reconstituted with the reductase, or with the artificial electron 
donor, cumene hydroperoxide (Burke and Mayer, 1973)-
Benzo(a)p.yrene: An assay which has been widely used to demonstrate 
mixed-function oxidase activity is aryl hydrocarbon hydroxylase 
(AHH), using benzo(a)pyrene as substrate. In the fluorimetric 
assay conditions used, the 3~ and phenols are strongly 
fluorescent, and contribute to over 9CP/o of the total fluorescence 
(Holder et_ al, 1973)• The phenolic derivatives are formed as a 
result of either direct hydroxylation, or (as more recent evidence 
suggests) via an intermediate arene oxide (Jerina and Daly,
197^; Nebert, 1979)- The AHH assay has been used for years as an 
index of benzo(a)pyrene metabolism, even though numerous other 
metabolites apart from the 3-bydroxy derivative are formed (Sims,
1987). Alternative methods have been used, including a radiometric 
assay (limited by loss or migration of label) and detection of the 
metabolite profile using HPLC (De Pierre and Ernster, 1978; Holder 
_et_ al, 1973)• The fluorimetric AHH assay has been extensively used 
by Nebert's group in their studies on the genetics of polycyclic 
aromatic hydrocarbon inducibility (i.e. the Ah locus), primarily 
in mice (reviewed, Nebert, 1978; Nebert 1979; Nebert and Jensen,
1979). The induction of other enzyme activities, including 
ethoxyresorufin O-deethylation, biphenyl 2- and ^--hydroxylation, 
and many others seem to be associated with the Ah locus. The 
demethylation of ethylmorphine and benzphetamine, on the other 
hand, show no association (Nebert and Jensen, 1979). The 
mechanism of induction at the Ah locus is discussed more fully, 
in Chapter 1. It does appear that inducibility of the Ah locus 
is important in many toxic and carcinogenic phenomena in animals 
(Nebert and Jensen, 1979). There is also evidence for heritable, 
AHH-inducibility in man , and this may possibly be linked to lung 
cancer incidence (Arnott, Yamauchi and Johnston, 1979). It is 
however difficult in human studies to distinguish whether raised 
AHH levels v/ere the cause or the consequence of the disease.
Although early studies (Lu e_t al, 1972) using partially 
purified cytochromes P-VpO? reconstituted with lipid and reductase, 
demonstrated that P-W 3  was better at catalysing AHH, later induction 
(Wiebel and Gelboin, 1973) and inhibition (Lesca et_ al, 1978a) studies, 
and experiments v/ith well-purified systems (Ryan _et al, 1982) have 
suggested that different forms of the cytochrome may contribute 
to the overall microsomal activities. It appears that cytochrome 
P^-A30 is far more active than cytochrome P-khS in catalyzing 
polycyclic aromatic hydrocarbon-induced aryl hydrocarbon hydroxylase 
activity (Nebert et al, 1981). A different spectum of benzo(a)pyrene 
metabolites are produced following different modes of induction 
(Lu and West, 1980), because of the alterations in the levels of 
cytochrome P-^30 isoenzymes and also of epoxide hydrolase. This 
Phase 2 enzyme would catalyse the formation of diols at the expense 
of the more fluorescent phenols (DePierre and Ernster, 1978). Thus, 
this evidence, together with further criticisms which are advanced 
in the Discussion section of this chapter, point against the AHH 
assay as a useful diagnostic method for distinguishing between 
different cytochrome P-^30 isoenzymes in microsomal preparations.
Specific Inhibitors*
There is not yet evidence for a truly, totally specific 
inhibitor of either cytochrome P-^50 or P - ^ 8 , but by careful 
manipulation of concentrations, certain chemicals show a higher 
selectivity toward one isoenzyme or the other. Inhibitors may 
bind to either the protein (substrate site) or the haem iron ,and 
the mechanism of inhibition has been discussed in more detail in 
Chapter 1.
Inhibition of cytochrome P-Vf8 may depend, on the large 
polycyclic size of the chemical, especially considering the 
nitrogen heterocycles such as the benzimidazole derivatives and 
the ellipticines, while inhibition of P-A^O is more dependent on 
hydrophobicity (Little and Ryan, 1982). Ellipticine (3»11-dimethyl- 
6lI-pyrido f^-3 ?b~carbazole) and its derivatives comprise a group of 
plant alkaloids, with strong anti-neoplastic activities towards 
both experimental tumours and human malignancies (Lecointe _et al,
1978; Lesca, Beaune and Konsarrat, 1981). Ellipticine is a substrate 
of the mixed-function oxidase system and can be hydroxylated in the 
7- and 9-positions, and further sulphated or glucuronylated 
(Lecointe _et al, 1978). The 9-kydroxy derivative is the most 
potent inhibitor of mixed-function oxidase activities (Lesca _et al,
1980) and can inhibit the mutagenic activation of various carcinogens 
both by rat (Lesca at al, 1978a, b, 1979b) and human (Lesca, Beaune 
and Monsarrat, 1981) microsomes, and can decrease the in vivo 
carcinogenicity of dimethylbenzanthracene (Lesca and Mansuy, 1980).
As an inhibitor, 9-bydroxyellipticine is far stronger than metyrapone 
or OC-naphthoflavone and acts by binding to the haem moiety (Lesca 
et al, 1979a) and preventing reduction of the cytochrome by its 
reductase (Guenther, Kahl and Nebert, 1980). It has a much higher 
affinity for cytochrome P-W $  than P-A30 (Lesca et al, 1978b),which 
makes it a useful tool for studying the heterogeneity of the mixed- 
function oxidase system. Recently, an in vivo dose of 9-hydroxy- 
ellipticine has been established, which preferentially inhibits the 
cytochrome P-AA-8 activities of microsomes prepared from the pretreated
animals (Delaforge, Ioannides and Parke, 1980a). This has been 
confirmed and used to modulate cytochrome P-4A8 activities in the 
studies on the activation of polycyclic aromatic hydrocarbons 
(Chapter 6) and aromatic amines (Chapter 3)-
In contrast to the ellipticines, norharman (which also binds 
to the haem iron and non-competitively inhibits benzo(a)pyrene 
metabolism, Fujino et_ al, 1980) acts as a co-mutagen, possibly 
by directing metabolism along more mutagenic routes (Ashby, Elliot 
and Styles, 1980). Other inhibitors which have a higher, but not 
absolute specificity towards cytochrome P-^ f30j as opposed to P-AA8, 
include SKF 323-A (Lu jet al, 1973) and metyrapone (Jonen ejt al, 197*0* 
SKF 323A binds to the substrate site of cytochrome P-A30 and may be 
metabolized to an active form which binds to P-A30 producing a A33 nm 
peak (Kamataki jet al, 1980). Structure-activity relationships of 
cytochrome P-0?0 and P-Of8 inhibitors have been discussed in more 
detail in Chapter 1.
Finally, it should be kept in mind that a different sensitivity 
to inhibitors may be observed in purified systems, as opposed to 
microsomal preparations, as in the latter the inhibitory pattern 
will be that of the cytochrome P-A-30 isoenzyme most closely 
linked to.the limiting reductase (Kamataki et al, 1980). The 
differences in the purified system would most probably not be due 
to alterations in the haemoprotein structure, but in the structural 
organization of the microenvironment of the cytochrome.
MATERIALS AND METHODS .
The purified cytochromes P-A30 and P-O+8, prepared from 
rabbits pretreated with phenobarbitone andyS -napthoflavone 
respectively (i.e. LM^ and LM^) v/ere a generous gift of 
Drs. M. Delaforge and M. J. Coon (University of Michigan, Ann 
Arbor, MI, USA). Excess detergent had been removed, and the 
cytochromes (31*3 nmol/ml) and LM^ (39.1 nmol/ml) were 
reconstituted v/ith reductase (20 nmol/ml) and dilaurovl phospha­
tidylcholine (1 mg/ml, sonicated into solution in buffer), in an 
optimal ratio of 1 nmol cytochrome : 1 nmol reductase : 30/ug 
dilauroyl phosphatidylcholine (M. Delaforge, personal communication). 
For the assay of ethoxyresorufin O-deethylation, the system v/as 
reconstituted in the assay buffer (2 ml) and allowed to stand for 
3 minutes, but otherwise the conditions v/ere exactly the same 
as those described for microsomes (Chapter 2). * The inhibitor, 
9-hydroxyellipticine was dissolved in dimethylsulphoxide (DMSO), 
so that the final concentration within the assay mixture could 
oe achieved v/ith a maximum volume of 20 yul, as this quantity of 
DMSO had no effect on the reconstituted activity.
Male Wistar albino rats (130-200 g) were used in the induction 
experiments. In the time-dependence study, the animals received 
a single intra-peritoneal injection of 3-methylcholanthrene 
(20 mg/kg in corn oil) and were killed at regular time intervals. 
Alternatively, in the study of dose dependence, the animals 
received a single i.p. dose of benzo(a)pyrene (in corn oil) and 
were killed 2h hours later.
Preparation of hepatic microsomal supernatants (S9) and micro­
somes, and all the enzyme assays were conducted as previously 
described (Chapter 2). The microsomal supernatant v/as assayed 
for the N-demethylation of benzphetamine, while the 2- and A- 
hydroxylation of biphenyl, the 0—deethylation of ethoxyresorufin,
hydrocarbon hydroxylase and cytochrome P—A30 concentration 
were determined in resuspended microsomes. Both fractions were also 
assayed for protein concentration.
RESULTS •
The rate of ethoxyresorufin O-deethylation by the reconstituted 
mixed-function oxidase system incorporating LM^ was shown to be 
linear v/ith the concentration of the cytochrome (Figure 3*1) in the 
range of 0.03-0.30 nmol/ml. No activity could be detected in the 
absence of either the reductase or the cytochrome, although some 
residual activity (60}o of complete system) was detected in the 
absence of the lipid (results not shown). In contrast, when 
cytochrome P-A30 (LM^) was used in a similar system, no activity 
was detected even at 1 nmol/ral (Figure 3-1)*
When 0.1 nmol LM./ml was used in a complete reconstituted
-8
system, a marked inhibition (lc/~ = 9-2 x 10 M) was achieved using
30
9-hydroxyellipticine (Figure 3*2). Attempts to study the kinetics 
of this inhibition were hampered by very complex kinetic plots, 
which may be due to the involvement of more than one enzyme 
(results not shown). It was noted that the inhibitor did not 
affect the fluorescence of resorufin.
The time-course of induction of cytochrome P-AA8 activity is 
shown in Figure 3-3* Following a single administration of 
3-methylcholanthrene, the pattern of induction of biphenyl 2-hydroxy­
lase, aryl hydrocarbon hydroxylase and ethoxyresorufin O-deethylase 
were very similar. Hov/ever, the extent of induction of ethoxy­
resorufin O-deethylase, *f8 hours after carcinogen administration, 
was markedly higher (10-fold) than that of biphenyl 2-hydroxylase 
(3-fold) and aryl hydrocarbon hydroxylase (2-fold). The microsomal 
levels of total cytochrome P-A3O v/ere slightly raised (*fOk), while 
biphenyl A-hydroxylase was unaffected (Figure 3*3). There v/ere 
excellent correlations between the activities of the cytochrome 
P-¥f8 assays i.e. between ethoxyresorufin O-deethylase and aryl hydro­
carbon hydroxylase (r = 0.99); between ethoxyresorufin'O-deethylase and 
biphenyl 2-hydroxylase (r = O.96)' and.between the aryl hydrocarbon hydroxy­
lase and biphenyl 2-hydroxylase (r = 0.93)5 while there was no relationship
between any of these enzyme activities and biphenyl 4-hydroxylase.
Following a single administration of low doses of benzo(a)- 
pyrene, ethoxyresorufin O-deethylase and biphenyl 2-hydroxylase 
v/ere markedly induced, biphenyl 4-hydroxylation showed a modest 
induction, while aryl hydrocarbon hydroxylase and total cytochrome 
P-450 levels were unaffected (Figure 3**0«
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Figure 3«1» Ethoxyresorufin 0-deethylation by solubilised purified
preparations of LHq (cytochrome F-^Q) and LI1 (cytochrome 
P-M80.
A reconstituted system comprised haernoprotein (0-1 nmol), 
cytochrome P-^30 reductase (0-1 nmol) and dilauroyl phosphatidyl­
choline (0-30 pig). The reaction v/as initiated by addition of 
NADPH (0.3/rmol). ( D  ) 3^ M and ( © ) LM^.
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Figure 3»2*' Inhibition of the IMt[-mediated O-deethylation of ethoxy- 
resorufin by 9-fr.ydroxyellipticine
A reconstituted system as in Figure 3*1 with 0.1 nmol of LM^ was 
used. 9-Hydroxyellipticine v/as dissolved in DMSO; the total volume 
of DMSO in the incubation system never exceeded 1%.
Figure 3«3« Effect of a single dose of 3-raethylcholanthrene on ra~fc
hepatic microsomal cytochrome P-Vf8-mediated mixed 
function oxidases
Animals received a single intraperitoneal dose of 3“methyl~ 
cholanthrene (25 rng/I\g). Each point represents the mean _+ S.D. of 
at least k animals for (© ) ethoxyresorufin O-deethylase,
( □  ) biphenyl 2-hydroxylase, (O ) aryl hydrocarbon hydroxylase, 
and (®) biphenyl A—hydroxylase activities, and ( ^ ) ■'cytochrome 
P-^50 content.
Activities of liver microsomes from untreated (control) rats 
were: ethoxyresorufin O-deethylase, 0.57 nmol/mg protein per min; 
biphenyl 2-hydroxylase, 21 pmol/mg protein per min; aryl hydro­
carbon hydroxylase, 51 pmol/mg protein per min; biphenyl A-hydroxy- 
lase, O.38 nmol/mg protein per min and cytochrome P-^50, 0.88 nmol/ 
mg protein.
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Figure Hepatic microsomal mixed-function oxidases following
administration of small doses of berizo(a)pyrene
Animals received a single dose of the carcinogen and were killed 2k hours later. Each point represents the mean + S.D. of k- animals. 
Activities are expressed per nmole of cytochrome P-^-30 and cytochrome 
P-A-30 levels per mg of microsomal protein; (o ) ethoxyresorufin 
0-deethylase; (<&) biphenyl 2-hydroxylase; ( V) biphenyl k-hydroxylase; 
(©) aryl hydrocarbon hydroxylase, and (□) cytochrome P-^ +30.
DISCUSSION.
The observation that the hepatic microsomal ethoxyresorufin 
O-deethylation is induced following 3-^ethylcholanthrene administration, 
but is unaffected by phenobarbitone, implicated cytochrome P-AA8 
in this reaction (Burke and Mayer, 197^)• Subsequent studies by the 
same workers, using partially purified hepatic preparations of 
cytochromes P - ^ O  and P-AA8 (from rat) confirmed that cytochrome 
P-ijlf8 preferentially catalyses this reaction (Burke and Mayer,
1975)- Although cytochromes P-^30 and P-AA8 from rat and rabbit 
are not identical, according to molecular weight and immunological 
criteria (Lu and West, 1978; 1980), similar observations have 
been made in this study, using the purified, reconstituted rabbit 
mixed~function oxidase systems. Ethoxyresorufin was readily 
deethylated when the LM^ form (i.e. cytochrome P-AA-8 from^ -naptho- 
flavone-indubed rabbits) was reconstituted with cytochrome P-A50 
reductase and dilauroyl phosphatidylcholine (Figure 3*1)* This
activity was markedly inhibited by 9-bydroxyellipticine (I —  =
-8 50 
9.2 x 10 M), the specific P-AA8 inhibitor (Lesca e_t al, 1978b) as
shown in Figure 3*2. The reason for some residual activity being 
observed in the absence of added dilauroyl phosphatidylcholine 
was probably due to some trace amount of lipid or detergent 
remaining in the protein preparations (Szutowski, 1980), or alterna­
tively a less tightly coupled system may catalyse this reaction.
Lipid dependency does seem to vary with substrate in reconstituted 
systems (Lu and West, 1978). In contrast, no deethylation of 
ethoxyresorufin was detected, even when a 10-fold higher concentration 
of cytochrome P-A30 (LM^), isolated and purified from phenobarbitone 
pretreated rabbits, was used (Figure 3.1). Similar findings, 
regarding the specificities of LM^ and LM^ towards ethoxyresorufin 
have recently been reported by other workers (Guengerich et al,
1982; Nilsen _et al, 1981).
However, when studies were carried out to analyse the kinetics 
of ethoxyresorufin O-deethylation and its inhibition by 9-hydroxy- 
ellipticine, using the LM^ reconstituted system, very complex plots
resulted (not shown), which may have been due to the involvement 
of more than one enzyme. Some other v/ork in this laboratory 
(H. Masson, unpublished results) has indicated that in purified 
reconstituted systems from rats, the reductase itself may be 
involved in the deethylation of ethoxyresorufin, at higher 
substrate concentrations and in the presence of the haemoprotein. 
Alternatively the complex kinetics may be the result of the LM^ 
preparation being a mixture of different proteins (Guengerich,
1979)> which may have different apparent Km’s and Vmax’s towards 
this substrate. Other workers have expressed problems in the 
kinetic analysis of this assay, due to the low solubility of the 
substrate in the aqueous environment, and the extremely low 
optimal concentration of ethoxyresorufin, which may result in 
its depletion during incubation (Burke, Prough and Mayer, 1977)*
The assay is also affected by both substrate (Warner and Neirns,
1979) and product (Pohl and Fouts, 1980) inhibition. The 
difficulties in kinetic interpretation of mixed-function 
oxidase reactions are discussed in more detail in Chapter 1.
Similar work has been carried out in this department, using 
purified rat hepatic cytochrome and P-AA8, which shov/ed the
same specificity of reconstituted activity toward ethoxyresorufin 
as did the rabbit preparations. Also of relevance to work presented 
in later chapters is the observation that benzphetamine N-demethylation 
is specific for the cytochrome P-**50, but not the cytochrome P-AA8 
form from induced rat liver (H. Masson, unpublished work).
Since the O-deethylation of ethoxyresorufin is specifically 
catalysed by cytochrome P-A48, this assay may provide a useful 
technique to monitor this form of the cytochrome, especially as 
less than 1 pmol resorufin per ml can be detected (Burke and Mayer, 
197^)* However, it seemed advisable to compare this assay with 
others which are commonly used to estimate cytochrome P-AA8 i.e. 
biphenyl 2-hydroxylation and aryl hydrocarbon hydroxylase (AHH), 
using benzo(a)pyrene as substrate. Neither of.these two methods
have proved to be fully satisfactory. Although the specificity 
of biphenyl 2-hydroxylation for cytochrome P-AA-8 has been 
demonstrated using purified preparations (Burke and Mayer, 1973)} 
it is only a minor route of metabolism (Creaven et al, 1963)} an^ 
in the fluorimetric assay is determined in the presence of much 
higher levels of ^-hydroxybiphenyl, which also contributes to the 
fluorescence. Therefore, for each sample a correction factor for 
this contribution has to be applied, which renders the assay less 
sensitive. The 2-hydroxybiphenyl is also unstable in its exciting 
light wavelengths, making the timing during fluorescence measurements 
critical (Bridges jst al, 196.5) • Gas liquid and high pressure liquid 
chromatography methods have been developed (Haugen, 1981), but 
these are not suitable for rapid screening of many samples and 
are not generally used. Furthermore, results from fluorescent 
and HPLC methods are not always in agreement (compare Haugen,
1981 and Burke and Mayer, 1975)* Further technical difficulties 
include the dependence of the distribution of the 2-, 3- and k- 
hydroxy metabolites on the solvent used for the biphenyl (Haugen, 
1981). Also, in common with other mixed-function oxidase assays, 
the substrate in extremely hydrophobic and can only be used at 
very low concentrations (0.1 - 0.2 mM) to avoid visible precipitation, 
and it must be ensured that the biphenyl concentration saturates 
both pathways of metabolism (Burke and Mayer, 1973)* The Tween 80 
used as a substrate solubilizer may also inhibit the reaction 
(Burke and Bridges, 1973)* In addition to these problems, in the 
rat and rabbit at least, biphenyl 2-hydroxylase activity reaches a 
maximum at about 3 weeks of age and disappears rapidly (Basu,
Dickerson and Parke, 1971; Creaven et al, 1963)} so it may be 
difficult to monitor basal cytochrome P-AA8 activities in older 
animals by this method.
As mentioned in the introductory section of this chapter, 
there is really very little evidence to suggest that AHH is an 
assay specific to any particular isoenzyme of cytochrome P-^30.
Also, this assay only detects a portion of the total metabolites
of benzo(a)pyrene, and because different forms of cytochrome P-k^O 
can oxygenate benzo(a)pyrene in different positions (Nebert and 
Jensen, 1979)1 they will differ in their contribution to the 
fluorescence measured. The metabolism of benzo(a)pyrene and other 
polycyclic aromatic hydrocarbons is considered in detail in 
Chapter 6. The AHH assay is also troubled by numerous technical 
variables, and the activity may be altered by the solvent used 
for the substrate and the conditions used during preincubation 
(Yang, Stickhart and Kicha, 1978). Benzo(a)pyrene has a very low 
solubility in water (estimated as 9-2k nM), so most of the benzo(a) 
pyrene added to the incubation must be adsorbed onto the glass, 
lipids, proteins or be simply undissolved (Hansen and Fouts,
1972). The binding of benzo(a)pyrene to non-enzymic protein 
sites decreases the concentration of free substrate and limits 
the overall rate of benzo(a)pyrene metabolism (Sims, 1970). There­
fore, solubilization of undissolved substrate may contribute to 
the overall rate of product formation. Also, the profile of benzo(a)- 
pyrene metabolites depends on both protein and substrate concentration, 
and with limiting substrate there is a recycling of benzo(a)pyrene 
metabolites, which are further oxygenated and may be conjugated 
or covalently bound to nucleophilic sites. These further metabolites 
will not fluoresce, and may be the reason for the lack of linearity 
which may be observed after 3-10 minutes incubation (De Pierre and 
Ernster, 1978; Holder et al( 1973)* Considering these points, it 
is perhaps not surprising that the assay does not lend itself to
analysis by Michaelis-Menten kinetics (Hansen and Fouts, 1972).
%
As a result, there is great variability in the literature for 
AHH activities quoted for similar samples by various laboratories.
For example, the values for control male rat hepatic preparations 
may range from 60 pmol (Tliorgeirsson et al, 1979) to I.Oyamol 
3“hydroxybenzo(a)pyrene/min per mg protein (Stohs and Wu, 1981).
The different methods available for measuring AHH‘have different 
limits of sensitivity, the version used in this chapter being 
the most sensitive (detection limit 0.2 pmol), and the alternative 
assays may result in different estimations of this activity in the
same sample (Finnen et al, 1983)- The actual 3-hydroxybenzo(a)- 
pyrene standard is seldom authentic and may contain other phenolic 
derivatives with similar fluorescence properties, so it is not
strictly true to express the results with respect to the 3-hydroxy
metabolite (Nebert, 1979)* In addition, there is a lack of 
linearity in the standard curve at the region generally measured 
during metabolism (Dehnen et al, 1973)*
When the assay was evaluated (see Chapter 2), it was observed 
that there was a loss in the 3-hydroxy standard with time,
especially rapid over the first 10 minutes of incubation. The
loss of fluorescence was greater in the microsomes from 3-methyl~ 
cholanthrene-induced rats compared to controls, suggesting more 
extensive further metabolism in the former, in agreement with 
others (Hansen and Fouts, 1972). This may explain the lack of 
linearity of the reaction with time. Other workers have shown, 
using HPLC, that a variety of metabolites may be formed by 
incubating 3- and 9-hydroxybenzo(a)pyrene with rat liver microsomes 
(Capdevila, Lubet and Prough, 1980). The assay was only linear up 
to O .67 mg protein (as opposed to 2.0 mg protein, quoted by 
Nebert, 1979)» which may be due to depletion of substrate as 
a result of its binding to non-enzymic sites (Hansen and Fouts, 
1972; Sims, 1970).
The pattern of induction of biphenyl 2-hydroxylase, aryl 
hydrocarbon hydroxylase and ethoxyresorufin Odeethylase was very 
similar, following a single administration of 3-methylcholanthrene 
(Figure 3*3)• However, the extent of induction of ethoxyresorufin 
0 -deethylation, A8 hours after carcinogen administration (10-fold) 
was more pronounced than that of biphenyl 2-hydroxylation (3-fold) 
and aryl hydrocarbon hydroxylation (2-fold). The initial decrease 
in these activities may have been due to competitive inhibition 
by 3-methylcholanthrene or a metabolite present in the liver. The 
total microsomal concentration of cytochrome P-A30 was slightly
increased (by kCP/o) ^ while biphenyl k-hydroxylation was relatively 
unaffected (Figure 3-3)- These results are qualitatively similar 
to those published by Burke, Prough and Mayer (1977)» although 
there may be large tissue and species differences in the inducibility 
of AHH (De Pierre and Ernster, 1978). The similarity in the pattern 
of induction is reflected by excellent correlations between the 
three pairs of activities. This is in agreement with ethoxy­
resorufin 0 -deethylation, biphenyl 2-hydroxylation and AHH all 
being associated with a single genetically controlled locus, 
comparable to the Ah locus of mice (Nebert, 1978; Nebert and 
Jensen, 1979)* Nebert’s group, using heterogeneic mice, have also 
shown a good correlation between AHH and ethoxyresorufin 
0 -deethylase, and a reasonable correlation between each of these 
two assays and biphenyl 2-hydroxylation (Lang, Gielen and Nebert,
1981). However, other workers (Levi and Hodgson, 1983) have 
failed to show any correlation between these activities using 
purified cytochrome P-k^O fractions from uninduced mouse liver 
although there was a good correlation between ethoxyresorufin 
O-deethylation and biphenyl ^f-hydroxylation in these preparations. 
Conversely, in the present studies with rats, no correlation could 
be observed between biphenyl 2-hydroxylation, AHH or ethoxyresorufin 
O-deethylation and biphenyl ^f-hydroxylation. These similar patterns 
of induction may reflect a common control mechanism for the three 
former activities, but this should not be taken as synonymous with 
their being catalysed by the same isoenzyme. Indeed, polycyclic 
aromatic hydrocarbons and other inducers stimulate the synthesis 
of more than one isoenzyme of the microsomal cytochromes P-A^O 
(Lau and Strobel, 1982) and there is evidence that the Ah locus 
in mice controls the induction of more than one form of the cytochrome 
(Nebert, 1979)- The different extents of induction also tend to argue 
against the involvement of only one isoenzyme catalysing all three 
activities, unless it is considered that there are different sites 
on the protein associated with the different substrates, or that 
perhaps the ethoxyresorufin is able to convert the cytochrome P-AA8 
into a higher spin state (and thus more readily reducible) than the
other substrates. This concept is covered in more detail in 
Chapter A.
Administration of small doses of benzo(a)pyrene to the animals 
resulted in a marked induction of ethoxyresorufin0 -deethylation 
and biphenyl 2-hydroxylation, with a modest effect on biphenyl 
^f-hydroxylation, while aryl hydrocarbon hydroxylase and total 
cytochrome P-^30 concentration remained fairly constant (Figure 3«^)« 
The ethoxyresorufin 0 -deethylase responded at a lower concentration 
of benzo(a)pyrene (0.03 mg/kg body weight) than did the other assays. 
The above arguments again hold for suggesting that it is probably 
not the same isoenzyme catalysing these three reactions, and if they 
do indeed have a common control mechanism as postulated before, 
this study suggests that the structural gene for the isoenzyme 
catalysing ethoxyresorufin 0 -deethylation must be derepressed at 
lower levels of activity of the regulator gene than is true for 
the isoenzyme(s) responsible for the other activities. An alternative 
explanation may be that the activation does not occur at a genetic 
level, but that ethoxyresorufin has some allosteric effect on an 
induced isoenzyme common to all activities. A major criticism 
which must be levelled at these induction studies, is that of 
necessity all the microsomes had been frozen and stored for a few 
days at -80°C. Although ethoxyresorufin O-deethylation and 
biphenyl 2-hydroxylation were never adversely affected by the 
freezing process, and according to Nebert (1979) the AHH activity 
stores well at -80°C, fresh AHH activity was not assayed in these 
preparations. In retrospect this was unfortunate, as recently it 
has been shown (Leboef et al, 1981) that as much as 70% AHH activity 
of human microsomes is lost on freezing, although the activity 
then stores well when microsomes are kept frozen. When it is also 
considered that control and induced AHH activities are not identical 
(Nebert, 1979* Kyan at al, 1982), it is possible that the apparent 
low inducibility of this activity is due to preferential loss of 
induced AHH activity on freezing.
CONCLUSIONS.
Studies with cytochrome P-A48 inducers have shown that 
biphenyl 2-hydroxylase, ethoxyresorufin O-deethylase and aryl 
hydrocarbon hydroxylase all have a similar time-course of induction. 
However, ethoxyresorufin O-deethylation was increased to a greater 
multiple of its control state than the other assays, and was also 
induced by lower concentrations of benzo(a)pyrene than the other 
activities. This suggests that the O-deethylation of ethoxyresorufin 
is the most responsive assay to altered levels of cytochrome P-AA8 .
It was also more rapid and reproducible than the other assays, and 
not marred by so many technical pitfalls.
The specificity of ethoxyresorufin O-deethylation for cytochrome 
P-¥f8 was confirmed, using the rabbit purified preparations, as was 
the high affinity of 9-hydroxyellipticine as an inhibitor for this 
form of the cytochrome. Similarly, benzphetamine N-demethylation 
has been shown to be fairly specific for the cytochrome P-^50 form 
induced typically by phenobarbitone.
The relationship between the cytochrome P-A^O isoenzyme(s) 
which catalyse both the activation of benzo(a)pyrene to mutagens 
and the O-deethylation of ethoxyresorufin is considered in detail 
in Chapter 6.
C H A P T E R
CHAPTER A. FURTHER STUDIES ON 9-HYDROXYELLIPTICINE
AND THE SUBSTRATE BINDING SITES OF 
CYTOCHROME P-AA8 .
INTRODUCTION .
General .
The carcinogen-induced cytochrome P-AA8 has different substrate 
specificity to the phenobarbitone-induced cytochrome P-A30 and is 
able to oxygenate molecules in sterically-hinaered positions (see 
Chapter 3)- Also, induced cytochrome P-AA8 may contain traces of 
the inducing agent or its metabolite. This is still a matter of 
controversy, with some authors maintaining that 3-raethylcholanthrene 
is bound to the cytochrome in a 1 : 1 ratio (Hashimoto and Imai,
1976), whereas others (e.g. Stern ert al, 1973; Witmer et al, 1973) 
have only been able to identify trace amounts of inducer remaining 
bound after washing.
These points have led to speculations concerning the substrate 
binding site of cytochrome P-AA8 and the mechanism of oxygenation. 
Three major alternatives are possible:-
(i) The type I substrate binding site of cytochrome P-A48 is much 
larger than that of cytochrome P-A30 so allowing positional 
differences in hydroxylation.
(ii) Perhaps due to bound inducing agent, cytochrome P-AA8 cannot 
accept another substrate, but instead activates oxygen to super­
oxide or peroxide, which may then hydroxylate substrates non- 
enzymically through the production of hydroxyl radicals (Ingelman- 
Sundberg and Habjbrk, 1982).
(iii) The cytochrome and the reductase may not be well coupled, 
thus allowing hydroxylation of the substrate through production 
of active oxygen species by single electron reduction by the 
flavoprotein reductase (Bosterling and Trudell, 1981; Lai, Grover 
and Piette, 1979).
In this chapter, spectral binding studies are presented, 
whereby the first of these possibilities has been investigated.
In addition further studies have been carried out on 9-hydroxy- 
ellipiticine in relation to its binding to and induction of cyto­
chrome P-AA8 , and also its mutagenicity.
Substrate Binding and Associated Spectra .
Much of the following information, unless otherwise indicated, 
has been drawn from two recent, comprehensive reviews (Jefcoate,
1978; Schenkman, Sligar and Cinti, 1981).
Haemoproteins undergo spectrophotometrically observable 
transitions, associated with changes in the electronic configuration 
of their iron-porphyrin prosthetic group. Characteristic spectra 
are formed when substrates bind to cytochrome P-A30, as defined in 
Diagram ^.1., and these depend on both the chemical structure and 
the isoenzyme of cytochrome P-A30. A single chemical may be able to 
bind in more than one way, depending on its functional groups.
Electron paramagnetic resonance (EPR) studies have indicated 
that cytochrome P-A50 may exist in different spin states, which 
are controlled by the axial ligation of the porphyrin iron (Scheidt 
and Reed, 1981). In the ferric high spin state, all the electrons 
of the 3d shell of the iron are distributed singly in each of the 
five electronic orbitals, two of which (due to the porphyrin structure) 
are in a higher energy state (s = 5/^). However, in the ferric low 
spin haem iron all of the electrons are in the lower energy level 
orbitals (s = /^2) as depicted in Diagram A.1. Four of the 
possible six ligands of the iron are occupied by the porphyrin 
nitrogens, while the fifth (perpendicular to this plane) is a thio- 
late ligand (presumably to a cysteine of the apoprotein) (Hahn 
pi. H i ’ 1982). The field strength of this ligand is so strong that 
the binding of the sixth ligand (however weak) results in a low-spin 
change (Sono and Dawson, 1982). There has been some controversy over
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the nature of the endogenous sixth ligand, and although it was origin­
ally believed to be nitrogenous (e.g. an imidazole group in the apo­
protein) , evidence has more recently accumulated to suggest that an 
oxygenous ligand is more likely, possibly an oxy-amino side chain from 
the protein structure or H2O (Dawson, Andersson and Sono, 1982; Yosh- 
ida, Imai and Hashimoto-Yutsodo, 1982). When the endogenous sixth lig­
and is displaced (for example by the binding of a substrate to the 
apoprotein), the resulting 5~coordinate haem iron is in a high spin 
state. The absolute optical spectra of cytochrome P-450 can be resolved 
into low spin ( peak at 4l6nm) and high spin ( peaks at 392nm and 645nm) 
components. A conversion from low to high spin states therefore results 
in a drop in the 4l6nm peak and an increase in the 592nm peak, and 
therefore the characteristic ’type I* difference spectrum. A large 
number of compounds do give this type of spectral change, presumably 
due to their binding to the substrate site of the apoprotein.
Certain chemicals, most particularly those possessing a 
primary amine group, bind to the ferric form of the cytochrome 
as a sixth ligand, forming a low-spin ferrihaemochrome. This 
results in a typical ’type II’ spectral change. A third type 
of spectrum can arise, known as the ’reverse type I ’, in which 
the iron is 6-co-ordinated with a weak ligand (e.g. butan-1-ol), 
so that it is stabilized in a low spin state, v/hich is different 
from that caused by the endogenous ligand (Guenthner, Kahl and 
Nebert, 1980).
The cytochrome P-4-50 isoenzymes in microsomes will be present 
in a mixture of spin states. Generally, the phenobarbitone- 
inducible P-4-50 is in a low spin state, while 3-methylcholanthrene- 
induced cytochrome P-Vf8 is usually in a high spin state. This may 
be related to inducer being bound to this isoenzyme (vide supra), 
although there is generally more high spin form than can be accounted
for by the presence of 3-methylcholanthrene (jefcoate, 1978), and cyto­
chrome P-448 can be in a high spin configuration even in the absence of 
bound hydrocarbon, although such compounds do stabilize the high spin 
state (imai, 1982b). Lipids, especially polyunsaturated free fatty 
acids are important in the spin equilibrium, and can themselves give a 
type I spectrum (Schenkman, Sligar and Cinti, 1981). Binding spectra de­
pend on the spin states of the mixture of cytochromes P-450 and the 
actual fractional change in spin-state elicited by the compound itself, 
together with other factors such as temperature, pH, substrate concen­
tration etc. Some chemicals,such as barbiturates and sex steroids can 
give a type I spectrum at low concentrations, but a reverse type I spect­
rum at higher concentrations. This latter type of spectrum is more likely 
to occur with microsomes ‘from 3-^ethylcholanthrene-induced animals (Guen- 
thner, Kahl and Nebert, 1980), so emphasising the need to use a wide 
range of substrate concentrations in this type of study, particularly 
as these two types of spectra can cancel each other out (Witmer e_t al, 
1975)* However, as spectral changes are reversible and dependent on 
both protein and substrate concentration, the data are amenable to 
Michaelis-Menten kinetics (as derived by Schenkman, 1970). It is not 
however reasonable to attempt to correlate the apparent substrate bind­
ing constant (Ks) with the of its metabolism, as this could only be 
valid if substrate binding, as opposed to dissociation were the rate- 
limiting step, and cannot take into account the partitioning of hydro- 
phobic substrates into the microsomes. It is not surprising, therefore, 
that these constants are very often not equivalent ( see, for ex­
ample, Burke and Bridges, 1975 5 Guarino _et al, 19&9 > Jefcoate,
1978 ). It must be remembered that sustrate binding is important 
in determining the rate of metabolism, although the kinetics of 
the mixed-function oxidase system are very complex and are affected 
by many factors , as discussed by Gander and Mannering,^1980).
The high spin state of the iron is generally believed to have a 
more positive mid-point potential , so that when a type I substrate 
is bound the rate of reduction of the complex by the reductase 
is normally increased. Conversely, the binding of a substrate 
to the type II site interferes with the interaction of the reduct­
ase ( see Diagram 4*1 ) (Guenthner, Kahl and Nebert, 1980 ).
Interestingly, the reduction of cytochrome ~P-k^O is itself associated 
with remarkable conformational changes (imai, 1982b). Recently 
published work (Guengerich, 1983), using purified cytochromes P-V?0 
have shown that many substrates may not produce significant changes 
in the apparent iron spin state, even when binding could be demon­
strated by alternative methods. In addition, the spin state could 
not necessarily be correlated with either the redox potential (which 
was a function of the substrate bound) or the catalytic activity of 
reconstituted enzyme systems. It appears that in microsomal systems, 
the changes in spin state are more pronounced.
9-Hydroxyellipticine.
The inhibitory properties of 9-dydroxyellipticine towards the 
mixed-function oxidase system have already been considered in 
Chapter 3* In this chapter, the actual binding of 9-Hydroxy- 
ellipticine to the terminal oxygenase is considered in more detail, 
together with an investigation of its role as an inducer of 
cytochrome P-44-8 and its mutagenicity.
9-Hydroxyellipticine is one of the major metabolites of 
ellipticine and may be sulphated or glucuronylated, although there 
is no evidence that it is further metabolized by the mixed-function 
oxidase system (Lesca and Mansuy, 1980; Paoletti et. al, 1978). 
Although it has the highest antineoplastic activity of all the 
derivatives (Paoletti et al, 1978), some preliminary studies have 
shown that 9-hydroxyellipticine is a direct mutagen towards strains 
TA98 and TA1538 of Salmonella typhii.iurium, but requires metabolic 
activation to express mutagenicity towards strain TA100 (Lecointe 
et_ al, 1978; Lesca et al, 1979b). Its anticarcinogenicity and 
mutagenic potential may have a common mechanism through intercalation 
with the DNA, although it is more cytotoxic and less mutagenic than 
its parent compound (Paoletti et al, 1978).
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Ellipticine and especially its 9-hydroxy derivative are 
strong inhibitors, both in vivo and in vitro, of mixed-function 
oxidase activity (considered in more detail in Chapter p).
They interact with the sixth haem ligand of the cytochrome 
through their basic pyridinic nitrogen (Paoletti et al, 1981), 
binding very strongly to give a type II spectrum (Lesca at al, 1979a).
It has been shown that 9-hydroxyellipticine has an especially high 
affinity for the heam iron of. cytochrome P--148 (Lesca afc al, 1978a, 
b). These authors suggested that at higher concentrations 9-hydroxy­
ellipticine could, due to its bow-shaped polycyclic structure, inter­
act with the type I site of cytochrome P-lpO (see Diagram 9-.2). This 
was postulated to explain the competitive nature of P-L18 inhibition 
which they found (Lesca at al, 1980). The types of 9-hydroxyellipticine 
binding have been clarified by studies presented in this chapter.
HO
Diagram 4-.2. Schematic representation of 9-hydroxyellipticine 
binding to cytochrome P-150, showing possible 
type I and type II interactions 
(taken from Lesca et al, 1980).
The parent compound, ellipticine, has been shown to be a good 
inducer of its own metabolism (Lesca e_t al, 1981) and to induce 
P-¥f8 type activity (Paoletti at al, 1978). This can result in 
the increased metabolism of benzo(a)pyrene to, DNA-binding metabolites, 
although the form of cytochrome was believed to be different from that 
induced by 3>-raethylcholanthrene and/5-naphtoflavone (Lesca and Mansuy,
1980). The inductive effect of 9-hydroxyellipticine has also been 
studied in this chapter.
MATERIALS AND METHODS»
Male V/istar albino rats (150-200 g) were used in all the 
induction experiments. Induction by phenobarbitone and p-methyl- 
cholanthrene and inhibition by 9-hydroxyellipticine were achieved 
as described in Chapter 2. For the 9-hydroxyellipticine induction 
experiment, the animals received either a single intra-peritoneal 
dose (20 mg/kg body weight) of :9-hydroxyellipticine in corn oil, 
or a single daily dose for three consecutive days. In the study 
with inhibitors of protein synthesis, the animals received a 
single injection (i.p.) of 9-hydroxyellipticine (20 mg/Rg body 
weight) together with actinomycin D (in 0.91 saline) 2l hours 
before (0.5 mg/kg body weight), and 16 hours before (0.25 nig/Rg 
body weight) killing. Alternatively, they received in addition 
to the single dose of 9-hydroxyellipticine, cycloheximide (in
0.91 saline) 2l hours before (2 mg/kg' body weight) 
and 16 hours before (1 mg/Rg body weight) preparation 
of liver microsomal fractions. Two groups of animals received 
corn oil and either actinomycin D or cycloheximide. In all 
cases, the animals were killed 2l hours after the last 
administration of 9-hydroxyellipticine or corn oil. The 
preparation of S9 fractions and microsomes and the assay of 
enzyme activities and protein were exactly as described in 
Chapter 2. The efficiency of the various S9 preparations (in the 
9-hydroxyellipticine-induction experiment) in activating benzo(a) 
pyrene to intermediates mutagenic to the TA100 strain of 
Salmonella typhimurium was also investigated. Similarly, the 
mutagenicity of 9-hydroxyellipticine to strains TA 98 and TA 100 
were determined in the presence or absence of an activating 
system derived from an Aroclor-pretreated rat. The standard 
Ames plate test method v/as used (see Chapter 2).
The source and specification of the purified preparations 
of cytochrome P-I50 (LM-,) and P-118 (LM^) were exactly as 
described in Chapter 3-
Substrate binding to■cytochromes P-150 and P-118, with a 
selection of type I and type II substrates, was studied using 
a Varian Cary double-beam spectrophotometer coupled with 
automatic base-line correction (Jefcoate, 1978). Microsomes (25% 
with respect to liver weight, in 50 mM potassium phosphate buffer, 
pH 7«1) containing 20% glycerol and 1 mM EDTA) were further 
diluted 1 : 10 in 0.1 M potassium phosphate buffer, pH 7*1 to 
give approximately 1 nmol cytochrome (assayed to
establish actual value). The purified rabbit liver cytochromes,
LM^ and LM^ were also diluted in 0.1 M phosphate buffer, pH 7-1 
to give a final suspension of 1 nmol/ml. These suspensions were 
divided between two cuvettes and a corrected baseline drawn.
Then required concentrations of substrate were added to the 
sample cuvette (with an equal volume of solvent in the reference) 
and the spectrum scanned between 370 nm and 500 nm. Pento­
barbital, hexobarbital, safrole, biphenyl, and 9-hydroxy­
ellipticine v/ere all dissolved in N,N-dimethyl formamide•
(DMF) and were made at a sufficient concentration to restrict 
the addition of DMF to about 0.1% of the volume in the cuvette. 
Aniline HC1 and benzphetamine HC1 were dissolved in water and 
neutralised v/ith KaOH, while perhydrofluorene and 1-phenylhexane 
were added as oily liquids in microlitre quantities and allowed 
time to equilibrate before scanning. As 9-hydroxyellipticine 
absorbs light in the region of interest, dual compartment cells 
were used. In these, the microsomal or pure cytochrome suspensions 
were placed in the front, and buffer v/as placed in the back, 
compartment of each cell. The substrate was then added to the 
front compartment of the sample cuvette, but in the back 
compartment of the reference, and solvent v/as placed in the other 
compartment of each. In this way, the contribution to the 
spectrum of the absorbance of the substrate v/as cancelled out.
In addition to substrate-binding spectra, absolute spectra 
were run in order to study the spin state of the iron in the 
P-150. In this case only the pure preparations, LM^ and LM^, 
were used and the spectrum v/as run against buffer in the range 
370 - 700 nm.
RESULTS.
Substrate Binding Studies ♦
The type II substrate, aniline, gave a typical type II spectrum 
with liver microsomal preparations from both phenobarbitone- and 
3-methylcholanthrene-induced rats, and with LM^ (P-150) and LM^ 
(P-118) purified cytochromes from rabbits. Similarly, the type I 
substrates pentobarbital, benzphetamine, hexobarbital, perhydro- 
fluorene and 1-phenylhexane interacted with the microsomal 
preparation from phenobarbitone-induced rats and the purified 
LM2 cytochrome, eliciting type I spectra. However, none of 
these type I substrates interacted with the microsomes from 
3-methylcholanthrene-treated rats or the LM^ purified cytochrome 
to give a characteristic spectrum (Table 1.1).
In contrast, safrole interacted with both cytochromes P-I50 
and P-118, both in the induced microsomes and in the purified 
preparations to give typical type I spectral changes (Figure 1.1). 
When perhydrofluorene was added to both reference and test 
cuvettes at concentrations that saturate the type I binding site, 
microsomes from phenobarbitone-induced animals and the LM 
purified cytochrome showed greatly decreased type I binding 
spectra with safrole. _In contrast, the microsomal preparation 
from '3-niethyl cholanthrene-induced animals and the LM^ 
preparation showed little change (Figure 1.1).
The interaction of 9-hydroxyellipticine with liver 
microsomes from both 3-methylcholanthrene- and phenobarbitone- 
induced rats gave a type II spectrum, with an asyrnmetric trough 
(Figure 1.2). Similar interactions were observed with the 
purified cytochromes P-I50 (LM2) and P-118 (LM^ _) from rabbits 
(Figure 1.2). A Lineweaver-Burke plot, using the difference 
in absorbance between the peak and the trough of the 9-hydroxy­
ellipticine spectrum, revealed an apparent Kq of 0.71/jlM for
microsomes from 3-methylcholanthrene-induced rats, and a value 
of 1.08/414 for microsomes from phenobarbitone-induced rats 
(Figure 1.3). Addition of the type I substrate, benzphetamine 
(0.1 mM) to both reference and test cuvettes, to saturate the 
type I binding site, resulted in an increase in the spectral 
interaction of 9-hydroxyellipticine with liver microsomes 
from phenobarbitone-induced rats. This was accompanied by a 
disappearance of the asymmetry and a shift of the spectrum to 
lower wavelengths (Figure 1.1). However, no similar changes were 
seen v/hen microsomes from the 3-roethylcholanthrene pretreated 
rats were used. When the solubilized cytochromes, LM^ and LM^, 
were used, similar results were obtained, perhydrofluorene 
augmented the 9-hydroxyellipticine spectrum, eliminated the 
asymmetry and shifted the spectrum with LM , but not LM^ (Figure
1.5).
In contrast, v/hen safrole (0.2 mM) instead of perhydro­
fluorene or benzphetamine was added to both test and reference 
cuvettes, there was an increase in the spectral interaction of 
9-hydroxyellipticine, a shift to lov/er v/avelengths and a loss of 
spectral asymmetry, with the liver microsomes from 3-roethylcholan- 
threne-induced rats (Figure 1.6), but this time no similar effect 
was seen with microsomes from phenobarbitone pretreated animals. 
With the purified rabbit hepatic LM^ and LM^ preparations, similar 
results were obtained (Figure 1.7)*
Administration of 9-hydroxyellipticine 1 hour before killing 
the animals resulted in competitive inhibition of the binding of 
safrole to the microsomes from 3-roethylcholanthrene-induced rats, 
but had very little effect on the binding to microsomes from 
phenobarbitone-induced animals (Figure 1.8).
Finally, an absolute spectrum v/as run of both the LM^ anh 
LM^ _ rabbit preparations, which revealed by the relative heights 
of the peaks at 390 nm and ll8 nm that was 60-70% high spin,
while LML, was predominantly in the low spin form. Addition of the 
type I substrate, perhydrofluorene, resulted in an almost total 
conversion of LM2 to a high spin state, by the emergence of a peak 
at 390 nm (Figure 1.9).
Mutagenicity of 9-Hydroxyellipticine and its Induction of Cytochrome 
P-118 .
Twenty-four hours after the administration of a single dose of 
9-hydroxyellipticine, a marked increase v/as seen in the ethoxy­
resorufin O-deethylase activity (10-fold) and in the 2-hydroxylation 
of biphenyl (10-fold) (Table 1.2). In contrast, there were no changes 
in the 1-hydroxylation of biphenyl, N-demethylation of benzphetamine 
or NADPH-dependent reduction of cytochrome c. The microsomal levels 
of cytochromes P-I50 and b^ were unchanged. However, the 9-hydroxy- 
ellipticine-pretreated animals were much more efficient in activating 
benzo(a)pyrene to mutagens in Salmonella typhimurium (TA 100), than 
were control animals (Figure 1.10A). In the absence of benzo(a)- 
pyrene there was no increase in the number of histidine revertants 
above the spontaneous rate, indicating that residual amounts of 
9-hydroxyellipticine, itself a weak mutagen, must have been very 
low or absent in the S9 mix (data not shov/n).
Repeated administration of 9-hydroxyellipticine resulted in 
small, statistically non-significant increases in ethoxyresorufin 
O-deethylase and biphenyl 2-hydroxylase activities (Table ^.3 ).
There were no changes in biphenyl k-hydroxylase and NADPH-cyto- 
chrorne c reductase activities, but benzphetamine N-demethylation 
v/as slightly lowered. Similarly, there were no changes in 
cytochrome P-450 and b^ levels. Microsomal preparations from 
9-hydroxyellipticine pretreated animals were more efficient than 
controls in activating benzo(a)pyrene to mutagens.(Figure 1.10B), 
but the effect v/as less pronounced than that observed following 
a single administration.
Administration of the protein synthesis inhibitors, cyclo- 
heximide and actinomycin D, prevented the enhancement of ethoxy­
resorufin O-deethylase following a single i.p. dose of 9-hydroxy­
ellipticine, but had little effect on the demethylation of benz­
phetamine (Table A. A). In addition, the same inhibitors of protein 
synthesis prevented the increase in the efficiency of activation 
of benzo(a)pyrene to mutagens in Salmonella typhimuriurn (TA 100) 
following a single administration of 9-hydroxyellipticine 
(Figure A-.11).
9-Hydroxyellipticine v/as shown to be a weak direct mutagen 
to both TA' 98 and. TA.100 strains of Salmonella typhimuriurn, at 
the concentrations studied (Figure A.12). At higher concentrations, 
9-hydroxyellipticine was toxic to the bacteria.
TABLE k.'l Spectral characteristics of the binding of various
substrates to microsomes from phenobarbit-.i'tone- and 
3-meth,ylcholanthrene induced rats and purified 
rabbit cytochromes P-^50 (HL,) and P-kk8
Microsomes from phenobarbitone-induced rats(PB, 1.2 nmol 
cytochrome P-k^O/ml) and from 3-niethylcholanthrene-induced rats 
(3-MC, 0.7 nmol cytochrome P-V?0/ml) and purified rabbit 
cytochromes P-V?0 (LM ) and P-A48 (LM^), both at a concentration 
of 1 .Qnmol/ml, were all suspended in 0.1M phosphate buffer, pH 7-A.
Substrates" were added (at the concentrations shown) to the 
sample cuvette, and for 9-*hydroxyellipticine, dual7compartment 
cells were used.
TABLE A.1.
Substrate Preparation
Wavelength 
Peak Trough 
(nm)
Type of 
Binding
Aniline PB A31 A02 ] Asymmetrical
(0.5-10 mM) 3-MC A30 A00 J type II
9-Hydroxyellip- PB • A28 A08
ticine 3-MC A29 ^09 Asymmetrical
(0.5-20 /vM) LM A30 A11 type II
LMi+ A26 393
Benzphetamine PB 38A A21 Type I
(0.05-0.10mM) 3-MC no spectrum -
T M2 38A A21 Type I
LM7A no spectrum -
Pentobarbital PB 386 A22 Type I
(1-10 mM) 3-MC no spectrum -
Hexobarbital PB 386 A23 Type I
(0.5-2.0 mM) 3-MC no spectrum -
Safrole PB 390 A20 Type I
(0.1-0.2 mM) 3-MC 38A A20 Type I
LM 386 A20 Type I
LM7A 381 A20 Type I
Perhydrofluorene LM 386 A20 Type I
(1 AL) LK7A AA5 A15
0
1-Phenylhexane LM 388 A20 Type I
(1 Al) LM,A no spectrum
TABLE 4.2.
Effect of a single administration of 9-hydroxyellipticine on the 
rat hepatic microsomal mixed-function oxidases
Animals received a single i.p. dose of 9-OHE (20 mg/Kg). Results 
are presented as means _+ S.D. for five animals, p 0.001. No 
activity v/as detected in three of the animals.
Control Test
Biphenyl 4-hydroxylase 0.82 + 0.10 0.8? + 0.18
(nmol/min/mg protein)
Biphenyl 2-hydroxylase 0.86 + l.59b 38 + l.9a
(pmol/min/mg protein)
Benzphetamine N-demethylase 6-2 + 1.3 6.1 + 2.1
(nmol HCHO/min/mg protein)
Ethoxyresorufin O-deethylase 40 + 17 398 + 25a •
(pmol/min/mg protein)
NADPH-cytochrome c reductase 43 + 5 4 8 + 7
(nmol/min/mg protein)
Cytochrome P-450 0.69 + 0.08 0.75 + 0.10
(nmol/mg protein)
Cytochrome b 0.40 + 0.02 0.44 + 0.04
(nmol/mg protein)
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TABLE 1.3
Effect of repeated administration of 9-hydroxyellipticine on the rat
hepatic microsomal mixed-function oxidases
Animals received s.ingle daily i.p. administrations of 
for three days. Results are presented as means + S.D.
9-OHE (20 mg/kg) 
for five animals.
Control Test
Biphenyl A—hydroxylase 
(nmol/min/mg protein)
0.66 + 0.08 0.66 + 0.12
Biphenyl 2-hydroxylase 
(pmol/min/mg protein)
35 + 15 5 0 + 5
Benzphetamine N-demethylase 
(nmol HCHO/min/mg protein)
1.3 i 0.2 3.5 + 0.1
Ethoxyresorufin O-deethylase 
(pmol/min/mg protein)
113 + 102 1p6 + 82
NADPH-cytochrome c reductase 
(nmol/min/mg protein)
50 + 6 11 + 5
Cytochrome P-I50 
(nmol/mg protein)
O.85 + 0.06 0.79 + 0.13
Cytochrome bj- 
(nmol/mg protein)
0.16 + 0.06 0.39 + 0.02
TABLE b.b.
Effect of inhibitors of protein synthesis on the enhancement of 
hepatic mixed-function oxidases by 9-hydroxyellipticine (9-OHE)
Animals received a single i.p. dose of 9-OHE (20 mg/kg) together 
with actinomycin D 2V h  before (0.5 mg/kg) and 16 h before (0.25 mg/Hg) 
killing, or cycloheximide 24 h before (2 mg/kg) and 16 h before (1 mg/kg) 
preparation of liver microsomal fractions.
Results are presented as means _+ SD. for five animals. 
ap <  0.001 when compared to animals receiving 9-OHE only.
Pretreatment Ethoxyresorufin 
0-deethylase 
(pmol/min per 
mg protein
Benzphetamine 
N-demethylase 
(nmol HCHO/min 
per mg protein)
Control 25° + 40 ■ 1.9 + o.b
9-OHE 640 + 30 1.9 + 0.2
Cycloheximide 290 + 66 1.7 + 0.3
9-OHE + cycloheximide 98 + 4a 1.8 + 0.4
Actinomycin D 180 + 27 1.9 + 0.2
9-OHE + actinomycin D 91 + 12a 1.8 + 0.4
Figure 4.1 Interactions of safrole with microsomes from
phenobarbitone-and 3-rcethylcholanthrene-induced 
rats and with LM^ and LM, rabbit preparations 
before and after saturation of the type I substrate 
binding site with perhydrofluorene.
A (-.-.) Both cuvettes contained microsomes from 3-methylcholanthrene- 
pretreated rats but safrole (0.2 mM) v/as only added to the test cuvette.
(.....) Perhydrofluorene (1 yUl) and microsomes from 3-methylcholanthren
pretreated animals were added to both reference and test cuvettes and
safrole (0.2 mM) in the test cuvette. (------ ) Microsomes from pheno-
barbital pretreated animals were added to both cuvettes and safrole
(0.2 mM) in the test cuvette, only. (------ ) Microsomes from phenobarbita
pretreated rats and perhydrofluorene (1 /jlL) were added to both cuvettes. 
Safrole (0.2 mM) was added only to the test cuvette.
B (-.-.) LM^ v/as added to both cuvettes and safrole (0.2 mM) in test
cuvette only. (......) LM, and perhydrofluorene (1 /-il) were added to
both cuvettes and safrole fo.2 mM) in test cuvette only. (----- ) LM
was added to both cuvettes and safrole (0.2 mM) in test cuvette only.
(------- ) LM and perhydrofluorene (1 Ml) was added to both cuvettes
and safrole (6.2 mM) in test cuvette only.
Microsomes and solubilised preparations were resuspended in buffer 
as described in Table 4.1.
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Figure 4.2.
Interaction of 9-h.ydroxyellipticine with microsomes .from phenobarbitpne- 
and 5-methylcholanthrene-induced rats and with LM and LM^ rabbit 
preparations
A (------ ) Interaction of 9-hydroxyellipticine (1 /UM) with microsomes
from 3-niethylcholanthrene-pretreated rats. (------ ) Interaction of
9-hydroxyellipticine (1 yuM) v/ith microsomes from phenobarbitone pre­
treated rats.
B (------ ) Interaction of 9-hydroxyellipticine (5/UM) with LM,
preparation. ( ) Interaction of 9-hydroxyellipticine (5 /aM)
with LM^ preparation.
Microsomes (0.7 nmol of cytochrome P-450/ml) and solubilized 
preparations (1.0 nmol of cytochrome P-^O/ml) were suspended in 0.1 M 
phosphate buffer, pH 7-4.
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Figure 4.3»
Lineweaver-Burk plots of 9-hydroxyellipticine (9-OHE) binding to 
liver microsomes from phenobarbitone-and 3-methylcholanthrene- 
induced rats
A. Phenobarbitone-induced microsomes (1.2 nmol P-4-50/ml) and B. 3-niethyl 
cholanthrene-induced microsomes (0.7 nmol P-4-50/ml) were suspended 
in 0.1 M phosphate buffer, pH 7*^ - and placed in the front compartment 
of both sample and reference cuvette. 9-Hydroxyellipticine was added 
in equal increments to the microsomes of the sample cell and to the 
back, buffer compartment of the reference cell to counteract the 
absorbance by this substrate.
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Figure 4.4. Interaction of 9-hydroxyellipticine with microsomes 
from phenobarbitone-induced rats before and after 
saturation of the type I binding site v/ith benzphetamine
(------ ), Both cuvettes contained microsomes from phenobarbitone-pre-
treated rats, but 9-hydroxyellipticine (5 juM) was added only to the
test cuvette. (------ ), Both cuvettes contained microsomes from
phenobarbiton&pretreated rats and benzphetamine (0.1 m!-l), and 9-hydroxy­
ellipticine (5 jlaM) v/as added only to the test cuvette.
Microsomes v/ere suspended as described in the legend to Table 4.1.
Figure *f.5«
Interactions of 9-hydrox,yellipticine with LM^ and LM;[ purified rabbit 
preparations, before and after saturation of type I binding site with 
perhydrofluorene
A (------ ) Both cuvettes contained the LM^ preparation and 9-hydroxy­
ellipticine (5 jaM) was added only to the test cuvette. (-----) Both
cuvettes contained the LMp preparation and perhydrofluorene (1 /a1), 
but 9-hydroxyellipticine 15 >uM) was only added to the test cuvette.
B As for A, except LM^ was substituted for
Solubilized preparations were suspended in buffer as described 
in the legend for Table *f.1.
0.015 A
Wavelength (nm)
0.010
0.005
AO 0
Wavelength (nm)
-0.005
- 0.010
Figure A.5.
+0.010
Wavelength (nm)
Figure ^.6. Interaction of 9-hydroxyellipticine with microsomes from
3-methylcholanthrene-induced rats, before and after 
saturation of the type I binding site with safrole
(----- ), Both cuvettes contained microsomes from 3~methylcholanthrene-
induced rats, but 9-hydroxyellipticine (5 m M) was added only to the
test cuvette. (------- ), Both cuvettes contained microsomes from
3-methylcholanthrene-induced rats and safrole (0.2 mM), but 9-hydroxy­
ellipticine v/as added only to the test cuvette.
Microsomes were suspended a£ described in Table *f.1.
Figure *f.7»
Interactions of 9-hydrox,yellipticine with rabbit LM^ and LM^ preparatio 
before and after saturation of the type I binding site with safrole.
A (------ ) Both cuvettes contained the LM^ preparation, but 9-hydroxy
ellipticine (3 >uM) was only added to the test cuvette. (------ ) Both
cuvettes contained the LM preparation and safrole (0.2 mM) but 
9-hydroxyellipticine (3 /aM) was only added to the test cuvette.
B As for (A), except LM^ was substituted for LM„,.
Solubilized preparations were resuspended in buffer as described 
in Table k.1.
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fFigure k .8 .
Effect of 9-hydroxyellipticine (9-OHE) administration on the spectral 
interaction of safrole with hepatic microsomes from rats pretreated 
with phenobarbitone or 3-niethylcholanthrene
A Animals received phenobarbitone (80 mg/kg i.p.) daily for 3 days,
either alone (o o) or in combination with 9-OHE (20 mg/kg i.p.)
1 hour before killing, (o □).
B Animals received 3-methylcholanthrene (20 mg/kg i.p.) daily for 5
3 days, either alone (©----- ©) or in combination with 9-OHE (20 mg/kg
i.p.) 1 hour before killing (0--- 0).
In all cases rats were killed 2k hours after the last administratio 
of phenobarbitone or 3-^ethylcholanthrene and the hepatic microsomes 
prepared from these were suspended (1 mg of protein/ml) in 0.1 M 
phosphate buffer, pH 7.k.
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Figure 4.9*
Absolute spectra of rabbit purified L1L, and LM, preparations
Purified LM^ (“-----) anc  ^ (------ ) preparations were suspended
in 0.1 M phosphate buffer, pH y.k at a concentration of 1.0 nmol/ml
and the spectrum recorded against buffer. (.....) 1 /jd of perhydro
fluorene was added to the LM^ preparation and the spectrum again 
recorded to show spin state change.
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Figure ^-.10.
Effect of 9~bydroxyellipticine (9-OHE) on the activation of 
benzo(a)pyrene to mutagens by hepatic post-mitochondrial 
supernatant
A. Single administration; (P Q) control, (B EO 9-OHE treated
B. Repeated administration; (o o) control, (o ©) 9-OHE treated
Animals were pretreated as described in Tables k.Z and ^.3«
Spontaneous reversion rates have been subtracted from each 
value, which are the means of triplicate assays. The standard 
deviations were always less than 15% of the mean.
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Figure A. 11. Effect of inhibitors of protein synthesis on the 9-hydroxy­
ellipticine (9-OHE) induced activation of benzo(a)pyrene to 
mutagens
Animal pretrbatment v/as as described in Table k.k. (o o) control;
(o ®) 9-OHE;  A) cycloheximide; (A A) cycloheximide + 9-OHE;
(p □) actinomycin D; (0 o) actinomycin D + 9-OHE. Spontaneous
reversion rates have been subtracted from each value v/hich are the 
means of triplicate assays. The standard deviations were alv/ays less 
than 2CP/o of the means.
Figure -^.12
Mutagenicity of 9-hydroxyellipticine in the presence and absence of 
an activating system (S9)
A. ' Using Salmonella t.yphimurium strain TA 100. B. Strain TA 98. 
Spontaneous reversion rates have been subtracted from each value. 
The activation system was derived from Aroclor 125^ pretreated rats
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DISCUSSION .
Substrate Binding Studies .
In the first series of results, the binding of various substrates 
to rat and rabbit liver cytochromes P-450 and P-448 have been examined. 
Type I substrates, hexobarbital, benzphetamine, pentobarbital, per­
hydrofluorene and 1-phenylhexane gave the expected type I spectral 
interactions with rat and rabbit cytochrome P-4.50, tut none elicited 
the characteristic spectral changes with cytochrome P-448 (Table 4.1). 
The decrease or absence of type I spectral changes with cytochrome 
P-448 have been reported by a number of workers (reviewed by 
Schenkman, Sligar and Cinti, 1981) and may be due to compensatory 
type I and reverse type I spectra (Witmer jet al, 1975)* These 
observations indicate that cytochrome P-448 may not have a typical 
type I binding site, or that this is occupied by the inducing 
chemical and/or a metabolite (Hashimoto and Imai, 1978). Alternatively, 
some product of the inducer may be bound at another, allosteric site, 
preventing interaction of type I substrates (Imai, 1982b). It may 
be for this reason that cytochrome P-448 is generally a high spin 
haemoprotein. Certainly, the absolute spectrum of the rabbit 
LM^ showed it to be 60-7Q& high spin (Figure 4.9)j in agreement 
with other workers (Guengerich, 1979; Du and West, 1980). There­
fore, if a substrate is to be able to produce a type I spectrum 
it must be able to push the cytochrome into an even higher spin 
state and so is unlikely to give a marked spectrum, even if the 
inducer were displaced. Other v/orkers have been unable to obtain 
a type I spectrum with LM/, with a series of polycyclic aromatic 
hydrocarbons and their metabolites, apparently for just this reason 
(Imai, 1982a, b). Cytochrome P-490, on the other hand, is in a low 
spin state (with a 6-coordinated haem iron) and can be dramatically 
converted to a high spin state by a type I substrate, which displaces 
the sixth ligand. This was clearly demonstrated from the absolute 
spectra of ILL, in the presence and absence of perhydrofluorene 
(Figure 4.9)- It should however be noted that the presence of 
detergent or dilution can apparently affect the spin state of H /
from 3-niethylcholanthrene-treated rabbits and also that the 
cytochrome P-^48 purified from similarly induced immature rats 
was found to be in a low spin state (Ryan et_ al, 1982). The same 
authors also noted that the form of cytochrome P-A-50 isolated from 
isosafrole-induced animals was in a high spin state regardless of 
whether the inducer was bound or not (Ryan et. al, 1982).
In contrast to the first series of substrates, safrole is 
able to interact with both cytochromes P-4-50 and P-AA8 , yielding 
typical type I spectral changes (Figure -^.1), and is indeed 
metabolized by both to form a safrole carbene complex with the 
haem iron (Delaforge, Ioannides and Parke, 1980b, 1981, 1982).
It is possible that safrole binds to a type I site of cytochrome 
P-¥f8 to which the other type I substrates do not bind, or that 
safrole can displace the inducer or its metabolite bound on the 
normal type I site of this cytochrome. This is unlikely, as 
safrole does not appear to have a very high affinity for 
cytochrome P-A48 (Ks = 0.13 mM; Delaforge, Ioannides and Parke,
1980b), although it must be considered that this value will not 
be the true spectral binding constant, as some competition between 
inducer and substrate may have occurred during its estimation. 
Furthermore, when the type I site is blocked with perhydrofluorene, 
safrole elicits an unchanged type I spectrum with cytochrome P-A48, 
whereas the spectral change with cytochrome P-VpO is greatly 
decreased by perhydrofluorene (Figure .1). This indicates that the 
type I site of cytochrome P-A30 accomodates safrole and other type I 
substrates, v/hereas cytochrome P-AA8 probably has two distinct and 
independent type I binding sites, one of which interacts pre­
ferentially with safrole, and the other may be blocked from binding 
normal type I substrates by the direct or an allosteric effect of the 
inducer. Alternatively, the cytochrome P-AA8 substrate-binding site 
on the apoprotein may be so dissimilar in structure to that of 
cytochrome P-A50 that safrole is one of only a very few substrates 
that they have in common. Biphenyl would have been a useful substrate 
to have clarified this point, as it is metabolized by, and binds to, 
both cytochromes P-k^O and P - M 8 (Burke and Bridges, 1973). In fact,
biphenyl is able to displace the safrole carbene complex from both 
cytochromes and P~kk& and restore their activities (Delaforge,
Ioannides and Parke, 1980b). However, unfortunately this compound 
was far too insoluble in an aqueous environment to be sure of the 
complete saturation of the type I binding site required in this 
type of experiment, although the.presence of a type I spectrum was 
confirmed, but with an unknown concentration of substrate remaining 
in solution. Recently published work with 21 different polycyclic 
hydrocarbons, which apparently bound specifically and tightly to a 
single hydrophobic substrate site near the haem domain of P-V4-8 , 
has suggested that the active area of this isoenzyme is a fairly 
rigid structure and differs from that of cytochrome P-A50 (Imai, 
1982a,b). It appears that for cytochrome P-k^O, at least, the 
presence of lysyl residues are important in the channeling and/or 
binding of more polar substrates, whereas alteration of these does 
not affect the binding or metabolism of less polar substrates 
(Kunz and Richter, 1983)*
The potent cytochrome P-AA8 inhibitor, 9-hydroxyellipticine 
(Delaforge, Ioannides and Parke, 1980a) interacted with both 
cytochromes P-A30 and P-/48 to give type II spectral changes, 
and in agreement with other studies (Lesca et al, 1978a,b; Lesca, 
Beaune and Monsarrat, 1981; Sauterau and Lesca, 1979) had a greater 
affinity for microsomes from 3-Methylcholanthrene, as opposed to 
phenobarbitone-induced rats (Figure The latter showed a
tendency towards a biphasic plot, v/hich may be due to the presence 
of different isoenzymes of various affinities and spin states. 
However, caution should be expressed in trying to evaluate apparent 
Ks values from non-linear Lineweaver-Burke plots (Gander and 
Mannering, 1980). As discussed in more detail below, it should be 
remembered that these spectra are the result of both type I and 
type II binding, and so the true K values would depend on the 
relative binding of 9-hydroxyellipticine to the different sites on 
the various isoenzymes.
The asymmetry of these spectra was corrected, and the spectrum 
enhanced and shifted to lower wavelengths, when the type I binding 
site was blocked (Figures k.k to f^-7)* This is similar to the case 
of aniline (Schenkman, 1970) and indicates that the spectrum of 
9-hydroxyellipticine has a type I component. It has been suggested 
that the bow-shaped polycyclic structure of 9-hydroxyellipticine 
would be able to interact with the type I site of the cytochrome 
(Lesca et_ al, 1979a: Lesca at al, 1980). Benzphetamine or perhydro­
fluorene displaced 9-hydroxyellipticine from the type I site of 
cytochrome P-V?0 (Figures and f^.5)> bat no displacement occurred 
with the cytochrome P-AA8 (Figure -^.3)* The binding of benzphetamine 
to cytochrome P-A30 (in the presence of phospholipid) has been shown 
to alter its conformation and consequently its CO-binding kinetics, 
but no such effect has been observed with cytochrome P-A48 (Gray, 
1983). In contrast, safrole displaced 9-hydroxyellipticine from 
cytochrome P-4A8 (Figures (^-.6 and k-.?), but not from cytochrome 
P-A30 (Figure -^.7)* This provides further evidence that cytochrome 
p_ZfA8 has a type I binding site, shared by safrole and 9-hydroxy­
ellipticine, and possibly also biphenyl (Delaforge, Ioannides 
and Parke, 1980b), which is different from that of cytochrome P-^-30* 
Administration of 9-hydroxyellipticine to rats inhibited competitively 
the binding of safrole to cytochrome P-W3, confirming that these 
two compounds interact with the same type I binding site of cytochrome 
P-AA8 (Figure -^.8). However, 9-hydroxyellipticine administration 
to phenobarbitone pretreated animals had only a very slight non­
competitive inhibitory effect on safrole binding (Figure +^.8).
It is possible that the safrole binding site and the 9-hydroxy­
ellipticine binding site are on different regions of the cytochrome 
P-A30 apoprotein, but both are affected by the binding of the more 
general ’type I ’ substrates. Alternatively, the lack of competition 
between the binding of the se two substrates may simply be due to the 
relatively poor affinity of 9-hydroxyellipticine ‘for cytochrome P-A-30, 
when given at this dose in vivo (Delaforge, Ioannides and Parke,
1980a). Other, unpublished work by these authors have shown that, 
in vitro, higher concentrations (10 piM) of 9-hydroxyellipticine 
were able to inhibit competitively the type I interaction of safrole
with cytochrome P~^30* However, caution should be expressed when 
interpreting the types of competition of binding, as by definition, 
all substrates must compete for effects on the spin-state of the 
iron, whichever site they bind.
Previous studies have suggested that cytochromes P-^30 from rat 
and rabbit have different properties (Lu and V/est, 1980), and also 
that pure and microsomal cytochromes are affected differently, 
due to changes in their hydrophobic environment (Sauterau and Lesca,
1979). However, in. the present study, the rabbit solubilized 
preparations and the crude microsomal preparations from induced rats 
exhibited the same specificity toward the various compounds 
investigated, indicating that the rabbit and rat forms of the cyto­
chrome may have similar substrate-binding sites.
The observation that 9-hydroxyellipticine has a type I 
component to its spectrum helps to explain some previous data 
from this department, where safrole and 9-hydroxyellipticine were 
administered in vivo and subsequent in vitro parameters measured 
(Delaforge, Ioannides and Parke, 1982). In this study it was shown 
that preincubation of microsomes with biphenyl could displace the 
safrole-carbene complex and restore spectral P-A50 levels and 
activities. However, although the spectral levels of P-A30 
from 9-bydroxyellipticine-treated animals could be restored by 
preincubation with biphenyl (presumably by displacing the haem 
complex of this inhibitor which would compete with the CO in this 
assay), the activities of these microsomes could not be restored.
This can be explained by the type I component of the 9-hydroxy­
ellipticine interaction competing with the biphenyl for the 
substrate-binding site (and thus metabolism). In the light of the 
present studies, a similar explanation could be forwarded for the 
competitive inhibitory effect of 9-hydroxyellipticine on the 
metabolism of safrole to form the carbene complex in microsomes 
from 3-roethylcholanthrene-induced rats. The relatively insignificant
effect on microsomes from phenobarbitone-induced rats was probably 
again due to the low affinity of 9-hydroxyellipticine for this 
form of the cytochrome.
Induction of Cytochrome P-448 by 9-Hydroxyellipticine
' The knowledge that 9-hydroxyellipticine can bind to the 
substrate site of the apoprotein, and also the observation that 
many inducers of the cytochrome P-430 group of enzymes evidence 
an initial inhibitory phase, followed by a phase of enzyme 
induction (Kato, Chiesara and Vassanelli, 1964; Pedemonte jet al,
1981), led to experiments to investigate the possible inductive 
effect of 9-hydroxyellipticine on the hepatic mixed-function 
oxidases.
Administration of a single dose of 9-hydroxyellipticine at 
the same level which results in a marked inhibition of P-448 
activities after one hour (Delaforge, Ioannides and Parke, 1980a) 
gave rise to a marked increase in the levels of these activities 
(i.e. ethoxyresorufin O-deethylation and biphenyl 2-hydroxylation) 
after 24 hours (Table 4.2), illustrating well the biphasic effect. 
There was, however, no effect on the cytochrome P-430-catalysed 
benzphetamine N-demethylation or the cytochrome P-430 reductase.
In addition, microsomal preparations from the 9-hydroxyellipticine 
pretreated animals were better activators of benzo(a)pyrene to 
mutagens (Figure 4.10A), a chemical carcinogen whose activation 
is catalysed primarily by cytochrome P-448 (as shown in Chapter 6). 
With repeated administration, the effect was not so marked 
(Table 4.3 and Figure 4.10B). This may partly be due to 
accumulation of this compound on repeat administration, resulting 
in inhibition of the induced cytochrome P-448 levels. In addition, 
the inductive effect may be partially masked by the cytotoxicity 
of 9-hydroxyellipticine. Although the dose given was well below 
the lethal levels, this compound is known to have some cumulative 
toxicity (Cros et al, 1973) and may exert its toxic effect through 
redox cycling (Paoletti et al, 1978). These single and multiple-
dose experiments cannot be strictly compared as they were run on 
separate occasions, with different groups of rats of different 
ages. This may partly explain the wide variation in ethoxy- 
resorufin O-deethylase and more particularly biphenyl 2-hydroxy­
lase observed between the two control groups. As has been covered 
in more detail in Chapter 3 5 biphenyl 2-hydroxylase activity is 
very dependent on the age of the animals and more prone to 
technical difficulties.
The enhancement of ethoxyresorufin O-deethylase following 
a single administration of 9-hydroxyellipticine was prevented 
by co-administration of the inhibitors of PNA and protein 
synthesis (actinomycin D and cycloheximide respectively), 
indicating that 9-hydroxyellipticine induces the formation of 
new enzymic protein (Table 4.4). Neither protein levels nor 
the enzyme activities were lowered significantly by the doses of 
these inhibitors used alone, suggesting that turnover of cyto­
chrome P-430 was decreased. Cytochrome P-430 is normally 
turned over very rapidly (Greim ejt al, 1970), but cycloheximide 
can inhibit its degradation (Guzelian and Barwick, 1979) and 
so its levels would be maintained. The depression of ethoxy- 
resorufin O-deethylase below control values by a combined 
administration of protein synthesis inhibitors and 9-hydroxy­
ellipticine may have been due to cytotoxic effects, or, less 
likely through the stimulation of the degradative pathways 
by 9-hydroxyellipticine. The inhibitors of protein synthesis 
also prevented the 9-hydroxyellipticine-induced activation of 
benzo(a)pyrene to mutagens (Figure 4.11). It is not possible 
to definitely conclude from these experiments that 9-hydroxy­
ellipticine has a direct true inductive effect on the cle novo 
synthesis of cytochrome P-448. It is conceivable that it could 
activate a rapidly turned-over form of the cytochrome, the 
inactive form of which is lost through the use of protein 
synthesis inhibitors. It does seem unlikely however that an 
inhibitor may also be an activator, but definitive studies would 
require the use of radiolabelled amino acids and/or the haem 
precursor, S-aminolevulinic acid.
Similar studies have very recently been published on enzyme 
induction by the parent compound, ellipticine (Cresteil ejt al,
1982). In these studies, the induced form was very similar to the 
>6-naphthflavone-induced P-448, according to molecular weight, 
chromatographic behaviour, immunological cross-reactivity, 
activities etc. As ellipticine induces its own metabolism to the 
9-hydroxy derivative, it is possible that the inductive effect 
that they have observed was actually caused by 9-hydroxyellipticine.
The Mutagenicity of 9-Hydrox.yellipticine .
The Ames test results showed 9-hydroxyellipticine to be a 
direct mutagen to both TA 98 and TA 100 strains of Salmonella 
typhimurium. This is in contrast to a previous study, where 
the compound v/as shown to be a direct mutagen to only the TA 98 
and TA 1538 strains, and required metabolism to exert its 
mutagenic effect on TA 100 (Lesca et al, 1979b). However, 
an enhanced mutagenic activity v/as observed with TA 100, when 
S9 mix v/as present, v/ith 9-hydroxyellipticine at a concentration 
of 5 /Ag/plate (Figure 4.12). The mutagenicity tests on 9-hydroxy­
ellipticine v/ere complicated by its extreme toxicity toward the bac­
terial strains, at concentrations greater than 10 yug/plate. This 
compound has previously been shown to be bacteriostatic (Alazard, 
Boquet and Paoletti, 1976). As 9-hydroxyellipticine is cytotoxic, 
mutagenic and an inducer of cytochrome P-448, it is quite possible 
that it may also be a carcinogen.
CONCLUSIONS•
The observations presented in this chapter indicate that 
the different substrate specificities of cytochromes P-V?0 and 
P-448 may be due, at least partly, to the presence of different 
type I binding sites.\ It seems that cytochrome P-4i>0
(phenobarbitone-induced) has only one type I binding site,
!
v/hich can accomodate various substrates of different chemicalI
structure and molecular dimensions. However, in cytochrome 
P-448, this substrate binding site is either absent or occupied 
by the inducing agent or its metabolite, but a second type I 
substrate-binding site, distinct from that of cytochrome P-4i>0, 
is also present. Possibly the binding of the inducing agent 
(or its metabolite) to cytochrome P-450 produces a conformational 
change in the normal type I site, so that its substrate 
specificity and site of substrate oxygenation are changed to that
characteristic of cytochrome P-448.
The cytochrome P-448 inhibitor, 9-hydroxyellipticine v/as 
demonstrated to have a type I component to the type II spectrum 
elicited by interaction with cytochromes P-450 and P-448. It was
found to specifically induce cytochrome P-448 activities, 
ethoxyresorufin O-deethylation, biphenyl 2-hydroxylation 
and the activation of benzo(a)pyrene to mutagens. 9-Hydroxy- 
ellipticine itself v/as also shov/n to be mutagenic in the Ames 
test.
C H A P T E R
CHAPTER 5. THE ACTIVATION OF AROMATIC AMINES AND AMIDES .
INTRODUCTION.
Metabolism at Nitrogen Centres .
The important enzymic oxidation reactions occurring at organic 
nitrogen centres can be sub-divided into N-hydroxylations and 
N-oxidations, leading to the formation of N-hydroxy compounds and 
amine N-oxides respectively. Other reactions which occur at or 
near an organic nitrogen include amide cleavages, transaminations, 
deaminations and N-dealkylations (Damani, 1982). The latter may be 
catalysed by a cytochrome P-4i>0 oxidative attack on the carbon alpha 
to the nitrogen, which produces an aminocarbinol, v/hich subsequently 
releases an aldehyde and a dealkylated amine (Prough and Ziegler,
1977)* This may be catalysed by the normal NADPH/t^-dependent 
mechanism or via the peroxidatic function of cytochrome P-450 
(Estabrook et_ al, 1984). Alternative mechanisms of dealkylation 
are discussed in Chapter 8.
Primary and secondary aliphatic or aromatic amines may be 
N-hydroxylated to produce hydroxylamines, whereas the corresponding 
N-hydroxy metabolites from aliphatic or aromatic amides are called 
hydroxamic acids (Damani, 1982; Patterson, 1978). Derivatives of 
the nitrogen-oxygen bond are characteristically unstable and sus­
ceptible to chemical alterations. The non- and post-enzymic 
chemistry of N-oxygenated compounds is discussed in a detailed 
review (Lindeke, 1982). Hydroxylamines can undergo enzymic or 
non-enzymic conversion to nitroso, nitrone and oxime derivatives 
and these may be possible intermediates in N-dealkylation and 
N-dearnination reactions. Tertiary aliphatic or aromatic amines 
are readily oxidized to amine N-oxides, which are chemically 
stable, but susceptible to in vivo or in vitro reduction to the 
parent amine and a number of other compounds (Lindeke, 1982).
The chemistry behind nitrogen oxidation has been examined in 
several comprehensive reviews (Damani, 1982; Hlavica, 1982;
Lindeke, 1982), and some of the structures may be found in Diagram 
9.1. Quantitatively N-oxidation is usually a minor reaction, but 
leads to pharmacologically and pathologically important metabolic 
intermediates. The biochemistry and pharmacology of hydroxylamines 
hydroxamic acids and N-oxides are presented in a review by 
Weisburger and Weisburger, 1973*
Metabolic oxidations at nitrogen centres are catalyzed 
predominantly by two different microsomal oxidases, both of which 
require molecular oxygen and NADPH for activity (Damani, 1982; 
Hlavica, 1982). The cytochrome P-^-30-linked mixed-function 
oxidase system is involved mainly in the oxidation of primary 
aromatic amines, imines, and the acidic nitrogens of amides, 
v/hile another enzyme (the mixed-function amine oxidase or 
* Ziegler enzyme) has a broad substrate specificity for the N~ 
oxidation of more basic aliphatic amines and tertiary aromatic 
or aliphatic amines, especially those with the structure
This enzyme will not oxidize secondary or tertiary amines with 
polar groups near to the nitrogen (Prough and Ziegler, 1977;
Ziegler and Poulsen, 1978). The secondary aromatic amines are 
believed to be substrates for both enzyme systems, although the 
mechanism of production of primary aromatic hydroxylamines 
from secondary amines differs in the P-Q50 and Ziegler enzyme 
catalyzed reactions. The cytochrome P-^30 pathv/ay involves 
initial dealkylation and subsequent N-hydroxylation, whereas 
the Ziegler enzyme involves initial N-hydroxylation followed by 
a rearrangement to lose the alkyl group (Damani, 1982). There 
are many exceptions to this generalization on the substrate 
preference of these two enzyme systems based on pKa (Gorrod, 1978), 
and electronic structure, nucleophilicity and steric features 
are also important, as for example, aromatic conjugation tends
\ (Ballou , 1982; Prough and Ziegler, 1977)*
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to delocalise electrons and prevent oxygenation (Ziegler, Poulsen 
and Duffel, 1980). The mixed-function amine oxidase is said to 
be specific for the N-oxidation of polycyclic amines (Pelroy and 
G andolfi, 1980), although it is believed that cytochrome P~Vf8 
can metabolise some tertiary amines to N-oxides (Hlavica, 1982).
The Ziegler enzyme (EC.1.I^ f.13*8) does not generally 
metabolize primary amines, but is stimulated by their presence, 
possibly through the displacement of an endogenous inhibitor (Prough 
and Ziegler, 1977; Ziegler and Mitchell, 1972; Ziegler and Poulsen,
1978). However, it has been shown to metabolize 2-naphthylamine 
(although with a high K ), and this may be because this compound 
has the abilityvto form imine tautomers (Damani, 1982; Hlavica,1 1982; 
Kriek and Westra, 1979):-
N H O H
Diagram 5«2. Biotransformation of 2-naphthylamine to hydroxylamine 
and nitroso compounds ( — ^represents enzymic and • -} chemical 
transformations).'
The mixed-function amine oxidase has been isolated and purified 
to homogeneity from hepatic microsomes by Ziegler and his coworkers 
(Ziegler, 1978; Ziegler and Mitchell, 1972). However, the mixed- 
function amine oxidase has also been discovered in the nuclear 
envelope of hamsters (Patton _et al, 1980) and rats (Surn and Kasper, 
1982). It is an NADPH-dependent (although NADH may also be used), 
FAD-containing flavoprotein and despite its name has a preference
for oxidising nucleophilic sulphur, and such compounds will compete 
for the same catalytic site (Sum and Kasper, 1982). It has a 
subunit molecular weight of 65,000 and may exist as octomers or 
tetramers and its physiological role may be the oxidation of 
endogenous cysteamine for protein disulphide bond formation 
(Patton at al, 1980; Ziegler and Poulsen, 1978; Zliegler,
Poulsen.and Duffel, 1980).
The activity of the enzyme is usually measured by the formation 
of the N-oxide of N,N-dimethylaniline, and it was believed that in 
nearly all species and tissues this N-oxide is produced solely by 
the amine oxidase. However, it has been shown using a purified 
system that cytochrome P-V+8 may also be involved (Hlavica and 
Hulsmann, 1979). The Ziegler enzyme is found predominantly in the 
liver, although it can also be found in other tissues (Sum and Kasper, 
1982). Particularly high concentrations are noted in pig and human 
tissue, whereas it is generally low in the rat, although activity 
has been found in all species tested (Dannan and Guengerich,
1982; Ziegler and Mitchell, 1972). Induction of the mixed-function 
amine oxidase by phenobarbitone and 3-rcethylcholanthrene has not been 
•observed (Prough and Ziegler, 1977)1 but it may be under hormonal 
control and varies throughout the life-cycle of the rat. There is 
very low activity in the foetus, a peak in the neonate and a second 
peak at weaning, after which it declines in young animals (especially 
females). The activity then increases with age, in the males 
particularly. There is also a weanling spike of activity in 
hamsters, although otherwise the activity is fairly constant in 
both sexes of this species (Ziegler, 1978). Conversely in the mouse, 
androgenic suppression of this enzyme has been found (Kloss e_t al, 
1982). The act ivity is detectable in human foetuses and its 
presence in the placenta and its ability to metabolise xenobiotics 
may be of significance to foetal toxicity (Osimitz and Kulkarni,
1982).
The postulated mechanism of the mixed-function amine oxidase 
is shown in Diagram 5.3* It is believed, that the enzyme remains 
as a stable hydroperoxy flavin intermediate ready to attack a
substrate. There is generally little NADPH oxidase activity as 
the enzyme reduction is carefully controlled by the presence 
of a substrate (Ballou, 1982). There is, hov/ever, a slow 
decomposition to release and the oxidized flavin (Cavagnaro,
Rauckman and Rosen, 1981).
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Diagram Possible Mechanism of the Mixed-function Amine Oxidase
(formulated from Ballou, 1982; Cayagnaro, Rauckman and Rosen, 1981; 
Hlavica, 1982; Poulsen and Ziegler, 1979 and Ziegler, Poulsen and 
Duffel, 1980).
Other enzymes which may be involved in oxidation at organic 
nitrogen include the amine oxidases (monoamine, oxidase(s) - EC.1.4.3»^- 
and benzylamine oxidase) (Lewinsohn, 1981). Monoamine oxidase is an 
FAD-linked flavoprotein, which exists in two forms, A and B, 
distinguishable by substrate and inhibitor specificity, although 
there is a considerable overlap (Neff and Yang, 197^ +). There is 
some controversy at present whether these represent two different iso-
enzymes j or simply tv/o different sites on the same protein (discussed 
by Schurr, 1982), and the activity is greatly affected by the 
phospholipid environment. Benzylamine oxidase on the other hand, 
contains copper and pyridoxal as cofactors, similar to' diamine 
oxidase (Zis et al, 1981), and so is inhibited by semicarbazide.
The amine oxidases are found in all mammalian cells and tissues 
so far examined, including human, and are integral membrane proteins, 
found predominantly in the outer mitochondrial membrane, but also 
in microsomes in the liver (possibly originating from plasma membrane 
fractions) and also in soluble fractions (which may have been 
released during" homogenisation) (Neff and Yang, 197^ -). They are 
found in the cardiovascular system, which is a major site for 
the oxidative deamination of a v/ide variety of amines, especially 
in the inactivation of neurotransmittors and other biologically 
active amines (Zis al? 1981). Their endogenous substrates are 
mainly phenylethylamines and indolethylamines (Neff and Yang, 197^5 
Schurr, 1982). Kynuramine is the substrate used in the monoamine 
oxidase assay (Krajl, 1965) as it is metabolised by a wide number 
of species and is not a substrate for the diamine oxidase (Weissbach 
et al, i960). However, although it is certainly an endogenous 
monoamine substrate in the blood vessels of the rat (Lewinsohn,
1981), this may not be observed in other species. Also, activity 
towards this substrate, but not benzylamine, is present in 
microsomes with similar substrate and inhibitor specficity to the 
mitochondrial form. It is not considered that the microsomal 
form is either due to contamination with mitochondrial membranes 
nor a precursor of the mitochondrial form (Erwin and Deitrich,
1971). There has been shown to be immunological similarities 
between the monoamine oxidases from a variety of sources, although 
they may have different catalytic properties (Schurr, 1982).
In general, monoamine oxidases have a broad substrate specificity, 
favouring a primary amino group, linked via a two carbon aliphatic 
chain to a hydrophobic residue, which may be aliphatic, aromatic 
or aryl alkyl in nature (Zeller, 1979). The general reaction 
is the conversion of amines to aldehydes, which may then be subject 
to further metabolism by aldehyde dehydrogenase. Hydrogen peroxide
may be released from monoamine oxidase, in contrast to superoxide 
release from diamine oxidases (Neff and Yang, 197*+; Zeller, 1979)*
For more information on monoamine oxidase with respect to 
multiple forms, inhibitors, substrate specificity etc., the 
reader is referred to the proceedings of the symposium held in 
Midland, MI, USA on ’Monoamine oxidase: Structure, function and 
altered functions’ (ed. Singer et al, 1979)*
The enzymic methods of oxidation at nitrogen centres depend 
on many factors, inaluding the species, strain, age and sex of 
the animal, the tissue and the presence of inducers and inhibitors. 
The rate of oxidation of the nitrogen depends also on the pH of 
the assay system and the structure of the compound (both the 
presence and stereochemistry of substituents,although no clear 
cut structure-activity relationship has yet been established 
(Hlavica, 1982).
The Distribution and Carcinogenicity of Aromatic Amines*
The aromatic amines belong to one of the well-defined groups 
of chemicals which have been shown to be carcinogenic in man 
(I.A.R.C. Monographs, 197*+; Kriek, 197*0* They are important 
intermediates in the dyestuff and pharmaceutical industries 
and are used in the manufacture of plastics and other synthetic 
polymers (Kriek and V/estra, 1979)* Bladder cancer v/as recognised 
as an occupationally-related malignant disease among workers 
engaged in the manufacture of aniline dyes. Aniline itself is 
not carcinogenic, but the bladder tumours v/ere probably due to 
contamination of the aniline with other aromatic amines such as 
2-aminonaphthalene, A-aminobiphenyl and benzidine. The 
carcinogenic potential of these compounds have been confirmed 
in animal studies, originally in dogs (I.A.R.C. Monographs,
197*1-; Kriek, 197*0- benzidine, *l—aminobiphenyl and 1- and 2- 
aminonaphthalene were also used as antioxidants in rubber, 
and again there was a high incidence of bladder cancer among 
v/orkers in the rubber and cable manufacture industries.
Although the level of contamination v/as' lower in these cases,
risk was increased due to the vapour hazard of the processes 
(I.A.R.C. Monographs, 197*+), and indeed it has more recently- 
been shown than benzidine may be taken in by inhalation, 
through the skin or by ingestion of contaminated food (Haley,
1982). Various aromatic amines have also been shown to be 
produced environmentally when plant and other organic 
matter is burned (Mayer, 1982; Radomski, 1979), and also may be 
present in cigarette smoke.
A large number of aromatic amines have been shov/n to be 
carcinogenic in man and experimental animals, although not all 
aromatic amines are potent carcinogens. Bladder cancer predominates 
but in rats and mice, liver, gastrointestinal tract and mammary 
gland tumours are also produced, dependent on the chemical structure 
particularly the type of aromatic ring and presence of other 
substituents (Kriek, 197*+; Radomski, 1979)* There is a wide 
variation of species sensitivity to aromatic amines, with- man 
and dog being estimated to be similarly sensitive to 2-amino- 
naphthalene, while the rat, hamster and monkey are an order 
of magnitude more resistant (Radomski, 1979)* There are also 
sex differences in sensitivity, with the female mouse for 
example being far more sensitive to the potent carcinogen 
benzidine than the male (Nelson et al, 1982), and also wide inter­
individual variations have been noted (Radomski, 1979)5 which may 
be related to immunological status. There is evidence accumulating 
that although 2-aminonaphthalene is a potent carcinogen, the 1-amino 
derivative in its pure form may not be carcinogenic, or possibly 
only weakly so (I.A.R.C. Monographs, 197*+; Mayer, 1982; Purchase 
et al, 19o1; Radomski, 1979)* However, definitive evidence for 
this has been hampered by the difficulty in obtaining 1-amino- 
naphthalene free from contamination by the 2-isomer. The most 
potent aromatic amine carcinogen is probably 4-aminobiphenyl» 
and this is also acutely toxic, resulting in methaernoglobinaemia 
(Radomski, 1979)- The *f,k1-diamino derivative of this compound 
(benzidine) is still widely used in the manufacture of aminoazo
dyes, which are used in the textile and leather industries. These 
may be reductively cleaved by intestinal anaerobic bacteria and 
possibly hapatic azoreductase to release carcinogenic aromatic 
amines. Indeed one such compound, N,N-dimethyl-*f-aminoazobenzene 
(DAB, butter-yellow), v/hich was used as a food colour, has been 
shown to produce liver tumours when fed to rats (Haley, 1982;
Prival and Mitchell, 1982). In addition to this, the colon cancer 
produced by certain aromatic amines, has a similar aetiology to 
that of 'spontaneous' human colon cancer, which has led to suggestions 
that they may contribute to the environmental cause of this disease 
(Radomski, 1979).
Metabolic Activation of Aromatic Amines.
General considerations.
Amine N-oxides are found naturally-in fungi, plants and some 
animal tissues (e.g. trimethylamine N-oxide), and generally the 
formation of N-oxides from tertiary amines is a detoxifying step, 
resulting in more stable and water soluble products (Hlavica, 1982).
A few exceptions are known, as nitroquinoline N-oxide and purine 
N-oxides are carcinogens, although possibly only after reduction 
to hydroxylamines (Hlavica, 1982). In contrast to this, N-hydroxyl- 
ation is a key reaction leading to the many toxic effects of aromatic 
amines such as necrosis, methaemoglobinaemia, immunological disorders 
and carcinogenicity (Weisburger and Weisburger, 1973)* Also, some 
further reaction products of the N-hydroxylated derivatives (possibly 
nitrosoderivatives or nitroxide radicals) may form stable complexes 
v/ith cytochrome P-A50 (Lenk and Sharmer, 1980; Lindeke, 1982).
There is a lot of support to the idea that N-hydroxylation 
is the primary mechanism in both bladder and liver carcinogenesis 
by these compounds. In general, acetamides are converted to the 
relatively stable, polar hydroxamic acids, the glucuronides of v/hich 
will not hydrolyse in the bladder, and so tend to produce liver rather 
than bladder cancer. The high level of acetylation of primary amines 
in rats may explain the preferential production of liver cancer in 
this species (Radomski, 1979)- The N-hydroxylamines derived from
well-known carcinogenic aromatic amines such as 4-aminobiphenyl 
and 2-naphthylamine have been implicated in the induction of 
bladder cancer by these agents (Damani, 1982). This is supported 
by the observation that 2-aminobiphenyl and 2,4’-diaminobiphenyl 
which are considered to be non-carcinogenic are also not 
N-hydroxylated (Radomski, 1979). It is believed that the 
N-glucuronide of the N-hydroxylated aromatic amines, such as 
4-aminobiphenyl and 2-aminonaphthalene are important in the 
transport of these otherwise very unstable N-hydroxylamines from 
the liver to the bladder. The glucuronide can then be hydrolysed 
in the bladder.due to the presence of urinary glucuronidase 
or simply due to the pH, and the resulting N-hydroxyarylamines 
are converted to carcinogenic electrophiles under the mildly 
acidic conditions of the bladder (Irving, 1978; Radomski, 1979). 
This has been demonstrated for the N-hydroxylated derivatives 
of 1- and 2-naphthylamine, which are believed to be further 
converted to either a protonated hydroxylamine or a hydrated 
aryl nitrenium-carbonium ion (Oldham, Kadlubar and Milo, 1981; 
Radomski, 1979). The conversion of N-hydroxylamines to such 
electrophiles will depend on the presence and position of 
substituents on the aromatic ring and therefore their stability. 
For example, N-hydroxy, 4-aminobiphenyl is much more stable than 
N-hydroxy, 2-naphthylarnine, while N-hydroxy, 1-naphthylamine 
tends to rearrange to 1,4-aminonaphthol which may explain the 
relative order of carcinogenicity of these compounds. Also the 
relative activity of benzidine, 4-aminobiphenyl and dichloro- 
benzidine, suggest a free radical mechanism in carcinogenicity, 
discussed in more detail later (Hlavica, 1982; Radomski, 1979). 
Certainly N-oxidation/hydroxylation products of the following 
(and other) aromatic amines have been found in the urine:- 
4-aminobiphenyl (Rhesus monkey); benzidine and dichlorobenzidine 
(nan J ; 4-aminoazobenzerP (rat); 1- and 2-naphthylamine (man, dog); 
dimethylaniline (rat); 2-acetylaminofluorene (rat) and 2-amino- 
fluorene (rabbit) (Hlavica, 1932).
Additional metabolism of most N-hydroxy metabolites appears 
to be required for DNA/protein interaction. Both N-arylhydroxyl- 
amines and hydroxamic acids are subject to conjugation reactions 
(e.g. glucuronylation, sulphation, acetylation, methylation 
and phosphorylation), which often result in further activation 
(Irving, 1978; Lotlikar, 1981; Reichert, 1981, Weisburger 
and Weisburger, 1973)* In addition, hydroxylamines tend to 
undergo an N-acetylation/deacetylation cycle, which may reduce 
the concentration of substrate able to bind to other macro­
molecules (Hlavica, 1982). Hydroxamic acids may also be 
activated via a transacetylation catalysed by N-0 acyltransferase 
(Damani, 1982; Irving, 1978; Lotlikar, 1981), and subsequent 
formation of an arylnitrenium ion. Alternatively, deacetylation 
followed by dehydrogenation may occur resulting in the production 
of nitrosamines and bisazoxyarene formation (Lenk and Sharmer,
Diagram The formation of nitreniurn ions from aromatic amides
It has also been suggested that the formation of nitroxide 
radicals is important in the metabolic activation of carcinogenic 
aromatic amines and this may be catalysed by a peroxide/peroxidase 
system and especially by co-oxidation with prostaglandin 
endoperoxide synthetase (Eling et al, 1983; Floyd, 1982; Kadlu'bar 
et al, 1982; Morton e_t al, 1983), and this may be of particular
1980).
transacetylation 
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(from Damani, 1982; Lindeke, 1982)
importance in extrahepatic tissues. The short-lived aromatic 
nitroxide is believed to bind to unsaturated endogenous 
constituents of the microsomal membrane to form a stable 
mixed nitroxide, v/hich is able to undergo redox cycling to 
produce active oxygen species (Lindeke, 1982; Stier ejt al,
1980). It may be the radical species produced which are 
involved in tumour initiation and promotion and also met- 
haemoglobinaemia related to arylamines (Floyd, 1982).
N-OH
Peroxidase
N-0NH-
6 P-450 or
" ■ '■■■■tew
Ziegler NADPH
mixed n i t rox ide
P - 4 5 0 / 
amine oxidase
f  ( f rom P -4 5  0 /  
reducf-ase ?!
OH
H O'— Oo
N= 0
Diagram Formation and redox cycling of a mixed nitroxide from
2-aminonaphthalene. (Floyd, 1982; Lindeke, 1982;
Stier _et al, 1980).
In conclusion, although N-hydroxylation is quantitatively a 
minor route of aromatic amine metabolism, it appears to be the first 
step in their activation (Shaw _et al, 1976). In contrast to this 
ring hydroxylation tends to lead to biologically inactive products 
which may be sulphated or glucuronylated (Lotlikar, 1981). The 
mixed-function oxidase system is able to perform both types of
hydroxylation, whereas the Ziegler enzyme will not oxygenate 
at carbon (Kriek and V/estra, 1979)- Induction experiments have 
shown that different isoenzymes of cytochrome P-4-30 are 
involved in different positions of oxidation, and there are also 
marked species differences in the preference for ring or 
N-hydroxylation (Kriek, 197^5 Lotlikar, 1981). For example, 
pretreatment of rats and hamsters with 3-rnethylcholanthrene 
markedly enhances N-hydroxylation (Lotlikar, 1981). It must be 
noted that although ring hydroxylation is normally a detoxifying 
step, the presence of phenolic hydroxyl groups does not necess­
arily render the carcinogen inactive, as both 3-hydroxy-4~amino- 
biphenyl and 3? 3'-dihydroxybenzidine are carcinogens. However, 
the more polar groups there are added to the ring, the less 
carcinogenic the derivative tends to become, v/hich may be due 
to a combination of effects on distribution and also metabolism 
of the nitrogen (Purchase _et al, 1978).
Specific examples.
Benzidine and A-aminobiphen.yl: The pathways of benzidine
metabolism are not entirely clear, and there is not total agreement 
in the literature. This may be partly due to the fact that the 
routes and rates of metabolism are largely dependent on the 
species and the tissue involved (Eling et al., 1983; Morton,
King and Baetcke, 1979)- The possible routes of benzidine 
metabolism are summarised in Diagram 3-6. Certainly, the liver 
does not appear to be the prime organ of activation of this
aromatic amine and it does not appear to be significantly
metabolised by liver microsomes by either an NADPH or arachidonic 
acid dependent pathway. However, co-oxidation of benzidine by 
the prostaglandin endoperoxide synthetase system occurs in the 
kidney medulla and this could be important in nephrotoxicity 
and bladder carcinogenesis (Eling et al, 19&3; Zenser, Mattamal 
and Davis, 1979). Indeed, benzidine is one of the most 
extensively studied aromatic amines with respect to metabolism 
via peroxidase/prostaglandin endoperoxide synthetase type 
mechanisms and the products have been shov/n to bind to proteins
and DMA (Morton jet al, 1983) and also to be mutagenic (Robertson
et al, 1983). The final reactive product of this 2 electron
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' oxidation pathway may be the nitrenium ion, as shown on 
Diagram 5 .6. (Eling et al, 1983; Josephy, Eling and Mason,
1983; Kadlubar et al, 1982), while other workers dispute 
this and claim that the nitroso derivative produced by oxidation 
of the hydroxylamine is most significant in macromolecular 
binding (Morton et_ al, 1983)* It is considered that acetylation 
is the most significant pathway of activation in the liver and • 
the balance between this' and deacetylation is key, (Eling 
et al, 1983) and this reaction is certainly shown to occur in 
intact hepatocytes (Brouns et al, 1982). However, there is 
disagreement over whether the benzidine is diacetylated before 
N-hydroxylation or whether it is the N-hydroxy-N-acetyl- 
benzidine which is then acetylated (compare Morton, King and 
Baetcke, 1979 and Martin jet al, 1982). Both authors are in 
agreement over the subsequent N-0 acyl transfer and formation 
of reactive nitrenium ion. It has also been suggested that 
glucuronide and glutathione conjugates may be important - in 
modulating the toxicity of benzidine (Zenser, Mattamal and 
Davis, 1979).
The metabolism of k-aminobiphenyl has not been subject to 
such intensive investigation as its , If * -diamino derivative, 
and although it is metabolised by the prostaglandin endo­
peroxide synthetase system, it is not known if this pathway 
is of toxicological significance (Kadlutar e_t al, 1982). 1-
Aminobiphenyl may be ring and N-hydroxylated, the former being 
predominantly the 3-bydroxy derivative with minor contributions 
of 2'- and I 1-hydroxy-A-aminobiphenyl. It appears that the 
involvement of cytochromes P-^ f30/P- ^ 8  in these hydroxylations 
is very dependent on species (McMahon, Turner and Whitaker,
1980; Morton _et al, 1983)* The phenolic hydroxyls may be 
sulphated, while the hydroxylamine derivative -may be further 
oxidised to form a nitroso derivative, or may be glucuronylated 
at the nitrogen to an unstable derivative, which may hydrolyse 
to form a nitrone (McMahon, Turner and Whitaker, 198O; Radomski,
1979). N-acetylation of ^-aminobiphenyl may also occur, followed
by N-hydroxylation-, N-0 acyl transfer and subsequent nitrenium 
ion formation, as described previously for benzidine (McMahon, 
Turner, Whitaker, 1980). It has been suggested that the 
^f-aminobiphenyl derived nitrenium ion can be stabilised by 
rearrangement,
while that of 3-a-minobiphenyl is not stabilised, which may 
contribute to the lack of carcinogenicity/mutagenicity of the 
latter (El-Bayoumy et al, 1981).
The amino-azo dyes: Studies were carried out on ^f-aminoazobenzene 
and ^--dimethylaminoazobenzene, and so the metabolism of these and 
the monomethyl derivative will be reviewed. Azo dyes can form 
radical anions after interaction with cytochrome P-V?0 reductase 
leading to subsequent superoxide formation (Mason et_ al, 1982) as 
shown in the scheme
FAD 
FMNH.
-NAD(P)H
• ©
R - N - N - R'
R - N = N - R f
It has also been shown that 4-methylazobenzene, at least, 
can be metabolised by the prostaglandin endoperoxide synthetase 
system (Kadlubar, 1982). Aminoazo compounds can be reduced by 
an FMN/NADH-dependent azo reductase to the corresponding free 
amines, which may be further metabolised (Prival and Mitchell,
1982), although reductive cleavage of 4-dimethylaminoazobenzene 
is said to abolish its carcinogenicity (Robertson, Harris and
McGregor, 1982). Possible pathways of metabolism of this group 
of aminoazobenzene derivatives is shown in Diagram 5*7* It 
seems that activation of 4~dimethylaminoazobenzene is dependent 
mainly on demethylation, which involves primarily cytochrome 
P-¥t8 as judged by induction and antibody inhibition studies 
(Igarashi _et al, 1982; Levine and Lu, 1982; Robertson, Harris 
and McGregor, 1982). The monomethyl derivative may then be 
again demethylated (by cytochrome P-4-50) and/or N-oxidised 
(by the Ziegler enzyme). Ring hydroxylation of any of the 
derivatives may occur (Levine and Lu, 1982),and if k-dimethyl- 
aminoazobenzene is hydroxylated at the aplha carbon, then the 
C-N bond will break (Ziegler and Pagano, 1982). The various 
phase 1 metabolites may undergo N-acetylation and conjugation 
with glucuronide, sulphate or glutathione (Levine and Lu, 1982).'
N-ox idat ion
Ziegler
4 -dim ethylami no azo benzene
Demethylat ion 
( P - 4 4 8 )HC HOCH
OH
azo-reduction 
to f reeN -hyd roxy la t i on
Z ieg lerOH req u i res
FMN/NADH)4-me thylaminoazobenzene
j Demethylat ion 
H C H O ^  ( P - 4 5 0 )
non-enzymic
ni t rone
non-enzymic
HCHO 4-ami noazobenze-ne
N -hydroxy la t i on  
Ziegler  I P -4 4 8 ?  )
OH
P.T.O. for details
Diagram 5*7. Possible pathways of metabolism of azobenzenes
(drawn from Hlavica, 1982; Igarashi e_t al, 1982; Kriek and Westra, 
1979; Levine and Lu, 1982; McMahon, Turner and Whitaker, 1980 
and Robertson, Harris and McGregor, 1982).
2-Aminoanthracene and 2-aminonaphthalene: It appears that the
amino group on these compounds is critical to their activity, as 
neither anthracene or naphthalene themselves are mutagenic 
(Kawalek and Andrews, 1981). 2-Aminonaphthalene (or 2-naphthyl- 
amine) can be metabolised by the prostaglandin endoperoxide 
synthetase system to intermediates which bind to RNA (Morton 
et al, 1983) and are mutagenic (Robertson et al, 1983)*
However, 2-aminoanthracene (or 2-anthramine) does not appear to 
be activated to mutagenic metabolites by this enzyme system 
(Robertson et al, 1983)* Indeed, although 2-aminoanthracene 
is a strong positive mutagen in the Ames test, it has been 
neglected as far as metabolic studies are concerned. It is 
probably both ring and N-hydroxylated, which compete as 
detoxification/activation pathways (Kawalek and Andrews, 1981). 
Studies with inducers and partially purified preparations of 
cytochrome P-450 isoenzymes have shown that in rat, induction 
by Aroclor, 3-raethylcholanthrene and to a lesser extent 
phenobarbitone tends to reduce activation of 2-aminoanthracene 
to a mutagen (Zeigbr , Chhabra and Margolin, 1979). In rabbit, 
it appears that the LM^ form (= P-448) is most active in 
metabolising 2-aminoanthracene to a mutagen (Norman, Muller- 
Eberhard and Johnson, 1979, 1982), possibly through N-hydroxylation, 
while cytochrome P-450 may be involved in ring-hydroxylation.
In contrast to the paucity of information on 2-aminoanthracene 
metabolism, 2-aminonaphthalene has been extensively studied and 
its possible pathways of metabolism are summarised in Diagram 3*8. 
More details of parts of this metabolism may be found in Diagrams 
p.2 and 3 -5 , and also the N-acetylated derivative may be subject 
to transacetylation and subsequent nitrenium ion formation as 
shown in Diagram 5*4. The role of the N-glucuronide of the 
hydroxylamine produced from 2-aminonaphthalene in the transport
r
s u lp ha te  / aceta te  I glucuronide
_________A_________
N-con jugat ion N/0 -con jugat ion
A
via t ransacety la t ion  or 
in s tab i l i t y  o f  e s t e r
✓ OH
NnH acidic pHnh2 P-A-5 0
or Z ieg ler
2-aminonaphthalene n i t renium ion 
peroxidase
isomerase?
mtroxide
phenol/  
d i o I /
g lu ta thone
conjugate
5,6 arene oxide
nitroso
NH Redox sr
Dimerisat ion or 
formation of  
mixed n i t rox id e
redox cycl ing
's' cycl ing 
1 ,2-naphtho-  
quinoneimine
Glutathione /
su lphate
conjugat ion
Diagram 3»8. Possible pathways of metabolism of 2-arninonaphthaIene 
(compiled from Bock-Hennig,U}lrich and Bock, 1982; Clayson and 
Ashton, 1963; Floyd, 1982; Hlavica, 1982; IAPC Monographs, 197zf; 
Kadlubar et al, 1982; Lindeke, 1982; Oldh am, Kadlubar and Milo,
1981 ; Radornski, 1979 and Stier e_t al, 1980).
of this active metabolite to the bladder has already been discussed 
in the previous section. It is again believed that for this 
aromatic amine, N-hydroxylation is an activating step, while ring
hydroxylation is detoxifying. In this case, the Ziegler 
enzyme has clearly been demonstrated to be capable of the 
activating step.
2-AminofIuorene and 2-acetylaminofluorene: The metabolism of
these two aromatic amines has been the subject of very 
extensive research, and although the arylamide has been studied
in most detail, the metabolism of both are linked via acetylation/ 
deacetylation and so will be considered together. An overview 
of the currently known routes of metabolism is shown in Diagram 
3.9* Both 2-aminofluorene and the acetylated derivative may be 
metabolised by ring or N-hydroxylation and these may then be 
further conjugated. Glucuronylation is quantitatively the most 
important reaction as far as excretion is concerned and this
in combination with ring-hydroxylation is primarily a detoxifi...
pathway (Kriek and V/estra, 1979)* Conversely N-hydroxylation 
followed by esterification leads to strongly electrophilic 
derivatives which have been shown to bind to nucleophilic 
macromolecules and therefore are implicated in mutagenesis/ 
carcinogenesis (Shaw at al, .1976).
There is some controversy over the involvement of different 
cytochrome P-V?0 isoenzymes in the various routes of hydroxylation. 
Certainly, hydroxylation at C-9 is negligible in control rats, 
but occurs at significant levels after induction by phenobarbitone 
or 3-methylcholanthrene, and this derivative is then subject to 
further transformations (Lenk and Rosenbauer-Thilman, 1980). 
Pretreatment with 3-^ethylcholanthrene enhances both N- and ring 
hydroxylation in rats, but only N-hydroxylation in hamsters 
(Hara et_ al, 1981; Lotlikar and Wang, 1982; Lotliker, Hong and 
Baldy, 1978). Also studies using antibodies against P-VpO and 
P-V-l-8 have shown that the latter contributes predominantly to the 
metabolism of 2-acetylaminofluorene (Kawajiri al,'1983), and 
further studies with purified cytochromes P-h30 (LM^) and P-V+8 
(LM^ _) have confirmed this (Johnson at al, 1980). However, when
3-methylcholanthrene is administered to rats concurrently with 
2-acetylaminofluorene, the carcinogenicity of the latter is
DIAGRAM 5*9* Pathways of metabolism of 2-acetylaminofluorene
and 2-aminofliiorene.
Compiled with reference to:-
Andrews, Hinson and Gillette, 1978; Brouns et al, 1980; Eling et al, 
1983; Floyd, 1982; Guenthner and Oesch, 1981; Hlavica, 1982; Irving, 
1978; Kadlubar jet al, 1982; Kaneda, Seno and Takeishi, 1979; Kriek, 
1974; Kriek and Westra, 1979; Lenk and Sharmer, 1980; Lotlikar, 1981; 
Meerman et al, 1982; E.C.Miller,1978; J.A.Miller, 1970; Mulder et adj 
1982; Razzouk, Mercier and Roberfroid, 1980; Steward and Floyd, 1980; 
Wirth and Thorgiersson, 1981; Yamazoe e_t al, 1980.
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reduced. This may be because (1) ring hydroxylation is induced 
preferentially to N-hydroxylation, so diverting metabolism 
along less toxic routes (not supported by research) (2) further 
metabolism (possibly isomerisation) of the N-hydroxylated 
metabolite is induced (3 ) 3-methylcholanthrene inhibits the 
arylamide N-hydroxylase which it has induced (shown in vitro)
(k) 3-methylcholanthrene induces an N-hydroxylase with lowered 
affinity for 2-acetylaminofluorene (demonstrated by research)
(3 ) ring hydroxylated metabolites of 2-acetylaminofluorene 
inhibit the N-hydroxylase. The effect is probably due to 
a combination of these possibilities and the reader is referred 
to the original research for further discussion of the above 
points (Batardy-Gregoire jet al, 1981; Johnson ejt al, 1980; 
Lotlikar , Hong and Baldy, 1978; and Razzouk e_t al, 1980). 
Isomerisation of N-hydroxy-2-acetylaminofluorene to the 1- 
or 3-hydroxy arylamide may be of significance in the detoxifi­
cation of this derivative (Hlavica, 1982; Lenk and Rosenbauer- 
Thilman, 1980), and certainly its conversion to 7-hydroxy-2- 
acetylaminofluorene is believed to be important in the 
resistance of guinea-pig and monkey to the carcinogenicity of 
this compound (Razzouk, Mercier and Roberfroid, 1980). 
2-Acetylaminofluorene has been shown to induce its own metabolism 
at both the N- and ring positions (Astrdm and De Pierre, 1982; 
Razzouk, Bartardy-Gregoiie and Roberfroid, 1982) and also to 
increase both epoxide hydrolase and glutathione transferase 
activity (Astrbm and De Pierre 1981; Kaberbhai, Bradshaw 
and Freeman 1982), but to depress the mitochondrial monoamine 
oxidase activity (Yoshida e_t al 1981). It does not appear to 
induce any of the cytosolic enzymes required for further 
activation of the N-hydroxylated derivative (Sato et_ al,
1981). Some workers believe that the N-hydroxylase induced is 
a unique form of cytochrome P-A50 (Cameron et- al, 1976;
Malejka-Giganti e_fc al, 1978) while others (Kawajiri e_t al,
1983; Razzouk, Batardy-Gregoire and Roberfroid, 1982) consider 
this to be equivalent to cytochrome P-V+8. In contrast to this, 
although the mixed-function oxidase system is believed to be
involved in the activation of 2-aminofluorene, this is not 
believed to be due to cytochrome P-*0-8 (Aune, Dybing and 
Nelson, 1.980). Other differences exist between the activation 
of the arylamine and arylamide, as 2-aminofluorene can be 
activated to mutagenic products by the prostaglandin endo- 
peroxide synthetase system, whereas the acetylated derivative 
cannot (Robertson et_ al, 1983)* N-Hydroxy-2-aminofluorene 
can thus be oxidised further to the nitroso-, nitro- and 
finally the dimerisation product (Eling e_t al, 1983; Kadlubar 
et al, 1982). Both N-hydroxylated products may undergo cyto­
solic reduction to the corresponding amine/amide (Kriek, 197*0.
It is also considered that cytochrome P-4^f8 can catalyse this 
reaction in anaerobic conditions (Yamazoe et al, 1980). 2-Nitro- 
sofluorene may bind to unsaturated lipid moieties in membranes 
to form a stable mixed nitroxide, which may undergo redox 
cycling as previously described for 2-aminonaphthalene (Steward 
and Floyd, 1980).
Further activation of N-hydroxy-2-acetylaminQ-fluorene may 
occur, producing either an N-acetyl-N-arylnitrenium ion (via 
unstable conjugates such as the N-O-sulphate) or an N-aryl- 
nitrenium ion (resulting from deacetylation/transacetylation) 
or a nitroxyl free radical (via one electron reduction)
(Forster ejt al, 1981)- These metabolic pathways have been the 
.subject of many reviews (e.g. Hlavica, 1982; Kriek, 197zt;
E. C. Miller, 1978; J. A. Miller, 1970 etc.). The products 
of such pathways have been shown to bind to protein, DNA and 
RNA and so are implicated in both the acute hepatotoxicity and 
carcinogenicity of 2-acetylaminofluorene (Meerman.and Mulder 
1981). Both acetylated and deacetylated DNA adducts are formed, 
although these bind to different positions on the deoxy guanine 
(Beranet et al, 1982; Kriek, 197*0. The N-7'adduct is rapidly 
excised leading to depurination, DNA strand breakages and cross­
links (Meerman, Beland and Mulder, 1981; Tarpley, Miller and 
Miller, 1982). Glutathione affords some protection against 
nitrenium-carbonium ion binding, by competing v/ith the other
nucleophilic sites (Meerman et al, 1982), and glutathione 
may also bind to 2-nitrosofluorene and N-hydroxy-2~amino- 
fluorene resulting in different products (Mulder et al, 1982). 
N-Acylhydroxamic acid N-O-acyltransferases exist in multiple 
forms in the cytosol of a variety of tissues, while the sulpho- 
transferase is predominantly a liver enzyme (Reigh and Floyd,
1981; Wirth and Thorgeirsson, 1981). The acyl .transferase may 
catalyse either an intra- or inter-molecular transfer and so may 
be equivalent to the AcCoA-dependent N-acetyl transferase which 
can convert 2-aminofluorene to 2-acetylaminofluorene (Hanna,,
Banks and Marhevka, 1982). Indeed, deacetylation appears to 
be a key step in 2-acetylaminofluorene mutagenesis and v/hereas 
the N-0 sulphate and acetoxy derivatives are important in 
carcinogenicity, these are not primarily involved in mutagenesis 
(Brouns ejt al, '198*1; Wirth and Thorgeirsson, 1981). This may be 
because they are too reactive/polar to penetrate the lipid 
membranes of the bacteria in the Ames test, unless the arylnitre- 
nium ion is reduced to a free radical, as occurs in the presence 
of ascorbate (Andrews, Hinson and Gillette, 1978; Brouns et al,
1980). Both N-hydroxy-2-aminofluorene and 2-nitrosofluorene are 
direct mutagens and may be further metabolised by the bacteria 
(Brouns et al, 19S0 ; Mulder jet al, 1982; Saccone, Das Gupta 
and Pariza, 1981). In rats and mice, 2-acetylaminofluorene is 
N-hydroxylated before deacetylation, while the reverse is true in 
guinea-pigs, both resulting in N-hydroxy-2-aminofluorene production 
(Kaneda, Seno and Takeishi, 1979)* The 2-nitrosofluorene derivative 
may be produced through dehydrogenation of this derivative or as a 
result of the peroxidase/dismutation pathway (See Diagram 3-9)*
MATERIALS AND METHODS.
In the experiment to determine the effect of in vivo 
alterations of the activities of cytochromes P~*f30 and P-*f*f8 
on the activation of 2-acetylaminofluorene, male Wistar albino 
rats (160-200 g) were used. They were pretreated with pheno- 
barbitone, 3-^ethylcholanthrene and/or 9-hydroxyellipticine 
as previously described (Chapter 2).
For the experiment on species and sex differences in the 
activation of a variety of aromatic amines to mutagens, both 
male and female V/istar albino rats (130-200 g), male and female 
CD1 mice (33-*l-0 g), male golden Syrian hamsters (100 - 120g), 
and the livers from pigs and both male and female humans were 
used. The sources of these were as described in Chapter 2, and 
the animals were not pretreated in any way.
Preparation of hepatic microsomal supernatant (S9) and 
microsomal suspension was also as previously described (Chapter 2). 
The microsomal supernatants were assayed for etbylmorphine and 
benzphetamine N-demethylation; aniline hydroxylase; monoamine 
oxidase (with kynuramine as substrate); and the N-oxidation of 
dimethyl-aniline (as an indicator of the activity of the Ziegler 
enzyme). Cytochrome P~VoO levels, NADPH-cytochrome c reductase 
and ethoxyresorufin O-deethylase were assayed in the resuspended 
microsornes, while both fractions were assayed for protein 
concentration. All these assays were performed strictly according 
to the regimen in Chapter 2.
Activation of various aromatic amines to mutagens in 
Salmonella typhimurium strains TA133& a^d TA100 was carried out 
according to the standard plate test method (Chapter 2). However, 
in the study of species and sex differences in activation, v/here 
uninduced preparations were used, the amount of S9 in the S9 mix 
was adjusted so that 100 yul S9 was applied to each plate. All 
carcinogens were dissolved in DH50 so that no more than 100 yul 
was applied to each plate. The spontaneous reversion rates of
the bacteria in the presence of 100 yul DI-ISO alone were in the 
range 1^-20 and 63-120 per plate for TA1338 and TA100 
respectively.
RESULTS.
Prior to each mutagenicity assay, all activation systems 
viere fully characterised with respect to mixed-function oxidase, 
mixed-function amine oxidase (Ziegler enzyme) and monoamine 
oxidase activities.
The mixed-function oxidase results for the rats which were 
pretreated v/ith phenobarbitone or 3“methylcholanthrene, either 
on their own or in combination v/ith 9-hydroxyellipticine are 
shown in Table' 3*1* These results are typical for the trends 
shown during this treatment regimen on at least 3 occasions.
The Ames test results using the S9 fractions derived frcm 
these animals are shown in Figures 3*1 a^d 3*2, v/ith ranges 
of 2-acetylaminofluorene of 0 - ^ 0  and 0 - 100yixg per plate 
respectively. When the concentration of 2-acetylaminofluorene 
exceeded AO/jog/plate, the correlation between the number of 
revertants per plate and the activity of ethoxy^resorufin 
O-deethylase ranged between r = 0.79 and r = 0.87, when this 
experiment was repeated on a number of occasions. There was, 
however, no significant or consistant correlation between the 
activation of 2-acetylaminofluorene and the other parameters 
measured.
The various enzyme activities of the preparations from the 
different species (males only) are shown in Table 3.2, £md the 
ability of these preparations to activate 2-acetylaminofluorene, 
2-aminofluorene, 2-aminoanthracene, 2-naphthylamine, A-amino- 
biphenyl and. benzidine to mutagens are shown in Figures 3*3 ~ 3*8 
respectively. In all cases A-aminoazobenzene and A-dimethylamino- 
azobenzene were toxic to the bacteria (strain TA 100) before 
mutagenicity was evident (results not shown)..
A comparison v/as made between the males and females of 
some of these species (i.e. rat, mouse and human), in both their
enzyme activities (see Table 3*3) ahd their ability to activat 
various aromatic amines to mutagens (see Figure 5*9 A - F).
The concentration range chosen to express these results fell 
within the linear part of the Ames test plot (compare v/ith 
Figures 3*3-3*8).
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FIGURE 5»1. The activation of 2-acetylaminofluorene (0-40 M.g/ 
plate) by rat liver preparations.
Each point represents the means of triplicate mutagenicity assays 
using strain TA100, and the standard deviations were always 
within the range of + 15% of the mean.
The S9 preparations were either from control rat livers (© ), or 
from those pretreated with phenobarbitone ( □ ) or 5-methylcholan- 
threne ( A ) alone, or in combination with 9-hydroxyellipticine 
( □ and a respectively).
The pretreatment regimen was as described in the legend to 
Table 5.1.
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FIGURE 5*3* Metabolic activation of 2-acetylaminofluorene to 
mutagens in Salmonella typhimurium strain TA 1538,
■Liver microsomal preparations were isolated from the species indicated.
Each determination was carried out in triplicate, with the standard 
deviations within the range +15% of the mean.
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FIGURE 5.4» Metabolic activation of 2-aminofiuorene to mutagens 
in Salmonella typhimurium strain TA 1^36- 
Liver microsomal preparations were isolated from the species indicated. 
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FIGURE 5.5. Metabolic activation of 2-aminoanthracene to muta­
gens in Salmonella typhimurium strain TA 100.
Liver microsomal preparations were isolated from the species indicated. 
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FIGURE 5.6. Metabolic activation of 2-naphthyfamine (2-amino- 
naphthalene) to mutagens in Salmonella typhimurium strain TA 100.
Liver microsomal preparations were isolated from the species indicated. 
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FIGURE 5.7* Metabolic activation of 4-aininobiphenyi to mutagens 
in Salmonella typhimurium strain TA 1558.
Liver microsomal preparations were isolated from the species indicated. 
Derivation of points as for Figure 5*3*
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FIGURE 5.8. Metabolic activation of benzidine to mutagens 
in Salmonella typhimurium strain TA 1538.
Liver microsomal preparations were isolated from the species indicated. 
Derivation of points as for Figure 5*3*
VFIGURE 5.9. A comparison of the activation of various aromatic
amines by microsomal preparations from male and female rata.
mice and humans.
A - shows the number of revertants per plate ( after subtraction 
of background ) in strain TA1558 in the presence of 40 ixg of
2-acetylaminofluorene and the various S9 fractions ( |2j] = 
male and j^ Qj = female ) .
B - as for A, but with 20 ,ug of 2-aminofluorene per plate.
C - as for A, but with strain TA100 and 5 2-aminoanthracene
per plate. '
B - as for C, but with 25 pg of 2-aminonaphthalene (or 2-naphth- 
ylamine) per plate.
E - as for A, but with 50 pg of 4-aminobiphenyl per plate.
F - as for A, but with 75 pg °i benzidine per plate.
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DISCUSSION.
Involvement of Cytochrome P-V7O Isoenzymes in the Activation of
2-Acetylaminofluorene.
Various combinations of inducers and inhibitors of the 
mixed-function oxidase system were administered to male rats 
in order to alter the levels of cytochrome P-A50 and P- -^48 
activity, and these were checked before any mutagenicity tests 
v/ere carried out (Table 5-1)* It can be noted that both
3-methylcholanthrene and phenobarbitone induction resulted 
in an increase in total cytochrome P-A30 levels, while only 
phenobarbitone was effective at inducing the reductase.
Ethoxyresorufin O-deethylase was markedly induced by 3~^ethyl~ 
cholanthrene. There was a wide variation in the control levels 
of ethoxyresorufin O-deethylation between 2 batches of rats kept 
at different times in the animal house. It was previously 
noted (in Chapter 3) that this activity is very sensitive to 
minute levels of inducer, and the elevated ethoxyresorufin 
O-deethylation levels could be related to the occasion when the 
area around the animal house v/as being painted, and so it is 
possible that this may have been caused by the rats inhaling 
some solvent.fumes. This was unfortunate, but did not nullify 
the results, as correlations were alv/ays made between the 
ability of specific preparations to metabolise certain substrates 
and to activate 2-acetylaminofluorene.
The induction of benzphetamine N-demethylation by pheno­
barbitone was repeatedly low, and this may partially be due to 
the alternative route of metabolism of this substrate (i.e. N- 
oxidation). This is certainly a likely reason for the apparent 
decrease in this activity in 3"*raethylcholanthrene-induced animals, 
where cytochrome P-AA8 would tend to divert metabolism to N-oxidation 
(Fok and Ziegler, 1970; Prough and Ziegler, 1977; Ziegler and 
Poulsen, 1978).
Initially Ames tests were run with the 2-acetylamino- 
fluorene concentration ranging from 0 - AO /Ag per plate 
(e.g. Figure 3.1). Over this concentration range there was 
no clearcut correlation between activation and either, 
cytochrome P-A30 or P-AA8 activity, although at the lowest 
concentrations (0 - 20 pug per plate), 3~methylcholanthrene- 
indueed preparations were most effective, while at AO jmg/plate, 
the phenobarbitone-induced preparation took the'dominant role 
in activation. It therefore seemed important to test higher 
2-acetylaminofluorene concentrations (Figure 3-2) and these 
showed clearly- that the phenobarbitone induced preparations 
were not as efficient as the 3-methylcholanthrene induced 
rats at activating 2-acetylaminofluorene. Indeed, at concen­
trations greater than AO pig/plate, the correlation between 
2-acetylaminofluorene activation and ethoxyresorufin 0-deethyl- 
ation ranged between r = 0.79 and ^  = 0 .87, on-several
occasions, although no consistent or significant correlation 
could be observed with any other enzyme activity. The activation 
of 2-acetylaminofluorene is believed to involve an initial 
N-hydroxylation, while ring hydroxylation is considered to be a 
detoxifying step (as discussed in the Introduction to this 
Chapter), and 3-methylcholanthrene is believed to induce both 
pathways in rats (Lotlikar and'Wang, 1982). The results show 
the clearest involvement of cytochrome P-AA8 in the activation 
of 2-acetylaminofluorene in the higher concentration range.
This may be because at lower’concentrations ring hydroxylation 
takes a more dominant role, perhaps because the N-hydroxylase 
induced by 3-methylcholanthrene has a lower affinity for 
2-acetylaminofluorene, possibly in turn due to competitive 
inhibition from the 3-methylcholanthrene itself (Batardy- 
Gregoire et al, 1981; Kazzouk'et al, 1980). Although some other 
evidence has been published, suggesting that -mainly cytochrome 
P-AA8 is involved in the activation of 2-acetylaminofluorene 
(e.g. Kawajiri et_ al, 1983), and also that the carcinogenicity 
of 2-acetylaminofluorene in a variety of species is related to 
the affinity of the N-hydroxylase for this substrate (Razzouk 
and Fruberfroid, 1982), yet other workers have been unable to find
a correlation between 2-acetylaminofluorene N-hydroxylation or 
ring hydroxylation and ethoxyresorufin O-deethylation (Lang,
Gielen and Nebert, 1981). It has also been published that 
phenobarbitone is the best inducer of 2-acetylaminofluorene 
(e.g. Weisburger and Weisburger, 1973)* it is quite likely, 
when considering the present results, and also those following 
Aroclor induction (Thompson, Whitaker and McMahon, 1980), that 
the discrepancies in the literature are due to comparative protein 
and substrate concentrations, which in turn effect both the route 
of metabolism and mutagenicity in'the Ames test. It should also 
be remembered -that N-hydroxylation of 2-acetylaminofluorene is 
only the first, and not necessarily rate-limiting step in activation 
and many other enzymes may be involved. The N-oxidative step 
itself may be catalysed by a variety of enzymes, although purified 
mixed-function amine oxidase cannot activate 2-acetylaminofluorene 
(Pelroy and Grandolfi, 1980). In a joint study with Dr. C. Ioannide 
and Miss C. Steele, we have some preliminary evidence (results not 
shown) that the unique cytochrome P-A50 induced by chronic ethanol 
ingestion (Morgan e_t al, 1982) may be more efficient at activating 
2-acetylaminofluorene and also A-aminobiphenyl and benzidine to 
mutagens. This may occur via a free radical mechanism (Ingelman- 
Sundberg an<^  Hagbjdrk, 1982). The alcohol-induced rats also had 
elevated levels of dimethylaniline N-oxidase (usually considered 
to measure the Ziegler enzyme), and so this served as a stimulus 
towards further studies on the involvement of N-oxidising enzymes 
other than the mixed function oxidase in activating a variety of 
aromatic amines.
Involvement of N-Qxidative Enzymes in the Activation of Aromatic 
Amines: Species and Sex Differences*
An extensive study was set up investigating species and sex 
differences in the activation of a variety of aromatic amines.
Rat, mouse and hamster were chosen as examples of common laboratory 
rodents, pig because it has a high level of the Ziegler enzyme 
(Dannan and Guengerich, 1982; Ziegler, 1978) and these were 
compared with human liver samples. No overall generalisations 
can be drawn when it is considered that only one male and one female
human liver sample was available, and it is known that there are 
variations in enzyme activities in humans due to genetic factors 
(Paine, 1981) and there are also the problems associated with post­
mortem changes and also previous exposure to alcohol, cigarettes 
and other drugs (Jakobsson _et al, 1982; Singh and Clausen, 1981). 
However, care was taken to ensure that drug-overdose had not been the 
cause of death.
The mixed-function oxidase, mixed-function amine oxidase and 
monoamine oxidase activities were determined in all preparations 
prior to mutagenicity assays (Tables 3-2 and 3*3)- agreement 
v/ith other studies (e.g. Hlavica, 1982; Mori jet al, 1983), hamster 
had the highest, and pig and human the lowest levels of cytochrome 
P-A30. Hamster also had by far the highest levels of ethoxyresorufin 
O-deethylase (i.e. P-AA8) and was active in the N-oxidation of 
N,N-dimethylaniline. It is possible that cytochrome P-AA8 also 
contributes to this activity, so that it may not be entirely due 
to the mixed-function amine oxidase (Cavagnaro, Rauckman and Rosen, 
1981; Das and Ziegler, 1970; Hlavica and HUlsman, 1979; Ziegler 
and Pettit, 196A). In order to attempt to limit the involvement
of the mixed-function oxidase in the N-oxidation of N,N-dimethyl-
aniline, the pH of the assay medium was raised to 8 .A, in contrast 
to pH7-6 used to .assay the N-demethylation of this substrate (Lake 
et al, 1979)- The high level of N,N-dimethylaniline N-oxidation
in the pig is likely to be entirely due to the Ziegler enzyme, as
the mixed-function oxidase activities (i.e. benzphetamine 
N-demethylation and ethoxyresorufin O-deethylation) are very low 
in this species. Benzphetamine N-demethylation is highest in the 
rat, again being low in pig and human, and in the case of pig, 
at least, this may be due to the alternative N-oxidation pathway 
(Fok and Ziegler, 1970; Prough and Ziegler, 1977)* Reductase 
activity is fairly constant across all specieL, although again is 
higher in the hamster. The human preparations had particularly 
low activity of the Ziegler enzyme, although the highest monoamine 
oxidase. Both these activities have been demonstrated to show 
considerable variation, dependent On tissue and age (Haenick,
Boehme and Vogel, 1981; Ziegler, 1978).
There were no significant sex differences in total cytochrome 
P-A30 level (Table 3*3)* The female mouse and human tended to have 
higher activities of benzphetamine N-demethylation and monoamine 
oxidase than the males (although these are not statistically 
significant). Other workers have reported that female mouse and 
human have higher Ziegler enzyme activity than the males (Dannan 
and Guengerich, 1982; Kloss et al, 1982), while (in agreement 
v/ith the present studies) in rats the reverse is true, with the 
males having the higher activity. The levels of mixed-function 
amine oxidase measured in the rat (and possibly other species) 
may be a low estimate because of the presence of endogenous 
substrates in the cytosol and microsomes (Cavagnaro, Rauckman and 
Rosen, 1981). This activity is also labile and subject to post­
mortem inactivation (Dannan and Guengerich, 1982; Ziegler and 
Poulsen, 1978).
The choice of concentration of aromatic amine and strain of 
Salmonella typhimurium used in the Ames test v/ere made after reference 
to the literature (e.g. Bartsch _et al, 1980; Connor ejb al, 1983; 
McMahon, Clue and Thompson, 1979; Purchase et al, 1978), although 
there v/as not alv/ays total agreement in the papers over the best 
strain to use. Most activated aromatic amines bind to C-8 of 
deoxyguanine and tend to intercalate (Kriek and V/estra, 1979), 
while the esters of aryl hydroxamic acids may also acylate (Martin 
et al, 1982). This may be the reason for this group of compounds 
being picked up by Salmonella typhimurium strains which detect 
base-pair substitutions (i.e. TA100), as well as those which 
detect the more expected frameshift mutations (i.e. TAI338 and 
TA98). Indeed, studies have been carried out on a series of aromatic 
amines and their derivatives, which have classified them according 
to their type of mutagenic activity and type of binding (see 
Scribner, Fisk and Scribner, 1979). These studies had found TAI338 
10 be generally one of the most sensitive strains, except for 
2-aminonaphthalene, as this derivative caused mainly base-pair 
substitution. Enzyme and substrate concentrations are also very
important in mutagenicity assays, and these are altered 
depending on the procedure (i.e. standard plate vs, preincubation) 
(Muller-Eberhard and Johnson, 1982). As the number of revertants 
depend both on the mutagenic activity and the toxicity of the 
compound, its concentration is sometimes very critical. It is 
believed that the toxicity of benzidine and A-aminobiphenyl 
leads to an underestimation of the mutagenicity of these compounds 
(Parodi _et al, 1981). This was certainly a problem with the 
aminoazobenzene derivatives used in this study, both of which 
were toxic to the bacteria (strain TA 100) before mutagenicity 
was evident (results not shown). Others have found it difficult 
to detect either A-aminoazobenzere or its A-dimethyl derivative 
as mutagens, and have suggested variations such as preincubation, 
higher concentrations of S9 (preferably Aroclor induced), the 
addition of a co-mutagen (norharman), the presence of riboflavin 
etc. (e.g. Ashby ejt al, 1982; Moran and Ames, 1983; Prival and 
Mitchell, 1982; Purchase et_ al, 1978; Robertson, Harris and 
McGregor, 1982; Zeig er and Pagano, 1982). It was not possible 
to draw any conclusions on the relative ability of the different 
species to activate the aminoazobenzenes from this study, even 
though rats and mice are susceptible to hepatocarcinogenicity 
by such compounds (Mori e_t al, 19833 -
All species (both male and female) were good at activating 
2-aminofluorene to mutagens (Figures 3 -A and 5*92), and all 
except for the rat were able to activate 2-acetylaminofluorene 
to mutagens (Figures 3.3)- As the main mutagenic metabolite(s) 
arise(s) from an N-oxidized product of 2-aminofluorene (Hongslo 
et al, 1983), the ability of various species to metabolically 
activate 2-acetylaminofluorene will depend on the relative 
acetylation/deacetylation (see Introduction for details). Rats 
(especially the males ) have a very high ratio of acetylation: 
deacetylation (Kriek, 197A; Kriek and Westra, 1979; Weisburger 
and Weisburger, 1973), v/hich could explain the present results, 
uamsters, on the other hand have high deacetylase activity (Kriek 
and Westra, 19V’A). Activation of 2-acetylaminofluorene in the
Ames test may also depend on the relative V of the J max
N-hydroxylase for this substrate (i.e. hamster and mouse is 
greater than rat) (Lotlikar jet al, 19&7; Razzouk elt al, 1980;
Shaw et al, 1976; Weisburger and Weisburger 1973)? whereas 
carcinogenicity depends on the affinity of the enzyme, which is 
the reverse order among these species (Razzouk and Roberfroid,
1982). Both the N-hydroxylation of 2-acetylaminofluorene 
(Reichert, 1981; Weisburger and Weisburger, 1973) a^d its acti­
vation to mutagens (Lesca, Beaune and Monsarrat, 1981) can be 
catalysed by human liver microsomes, as.has also been shown in 
the present study. In all species, the presence of cytosolic 
fractions are important to enhance the mutagenicity of both 
2-aminofluorene (Saccone, DasGupta and Pariza, 1981) and 
2-acetylaminofluorene (McGregor et al, 1980). The mixed-function 
amine oxidase has been shown to activate 2-aminofluorene, possibly 
via the formation of nitroxide radicals (Hlavica, 1982; Pelroy 
and Gandolfi, 1980), but it is not believed to metabolise 
2-acetylaminofluorene. The high ability of the pig preparations 
to activate the latter may well depend on a deacetylation step 
followed by Ziegler-enzyme catalysed activation.
2~Aminoanthracene is one of the most potent aromatic amine 
mutagens, being detected in the range 0.5 - 5*0 /-*■£ per plate, 
and well activated by all species (Figure 3*5) and with no 
obvious sex differences (Figure 5*9C). No correlation was 
observed with any of the enzyme activities studied, which points 
against the involvement of the major group of cytochromes P-A50 and 
P-hA8 in its activation. 2-Arninonaphthalene (or 2-naphthylarnine) , 
on the other hand, was poorly activated by most of the species, 
apart from hamster (Figure 5*8). Also the female rat and human were 
approximately 50% as effective as the males in activation of this 
compound (Figure 5*9D). Others have found it-to be only a weak 
mutagen (Bos et al, 198O; El-Bayoumy et al, 1981) and this may be 
because its major metabolite (1-hydroxy-2-aminc^jiaphthalene) is 
cytotoxic to the bacteria (Eock-Hennig, Ullrich and Bock, 1982).
It may have been more mutagenic to strain TA1538 rather than 
TA100, as it is predominantly a frameshift mutagen (Mayer, 1982).
Also, it has been shown to require Aroclor or phenobarbitone 
induction of rats for significant N-hydroxylation (Hlavica,
1982) and mutagenic activation (Mayer, 1980, 1982; MUller,
1980) to be detected. Apparently mutagenicity can be 
enhanced if ring hydroxylation is blocked by the presence of 
non-carcinogenic aromatic hydrocarbons (Kawalak and Andrews,
1981). In agreement with other studies, the order of ability 
to activate 2-aminonaphthalene among the rodents was hamster 
followed by rat then mouse (Mayer, 1982; MUller et al, 1980;
Prival and Mitchell, 1982). However, none of these are 
particularly susceptible to carcinogenicity of 2-aminonaphthalene 
(IARC Monographs, 197^; Radomski, 1979)* There is considerable 
variation in the ability of human liver to activate this compound 
(Mayer, 1982), and it is believed that both the mixed-function 
oxidase and the Ziegler enzyme can contribute to its metabolism 
(Hlavica and Hulsman, 1979)* In pigs, the Ziegler enzyme may
be the only route of activation of this compound (Ziegler, 1982) 
and the mixed-function amine oxidase may also activate 2-amino- 
anthracene (Pelroy and Gandolfi, 1980).
4-Aminobiphenyl was activated quite efficiently by the mouse 
and hamster preparations, v/ith the pig being the weakest (Figure
5.7) • Also, the female rat and human were approximately J>CP/o and 
50% (respectively) efficient as the males in activation of this 
aromatic amine (Figure 5-9E). Others (Lazeer and Louie, 1977) 
have shown the mouse to be able to activate A-aminobiphenyl, 
and this species, together with hamster and rat are able to 
both N-hydroxylate and ortho-hydroxylate this derivative (McMahon, 
Turner and Whitaker, 1980). Activation may thus depend on the 
ratio of hydroxylation in these 2 positions. Some have shown 
that N-hydroxylation of A-aminobiphenyl is induced by Aroclor 
and 3-methylcholanthrene (McMahon., Turner and' Whitaker, 1980), 
while others claim that phenobarbitone is the best inducer of 
A-aminobiphenyl activation to mutagens (Bos et al, 1982; Hlavica,
1982). However, work carried out in this laboratory with 
purified cytochromes P-A50 have suggested that the /3-naphtho- 
flavone induced form is the most efficient at activating A-amino-
biphenyl (Masson ejt al, 1983)? while neither cytochrome P-A50 
or P-AA8 were .able to activate benzidine to a mutagen. Benzidine 
is also not metabolised by the mixed-function amine oxidase 
(Ziegler and Poulsen, 1978), but can be activated by the prosta­
glandin endoperoxide synthetase system in extrahepatic tissues 
(Hlavica, 1982; Reigh and Floyd, 1981). Indeed, benzidine was 
only activated to any extent by the hamster and mouse preparations 
(Figure 5*8), in agreement with others who have shown mouse (Lazeer 
and Louie, 1977) and hamster (Prival and Mitchell, 1982) to 
activate this mutagen. However, the female mouse was only ZQP/o 
as efficient as the male in the Ames test (Figure 5*9F). The 
N-hydroxy-diacetyl derivative is believed to be a key metabolite, 
and the production of this by acetylation and N-hydroxylation is 
particularly high in the hamster and mouse (Morton, King and Baetcke, 
1979)? while the rat is better at ring hydroxylation (Prival and 
Mitchell, 1982). The mutagenicity of benzidine is far more 
pronounced in vivo and in intact hepatocytes than when using 
liver fractions, possibly because of the critical N-acetylation 
step (Bos _et al, 1980; Brouns et al, 1982).
NOTE ADDED IN PROOF.
Recently, in a paper published by Hammons et al,1985* the work 
on the metabolic activation of arylamines by various species, 
and the involvement of different enzymes in this, has been 
confirmed and extended.
CONCLUSIONS.
The aromatic amines and amides are a group of known- human 
carcinogens which may be metabolised by a variety of enzyme systems 
including the mixed-function oxidase, mixed-function amine oxidase 
(or Ziegler enzyme) and possibly monoamine oxidase, and also the 
prostaglandin endoperoxide synthetase.system and other free- 
radical mechanisms. The actual route and enzyme system used 
in metabolism depends on the species, strain, age and sex of the 
animal, the tissue, the presence of inducers and inhibitors, the 
structure of the compound and also the in vitro assay conditions 
used. It is generally believed that N-hydroxylation is the 
first step in activation, while ring hydroxylation is a 
detoxifying step. The former may lead to. aryl nitrenium ion 
formation or nitroxide radical production.
Studies using rats treated with various inducers and inhibitors 
of the mixed-function oxidase system suggest that at higher 
concentrations of 2-acetylaminofluorene, at least, cytochrome P-AA8 
is involved in its activation. However, when the activation of
2-acetylaminofluorene is compared with 2-aminofluorene,'
it suggests that the deacetylation step is 
important in the mutagenicity of the amide, and this is poorly 
metabolised in rats compared with the other species tested. In 
the studies using the preparations from a variety of species, 
there was no clear cut relationship between- the activation of any of 
the aromatic amines and any particular enzyme system. This is not 
entirely surprising as it is quite likely that different enzymes 
contribute to metabolism to a different extent in the various 
species. In the pig, for example, the Ziegler enzyme may be the 
main enzyme involved in metabolism of aromatic amines. Of all 
the species the hamster was most consistently able to activate 
the aromatic amines to mutagens, and this may have been related 
to its high levels of both cytochrome P-AA8 and the Ziegler 
enzyme.
C H A P T E R
CHAPTER 6. THE ACTIVATION OF POLYCYCLIC AROMATIC HYDROCARBONS.
INTRODUCTION.
Distribution and Carcinogenicity of Polycyclic Aromatic Hydrocarbons.
The first pure chemicals that were shown to cause cancer in 
experimental animals were the polycyclic aromatic hydrocarbons, 
dibenz(a,h)anthracene and benzo(a)pyrene. A number of these 
compounds, including benzo(a)pyrene, are formed during the incomplete 
combustion of organic materials, and so are widespread environmental 
pollutants found in the air, water and soil (Guenthner and Oesch,
1981). Polycyclic aromatic hydrocarbons may also be present in bacteria 
and higher plants, either through contamination or biosynthesis in 
these organisms (Harvey, 1981). Human exposure may be increased 
by contact with the particulate matter in urban air (with vehicle 
exhaust fumes being a major contribution), cigarette smoke, coal tar, 
and even charred foods and certain alcoholic beverages (Nagas and 
Sugimura, 1978). Indeed, the carcinogenicity of these compounds 
was first suggested by the observation that workers in contact with 
coal tar showed a higher frequency of skin cancer than the rest of 
the population. This was confirmed by skin painting experiments 
with animals (especially mice), where initially complex mixtures 
and later pure compounds were tested. Since then a number of 
studies have demonstrated the carcinogenicity of numerous polycyclic 
aromatic hydrocarbons in many different species, including man 
and in a variety of tissues, including lung and skin. They have 
also been shown to cause malignant transformations and mutagenesis 
when applied to cells in culture (DePierre and Ernster, 1978). It 
was demonstrated over 2p years ago that these carcinogenic compounds 
bind to nucleophilic macromolecules, and that .their potency as 
carcinogens was related to their ability to bind to DMA (reviewed 
by Conney, 1982; Phillips and Sims, 1979). It was also clear that 
since the hydrocarbons do not possess reactive groups, their 
metabolic activation was necessary be fore trev could react with
nucleic acids. It is these pathways of activation and the 
enzymes involved in them that is the subject of this chapter.
For a more complete discussion of the historical aspects of 
the research on polycyclic aromatic hydrocarbons, the reader 
is referred to a number of reviews on the subject (e.g. ,Brookes, 
1977; Conney, 1982; DePierre and Ernster, 1978; Phillips and 
Sims, 1979).
Metabolic Activation of Polycyclic Aromatic Hydrocarbons.
The mixed-function oxidase system has a primary role in the 
metabolic activation of polycyclic aromatic hydrocarbons, and 
early studies (Jerina and Daly, 197A) revealed a novel type of 
metabolism of these compounds to arene oxides or epoxides. These 
may be produced across unsaturated bonds at various positions 
on the moleaule, dependent on substituents and*other steric. 
factors. The structures of the compounds considered in this 
chapter are shown in Diagram6.1,and the regions of these molecules 
of most interest are the 1K-region1 and’bay-region'. Initial 
studies concentrated on epoxides formed across the K-region, 
as these are the most stable and therefore the easiest to 
isolate (Brookes, 1977)? and were shown to bind with nucleic 
acids (Phillips and Sims, 1979). The further metabolism of the 
epoxides of polycyclic aromatic hydrocarbons is shown in 
Diagram 6.2. and the route taken depends on their stability 
and the specificity of the various enzymes. The extent of DNA 
binding depends on the steady-state levels of the epoxides, 
and the enzymes involved in their metabolism are affected 
by the physiological state of the individual, diet, exposure 
to xenobiotics etc. Different forms of cytochrome P-A50 are 
involved in the metabolism of these molecules at different 
positions, with cytochrome P-AA8 being most efficient at oxidizing 
at the sterically-hindered bay-regions (Nebert and Jensen, 1979). 
Also, if the amount of polycyclic aromatic hydrocarbon is limited, 
it tends to be recycled to produce secondary and tertiary metabolites 
(DePierre and Ernster, 1978; Harvey, 1981). This is particularly 
true for the phenols and dihydrodiols and the latter may be 
metabolised to vicinal diol epoxides (Conney, 1982), which are
Bay Region
8 7 6
Benz (a)anthracene
Bay Region
7 , 12-Dimethyl  benzanfhracene
Bay Reg ion
9 ^Bay Region
Dibanz (a,h)anthracene
Bay Region
2 1 
3-Mefhy lcho lanfhrene
Bay Reg ion
7 6 5
Benzo (a)pyrene
Bay Regions
Di benzo (a, i )pyrene
DIAGRAM 6.1. The structures of the polycyclic aromatic hydrocar­
bons referred to in the text.
The K- and bay- regions are indicated.
believed to be the active carcinogenic intermediates. Other 
possible culprits are transient oxyradicals, cation radicals 
or hydroxymethyl derivatives (DePierre and Ernster, 1978). The 
most popular current theory is that the proximate carcinogenic 
metabolites are the bay-region diol epoxides, where the epoxide 
is part of the bay region and therefore not readily available 
for detoxification by epoxide hydrolase (Conney, 1982; Phillips 
and Sims, 1979)* The ease of triol carbonium ion production 
from such an intermediate is an important factor in its DMA-binding 
capacity, and breakage of the epoxide ring is helped by the 
hydroxide group of the syn isomer (Hulbert, 1979) (see Diagram 
6.3 for the example in benzo(a)pyrene). The presence of a 
bay-region is not alone sufficent to conclude that a polycyclic 
aromatic hydrocarbon is carcinogenic, as benzo(e)pyrene has 
two bay-regions, but is is not a carcinogen. However very little 
metabolism around the bay region occurs in this derivative 
(Conney, 1982; Levin _et al, 1982).
A relatively recent line of research in the metabolism 
of polycyclic aromatic hydrocarbons, is that which has shown 
that they may be co-oxidized by the prostaglandin endoperoxide 
synthetase and other peroxidases, including haemoproteins 
(reviewed by Eling _et al, 1983)* This has been most extensively 
investigated for benzo(a)pyrene, the metabolism of which generally 
has received a lot of attention (See Diagram 6.3). It is believed 
that one electron oxidation, rather than epoxidation is involved 
in the production of 6-hydroxybenzo(a)pyrene, and further oxidation 
produces the various quinones via a 6-oxyradical. This may be 
catalysed by either cytochrome P-A30 or the prostaglandin synthetase 
system (Rennebejg et_ al, 1981) and may be followed by further redox 
cycling between the quinone and hydroquinone derivative, resulting 
in the production of active oxygen species and thus DMA damage 
(Hawco, Hulett and O'Brien, 1 9 o 0 ) .  Similar free radical formation 
has been described for other hydrocarbons, such as dibenzo(a,i)- 
pyrene, 3-methylcholanthrene and 7,12-dimethylbenzanthracene 
(Penneberg et al, 1981)r It has also been demonstrated that the
1) Glucuronide + sulphate
2) Catechol / Methylated catechol
Further metabolism
1) conjugation
2) dehydrogenation
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OH
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DIAGRAM 6,2o General routes of metabolism of polycyclic 
aromatic hydrocarbons*
Where R «= the remainder of the ring system of the hydrocarbon 
in question ; GSH = reduced glutathione.
( DePierre and Ernster, 1978 ; Nebert and "Jensen, 1979 )
prostaglandin endoperoxide synthetase system can catalyse the 
bay-region epoxidation of the benzo(a)pyrene-7 ,8-diol, thus 
producing DNA-binding, mutagenic derivatives. It is believed 
that in extrahepatic tissues such as the lung, this mechanism 
probably occurs at a similar rate to the cytochrome P-A48- 
catalysed reaction, although it is unlikely to be of great 
significance in the liver (Guthrie jet al, 1982; Marnett,
Panthananickal and Reed. 1982). Metabolism of benzo(a)pyrene ' 
and other hydrocarbons (such as benz(a)anthracene and 7,12- 
dimethylbenzanthracene) by the prostaglandin endoperoxide 
synthetase system may be inhibited by antioxidants, including 
vitamins C and E, which may be related to their inhibitory 
effect on carcinogenesis (Eling et al, 1983)*
Benzo(a)pyrene: The range of benzo(a)pyrene metabolites which
may bind to DNA include primary arene oxides, diol epoxides,* 
phenols oxygenated further and quinone-derived free radicals.
In addition, the glucuronides, which are generally considered 
to be detoxification products may be broken down by glucuronidase 
to release benzo(a)pyrene oxy radicals (Nebert and Jensen, 1979)- 
The production of the 7,8-diol, 9,10-epoxide of benzo(a)pyrene 
is most efficient at low benzo(a)pyrene concentration, and more 
of the 7,8-diol partitions into the microsomes than the parent 
compound (Fahl, 1982). Oxidation at the 9,10-position is 
stereoselective and it is predominantly the anti-isomer which is 
produced (see Diagram 6.3 ) (DePierre and Ernster, 1978). Purified 
systems containing reconstituted mixed-function oxidase (with P-AA8 
as the terminal cytochrome) and epoxide hydrolase were shov/n to produc 
this bay region diol epoxide, which is believed by many not to be 
further metabolised by epoxide hydrolase (Conney, 1982; Levin et al
1982). Certainly, added epoxide hydrolase had very little effect 
on the mutagenicity of the diol epoxide in the* Arnes test, but it 
was shown to reduce DNA binding in a purified system and this was 
related to further metabolism (Gozukara et al, 1981).
DIAGRAM 6.5. The metabolism of benzo(a)pyrene.
Compiled with reference to
Brookes, 1977 » Conney, 1982 ; DePierre and Ernster, 1978 ; 
Eling et. aJ, 1983 ; Fahl, 1982 ; Guenthner and Oesch., 1981 ; 
Harvey, 1981 ; Keller, Turner and Jefcoate, 1982 ; Levin 
et al, 1977, 1982 ; Nebert and Jensen, 1979 ? Selkirk et al. 
1982 ; Weston, Grover and Sims, 1982' ; Wrighton et. al , 1982.
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DIAGRAM 6.3.
Activated benzo(a)pyrene derivatives tend to bind most 
extensively to proteins, including the histones surrounding 
the DNA and also to enzymes, including those associated with 
the mixed-function oxidase system and glutathione transferase, 
and thus cause inhibition. The quinones are particularly noted 
for their ability to inhibit benzo(a)pyrene metabolism, and thus 
removal of these derivatives via glutathione or glucuronide 
conjugation may apparently increase the mutagenic effect of 
benzo(a)pyrene, through release of the inhibition of other 
metabolic pathways, (Keller, Turner and Jefcoate, 1982; Levin 
et al, 1982). "Additional metabolic pathways which are not 
indicated 011 Diagram 6,3 include the production of hydroxy- 
methyl derivatives and also the reduction of diols to catechols 
via a diol dehydrogenase (Levin jet al, 1982; Phillips and Sims,
1979; Selkirk et al, 1982).
Dibenzo(a,i)pyrene: In contrast to the vast amount of research 
which- has been carried out on the metabolism of benzo(a)pyrene, 
there is an extreme paucity of information on dibenzo(a,i)pyrene 
(see Diagram 6.4). This is a highly tumorigenic compound, with 
2 bay regions, and the bay region diol epoxides have a high chemical 
reactivity (Conney, 1982; Hecht et al, 1981). The production of 
the mutagenic_and carcinogenic 3>4-diol-1,2-epoxide has been 
demonstrated using purified, reconstituted enzyme systems 
(Hecht et al, 1981).
Benz(a)anthracene: Paradoxically, the metabolism of benz(a)-
anthracene, which is a relatively weak carcinogen and mutagen, 
has received quite a lot of attention (see Diagram 6.3 ). It is 
believed that its low potency is probably due to a poor rate 
of metabolism to the proximate carcinogen (Jacob, Grimmer and 
Schmoldt, 1981), although the production of the bay-region diol 
epoxide has been shown using purified, reconstituted systems 
containing mixed-function oxidase components and epoxide hydrolase 
(Glatt et al, 1981). This derivative has been shown to be far 
more mutagenic than the non-bay region 8 ,9-diol-10,11 epoxides 
and the 10,11-diol-8,9-epoxides (Phillips and Sims, 1979).
o
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■ OH
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DIAGRAM 6,4* The metabolism of dibenzo(a,i)pyrene.
Compiled with reference to Conney, 1982 ; Hecht et al, 1981 
Stereochemistry is relative.
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Where MFO = mixed-function oxidase 
EH = epoxide hydrolase 
PES = prostaglandin endoperoxide synthetase 
GSH = glutathione conjugation 
( Stereochemistry is relative )
DIAGRAM 6.5. The metabolism of benzfa)anthracene.
Compiled with reference to Conney,1982; DePierre & Ernster, 
1978; Glatt et al,1981; Guthrie et al,1982; Jacob,Grimmer & 
Schmoldt,1982.
As with benzo(a)pyrene, the anti-diol epoxide is the major 
metabolite, mammalian mutagen and tumorigen, whereas the syn- 
diol epoxide is a stronger bacterial mutagen and reacts far more 
rapidly with DNA (Conney, 1982). Additional pathways which 
are not shown in Diagram 6.3 • include the reduction of epoxides 
by epoxide reductase and the inactivation of diols by dihydrodiol 
dehydrogenase (DePierre and Ernster, 1978; Glatt et_ al, 1981).
7,12-Dimethylbenzanthracene: Methyl substitution of the benz-
anthracene ring may significantly alter the stereochemistry 
of epoxidation-and diol formation (Harvey, 1981) and 7,12-dimethyl­
benzanthracene is a far more potent carcinogen than its parent 
compound and forms different DNA-binding products (Phillips and 
Sims, 1979)* As can be seen in Diagram 6.6 ., both hydroxylation 
of methyl groups and the production of arene oxides and diols 
etc. may occur. The 7-hydroxylmethyl substitution tends to 
enhance, while the 12-hydroxymethyl inhibits the production of the 
bay region diol epoxide (Yang, Easton and Chou, 1980).
Dibenz(a,h)anthracene: Dibenz(a,h)anthracene is a strong carcinogen 
with two bay regions in the symmetrical molecule, and it is 
extensively metabolized to the bay region diol epoxide (see Diagram
6.7), v/hich itself is a strong mutagen and tumorigen.
3-Hethylcholanthrene: Another strongly carcinogenic derivative of
benz(a)anthracene is 3-methylcholanthrene, v/hich is metabolised to 
a large range of metabolites, as shown in Diagram 6 8 . Hydroxylation 
at the 1-position (and to a lesser extent at the 2-position) appears 
to be an essential prerequisite for bay region diol-epoxide 
formation. The 9 j10-diol-7,8-epoxide is not formed directly 
from the parent compound by a purified reconstituted system of 
mixed-function oxidase and epoxide hydrolase (Wood _et al, 1978).
Also, the K-region epoxide is not particularly active, and only 
the 2-keto derivative of this is mutagenic in the Ames test (Conney, 
1982).
Where:-
MFO=mixed-function oxidase 
EH=epoxide hydrolase 
GSH=glutath.ione conjugation 
Stereochemistry is relative
lOH
«!)oH
DNA / S
binding
DIAGRAM 6.6. The metabolism of 7>1 2-dimethylhenzanthracene.
Compiled with reference to Brookes,1977; Conney,1982; Glatt 
et al,1981; Harvey,1981; Yang, Easton & Chou,1980.
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DIAGRAM 6.7. The metabolism of dibenz(a.c)anthracene.
Where; MFO = mixed-function oxidase : EH = epoxide hydrolase
Stereochemistry is relative.
Compiled with reference to Conney, 1982 ; Jerina and Daly, 1974
Platt et al, 1982.
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DIAGRAM 6.8. The metab.olism of 3-methylcholanthrene,
Abbreviations as before.
Compiled with reference to Conney,1982; DePierre & 
Ernster,1978; Wood et al,1978.
In summary, it appears that the levels (and types) of 
cytochrome P- ^ 0  isoenzymes and also of epoxide hydrolase 
have an essential role in the activation of polycyclic aromatic 
hydrocarbons. These also have to compete against the action 
of conjugating enzymes and also non-enzymic breakdown of 
intermediates. In addition, in extrahepatic tissues, prosta­
glandin endoperoxide synthetase may have a role in the activation 
of certain of these compounds into derivatives capable of reacting 
with nucleophilic macromolecules..
MATERIALS AND METHODS.
In the first series of experiments, where the role of cytochrome 
P-¥f8 in the activation of benzo(a)pyrene was investigated, male 
V/istar albino rats (150-200 g) were used. The induetion/inhibition 
regimen with phenobarbitone, 3-^ethylcholanthrene and 9-hydroxy- 
ellipticine was exactly as described in Chapter 2. In.the experiment 
using various inducing agents and chemical carcinogens, animals 
received a single intraperitoneal dose (50 mg/kg body weight) for 
3 days of 3-methylcholanthrene, benzo(a)pyrene, benzo(e)pyrene, 
2-aminoanthracene, 2-acetylaminofluorene, ?,12-dimethylbenzo(a)- 
anthracene, or phenobarbitone. All animals were killed hours 
after the last injection. Furthermore some animals were pretreated 
with a single dose of Aroclor 125^ (500 mg/kg body weight) and 
killed 5 days later, as described by Ames, McCann and Yamasaki 
(1975) lor the preparation of hepatic activation systems for use 
in the mammalian/Salmonella typhimurium mutagenicity assay. The 
vehicle used for all the chemicals was corn oil, apart from 
phenobarbitone which was dissolved in 0.9% saline.
In the study of species and sex differences in the activation 
of various polycyclic aromatic hydrocarbons, the specifications 
for the various preparations were exactly as described in Chapter 5 •
Hepatic microsomal supernatants (S9) and microsomal suspensions 
were prepared exactly as described in Chapter 2, and were assayed 
for their various enzyme activities according to the procedures 
outlined in Chapters^2 and’
The activation of benzo(a)pyrene to mutagens in the TA100 
strain of Salmonella typhimurium was investigated using S9 
preparations from the variously pretreated rats, according to the 
standard Ames test (plate) procedure (see Chapter 2). In addition, 
the ability of the various species (i.e. rat, mouse, hamster, 
pig and human) to activate a range of polycyclic aromatic 
hydrocarbons (i.e. 3-^ethylcholanthrene, benzo(a)pyrene, 
dibenzo(a,i)pyrene, benz(a)anthracene, 7 ,12-dimethylbenzanthracene 
and dibenz(a,h)anthracene) to mutagens in strain TA 100 was 
investigated. The standard plate test procedure for the Ames
test (see Chapter 2) was again used, but the proportion of 
S9 in the S9 mix was raised to incorporate 125 /a1 per plate 
( ie.25% S9 in S9 mix). All polycyclic aromatic hydrocarbons 
were dissolved in DMSO at such a concentration to allow the 
maximum dose per plate to be incorporated in 100 jXL.. The 
spontaneous reversion rate in the presence of 100 ^ ul.DMSO 
(65 - 150) subtracted from the other values.
Statistical analysis was carried out using simple linear 
regression.
RESULTS.
The mixed-function oxidase activities of the preparations 
from the rats treated with various inducers and inhibitors of 
this system are shown in Tables 6.1. and 6.2. The Ames test 
results with benzo(a)pyrene as mutagen related to these S9 
preparations are shown in Figures 6.1 and 6.2 respectively.
In both of these studies there was.an excellent direct 
correlation (r = 0.95 in both cases) between benzo(a)pyrene 
activation . and ethoxyresorufin O-deethylase activity as 
shown in Figures 6.3* and 6.5. In the first experiment there was 
also an excellent inverse correlation between benzo(a)pyrene 
activation and benzphetamine N-demethylase (r = -0.99)
(Figure 6.4) although no correlation between these activities 
could be observed in the second experiment (r = -0.14).
The mixed-function oxidase activities of the various 
species used to activate a selection of polycyclic aromatic hydro­
carbons are shown in Table 6.3. These all fall within the 
range found previously (see Tables 5*2 and 5*3)• The ability of 
the males of these species to activate 3-rnethylcholanthrene, 
benzo(a)pyrene, dibenzo(a,i)pyrene,' benz(a)anthracene, 7 ,12- 
dimethylbenzanthracene and dibenz(a,h)anthracene are shown in 
Figures 6.6-6.11. Not all of the preparations were able to 
achieve the doubling of the spontaneous reversion rate, v/hich is 
generally taken as a positive result in the Ames test, with the 
pig, rat and human preparations being particularly poor. Also, 
some of the hydrocarbons (notably dibenz(a,h) anthracene and 
dibenzo(a,i)pyrene) were only marginally activated by any of the 
preparations. A comparison was also made betv/een the males and 
the females of some of these species (Figure 6.12 A-F). The 
female human preparation was generally much poorer at activating 
these compounds than the male, v/hich v/as especially noticeable 
with 7,12-dime thy lhenzanthracene (Figure 6.12 E), while with 
rat and mouse the dominant sex depended considerably on the 
structure of the compound.
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FIGURE 6.1. Effects of different liver microsomal preparations 
on the mutagenicity of benzo(a)pyrene in the Ames test.
The Ames test was carried out using' the Salmonella typhimurium 
strain TA100. Activation systems were derived from control 
( © ) rats, and rats pretreated with 3-methylcholanthrene
( A— A ), 3-methylcholanthrene + 9-hydroxyellipticine ( A—a) , 
phenobarbitone ( □— □ ) and phenobarbitone + 9-hydroxyellipticine 
( m—m ) .
Three animals were used for each pretreatment ( see Table 5,1 ). 
Results shown are typical, and are for one animal.
Each point represents the mean of three plates which did not 
differ from each other by more than 15%»
Spontaneous revertants have been subtracted.
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FIGURE 6.2. Activation of benzo(a)pyrene to mutagens in the Ames 
test by liver preparations derived from rats.pretreated with 
mixed-function oxidase inducers.
The Ames test was. carried out using the Salmonella tvnhimurium 
strain TA100.
Activation systems were derived from rats pretreated with 
benzo(a)pyrene (0— ®), benzo(e)pyrene (a— a), 3-methyl- 
cholanthrene ( O —□ ), 7»12-dimethylbenz(a)anthracene (O—O ) ,
Aroclor 1234 ( m— n) » 2-aniinoanthracene ( , 2-amino-
naphthalene ( ) and phenobarbitone (A— a ).
Each determination was carried o$tt in triplicate ( as in 
Figure 5.1•)•
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FIGURE 6.^. Correlation between ethoxyresorufin O-deethylation 
and activation of benzo(a)pyrene to mutagens in the Ames test • 
bv liver microsomal -preparations from rats pretreated vith V 
5-methylcholanthrene or -phenobarbitone.
Benzo(a)pyrene activation is taken as the number of revertants 
per plate at a concentration of 15 /Ag.
Liver microsomal preparations were from 3-niethylcholanthrene ( A ) 
phenobarbitone ( □ ), 3-methylcholanthrene + 9-dydroxyellipticine 
( A ), phenobarbitone + 9-hydroxyellipticine (n ) - pretreated, 
and control ( ©) rats,
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FIGURE 6.5. Correlation between ethoxyresorufin O-deeth.ylation 
and activation of benzo(a)pyrene to mutagens by liver microsomal 
preparations from rats pretreated with various mixed-function 
oxidase inducers.
Benzo(a)pyrene activation was taken as the number of revertants 
per plate at a concentration of 10 Activation systems were 
from rats pretreated with benzo(a)pyrene (©), benzo(e)pyrene (a) , 
3-methylcholambhrene (□), 7} 12-dimethylbenzanthracene (o), 
Aroclor 1254 ( a )» 2-aminoanthracene 05b ,  2-naphthylamine 
and phenobarbitone ( A ).
FIGURE 6.6. The ability of various animal species to activate
5-methylcholanthrene to mutagens.
Each point represents the mean, of duplicate determinations after 
the subtraction of the spontaneous reversion rate.
The symbols are:- 
Male rat - A  
Male mouse - O  
Male hamster - A 
Male pig - ©
Male human ~ □
Hepatic preparations from each used as the activating system.
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benzo(a)nyrene to mutagens. 
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FIGURE 6.12. The activation of a selection of polycyclic aromatic 
hydrocarbons by hepatic microsomal preparations from both male and 
female rat, mouse and human*
The graphs represent the means of duplicate determinations of the 
number of revertants per plate in strain TA100, after the spontan­
eous revertants had been subtracted, in the presence of:- 
A -■ 20 MS 3-roethylcholanthrene
b - 10 MS benzo(a)pyrene
C - 20 Jug dibenzo(a,i)pyrene
D - 20 jug benz(a)anthracene
E - 80 jug 7»12-dimethylbenzanthracene
F - 20 jug dibenz(a,h)anthracene
In each case represents males, 
represents femalesand
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DISCUSSION.
Enzymes Involved in the Activation of Benzo(a)pyrene.
The effect of pretreatment of rats with 3-methylcholanthrene 
or phenobarbitone, either alone, or in combination with the 
cytochrome P-AA8 inhibitor, 9-hydroxyellipticine, on the mixed- 
function oxidase activities is shown in Table 6.1. In agreement 
with the results in Chapter 5, total cytochrome P-^50 levels and 
the activity of its reductase were stimulated most markedly 
by phenobarbitone. Also, as expected, ethoxyresorufin O-deethylation 
was induced by 3~methylcholanthrene and this activity was inhibited 
by 9-hydroxyellipticine (compare with results of Chapter 3 an<3- )^ • 
Aroclor 123^ was also able to induce both total cytochrome P-A50 
levels and., ethoxyresoruf in O-deethylase, and the latter was also 
enhanced by pretreatment with benzo(a)pyrene but not by benzo(e)- 
pyrene or phenobarbitone (Table 6.2). In the first experiment, 
phenobarbitone again did not stimulate benzphetamine N-demethylation 
(Table 6.1), although a certain amount of induction of this activity 
was demonstrated in the second experiment, together with Aroclor,
7,12-dimethylbenzanthracene and 2-aminoanthracene pretreatment 
(Table 6.2). The limitations of this assay are discussed in 
Chapter 3« ' ' -
The variations in the abilities of the different S9-preparations 
to activate benzo(a)pyrene to mutagens in the Ames test are shown in 
Figures 6.1 and 6.2. These parallel their abilities to deethylate 
ethoxyresorufin, and indeed, simple linear regression analysis 
(Figures 6.3 and 6.3), revealed that ethoxyresorufin O-deethylation 
correlated with benzo(a) -pyrene activation to mutagens (r = O.93 in 
both cases). Other workers (Gurtoo and Bejba, 197A; Levin et al,
1977; Nagao and Sugimura, 1978; Razzouk et al,. 1978; Unger and 
Guttenplan, 1980) have shown that microsomes from 3-raethylcholanthrene 
induced animals are superior at activating benzo(a)pyrene to DNA- 
binding/mutagenic intermediates, and indeed that the mutagenicity 
of this hydrocarbon is dependent on the presence of 'MC-P-^8 1 in 
the hepatic preparations (Kawajiri et al, 1983). It is not 
surprising that benzo(a)pyrene activation was inversely correlated
with benzphetamine N-demethylation in the first experiment 
(Figure 6.A) and not correlated at all in the second (results 
not shown). It is possible that the benzphetamine N-demethyl- 
ation activity induced by,some of the carcinogens in the 
second experiment (i.e. 7,12-dimethylbenz(a)anthracene and
2-aminoanthracene) may be due to other isoenzymes of cytochrome 
PrA30 rather than the classical phenobarbitone-induced type. 
Otherwise apparent induction by these compounds may be due to 
inhibition of the alternative N-oxidation pathway of benzphetamine 
metabolism.
Ethoxyresorufin O-deethylation is an extremely specific 
and sensitive assay of cytochrome P-AA8 (See Chapter 3 for full 
discussion), and so the excellent correlation between this and 
benzo(a)pyrene activation to mutagens to strain 'HA100 in the Ames 
test, indicates that cytochrome P-V+8 is a critical rate-limiting 
step in this. It has also been shown, using purified preparations, 
that the activation of benzo(a)pyrene is proportional to the 
concentration of cytochrome P-AA8 present (Levin et al, 1977)*
The present results also suggest that the enzyme in question 
is present in small amounts in control and phenobarbitone-induced 
preparations. This is in contrast to another study, which 
suggestedth'at different forms of cytochrome P-A50 were involved 
in the activation of benzo(a)pyrene, when the effects of antibodies 
against P-AA8 were compared in control versus 3-methylcholanthrene- 
induced preparations (Levin et al, 1982).
Benzo(a)pyrene activation has previously been related to 
aryl hydrocarbon hydroxylase activity (Lang, Gielen and Nebert, 
1982; Razzouk et al, 1978; Zeiger, Chhabra and Margolin, 1979), 
while in other publications (Baker et al, 198O; Felton and Nebert, 
1973) an inability to correlate these activities has been reported. 
This is not entirely surprising as aryl hydrocarbon hydroxylase 
measures predominantly 3- and 9- hydroxylations, while the Ames 
test assays for epoxides, diol epoxides and possibly quinones.
It has also been previously discussed (see Chapter 3) that although
aryl hydrocarbon hydroxylase and ethoxyresorufin O-deethylase 
activities correlated fairly well during a time course of 
induction, the latter was far more responsive to induction by low 
doses of benzo(a)pyrene. Research carried out on cytochrome 
P-450 isoenzymes in rabbit and hamster have also shown that it 
is not the same form which hydroxylates benzo(a)pyrene and 
activates benzo(a)pyrene to mutagens (Chiang.and Steggles, 1983)* 
However, in a recent publication (Tauc et al, 1984) it has been 
suggested that there is a good correlation between benzo(a)pyrene 
activation to mutagens and both ethoxyresorufin O-deethylation 
and aryl hydrocarbon hydroxylase, and these workers suggest the 
use of all three parameters to characterise the ability of 
various S9 preparations to metabolise polycyclic aromatic 
hydrocarbons in general.
There is some evidence for multiple forms of cytochrome 
P-448 in mice (Lang and Nebert, 1981) and for there being at 
least.two different cytochromes P-448 with' different 
specificity for the metabolism of benzo(a)pyrene (DePierre and 
Ernster, 1978). However, it does appear that it is the same 
form which both activates benzo(a)pyrene under the conditions 
of the assay and also deethylates ethoxyresorufin, as the two 
activities are so v/ell correlated even after treatment with 
very diverse inducers (Figure 6.3 ). This may not also be true in 
rabbits, as the purified form LM6 was,found to be more efficient 
at activating benzo(a)pyrene than LM4 , v/hich is the form best 
at O-deethylating ethoxyresorufin (Norman, Muller-Eberhard 
and Johnson, 1979)-
In the present studies, it v/as shown that the extent of 
inhibition of ethoxyresorufin O-deethylation by 9-hydroxyellipticine, 
the specific cytochrome P-448 inhibitor (see Chapter 4) was greater 
(i.e. 90%) than the inhibition of benzo(a)pyrene activation (50%), 
suggesting that ethoxyresorufin is more specific (i.e. has higher 
affinity) for this enzyme. Other studies, performed in vitro 
have shown an inhibition.of benzo(a)pyrene activation by 9-hydroxy­
ellipticine (Lesca et. al, 1979) and also by 7,8-benzoflavone 
(Razzouk et al, 1978).
As outlined in the introduction to this chapter (see 
Diagram 6.3 ), benzo(a)pyrene metabolism is complex and depends 
on both cytochrome P-450 isoenzymes and the presence of 
competing pathways (Lu jet al, 1980). Benzo(a)pyrene metabolites 
compete v/ith the parent compound and with each other for 
further metabolism, and quinones are potent non-competitive 
inhibitors of epoxidation of both benzo(a)pyrene and its 7,8- 
diol (Keller, Turner and Jefcoate, 1982). Activation will 
therefore depend on the regio- and stereo-selectivity of.the 
cytochromes and the rate of reaction. In the whole cell,.the rate 
of the conjugation pathways is very important (Bock et_ al,.
1981; Brouns et al, 1979), but in the Ames test conditions, 
the role of these enzymes is negligible due to lack of cofactors 
(Malaveille et al, 1981). Hov/ever, under such assay conditions pre­
dominantly epoxide hydrolase activity (Tauc et; al, 1984) and a certain 
amount of glutathione conjugation may occur, dependent on the cyto­
solic glutathione concentration (DePierre and Ernster, 1978;
Viviani et al, 1980). Other cytosolic components may be important, 
and it is believed that certain proteins may help to transport 
the benzo(a)pyrene to the microsomal mixed-function oxidase system 
(Hanson-Painton, Griffin and Tang, 1981).
Various studies have shown that 3-methylcholanthrene-induced 
cytochrome P-448 in rats, mice and rabbits is most proficient in 
both the overall metabolism of benzo(a)pyrene and especially 
in the further bay-pegion epoxidation of the 7,8-diol (Belvedere 
et al, 1980; Chiang and Steggle§, 1983; Gozukara et- al, 1982;
Lu e_t al, 1972; Nilsen _et al, 1981; Wang 1981). The phenobarbitone- 
induced cytochrome P-450 is relatively inactive in this metabolic 
step, but tends to produce more of the K-region epoxide (Nilsen 
et_ al, 1981; Wang,- 1981). In addition phenobarbitone, but not
3-methylcholanthrene is able to induce epoxide hydrolase (as well 
as many of the conjugating enzymes), and so phenobarbitone-induced 
preparations tend to produce a higher proportion of diols (Gozukara 
et. al, 1982; Oesch et_ al, 1977; Pickett _et al, 1981; Viviani _et al,
1980). In addition, as the 4,5-oxide produced predominantly in 
the phenobarbitone-induced preparation is a good substrate for
epoxide hydrolase, the activity of this enzyme tends to lower 
the activation of benzo(a)pyrene by these preparations. The 
effect of epoxide hydrolase in 3-niethylcholanthrene-induced 
preparations is far more complex, as it is an integral step 
for the production of the bay region diol epoxide, which is then 
a poor substrate for this enzyme (Oesch et_ al, 1977; Viviani 
ei: al, 1980). Indeed the balance between the activities of 
cytochrome P-448 and epoxide hydrolase is critical in the 
activation of benzo(a)pyrene (Alexandra, Dansette and Fragginet,
1980; Tauc ei:.-al, 1984), and this has been demonstrated using 
purified preparations (Levin et_ al, 1.977). A useful extension 
to the work presented in this chapter v/ould be to also measure 
the effects of the various pretreatments on epoxide hydrolase 
activity and thus the spectrum of benzo(a)pyrene metabolites.
As mentioned in the introduction, the predominant DNA- 
bound product found after in vivo administration of benzo(a)- 
pyrene is that arising from the bay-region diol epoxide. It is 
the anti-isomer which is mainly formed, although the syn-isomer 
is the most potent bacterial mutagen (DePierre and Ernster,
1978). Certainly, the strain of Salmonella typhimurium (TA100) 
used in this experiment is most responsive to the 7 ,8-diol- 
9,10-epoxide of benzo(a)pyrene, although it picks up the 4,5- 
oxide and the 6-hydroxy derivative to a lesser extent (Oesch,
1980). It is likely that the bay-region epoxidation is the 
activation step correlating most directly with ethoxyresorufin
O-deethylation. However, as a similar trend v/as observed 
in the ability of the S9 preparations from the first experiment 
to activate benzo(a)pyrene to mutagens to strain TA 1537.(results 
not shov/n) which is believed to be most responsive to the 
K-region epoxide (Oesch, 1980), it is possible that 4,5~oxidation 
also contributes to the correlation. If this-were true then the 
low level of activation achieved by' the phenobarbitone-induced 
preparations could be due to the activity of the induced epoxide 
hydrolase.
Species Differences in the Activation of Polycyclic Aromatic 
Hydrocarbons.
The mixed-function oxidase activities of the various species 
were within the range reported in the previous chapter (see Table 
6.3 ). The hamster always had- the highest cytochrome P-450 levels, 
and the activities of ethoxyresorufin O-deethylase, benzphetamine 
N-demethylase and cytochrome c reductase. Conversely,the pig 
showed low levels in all these mixed-function oxidase activities 
and the human female hepatic preparation had the highest cytochrome 
P-450: cytochrome P-448 ratio of all the preparations. The human 
total cytochrome P-450 levels were within the range previously 
published (Autrup, 1982).
The ability of the S9 preparations from the males of these 
various species to activate a selection of polycyclic aromatic 
hydrocarbons is shown in Figures 6.6-6.11. Unfortunately, the 
level of activation.of some of these (especially dibenzo(a,i) 
pyrene and dibenz(a,h)anthracene v/as rather lov^ , and did not 
exceed the doubling of spontaneous revertants which is often 
set as a positive result. These polycyclics have been shown to 
be relatively weak mutagens (Andrews,Thibault and Lijinski,
1978? Nagao and Sugimura, 1978), especially with untreated 
preparations, which are poor at activating this group of compounds. 
The level of activation may have been improved if the preincubation 
method had been used (Unger and Guttenplan, 1980). The level 
of S9 per plate (i.e. 125 A*l) was below that which has been shov/n 
to markedly inhibit the activation of polycyclic aromatic hydro­
carbons, by control liver preparations (Nagao and Sugimura, 1978). 
However, it would.have been better to have used a full range of 
S9 concentrations, as workers have noticed, that, with induced pre­
parations, at least, as the protein concentration per plate is 
increased, so the activation of these compounds is decreased 
(Bartsch et al, 198O; Muller et al, 198O; Nagao and Sugimura,
1978). This could be due to either losing some of the mutagenic 
oxides through protein binding (Guenthner and Oesch, 1981) or 
through enhancement of the deactivation pathways (Baker et al, 1980).
The shapes of the mutagenicity curves suggest that for many, 
the levels of substrate v/ere too high (i.e. the graphs rapidly 
reach a maximum and level off). However the choice of 
hydrocarbon dose was within the range used by others (e.g.
Andrews, Thibault and Lijinsky, 1978; Baker _et al, 1980;
Felton and Nebert, 1975; Nebert and Jensen, 1979; Purchase 
et al, 1978),and the problem may be one of the toxicity of 
the metabolites competing with their mutagenicity (Unger and 
Guttenplan, 1980).
The hamster was consistently the best preparation at 
activating this group of compounds with the exception of
7,12-dimethylbenzanthracene which was activated most efficiently 
by the human male preparation (Figure 6.10). The hamster has 
previously been shown to be superior to the rat in its ability 
to metabolise benzo(a)pyrene (Gingell jet al, 198l)»and to 
activate both benzo(a)pyrene and 3-methylcholanthrene to mutagens 
(Amachar, Paillet and Zelljadt, 1982; Chiang and Steggles,
1983)* This could be related to the high cytochrome P-448 
levels in this species, and it has previously been shown to 
have high levels of both.ethoxyresorufin 0-deethylase 
(Burke, Prough and Mayer, 1977) a.nd biphenyl 2-hydroxylase 
(Creaven et al, 1965) activities. The different species 
response to 7,12-dimethy\Jbenzanthracene may be related to the 
fact that its metabolism has previously been shown to be under 
different genetic control to most other polycyclics, in mice 
at least (Nebert and Jensen, 1979)* In addition, the 
mutagenicity of this compound is not affected by epoxide 
hydrolase levels, but by dihydrodiol dehydrogenase (Glatt _et 
al, 1981), and so the activity of the latter enzyme may play an 
important role in modulating its mutagenic activation by various 
species. The pig preparations were unable to 'achieve a significant 
level of activation of any of the polycyclic aromatic hydrocarbons, 
which relates v/ell to the low mixed-function oxidase activity 
in this species.
The sex-differences in activation of this group of compounds 
varied according to both species and chemical structure (Figure 
6.12 A-F). The most significant of these v/ere the unique ability 
of the female mouse to activate benzo(a)anthracene and also its 
superiority in activating benzo(a)pyrene (Figure 6.12 D, B).
It has previously been shown that untreated mouse is superior 
to rat in the activation of benzo(a)pyrene (Baer-Dubowski and 
Alexandrov, 1981; Rouet et; al, 1981). In both humans and rats 
the males were better than the females at activating many of the 
hydrocarbons. This has previously been reported for benzo(a)pyrene, 
where male rats have been .shown to be able to metabolise it far more 
extensively than females (Chao and Chung, 1982; Kamataki jet al,
1982; Kato and Kamataki, 1982; Leber, Kercher and Freudenthal,
1976; Seitz, Garro and Haber, 1981), and this has been related 
to steroid metabolism (Paine, 1981; Pasleau, et al, 1981), cytochrome 
P-448-levels (Kremers et al, 1981), and the efficiency of electron 
transport from the reductase (Kitada et. al, 198O; Vodicnik _et al,
1981); The greater capacity of the human male compared with the 
female at activating these compounds may also be related to the 
cytochrome P-448 levels (see Table 6 .3 )* Certainly, cytochrome 
P-448 appears to be important in the activation of benzo(a)pyrene 
and 3-methylcholanthrene (Kawajiri et. al, 1983; Lesca et al, 1978b) 
and possibly other polycyclic aromatic hydrocarbons, although -its 
involvement in the activation of benz(a)anthracene and its 7 ,12- 
dimethyl derivative is not so clear cut (Felton and Nebert, 1975).
A wide variation in the ability of human preparations to 
metabolise a selection of substrates has been noted and both 
genetic and environmental factors are believed to contribute to 
this (Conney, 1980, 1982; Leboef et al, 1981). A full discussion 
of the problems of obtaining and standardising human tissue 
samples is presented elsev/here (Bahr jet al, 1982). It would 
certainly have been interesting to have known whether the male 
human liver donor had been a heavy smoker, as this could have 
contributed to the relatively high cytochrome P-448 levels 
(Boobis e_t al, 1980; DePierre and Ernster, 1978). There is now 
plenty of evidence of multiple forms of cytochrome P-450 in human 
liver.samples, through kinetics (Boobis et al, 1980); inhibitors
(Kapitulnik, Poppers and Conney, 1977) and purified preparations 
(Autrup, 1982; Guengerich et al, 1982; .Lu and West, 1980). It 
seems that these multiple forms are common to all individuals, 
but vary in proportions (Guengerich jet al, 1982), although there 
are no clear cut sex differences (Kremers et al, 1981). Some 
workers report no cross-reactivity or comigration occuring between 
rat and human cytochromes P-450 ' (Leboef jet al, 1981; Lu
and West, 1980), while others have reported-some homology between 
human P-450 and rat P-448 (Autrup, 1982; Fujino et al, 1982), .or 
phenobarbitone-induced rat P-450 (Lesca, Beaune and Monsarrat,
1981). There has also been.discovered some homology between 
human and mouse P-450 (Walz, Vlasuk and Steggles, 1985)* In 
addition, the cytochrome P-450 reductase from human preparations 
is similar to that from pig,, but different from that of rat 
(Masters jet al, 1975)* As far as comparative metabolism' is 
concerned, it has been suggested that all eukaryotic species 
produce basically the same range of metabolites from benzo(a)pyrene 
(Selkirk et al, 1982), but there are quantitative differences 
(Selkirk, Cohen and MacLeod, 1980). Indeed, the overall pattern 
of metabolites produced from benzo(a)pyrene differs between rat 
and human, as the latter produces a greater range of metabolites 
(DePierre and Ernster, 1978; Leber, Kercher and Freudenthal,
1976), although both are believed to produce the bay region 
diol epoxide (Santella, Grunberger and Weinstein, 1979)* Other 
polycyclic aromatic hydrocarbons and additional species have not 
received such detailed analysis of metabolic patterns. All K-region 
oxides are mutagenic, but this does not necessarily mean that these 
are the main in vivo metabolites or the principle carcinogens 
(Harvey, 1981). Certainly it is the epoxides or diol epoxides 
which are the major mutagens of polycyclics such as benzanthracene 
and dibenzanthracene, rather than diols, phenols or quinones, 
which are only weakly mutagenic (DePierre and "Ernster, 1978;
Nagao and Sugimura, 1978; Oesch, Bentley and Glatt, 1976; Platt 
je_t al, 1982; Unger and Guttenplan, 1980). The main mutagenic 
derivatives of 3-methylcholanthrene are the 9,10-diol of
1-hydroxy-3-methylcholanthrene and also the 2-keto derivative 
(Wood et al, 1978). Metabolism at the methyl groups of'7,12- 
dimethylbenzanthracene is important in its activation, and this 
may involve cytochrome P-448 (Conney, 1982). In addition
6-hydroxymethyl derivatives of benzo(a)pyrene may also be 
mutagenic (Nagao and Sugimura, 1978).
It is not surprising that a simple clearcut correlation 
between levels of cytochrome P-448 activity and polycyclic 
aromatic hydrocarbon activation is not apparent, when 
considering a range of compounds and a variety of species.
However, as discussed above, some trends have been noted 
between cytochrome P-448 levels and mutagenic activation.
Both species (Baker et al, 1980) and strain (Nebert and Jensen,
1979) differences have been observed in the pathways of activation 
and DNA-bound products of these hydrocarbons. It is unlikely that 
there is a major contribution from the prostaglandin endoperoxide 
synthetase system in hepatic preparations (Eling ejt al 1983)? 
although it is not known how much species variation occurs in its 
tissue distribution.
The key role of epoxide hydrolase in the activation of 
polycyclic aromatic hydrocarbons has been previously mentioned, 
and there may be 1,000-fold species variation of in vivo activity 
of this enzyme (Guenthner and Oesch, 1981b, Oesch, Bentley and 
Glatt, 1976). It therefore again would have been useful to 
have measured epoxide hydrolase activity in the various 
preparations used. Epoxide hydrolase is a well-conserved enzyme, 
with many similarities being noted between those from hamster, 
rat and human tissues (V/alz, Vlasuk and Steggles, 1983)* Mice 
generally have high levels of mixed-function oxidase activity, 
but a low level of epoxide hydrolase, v/hile the opposite is true 
in the rat(Oesch &t al, 1977)* This helps to explain why mouse 
preparations were generally superior to rats in the activation 
of polycyclics, although this did depend on sex (Figure 6.12).
The contribution of epoxide hydrolase will also depend on the 
chemical structure, as the mutagenicity of benzanthracene, but 
not 7 ,12-dimethylbenzanthracene is reduced by this enzyme 
(Glatt et al, 1981)- The difference in the ability of the rat 
and mice preparations to activate this group of compounds v/as 
not as marked as those published (Oesch «et al, 1977), but this 
could be due to strain differences. Human epoxide hydrolase 
activity is generally higher than either rat or mouse (Kremers 
e_c al, 1981; Oesch, Bentley and Gl«a-tt„ 1976) and only a slight
inter-individual variation has been noted (Autrup, 1982), 
although it can be enhanced in individuals such as epileptics 
who have received phenobarbitone or phenytoin (Craven, Walker 
and Murray-Lyon, 1982). The present results (Figures 6.6 and 
6 .10) suggest that both 3-methylcholanthrene and 7?12-dimethyl 
benzanthracene are relatively resistant to the action of human 
epoxide hydrolase. It must be borne in mind that the relative 
concentrations of both substrate and activating system are 
critical with respect to recycling metabolites, and thus 
both their mutagenicity (Oesch, Bentley and Glatt, 1976) and 
toxicity (Unger and Guttenplan, 1980).
As previously discussed, the strain of Salmonella 
typhimurium used in the Ames test will affect the spectrum 
of results, as they tend to be sensitive to different mutagens.
Strain TA 1337 only picks up K-region epoxides (Oesch, 1980) 
and so mutagenicity in this strain would be very sensitive to 
levels of epoxide hydrolase. The strain used in these 
experiments (TA 100) is sensitive also to bay-region diol 
epoxides and those derivatives which produce base-pair 
substitution mutations, while TA98 would pick up a different 
range of mutagens again, of the frame-shift variety (Fahl,
Scarpelli and Gill, 1981). Another factor v/hich could have 
made a difference to the spectrum of results obtained is if 
whole cells, or at least the cofactors for conjugation had 
been supplied as the activating system (Selkirk et al, 1982).
Indeed, it is probably the lack of phase 2 metabolism which 
contributes to the poor correlation between mutagenic and 
carcinogenic potency of this group of compounds (Andrews,
Thibault and Lijinsky, 1978). There has certainly been reported 
a variation in the rate of glucuronylation among different 
rodents (Selkirk, Cohen and MacLeod, 1980). The effect of 
glutathione on the activation of polycyclic aromatic hydro­
carbons depends on the compound, as it is for example an 
important regulator of the mutagenicity of benzo(a)pyrene, 
but not 3-methylcholanthrene (Felton and Nebert, 1975)* Several 
glutathione transferases have been reported in human tissues and 
certainly the major products of benzo(a)pyrene in cultured human 
tissue are the sulphate esters and glutathione conjugates (Autrup, 1982).
CONCLUSIONS.
The polycyclic aromatic hydrocarbons are a group of carcinogens 
v/hich are predominantly metabolically activated by a series of 
epoxidation, hydration and further vicinal epoxidation steps to 
produce bay-region diol epoxides. The enzymes involved in these 
are the mixed-function oxidase system and epoxide hydrolase, 
with cytochrome P-448 having a key role in the oxidation step 
at the sterically-hindered bay-region. Other positions of 
oxidation may also contribute to their carcinogenicity and 
mutagenicity, and the relative importance of these depend on 
chemical structure, the presence of specific enzymes (and thus 
the species and pretreatment of the animal source) and also the 
detector organism.
In an experiment where male Wistar albino rats received a 
range of inducers and inhibitors to modulate the mixed-function 
oxidase system, an excellent correlation betv/een ethoxyresorufin 
O-deethylation and benzo(a)pyrene activation was achieved. It 
v/as concluded that the same form of cytochrome P-448 v/as critical 
to both, and evidence v/as presented to suggest that considering 
the strain of Salmonella typhimurium used (TA100), the key step 
in benzo(a)pyrene activation to mutagens v/as probably the 9 510- 
epoxidation of the 7,3-diol.
Among the various species tested, the hamster v/as the most 
proficient at activating the majority of the polycyclic aromatic 
hydrocarbons. In addition the male rat and human preparations 
were superior to the female in activating most of these compounds. 
These could be related to their higher cytochrome P-448 levels.
The contribution of the levels of activity of other enzymes such 
as epoxide hydrolase and dihydrodiol dehydrogenase could not be 
ruled out.
C H A P T E R
CHAPTER 7* THE METABOLIC ACTIVATION OF NITROSAMINES.
INTRODUCTION.
The Distribution and Carcinogenicity of Nitrosamines.
The nitrosamines consist of a group of chemicals, with 
wide-ranging structures (see Diagram 7*1), which are potent, 
versatile carcinogens, inducing tumours in all animal species 
studied, and in most organs and tissues (Lijinsky and Reuber, 
1981; Schmahl, 1981). The organotropy depends on the animal 
species, dose and chemical structure, and there is not always 
a close relationship between carcinogenic and mutagenic 
potency. Short-chain, polar nitrosamines, such as dimethyl- 
nitrosamine, are rapidly distributed throughout the body 
fluids to all tissues, and diethylnitrosamine is known to be 
a transplacental carcinogen (Schmahl, *1981). Nitrosamines 
have been a useful tool in studying mechanisms of carcinogenesis 
and much of the early work (reviewed in the I.A.R.C. Monographs, 
1978) concentrated on the toxic and carcinogenic effects of the 
simplest derivative, dimethylnitrosamine.
Humans may be widely exposed to low levels of N-nitroso 
compounds, through their formation in the environment and 
subsequent absorption from food, water, air, industrial and 
consumer products (e.g. rubber, cosmetics, alcoholic beverages) 
and from tobacco smoke and some naturally occurring compounds 
(I.A.R.C. Monographs, 1978; Lai and Arcos, 1980). Added to this 
is the problem that they may be formed in vivo, at the acid pH 
of the stomach,from ingested nitrite and amines. The nitrite 
concentration may be particularly high in certain types of 
preserved meats and fish,in a variety of vegetables and some 
sources of well-water, and can both be recycled in the saliva 
and also formed through the reduction of nitrate by bacteria.
A particular problem occurs with individuals who have anacidic 
stomachs, v/here bacterial overgrowth may occur, and there is 
presently much speculation over whether the subsequent nitros-
/
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DIAGRAM 7.1. The structures of some nitrosamines which are 
referred to in the text.
amine formation is a contributory factor to the high incidence 
of gastric cancer in such patients. This may be enhanced by the 
administration of nitrosatable amine drugs. There has been a 
particular concern over the use of acid-suppressor drugs for those 
v/ith gastric ulcers, and this was the subject of a conference 
recorded in ’The Safety Evaluation of Nitrosatable Drugs and 
Chemicals’ ed. G. G. Gibson and C. Ioannides, 1981.
Nitrosatable substances which may occur in the environment 
include both secondary and tertiary amines, quaternary 
ammonium compounds, ureas, -carbamates and guanidines, and so 
may include various agricultural chemicals and drugs. Formation 
of N-nitroso compounds has been detected in vivo (reviewed by 
Lijinsky, 1981) and both dimethyl- and diethyl-nitrosamine 
have been detected in the blood after ingestion of normal 
dietary items. The presence of thiocyanate (found in elevated 
levels in the saliva of smokers) increases the rate of nitrosamine 
production, and this process is inhibited by ascorbic acid 
andcA-tocopherol. There is also the addtional problem that 
transnitrosation may occur, leading to the production of more 
active nitrosamines from comparatively innocuous compounds. The 
principal nitrosamines found in food include dimethyl-, diethyl-, 
dibutyl-nitrosamines and nitrosopiperidine and nitrosopyrrolidine 
(Lijinsky, 1981).
Nitrosamines require metabolic activation to form the 
ultimate carcinogens which react with DNA, and it is believed 
that the 0 -alkylation of guanine is a key step (Lai and Arcos,
1980). It is not only the formation of this derivative, but its 
persistence within the DNA that is important, and the rate of 
repair of the alkylated base is critical in determining tissue 
susceptibility (Pegg, 1980).
Although a direct cause and effect relationship between 
nitrosamines and human cancer and genetic disease is yet to be 
firmly established, this group of chemicals is very widely
distributed and are carcinogenic in animals when administered 
chronically, at very low doses, equivalent to human exposure.
Human exposure to them or their precursors should therefore 
be limited.
Metabolism of Nitrosamines.
Dialkylnitrosamines are believed to be activated primarily 
by oxidative dealkylation catalysed by the microsomal enzymes, 
particularly by the cytochrome P-A-50 system (Lotlikar, 1981).
The enzyme involvement is considered in more detail in the 
discussion. There are species and tissue differences in metabolic 
activation, and this can be a major, although not the only 
influence on carcinogenicity. Other influences include DNA 
binding and repair, and cytoplasmic transport of the active 
intermediates to the nucleus. These points are discussed 
in some detail in the review by Lai and Arcos, 1980.
Hydroxylation may occur at various positions along the 
aliphatic chain and may lead to further oxidation to a keto 
group or additional hydroxylation and conjugation (for example, 
glucuronylation). If a nitrosamine is hydroxylated in the 
^-position and subsequently undergoes sulphate conjugation, 
this results in the production of a direct-acting alkylating 
agent, v/hich is mutagenic (Michejda, Andrews and Koepke, 1979):-
A carboxylic acid group may arise from O-hydroxylation and then 
further hydroxylation is likely to lead to scission of the side 
chain. However, it appears to be oC-hydroxylation of the aliphatic 
nitrosamines which leads to the production of the most mutagenic 
derivatives, as any substances which alter this step, also modulate 
the toxicity and carcinogenicity of nitrosamines. This is also
Q U O .  jJ .L lW —
transferase
sulpho-
believed to be the rate-limiting step (Ioannides and Gibson,
1981) in the scheme outlined in Diagram 7.2. The hydroxylated 
group is released (after rearrangement) as an aldehyde, which 
is not mutagenic and may be further metabolised and excreted 
as carbon dioxide. The mono-alkylated nitrosamine or its 
tautomeric rearrangement product could bind to macromolecules . 
(Argus et al, 1978), or more probably, further breakdown would 
release an alkyl carbonium ion, which v/ould be electrophilic.
In general, the shorter the chain length (i.e. methyl compared 
with ethyl, propyl, butyl etc.), the more active is the 
alkylation (Suzuki, Aoki and Okada, 1981).
Mechanisms of activation of nitrosamines have been studied 
using various acetoxy derivatives, which may hydrolyse either 
spontaneously, or with the aid of an esterase to produce the 
unstable hydroxylated compound (Suzuki, Aoki and Okada, 1981). 
It is believed that different mechanisms of activation are 
required for the aryl or cyclic nitrosamines (Ashby, 1981). 
Nitrosamines may interact with cytochrome P-V?0 either at the 
substrate site on the apoprotein, v/hich normally leads to 
dealkylation, or as a haem ligand, v/hich leads to denitrosation 
(Appel jet al, 1980; Ioannides.and Gibson, 1981). These 
competing pathv/ays may explain some of the anomalies noted in 
the stoichiometry of N^ production during the metabolism of 
nitrosamines (Lorr, Tu and Yang, 1982). There has been a great 
deal of interest recently in the role of denitrosation as a 
deactivation pathway, particularly for the long alkyl chain 
nitrosamines, and a proposed scheme is shown in Diagram 7*3*
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DIAGRAM 7.2. The pathways of metabolism of aliphatic nitrosamines.
Produced with reference to Appel & Graf, 1982; Bar.tsch,'1981;
Kunz et al,1978; Suzuki,Aoki & Okada, 1981.
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Diagram 7»3« Proposed scheme of denitrosation of N-nitrosamines
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(from Appel and Graf, 1982).
Dimethylnitrosamine: The metabolism of dimethylnitrosamine has
been extensively studied, and proceeds according to the general 
scheme outlined in Diagram 7.2, releasing formaldehyde v/hich may 
be further metabolised to carbon dioxide, and a carbonium ion 
which binds to DNA (Gangolli, *1981; Kroeger-Koepke et_ al 1981).
The greater variety of metabolites produced (Chin and Bosmann, 
1980) and the effects of inhibitors of catalase and alcohol 
dehydrogenase (Chin and Bosmann, 1978; Phillips et_ al, 1975) have 
suggested that the pathway of metabolism of this nitrosamine may 
be more complicated than originally envisaged. There is certainly 
some controversy over the enzyme involved in dimethylnitrosamine 
activation, with some evidence for cytochrome involvement
(Ioannides and Gibson, 1981), v/hile others have suggested the 
involvement of an amine oxidase (Gangolli, 1981). This is 
considered in more detail in the discussion. It certainly 
appears that cytochrome P-VpO is involved in reductive breakdov/n 
of dimethylnitrosamine to monomethyl-and dimethyl- hydrazines 
and in its denitrosation (believed to be detoxification pathways) 
(reviewed by Ioannides and Gibson, 1981).
Methylethylnitrosamine: There has been comparatively little
research on the metabolism and carcinogenicity of this 
derivative, although it is known to be carcinogenic to rats,
(IARC Monographs, 1978) .Methylethylnitrosamine- may., be v oxidatively 
deethylated (at a greater rate than diethylnitrosamine) 
or demethylated (to a lesser extent than-dimethylnitrosamine), 
and both reactions are induced by phenobarbitone and lowered 
by 3-methylcholanthrene administration (Chau, Dagani and Archer, 
1978). The main DNA-binding intermediate, appears to be the ethyl- 
carbonium ion released from the monoethylnitrosamine (Lai and 
Arcos, 1980).
Dipropylnitrosamine: Extensive metabolism of dipropylnitrosamine 
occurs through mainly do and some <0-1 hydroxylation. The former 
may result in further oxidation to produce a carboxylic acid 
moiety, while the 2-hydroxylated derivative may be glucuronylated 
or further oxidised to form a keto group (IARC Monographs,
1978; Suzuki and Okada, 1981). A process of fB> -oxidation 
(comparable with that occurring in fatty acid oxidation) may 
occur in any of the longer chain nitrosamines, until either methyl 
alkyl nitrosamines or dimethylnitrosamine are formed, v/hich 
may then be metabolised as previously described (Lai and Arcos,
1980). A large range of metabolites of dipropylnitrosamine have 
been found in the urine of rats treated with this compound (IARC 
Monographs, 1978), and it may also be deactivated via the 
denitrosation pathway(Appel and Graf, 1982).
N-Nitrosopiperidine: This nitrosamine is found in particular
in cooked bacon and has been shown to be carcinogenic to a 
variety of species including rats, mice and hamsters. Various 
derivatives have also been shov/n to be carcinogenic, including 
^-hydroxy- (produced by rat microsomes), 3-hydroxy-, 2- or 3- 
methyl- and 4-keto- nitsosopiperidine (IARC Monographs, 1978).
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DIAGRAM 7.4. Possible pathways of metabolism of N-nitrosopyrroIidine
Compiled with reference to Autrup,1982; IARC Monographs,1978;
McCoy, Hecht & McCoy,1982.
N-Nitrosopyrrolidine: The metabolism of this cyclic nitrosamine
has received more attention than that of nitrosopiperidine
and some possible pathways are shown in Diagram
Both (p- and y9-hydroxylation occur, although the former is
believed to be more significant in activation and is induced
by Aroclor in both rats and mice, although the effect
of 3~niethylcholanthrene depends on the species (McCoy,
Hecht and McCoy, 1982). A combination of microsomal and 
cytosolic components are required to both activate nitroso- 
pyrrolidine to mutagens (McCoy, Hecht and McCoy, 1982) and 
to metabolise it to a v/ide range of products including carbon 
dioxide (Farrelly, Stewart and Hecker, 1982).
MATERIALS AND METHODS.
The Role of Cytochromes P-V?0 and 2-kkS in the Metabolic Activation 
of Dimethylnitrosamine.
Male Golden Syrian hamsters (100-120 g) were used.
Induction of liver microsomal enzymes was achieved by intra- 
peri toneal administration of either phenobarbitone (80 mg/kg body 
weight), 3-raethylcholanthrene (20 mg/kg) or Aroclor 125^ + (500 mg/kg) 
daily for 3 days. Animals were killed 2k hours after the last 
administration.
The microsomal supernatant (S9) and microsomal suspension were 
prepared as previously described (Chapter 2). Dimethylnitrosamine 
demethylase activity was determined in the S9 fraction, at various 
substrate concentrations (2-100 mM), -by an adaption of the method 
described for benzphetamine (see Chapter 2). The microsomal 
suspension, v/as used to assay for ethoxyresorufin O-deethylation, 
NADPH-cytochrome c reductase and cytochrome P-^ -50? as previously 
described. Protein was determined in both fractions as 
before (Chapter 2).
Activation of dimethyl^jiitrosamine t° mutagens v/as determined 
using the standard Ames test plate procedure, but with double 
the amount of S9 fraction in the S9 mix (i.e. 100 /fL/plate). 
Salmonella typhimurium strain TA 100 v/as used, and the spontaneous 
reversion frequency v/as in the range 66-101 revertants/plate.
Species and Sex Differences in the Activation of Nitrosamines.
The specification of the sources of the hepatic preparations 
from a variety of species of both sexes v/as exactly as previously 
described (Chapters 2 and 5)* Prior to each mutagenicity assay, all 
activation systems v/ere fully characterised v/ith respect to 
monoamine oxidase, mixed-function amine oxidase and mixed-function 
oxidase activities (as previously described in Chapters 2 and 5)-
Metabolic activation of nitrosamines to mutagenic 
intermediates v/as determined using the Ames pre-incubation 
method, and employing Salmonella typhimurium strain TA 100. 
Activation was carried out by using double the normal amount 
of S9 in the S9 mix (i.e. 100 • jul/plate). Dimethylnitrosamine, 
methylethylnitrosamine and nitrosopiperidine were dissolved 
in water,while nitrosopyrrolidine-and’dipropylnitroeamine 
were dissolved in DMSO. Appropriate blanks were used and 
the amount of DMSO never exceeded 100 fSL per plate. Each 
nitrosamine v/as preincubated with the activation system and 
the bacteria for 30 minutes at 37°C in a shaking water bath. 
The same activation systems were employed in all mutagenicity 
studies to allow direct comparison.
The spontaneous reversion rate was in the range kk - 75 
revertants/plate.
RESULTS .
The Role of Cytochrome P-450 and P-448 in the Metabolic Activation 
of Dimethylnitrosamine.
As expected, pretreatment with the different inducing agents 
resulted in an increase in the hepatic concentrations of 
cytochrome P-450 (Table 7.1). Ethoxyresorufin O-deethylation 
was enhanced by both 3-methylcholanthrene and Aroclor 1254, 
but unaffected by phenobarbitone-pretreatment. The NADPH- 
dependent reduction of cytochrome c was stimulated only by 
phenobarbitone and Aroclor pretreatment.
The activity of dimethylnitrosamine demethylase showed a 
biphasic response with respect to substrate concentration 
(Figures ?,1 and 7.2), and at low dimethylnitrosamine 
concentrations (2 mM), pretreatment with the enzyme-inducing 
agents lowered the demethylation rate. Conversely, at high 
substrate concentrations (300 mM), all pretreatments increased 
the demethylase activity (Figure 7.1). However, when dimethyl- 
nitrosamine-demethylase is expressed per nmol of cytochrome 
P-450, all pretreatments gave rise to inhibition of enzyme 
activity (Figure 7-2).
Pretreatment of hamsters v/ith phenobarbitone, 3-methyl- 
cholanthrene or Aroclor 1254 did not significantly alter the 
capacity of their hepatic preparations to activate dimethyl­
nitrosamine to mutagens in the Ames test (Figure 7-3). However, 
when mutagenicity is expressed as the number of revertants/ 
nmol P-450, the liver microsomal preparations from the pretreated 
animals were far less effective activators of dimethylnitrosamine 
than were the preparations from control animals (Figure 7.4).
Species and Sex Differences in the Activation of Nitrosamines.
All activation systems used in the mutagenicity assays were 
fully characterised with respect to microsomal mixed-function 
oxidases, mixed-function amine oxidase and monoamine oxidase 
(Tables 7.2 and 7*3).
There was a marked species difference in the metabolic 
activation of the various nitrosamines into intermediates 
mutagenic in the Ames test. The hamster was the only species 
which activated all the nitrosamines studied (Figures 7*5 - 7-9)? 
while the rat only weakly activated nitrosopiperidine, the 
strongest mutagen under these conditions (Figure 7-9)* A 
comparison of the ability of the males and females of mouse, 
rat and human to activate these five nitrosamines is shown in 
Figure 7.10.
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FIGURE 7»1» Hamster hepatic dimethylnitrosamine demethylation»
Effect of substrate concentrations (expressed with..respect to protein). 
Dimethylnitrosamine demethylase activity was determined in liver micro­
somal supernatant preparations from untreated male hamsters (© ), or 
from hamsters pretreated with phenobarbitone ( s ), 3-methylcholanthrene 
( o) or Aroclor 1254 (D )•
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.FIGURE 7«2, Hamster hepatic dimethylnitrosamine demethylation :
Effect of substrate concentrations (expressed w.r.t. cytochrome P-450)»
( Legend as for Figure rl^^. )
FIGURE 7.5. The ability of hamster hepatic preparations to 
activate dimethylnitrosamine to mutagens : Effect of various 
pretreatments.
Activation of dimethylnitrosamine was determined by the increase 
in the number of revertants of Salmonella.typhimurium (strain TA100) 
■in the Ames test, using liver microsomal supernatants (100 |H/plate) 
from control male hamsters (®), or from hamsters pretreated with 
phenobarbitone (m ), 3-methylcholanthrene (o ) or Aroclor ( □ ).
Results are expressed as the means of triplicate determinations 
after subtraction of the spontaneous reversion rate.
The standard deviations always fell within + “ly/s of the mean.
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FIGURE 7«4« The ability of hamster hepatic preparations to 
activate dimethylnitrosamine to mutagens: Results expressed 
per nmol cytochrome P -4 5 0 »
Legend as for Figure 7*3•
FIGURE 7.5* Metabolic activation of dimethylnitrosamine to 
mutagens in'Salmonella typhimurium strain TA100.
Liver microsomal preparations were isolated from male mouse (o), 
hamster { a ), rat ( A ), pig ( © ) and human ( □ ).
Each point represents the mean of triplicate plates, after subtraction 
of the spontaneous reversion rate.
The standard deviation was always within +15% the mean.
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FIGURE 7.10. A comparison of the activation of various nitrosamines 
by microsomal -preparations from male and female rats,, mice and humans,
A - shows the number of revertants per plate (after subtraction 
of the background) in strain TA100 in the presence of 1,500 
of dimethylnitrosamine and the various S9 fractions, 
h - as for A , bbt with 1,000 yUg of methylethylnitrosamine/plate
0 - as for A , but with 250 yUg of dipropylnitrosamine/plate
D as for A , but with 750 of N-nitrosopyrrolidine/plate
E - as for A , but with 500 yug of fl-nitrosopiperidine/plate
Where
and
17"
represents male^ 
represents female
* denotes those preparations achieving at least a doubling of 
the spontaneous mutation rate.
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DISCUSSION*
The Role of Cytochromes P-9-30 and P-998 in the Metabolic Activation 
of Dimethylnitrosamine.
Dimethylnitrosamine demethylase is an enzyme system 
associated with the endoplasmic reticulum of the liver and 
thought to convert dimethylnitrosamine to an unstable reactive 
intermediate which interacts with DNA and other liver macro­
molecules resulting in the subsequent expression of hepato- 
toxicity or frepatocarcinogenicity (as reviewed by Lai and 
Arcos, 1980 and described in more detail in the Introduction).
In many respects dimethylnitrosamine demethylase is a 
typical P-A50 system, requiring NADPH/O^ and inhibited by CO 
and depressed by CoCl^ (Aune Ojt al, 1981). However, about 2QP/o 
of the activity is resistant to CO (Argus et al, 1978), and in 
general a decrease in its activity has been noted after pre­
treatment of rats v/ith the microsomal cytochrome P-930 
inducers such as 3-methylcholanthrene, Aroclor 1239, /3-naptho- 
flavone, phenobarbitone etc. (Phillips et_ al, 1973)* In 
addition, pretreatment of animals with such chemical agents 
usually resulted in a decrease in both the acute toxicity and 
carcinogenicity of subsequently-administered dimethylnitrosamine 
(reviewed by Ioannides and Gibson, 1981; Lai and Arcos, 1980). 
Indeed, 3-methylcholanthrene and phenobarbitone were believed 
to repress cie novo synthesis of dimethylnitrosamine demethylase 
(Arcos et al, 1973)• Also, dimethylnitrosamine N-demethylase 
shows an unusual stability to storage and various agents 
compared with 'normal1 mixed-function oxidase activities 
(Lake et_ al, 1979)- However, the literature is very controversial 
v/ith respect to the effect of inducing agents on dimethylnitrosamine 
demethylation (see Chin and Bosmann, 1978; Gravela, Pani' and 
Bertone, 1979; Sipes, Slocumb and Holtzman, 1978).
This discrepancy has been clarified somewhat, when .two 
different dimethylnitrosamine demethylases were reported in
isolated rat microsomes (Arcos et al, 1977)• A high affinity 
form, functioning in the range up to 9 mM dimethylnitrosamine 
(named dimethylnitrosamine demethylase I), was repressed by 
typical mixed-function oxidase inducers (e.g. 3~mathylcholanthrene, 
Aroclor etc). Hov/ever a much lower affinity enzyme (dimethyl­
nitrosamine demethylase II), which did respond to typical 
mixed-function oxidase inducers, operated at a much higher 
substrate concentration(30-200 mM). The divergent results 
in the literature could be explained according to the substrate 
concentration used in the assays (Aune et_ al, 1981). Both 
enzymes have been shown to be slightly induced by tryptophan 
and indole (Mostafa, Ruchirawat and V/eisburger, 1981), and also 
both aliphatic alcohols (Schv/artz et al, 1980) and acetone 
(Glatt, deBalle and Oesch, 1981; Haag and Sipes, 1980) have been 
shown to affect dimethylnitrosamine demethylation and its 
activation to mutagens and toxicity in vivo. It appears to be a 
high affinity form of the enzyme which is induced by acetone 
(Sipes, Slocumb and Holtzman, 1978), and indeed the dimethyl­
nitrosamine demethylase I is more likely to be of importance 
in vivo, as the local concentration of its substrate is unlikely 
to reach 9 mM (Argus _et al, 1978). There have, hov/ever 
recently been some discrepancies reported between the effects 
of inhibition of dimethyl­nitrosamine demethylase I and the 
toxicity of the nitrosamine in vivo (Lai and Arcos, 1980).
The low affinity enzyme seems to be associated v/ith the murine 
Ah locus, and this activity is believed to have some contribution 
from both cytochromes P-998 and P-930, although it is an unusually 
small substrate for cytochrome P-998(Aune et al, 1981; Guttenplan, 
Huttbrer and Garro, 1978).
The enzyme involvement in dimethylnitrosamine demethylation 
may be even more complex than outlined above, and some workers 
have suggested that there are at least 3 different enzymes
(Lake et, al, 1982), and others suggest 9 distinct Km values
are discernable (Sipes, Slocumb and Holtzman, 1978). One of these 
may be a form v/hich is induced by pyrazole, v/hich is of very high
affinity (K^ = 0.08 mM) and is inhibited by high dimethylnitrosamine
concentrations,, and may be an unusual type of cytochrome 
P-950 (Evarts et al, 1982; Tu et al, 1981). Kinetic 
analysis of this reaction is complicated as dimethylnitrosamine 
tends to alter protein structure and so could activate its own 
metabolism (Lake et al, 1982). The involvement of other enzyme 
systems apart from the mixed-function oxidase system has been 
suggested, especially as the stoichiometry of production 
during dimethylnitrosamine metabolism is not always as expected 
from the proposed oxidative dealkylation pathway (Gangolli,
1981). Studies carried out both in vivo and in vitro have 
suggested the Involvement of a microsomal amine oxidase in 
dimethylnitrosamine metabolism (Lake ejb al, 1978; Phillips _et al, 
1978; 1982), and in its activation to mutagens (Rowland et al,
1980). Inhibitors and substrates of monoamine oxidase have been 
shown to protect against mutagenic activation of dimethylnitros­
amine in the Ames test and also against hepatotoxicity (Gangolli,
1981). These workers, hov/ever, found no competitive effect with 
diamines or mixed-function oxidase or mixed-function amine oxidase 
substrates. In agreement v/ith this, purified Zeigler enzyme does 
not metabolise dimethylnitrosamine (Aune et_ al, 1981; Lai et al,
1979) and inhibitors of this enzyme do not affect dimethylnitrosamine 
demethylation or necrosis caused by this substrate (Gomez, Godoy and 
Castro, 1981), although they do lower covalent binding (Lake et al, 
1978). Some workers (Gomez, Godoy and Castro, 1981) have shown
that administration of inhibitors of diamine oxidase will decrease 
dimethylnitrosamine toxicity. Although a nuclear component to 
dimethylnitrosamine metabolism has been suggested, this has not been 
confirmed by Lai and cov/orkers, who have also not been able to 
show any involvement of mixed-function amine oxidase or mono­
amine oxidase (reviewed in Lai and Arcos, 1980). Hov/ever, several 
groups have noted the requirement of a cytosolic fraction for 
efficient activation of dimethylnitrosamine (e.g. Lake e_t al,
1978; Sipes, Slocumb and Holtzman, 1978), and Kroeger-Koepke 
and Michejda (1979) also provide evidence for the involvement 
of a number of nitrosamine demethylases, some of which are 
membrane bound and others perform their function in the cytosol.
Further complications are added by the observation that dimethyl­
nitrosamine metabolism and activation may also be supported by 
NADH in the place of NADPH, although this is not quite so active 
((Fong, Lee and Lin, 1982). In summary, studies with inducers, 
inhibitors and various subcellular fractions show that there 
are multiple pathways in the metabolism and activation of 
dimethylnitrosamine, only some of which are dependent on 
cytoahrome P-450 (Godoy, Gomez and^Castro, 1978) and, in particular, 
the high affinity forms are not classical cytochromes P-930 (Tu 
et al, 1981).
In the present studies, hamsters were used, as unlike the 
rat, these readily metabolise dimethylnitrosamine to mutagens 
in the Ames test (Prival, King and Sheldon, 1979)- Pretreatment 
of hamsters with phenobarbitone, 3-methylcholanthrene or Aroclor 1254 
provided the expected induction of mixed-function oxidase activity 
(Table 7-1)> and although the basal cytochrome P-448 activity is 
higher in the hamster than the rat, it still responds to inducers 
even though the effect is less marked. Also, in agreement with 
the studies described above, which had been carried out in rats 
and mice, dimethylnitrosamine demethylation in hamsters showed 
a biphasic response v/ith respect to the inducers. Aroclor and 
3-methylcholanthrene, in particular decreased the demethylation 
of low concentrations of dimethylnitrosamine (2 mM), which is 
in agreement v/ith others (Hutton, Hackney and Meier, 1979) v/ho 
also shov/ed dimethylnitrosamine demethylase I of hamsters to be 
repressed by 3-methylcholanthrene. However, at high substrate 
concentrations (100 mM dimethylnitrosamine), all pretreatments 
induced the demethylase activity when it was expressed with 
respect to protein concentration (Figure 7*1), but v/hen considered 
with respect to cytochrome P-450 concentration (Figure 7.2), 
all pretreatments lov/ered dimethylnitrosamine -demethylase activity.
In addition, pretreatrnent v/ith the various mixed-function oxidase 
inducers did not enhance the hamsters' ability to activate 
dimethylnitrosamine to a mutagen (Figure 7-3)i and indeed, if 
this were expressed as revertants per nmol P-450, (Figure 7.4), 
then the induced preparations were less effective activators.
Overall, there was no correlation betv/een cytochrome P-V?0 
concentrations, microsomal dimethylnitrosamine demethylation 
and activation of dimethylnitrosamine to mutagens, although 
others have found a good correlation betv/een dimethylnitrosamine 
demethylation and its activation to mutagens (jPrantz and 
Mailing, 1975; reviewed by Ioannides and Gibson, 1981). It 
therefore appears that, in agreement v/ith the work in rats 
(Lake et al, 1976), dimethylnitrosamine demethylation by the 
mixed-function oxidase is not the rate-limiting step, and that 
other microsomal or cytosolic enzymes are involved in the 
activation of this nitrosamine in hamsters. Others have been 
unable to show a correlation betv/een dimethylnitrosamine 
demethylation and carcinogenicity, and so this led to the proposal 
that other routes apart from formaldehyde production may be 
important (Argus _et al, 1978). Although carbon monoxide has 
been shown to reduce dimethylnitrosamine binding to macromolecules, 
at low nitrosamine concentration (0.2 mM) (Chin and Bosmann, 1980), 
the aikylation of macromolecules has also been shown to be lowered 
by inducers and increased by inhibitors of cytochrome P-V?0 
(Appel et al, 1979). Certainly, it cannot be one of the major 
forms of cytochrome P-V?0 or P-448 involved in its activation.
This work has been further substantiated by the use of purified 
cytochromes P-V?0 (Masson, Ioannides & Gibson, 1983)j although 
other workers have shov/n that at a substrate concentration of 
200 mM, dimethylnitrosamine may be demethylated by pure cytochrome 
P-V?0 (reviewed by Ioannides and Gibson, 1981). However, metabolism 
by the major forms of cytochrome P-V?0 is unlikely to be of 
relevance in vivo. Inducer and kinetic studies of this nature 
are complicated by the competition betv/een the oxidative 
demethylation (activation)pathway and the denitrosation 
(detoxification) route. There is also some controversy over the 
relative involvement of cytochromes P-A50 and P-W3 in the latter 
(see Appel et al, 1979; 1980; Ioannides and Gibson, 1981), and 
therefore the effect of various mixed-function oxidase inducers 
on this pathway. It is possible that competition betv/een these 
two routes of metabolism could be responsible for some or all of
the apparent differences in enzyme affinities. Also of relevance 
to a critical discussion of this work are some of the problems 
associated with the dimethylnitrosamine demethylation assay 
itself. It has been questioned (Chin and Bosmann, 1976) v/hether 
it is truly relevant to extrapolate back from formaldehyde 
production to the initial hydroxylation step, as there are many 
interfering factors involved. Also, there is a considerable 
variation in the amount of dimethylnitrosamine which is.channelled 
towards formaldehyde production, and the semicarbazide itself, 
which is incorporated in the assay system may be responsible 
for a proportion of the formaldehyde and nitrogen released 
(Kroeger-Koepke et al, 1981).
Species and Sex Differences in the Activation of Nitrosamines.
All the microsomal preparations from the various species 
were fully characterised with respect to mixed-function oxidase, 
monoamine oxidase and mixed-function amine oxidase activities, 
as has been discussed in Chapters 5 and 6 (see also Tables 
7.2 and 7-3).
The hamster v/as the only species v/hich activated all 
nitrosamines studied (Figures 7«5“7.9) while the mouse was 
reasonably efficient. Hov/ever, the mouse activated nitroso- 
pyrrolidine only weakly, v/hich v/as one of the nitrosamines most 
readily activated by the human preparation (Figure 7-8). It 
has been suggested that a monoamine oxidase type enzyme may 
also be involved in the activation of this nitrosamine (Phillips 
et al, 1978). Hone of the aliphatic nitrosamines were activated 
by rat, pig or human preparations, and indeed the rat only 
activated nitrosopiperidine, the strongest mutagen (Figure 7-9).
The sex differences in the activation of the various nitrosamines 
(Figure 7.10) varied according to the species and to their chemical 
structure. The most marked differences were noted for nitroso- 
pyrrolidine, v/here the female mouse v/as far more efficient than 
the male in activation, and conversely the male human was more
active than the female. There v/as no clearcut correlation betv/een 
efficiency of activation and any individual enzyme activity studied, 
and it is quite probable that a complex interaction of enzyme 
systems is involved for a variety of nitrosamines, as has been 
discussed in detail for the dimethyl derivative.
There is much controversy in the literature over the order 
of mutagenic potency of various nitrosamines (compare for 
example Brambilla jet al, 1981 and Lee and Guttenplan,- 1981) and it 
is a little surprising that nitrosopiperidine should appear to be 
the strongest mutagen in this study, as it is generally considered 
to be rather v/eak (Katz, Kramer and Weinstein, 1980). Some 
workers have reported that it is difficult to correlate mutagenic 
and carcinogenic potency of nitrosamines (e.g. Ashby 1981;
Brambilla ejt al, 1981), v/hile others have achieved a reasonable 
correlation (Bartsch, 1981; Lee and Guttenplan, 1981).
Certainly, the conditions under which the mutagenesis assay takes 
place-is critical, and as only a small proportion of the 
nitrosamines are metabolised in vitro, a saturating concentration 
(up to the limits of bacterial toxicity) of the carcinogen in the 
assay has been suggested (Lee and Guttenplan, 1981). These authors 
have also found further stabilization of the active intermediates 
of dimethylnitrosamine, at least, if the pH of the assay v/ere 
lowered to 6.9 . There is a general consensus of opinion that 
nitrosamines are difficult to detect as mutagens in the Ames 
test (e.g. Ashby, 1981; Bartsch 198O; 1981; Guttenplan, 1979; 
Malaveille et al, 1979 ; Yahagi et al, 1979), and following the 
advice of these authors the preincubation variant of the Ames 
test v/as used. This is particularly effective for the short-chain 
alkyl nitrosamines (Ashby, 1981), and in retrospect, dipropyl- 
nitrosamine may have given a more positive result if it had been 
incorporated using the standard plate procedure (Bartsch, 1981).
The general advantages of the preincubation method is that the 
effective concentration of the carcinogen in contact with the 
activating system, and bacteria is raised, and also the trapping 
of electrophiles by the agar is prevented. In addition, a more
concentrated S9 mix was used to enhance activation of the 
nitrosamines, and generally the carcinogens were incorporated 
at high concentrations (compared with the aromatic amines and 
polycyclic aromatic hydrocarbons), although a careful note 
was made of their effect on bacterial viability. The bacterial 
strain, TA 100 was used as this was the most sensitive of those 
available (McMahon, Cline and Thompson, 1979)* A new strain 
(TA 92) is believed to be less resistant to nitrosamine mutagenicity 
(Ashby, 1981; Lee and Guttenplan, 1979), and further enhancement 
of bacterial sensitivity would have been achieved if exponentially- 
growing cultures,which.had'been pretreated with the nitrosamines 
had been used (Guttenplan, 1979).
The efficiency of the hamster preparations in activating 
nitrosamines has been reported before for dimethylnitrosamine 
(McCoy, Hecht and McCoy, 1982), dipropylnitrosamine (Bartsch,
1980; 1981) and nitroso^pyrrolidine (Raineri et al, 1981). The 
reason why the hamster is better than the rat or mouse in 
activating dimethylnitrosamine does not appear to be related 
to their relative dimethylnitrosamine demethylase activity, but 
to some inhibitory microsomal factor in the other rodents (Prival 
and Mitchell, 1981; 1982; Prival, King and Sheldon, 1979). Also 
both CC-hydroxylase and aldehyde dehydrogenase activities are 
important in the activation of nitrosopyrrolidine (McCoy, Hecht 
and McCoy, 1982). This oC-hydroxylaiion pathway has been shown to 
be active in human preparations (Autrup, 1981), which may be the 
reason for the effective activation of nitrosopyrrolidine in this 
species. Indeed, human microsomes have been shown to be able to 
activate a wide range of nitrosamines.(Bartsch, 1981; 1982; I.A.R.C. 
Monographs, 1978; Purchase e_t al, 1978), although there is a wide 
individual variation (Czygan e_fc al, 1973). This may be the 
reason why the present results are at complete variance with 
previously published data (Autrup and Stoner, 1981) v/hich found 
human tissue to be best at activating symmetrical, acyclic 
nitrosamines, but in agreement with others (Bartsch, 198O; 1981) 
who found human samples better than rats in activating nitroso­
pyrrolidine and nitrosopiperidine. It is believed that there has 
been no previously published work, v/hich has compared the ability
of preparations from pig to activate nitrosamines. This study 
has shown this species to be a poor activator of most nitrosamines, 
which extends the belief that the Ziegler enzyme is not involved 
in the metabolism of dimethylnitrosamine to other members of this 
group. Also methylethyl^itrosamine is rarely considered in 
species comparisons of activation, and this study has shown a 
very similar response to the dimethyl derivative.
CONCLUSIONS.
The metabolism and activation of dimethylnitrosamine in 
hamsters has been studied in some detail. Similar to previous 
work in rat and mouse, the dimethylnitrosamine demethylase 
activity was shown to be biphasic in its response to mixed- 
function oxidase inducers.-;, , suggesting at least two different 
enzymes involved. Mutagenicity studies failed to establish 
a clear relationship betv/een dimethylnitrosamine activation and 
either its demethylation or any of the major cytochrome 
or P-¥f8 activities. Similarly, in an extended study with a 
range of nitrosamines and a variety of animal species, no 
clearcut relationship was observed between mutagenic activation 
and either mixed-function oxidase, mixed-function amine oxidase 
or monoamine oxidase activity. It is suggested that nitrosamine 
activation is a multicomponent pathway, either involving a variety 
of enzymes or a specific, yet unidentified enzyme. It is also 
conceded that complications arise in the analysis of nitrosamine 
metabolism due to the competition which occurs between activation 
and denitrosation (deactivation) pathv/ays. Some of the problems 
concerning the detection of nitrosamines as mutagens have been 
discussed.
C H A P T E R  8
CHAPTER 8. METABOLISM BY NON-MAMMALIAN CYTOCHROMES P-^50
AND BY MODEL ENZYME SYSTEMS .
INTRODUCTION.
Plant and Yeast Cytochromes P-450.
The majority of this thesis has been dedicated to the study of 
mammalian, hepatic cytochromes P-^O, however some consideration 
is nov/ given to the mixed-function oxidases found in plants and 
yeasts. Indeed, cytochrome P-V?0 is widely distributqd^-in^iature 
and is found in organisms from all animal and most plant phyla, and 
it is also found in many microorganisms.
Yeast: The presence of cytochrome P-^50 is well established in a
variety of fungi and bacteria, although detection in certain strains is 
sometimes difficult and often requires prior purification, frequently 
following induction by a particular carbon source. A full survey 
of the distribution and role of cytochromes P-450 in microorganisms 
may be found in a review on the subject by Callen, 1978. In general, 
fungal and bacterial cytochromes P-A-50 can metabolise substrates 
similar to the mammalian systems, although each isoenzyme appears 
to be more specific and operates within a narrower range of 
substrates (Berg and Rafter, 1981). This is particularly true for 
bacterial sources, which appear to be mainly involved in tie hydroxy- 
lation of hydrocarbons, fatty acids and steroids, although there is 
some controversy at present over v/hether these activities can be 
induced by substrates (Berg and Rafter, 1981; Narhi and Fulco,
1982). Bacterial cytochromes P-A-50 have been extensively used 
in mechanistic studies as they are soluble and stable, and hence 
easy to purify, and have many immunological similarities with 
mammalian cytochrome P~V?0. They do however use NADH as a cofactor 
and involve an extra iron sulphur protein in electron transport, .and 
may not fully represent the mechanism associated with the membrane- 
bound NADPH-linked forms found in higher organisms (Callen, 1978).
The mixed-function oxidase system of yeast, however bears much —  
closer resemblance to the mammalian enzyme with an analogous electron 
transport system (Callen and Philpot, 1977), and may even be similarly
affected by inducers and inhibitors, including phenobarbitone, 
3-methylcholanthrene and polychlorinated biphenyls (Callen, 1978; 
Karenlampi, Marin and Hanninen, 1982). The present study concentrates 
on the yeast, Saccharom.yces cerevisiae, and there is much evidence 
in the literature that the levels of cytochrome P-450 in this 
species is markedly affected by the growth phase of the culture, 
the strain, and in partieular by the concentrations of glucose 
and oxygen in the medium (Callen, 1978; Karen3a.mpi, Marin and 
Hanninen, 1982; King, Azari and Wiseman, 1982; Trinn, Kappeli 
and Fiechter, 1982). The latter appears to reflect an inverse 
correlation between cytochrome P-450 levels and that of the 
mitochondrial cytochromes (Trinn, Kappeli and Fiechter, 1982), and so 
high cytochrome P-450 levels may be achieved by culturing the yeast 
in high glucose and low oxygen concentrations, which lower the 
intracellular cyclic AMP levels (King, Azari and Wiseman, 1982). 
Although the principal metabolic pathways catalysed by yeast 
cytochrome P-450 appear to involve hydrocarbons, steroids 
(especially lanosterol) and fatty acids (Aoyama _et al, 1983;
Callen and Philpot, 1977), their metabolic capacity is far greater than 
that of bacteria and may include various xenobiotics, such as benzo- 
(a)pyrene and other polycyclic aromatic hydrocarbons, ethoxyresorufin, 
aflatoxin , dimethylnitrosamine and 2-naphthylamine (Callen and 
Philpot, 1977; Karenlampi, Marin and Hanninen, 1982; King, Azari and 
V/iseman, 1982; Wackett and Gibson, 1982). It is believed that there 
are multiple forms of cytochromes P-450 and P-448 in yeast, as both 
the affinity and activity of aryl hydrocarbon hydroxylase activity 
is altered by various inducers (King, Azari and Wiseman, 1982; 1984). 
The high affinity isoenzyme has been shown to metabolise benzo(a)- 
pyrene to its 3~kydroxy-, 9-hydroxy- and 7 58-dihydro-7 ,8~dihydroxy- 
derivatives (King, Azari and V/iseman, 1982), and this particular 
cytochrome P-448 has been purified and studied in some detail 
(King, Azari and V/iseman, 1984). Its molecular weight and amino 
acid composition show similarities to the mammalian form, although 
in contrast to the rat hepatic cytochrome P-448, it is mainly in a 
low spin form. In addition to benzo(a)pyrene metabolism and binding, 
it was also shown to produce binding spectra with ethylmorphine,
lanosterol, dimethylnitrosamine, perhydrofluorene (all Type I) 
and also with aniline and benzphetamine (Type II) among others 
(King, Azari and V/iseman, 1984). It is this enzyme preparation 
v/hich has been used in the majority of the present studies on- 
yeast.
Plant: The study of cytochrome P-450 in higher plants has not 
reached a state of development comparable to that achieved with 
the mammalian and microbial enzymes. The main reasons for this are 
the low cytochrome P-450 levels inherent to most plant tissues, 
the spectroscopic masking: of the enzyme by ill-defined pigments 
(possibly carotenoids), the high amount of phenolic compounds 
present, and the exceptionally low stability of the reduced 
form of the enzyme in isolated plant microsomes (Reichart et_ al,
1982). Nevertheless, cytochrome P-450 enzymes have been detected 
in a number of plant species (West, 1980), localised in the 
endoplasmic reticulum and implicated in several metabolic pathways. 
Plant cytochromes P-450 seem to have a very high substrate 
specificity and are primarily involved in intermediary metabolism. 
This is in contrast to the mammalian hepatic forms which generally 
have a broad substrate specificity and can metabolise a wide range 
of foreign compounds. Their involvement is firmly established in 
oxidation of terpenes (Hendry, Houghton and Jones, ...1981), in the 
oj- and in-chain hydroxylation and desaturation of fatty acids 
(Hendry, Houghton and Jones; Narhi and Fulco, 1982; Salaun at al, 
1981) and in the 4-hydroxylation of trans-cinnamic acid, a flavanoid 
and lignin precursor (Higashi et al, 1981; Salaun et al, 1981).
Plant cytochromes P-450 may also be able to metabolise certain 
pesticides, and certainly are subject to induction by some such 
xenobiotics (Dohn and Krieger, 1981; Higashi at al, 1981). In 
addition, cytochrome P-450 levels may be raised by wounding, ageing 
and by phenobarbitone, ethanol and divalent manganese (Hendry, 
Houghton and Jones, 1981; Salaun et_ al, 1981). Plant cytochrome 
P-450 may also be affected by light (Hendry, Houghton and Jones, 
1981), and indirect evidence has suggested the existence of
multiple forms of cytochrome P-450 enzymes in plants (Peichart 
et_ al, 1982; Salaun et al, 1981). In the present study, the 
content and activity of cytochrome P-450 in the avocado pear 
mesocarp (Persea americana) has been studied, as this contains rela­
tively high levels of reasonably stable enzyme in comparison with 
the majority of plant tissues investigated (Markham, 1976; Rich 
and Bend&ll, 1975)-
Haemoglobin and Chemical Systems.
Haemoglobin: The major physiological function of haemoglobin in
the erythrocyte is to transport oxygen to the tissues, whereas 
the function of cytochrome P-450 of the hepatocyte is to catalyze 
the activation of oxygen for the metabolism of various endogenous 
and xenobiotic substances. Nevertheless," both haemoproteins are 
b-type cytochromes containing a protoporphyrin IX prosthetic group 
bound in a hydrophobic pocket. Indeed, the active sites of these 
globular haemoproteins are closely surrounded by protein side 
chains, v/hich provide some steric hindrance to entering ligands, 
including Cu, and. CO (Traylor et_ al, 1981), and additionally, 
the binding of 0^ to the haem depends on the electron density 
of the iron. Haemoglobin is a tetrameric protein with one haem 
group per chain, and it has the ability to bind dioxygen to 1 or 2 
of these haems and then have subsequently increased affinity of 
the remaining haems for oxygen. This co-operativity is believed 
to occur through altered protein configuration. The particular 
physiological function of a haemoprotein is due to the protein 
structure around the haem, and in particular its axial ligation.
The nature of the immddiate environment is one of the critical 
variables in controlling the chemistry of the iron atom, and so 
its spin-state. This has previously been discussed in detail 
for cytochrome P-450 (see Chapter 4), however, in normal reduced 
haemoglobin the iron II is 5-coordinate, v/ith the protein providing 
a single axial imidazole ligand from the histidine and protecting 
the vacant 6th coordination site for 02~binding. A full 
discussion of the stereochemistry of haemoproteins is presented 
in the recent review by Scheidt and Reed, 1981. In addition, a
very complete consideration of tetrapyrrole.structure in relation 
to oxygen binding and activation can be found in the comprehensive 
review by Bonnett, 1981.
Both cytochrome P-^30 and haemoglobin can also act as the 
terminal electron acceptor for two reductase enzymes, one of v/hich 
is specific for NADH and utilises cytochrome b,_ as the proximate 
electron acceptor (Blisard and Mieyal, 1981; Golly and Hlavica, 
1983; Yubishi, Tamura and Takeshita, 1981). It appears that there 
are structural similarities between the cytochromes b^ and 
corresponding reductases in erythrocytes and hepatocytes (Golly 
and Hlavica, 1983)* In addition, the NADPH- dependent enzyme 
from liver can catalyse the reduction of methaernoglobin (Blizard 
and Mieyal, 1979)* Within the erythrocyte, the NADH-dependent 
system is responsible for maintaining the haemoglobin in the 
reduced form v/hich binds oxygen, and so preventing methaemo- 
globinaemia (Yubishi, Tamura and Takeshita, 1981), v/hereas the 
NADPH-dependent enzyme has been thought to be of little physio­
logical significance. In contrast, it is generally accepted that 
the NADPH-dependent reductase of the hepatocyte plays the major 
role as the source of reducing equivalents for the monooxygenase 
activity of the P-^30 system, with a minor contribution by the 
NADH-dependent reductase (see Chapter 1). However, recently a 
monooxygenase-like activity has been observed in erythrocytes, 
v/hich has implicated a key role of NADPH (Blisard and Mieyal,
198']).
Juchau and Symms (1972) first noted that the aniline hydroxy­
lase activity of the human placenta v/as entirely attributable 
to the reduced haemoglobin present. In addition, haemoglobin 
has been shown to enhance the aniline hydroxylaling capacity 
of liver microsomes (Jonen, Kahl and Kahl, 1978). Similarly, 
the addition of haernatin to a variety of microsomes (particularly 
extrahepatic) results in the enhanced metabolism of a selection 
of substrates, possibly through interaction with the flavoprotein 
reductase (Omiecinski, Namkung and Juchau, 1981). Haemoglobin, 
itself has been implicated as a catalyst for various reactions, 
including the dealkylation of aromatic N,N-dimethylamine N-oxides,
decarboxylation of dopa, lipid peroxidation (both quasi­
lipoxygenase and lipohydroperoxidase activities), hydroxylation 
of aniline, N-oxidation of *f-chloroaniline, reductive dehalogen- 
ation and esterase activity (Baker, Nelson and Vandyke, 1983;
Elbaum and Nagel, 1981; Mieyal et al, 1978; Symms. and Juchau, 197*0* 
Its activity is considerably enhanced by the presence of electron- 
donating systems, such as flavoproteins and NAD(P)H, ascorbate, 
and methylene blue (Meiyal et al, 1978; Symn£ and Juchau, 197*0. 
Cytochrome P-*f30 reductase can also promote the aniline hydroxylase 
activity of haemoglobin, whilst being unable to catalyse this 
reaction on its own (Jonen, Kahl and Kahl, 1978). In addition, 
isolated haemoglobin may be substituted for cytochrome P-*l-30 in 
a reconstituted aniline hydroxylase system containing the 
cytochrome P—A30 reductase (Mieyal jet al, 1978; Symms and" Juchau, 
197*0 • The ability of haemoglobin to hydroxylate aniline and 
acetanilide has been presented as evidence for the activation 
of molecular oxygen by this haemoprotein (Jonen, Kahl and Kahl, 
1978). However, as cytochromes b,_ and c, v/hich reportedly do 
not bind oxygen, can also p-hydroxylate aniline (Symms and Juchau, 
1978), this may instead add further support to the theory that 
it is the aniline bound as a haem ligand (c.f. Type II substrate 
site of cytochrome P-*f30), rather than the oxygen, v/hich is 
activated. Some workers (e.g. Jonen, Kahl and Kahl, 1978; Juchau 
and Symms, 1972) have been unable to demonstrate activities in 
haemoglobin with typical Type I substrates of cytochrome P-A30, such 
as benzo(a)pyrene hydroxylation, and aminopyrine or ethylmorphine 
N-demethylation. However, haemoglobin has been shov/n to be 
proficient at nitroreduction, with.p-nitrobenzoic acid as substrate 
(Juchau and Symms, 1972) and is believed to be capable of catalysing 
the N-dealkylation of benzphetamine, a typical cytochrome P-^30 
reaction (Mieyal et al, 1978).
The aniline hydroxylation reaction can also be catalysed by 
whole or lysed erythrocytes (Blisard and Mieyal, 1979), even 
though these contain scavenging systems for activated oxygen, 
such as superoxide dismutase, catalase and glutathione peroxidase
(Gerli et al, 1981; Petkau, Copps and Kelly, 1981). It appears 
to involve predominantly the NADPH-reductase (Blisard and Mieyal,
1981) and the reaction has an absolute requirement for oxyhaemo- 
globin, as shown in Diagram 8.1. In contrast to the mixed-function 
oxidase system, v/here the substrate is believed to bind to the 
oxidised form of cytochrome P-*r30 (see Figure 1.2), aniline binds 
only very weakly to methaemoglobin. Indeed, contrary to popular 
belief, it has been suggested that the catalytic cycle of 
cytochrome P-A-30 may be analogous to haemoglobin, with substrates 
binding to an oxy-ferrous intermediate of the cytochrome (Mieyal 
and Blumer, 1978). This view is not shared by others, even 
though haemin and aniline are also believed to undergo a similar 
catalytic cycle to haemoglobin (Adams and Berman, 1982). Both 
cytochrome P-A-30 and haemoglobin-catalysed aniline hydroxylation 
are affected by catalase,. superoxide dismutase and hydroxyl radical 
scavengers (Ingelman-Sundberg and Ekstrom, 1982) and both H«0„
cL cL
and O^* may be involved in the autoxidation of haemoglobin 
(Tomoda, Yoneyama and Tsuji, 1981). Also included in Diagram 8.1 
is the proposed mechanism for haemoglobin-catalysed lipid 
peroxidation (Kuhn et; al, 1981).
It appears, therefore that the metabolic capacity of 
erythrocytes is far greater than was originally envisaged, with 
the NADPH-linked reductase playing a significant role. It has been 
proposed that the red blood cells could be an important site for the 
activation of aromatic amines (Golly and Hlavica, 1983), and it has 
also been shown that erythrocytes can enzymically reduce nitroso- 
benzene (resulting in aniline production) and also N-hydroxy-2- 
acetylaminofluorene (Eyer and Lierheimer, 1980). In addition 
to the above mentioned activities, erythrocytes also contain 
acetylating enzymes which could also affect the toxicity of 
various compounds (Mandelbaum-Shavit and Blondheim, 1981).
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DIAGRAM 8.1. Proposed mechanisms for haemoglobin-catalysed 
aniline hydroxylation and lipid peroxidation*
Compiled with reference to Blisard and Mieyal, 1979 » Kfihn et al, 
1981 ; Mieyal and Blumer, 197& » Mieyal et al, 197^.
Chemical systems: There are many chemical systems which,
due to their ability to hydroxylate organic compounds, have been 
used to investigate the mechanisms of oxygen activation and 
hydroxylation by cytochrome P-A30. In these model systems it is 
important that hydroxylation simulates typical enzyme properties 
including (1) the epoxidation of = CZ bonds; (2) electro- 
philic hydroxylation of aromatic compounds; (3) specific hydroxy­
lation of aliphatic compounds and (A) the NIH shift (Sakurai 
and Ogawa, 1979)- This last property is the intramolecular 
migration and retention of substituents during aromatic hydroxy­
lation, arising from an epoxide intermediate and demonstrated 
using labelled substrates (Jerina and Daly, 197A; Jerina et al, 
19^7; Sakurai and Kito, 1977)* The conditions of chemical 
hydroxylation should a.lso be reasonably physiological.
Many non-haem compounds are able to effect the p-hydroxylation 
of aniline, including the Fe(ll)-EDTA-asc:orbate system of 
Udenfriend (Udenfriend et_ al, 193^). The proposed mechanism 
of this reaction is shown in Diagram 8.2. and it is believed 
that the EDTA changes the electronic- configuration of the iron.
Also ascorbic acid has been shown to act in vivo as an electron 
donor, where it undergoes continual redox cycling with the aid 
of ascorbate free radical reductase and ascorbic acid oxidase 
(Arrigcni, Depierro and Borraccino, 1981). The Udenfriend system 
is particularly good at aromatic ring hydroxylation, which is 
probably due to the peroxidative effect of the ascorbate in the 
presence of metal ions, and is stimulated by flavoproteins 
(Symms and Juchaur, 197^). It does not, however, hydroxylate 
via an epoxidation mechanism and so does not cause the NIH shift 
(Bonnett, 1981; Sakurai and Kito, 1977)*
Several Fe(II)-thiol complexes are also able to p- and 
o-hydroxylate aniline (Sakurai and Ogawa, 1979) and to catalyse 
hydroxylation, with concurrent methyl group migration, of 
p-toluidine (Sakurai and Kito, 1977). It is believed that
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interaction between the thiol group and the Fe(ll) is important 
in both these reactions, and may mimic the thiolate ligand of 
the cytochrome haem iron, which is considered to be an
essential factor in both its catalytic and spectral properties. 
Cysteine and thiosalicylic acid are the most studied thiol 
compounds, and Fe(Il) may be replaced by haemin for a nearer 
approximation of cytochrome P-k^O. A proposed reaction scheme 
is shown in Diagram 8 .3.
The ability of both haemoglobin- and inorganic iron-based 
systems to mimic cytochrome P-A30 in the metabolism and 
activation of various chemicals has been studied. This has not 
been limited solely to the metabolism of aniline (see V/ilmer, 
Kligerman and Erexson, 1981 for proposed metabolic pathway of 
aniline), as there is some evidence that the hydroxylation of 
this substrate by cytochrome P-A-30 occurs by a different 
mechanism to other reactions, such as the O-demethylation of 
p-nitroanisole (ingelmen-Sundberg and Ekstrom, 1982).
MATERIALS AND METHODS.
Plant and Yeast Cytochromes P-V?Q«
Plant: Avocado pears (Persea americana) were purchased locally,
not more than 2kh. before used, and were stored at 0-^°C.
The fruits used were ripe, but not too soft, and the mesocarp 
was scooped out from the fruit and homogenised in 2 volumes of 
100 mM potassium phosphate buffer, pH 7-^ -j containing 0.1% v/v 
2-mercaptoethanol. A Waring blender was used (10s low speed,
13s high speed) and the homogenate was squeezed through a single 
layer of nylon bolting cloth and centrifqged at 10,000 g for 
20 minutes. The resulting post-mitochondrial supernatant v/as 
collected (taking care to exclude the floating lipid layer) 
arid centrifuged at 103,000 g for 1 hour. The resulting microsomal 
pellets were resuspended in 100 mM potassium phosphate buffer, 
pH 7-^ f, containing 2C% glycerol, 0.1 mM dithiothreitol and 0.1 mM 
EDTA, to a concentration of 1 ml per 10 g of original tissue. 
Microsomal suspensions were stored at -80°C until required, 
and had been prepared and donated by Miss T.V.L. Kingsland.
Samples of the microsomes were diluted in the resuspension 
buffer (glycerol was needed for stabilisation) to a concentration 
of 1-2 mg protein/ml and were assayed for total cytochrome P-V?0 
concentration and for binding spectra with a variety of substrates, 
according to the methods previously described on pages kZ and 102 
respectively. Other assays carried out on undiluted microsomal 
suspensions included protein, NADPH-cytochrome c reductase, 
benzphetamine and ethylmorphine demethylations, ethoxyresorufin 
O-deethylation and benzo(a)pyrene hydroxylation, all carried out 
as previously described (see Chapter 2) apart from the addition 
of glucose-6-phosphate dehydrogenase (3 units per assay) to 
complete the NADPH-generating system where required (i.e. in the 
demethylation assays). The microsomes were, in addition assayed 
for lauric acid (o,to-1) hydroxylase (Orton and,Parke»*v1982).
Both the S9 fraction and the microsomal suspension were tested 
for their abilities of activate benzo(a)pyrene (0-20 pg/plate) 
to mutagens in Salmonella typhimurium strain TA100, using both
the standard plate test and preincubation variants of the Ames 
te^t(see Chapter 2). The cofactors used in preparing the 
activating system were supplemented with 0.1 mmol NADPH and 
4 units of glucose 6-phosphate, dehydrogenase in every 2 ml 
standard cofactor preparation. The activating system (*S9 mix') 
v/as prepared so as to supply 50 - 1'50 jxl of microsomes or S9 per 
plate and was filtered through sterile Millipore filters.
Yeast: Highly purified yeast cytochrome P-448 was donated by
Drs. D. J. King and M. P. Azari and was prepared from Saccharomyces 
cerevisiae exactly according to the methods detailed in King,
Azari and Wiseman, 1984. The yeast (NCYC No. 240) was grown 
at 30°C for 44 h in a medium containing 1% yeast extract,
2% mycological peptone, 0.5% NaCl and 2C% glucose to obtain 
cells in a sta^e of glucose repression. For the experiment 
where a benzo(a)pyrene-induced preparation v/as used, the medium 
also contained this inducer at a concentration of 2.4 mg/100 ml. 
Both microsomes and purified preparations were used in a pre- 
incuhation variant of the Ames test, with benzo(a)pyrene as 
carcinogen and Salmonella tvphimurium strain TA100 as detector 
organism. Dimethyl^formamide (DMF) was used as a solvent for 
benzo(a)pyrene, as the yeast preparations were adversely affected 
by DMSO, and the carcinogen solution was made up to a sufficient 
strength so that a maximum of 10 pi of solvent were used per 
plate. The mixed function oxidase system v/as reconstituted in 
the ratio 1 nmol cytochrome P-450 : 1 unit reductase : 30 jJ-g 
dilauroyl phosphatidylcholine, and v/as left for 5-10 minutes 
before adding the buffer and NADPH (5 yUmol/plate) to complete 
the activating system, which v/as then filter-sterilised through 
0.45/1 pore Millipore filters. The incubations were alv/ays tested 
concurrently for their effects on bacterial viability, by removing 
and diluting small samples at the start and finish of the pre­
incubation period. The microsomal and purified preparations 
were also assayed for protein and total cytochrome P-450 
concentrations, and the binding and metabolism ■ of a variety 
of substrates, including ethoxyresorufin and benzo(a)pyrene
(as previously described).
Haemoglobin and Chemical Systems.
Source of haemoglobin: Blood v/as obtained from either goats
(University of Surrey Animal breeding unit) or from a human 
volunteer (taken under sterile conditions by Dr. A. N. Smith) 
and v/as used to prepare both whole erythrocyte and haemolysate 
suspensions according to the method described by Blisard and 
Mieyal, 1979• Blood was obtained aseptically and used either 
immediately or after overnight storage in a refrigerator. 
Erythrocytes were gently spun down by low speed centrifugation 
(2,000 rpm, 10 min. in a Mistral 6 L centrifuge) and v/ashed 
two times in tv/ice the original volume of 0 .9% saline (containing 
6 mM glucose), and another two times in twice the original volume 
of 0.9% saline alone. They were finally resuspended in either, 
two volumes of 0.9% saline or distilled water to give the eryth­
rocyte suspension (RBC) or haemolysate, respectively. All 
solutions and glassware were sterile and prechilled. Pure 
haemoglobin was from beef blood (Type I, crystallized, Sigma) 
and was approximately 75% in the oxidised form.
Estimation of haemoglobin concentration: The total haemoglobin
concentration of erythrocyte and haemolysate suspensions v/as
estimated by the method of Van Kampen and Zijlstra, 1961. This
assay is based on the knowledge that all common haemoglobin
derivatives can be converted to hemiglobincyanide, a stable
compound with an absorption peak at 540 nm. The solution
strictly obeys Beer-lambert’s Law at this wavelength, and the
optical density of the diluent is zero. Haemoglobin is converted
to hemiglobin by K_Fe(CN)/-, and this then reacts v/ith KCN to t? 0
give hemiglobincyanide.
The diluent used v/as that found to be optimal by Van Kampen 
-and Zijlstra (1961) and consisted of K^Fe(CN)^ (200 mg),
KCN (50 mg) and KH^PO^ (140 mg) made up to 1 dm^ v/ith distilled
water to give a final pH of 7*2. A 20 jH sample of homogenised 
blood or haemolysate was added to 5 nil of'diluent, and mixed.
After 3 min, the absorbance was measured, against distilled 
water, at 5^0 nm, in a Cecil CE 2?2 linear readout spectro­
photometer, using cuvettes with a 1 cm. light path. The
concentration of haemoglobin was calculated, using the extinction
-1 '
coefficient value of 11 mM cm for the haemoglobin monomer.
Enzyme assays: Both the aniline hydroxylase (see p.35) and
the dimethylnitrosamine N-demethylase (p.kj>) assays were adopted 
to incorporate activating systems based on haemoglobin and 
non-haem iron. Details of these various activating systems 
may be found in Chart 8.1. In the experiment investigating 
the effects of haemoglobin on the ability of various S9 fractions 
to hydroxylate aniline, the incubation conditions and assay 
procedure were identical to those previously described, except 
that 5C% of the S9 fraction was replaced with haemoglobin 
(5*0 mg/ml) or the assay buffer. However, when the haemoglobin/ 
chemical activating systems v/ere incorporated, the following assay 
conditions were used:-
Tris-HCl buffer (0.3M) pH 7*6 or pH 6.0 0.5 ml
Aniline HC1 (0.9-M) , neutralised 0.5 ml
Activating system 1.0 ml
Total 2.0 ml
This was incubated for 60 or 120 min at 37°C, and the 
reaction v/as terminated by immersion in ice. This was to prevent 
denaturation of haemoglobin and subsequent production of active 
oxygen species, v/hich could be brought about by protein precipitation 
(Blisard and Mieyal, 1979)* Extraction of p-aminophenol and 
estimation of the blue colour v/ere exactly as previously described
(p*55)*
CHART 8.1. The activating systems .
a) Erythrocyte suspension (jRBC) (Blisard and Mieyal, 1979)
0.5ml BBC with i) 0.5 ml Tris-HCl buffer (0.3.M) pH 7*6
or ii) 0.5 ml 2k mM glucose (final concentration 6 mM)
or iii) 0.5 ml 2b- mM glucose (final concentration 6 mM)
plus 20 jOl methylene blue (1 mM) - final concentration
-510 M
b) Haemolysate (Blisard and Mieyal, 1979)
0.5 ml haemolysate with
i) 0.5 ml Tris-HCl buffer (0.3M) pH 7-6
or ii) 0.5 ml NADPH-generating system
(0.01M NADP/0.1M glucose-6-phosphate) 
or iii) 0.5 ml NADPH-generating system
plus 20 fXL methylene blue (1 mM) - final concentration 
10~5M
c) Fe-thiol. (Sakurai and Ogawa, 1979)
0.5 ml cysteine (O.Am ) - final conc. 0.1M 
plus 0.5 ml Fe(Il) (O.OAm ) - final conc. 0.01M
d) Udenfriend system. (Mailing, 1966; Symms and Juchau, 197^5
Udenfriend, 195^)
0.05 ml Fe(ll) (O.OAM) - final conc. 1 mM
0.1 ml EDTA (O.OAM) - final conc. 2 mM
0.25 ml ascorbate (0.08m ) - final conc. 10 mM
plus i) 0.6 ml Tris-HCl buffer (0.3M) pH 6.0 or 7*6
or ii) 0.25 ml O.OOSM FMN-final conc. 1mM, and
0.35 ml Tris-HCl buffer (0.3M) pH 6.0 or 7*6
e) Haemoglobin (Hb) (Jonen, Kahl and Kahl, 1976; Mieyal et. al, 1976;
Symms and Juchau, 197^ -)
0.5 ml Hb suspensions (5 mg/ml) with 
i) 0.5 ml Tris-HCl buffer (O.3M) pH 6.0 or 7*6 
or ii) 0.05 ml FMN (O.OOSM) - final conc. 0.2 mM and
0A3 ml Tris-HCl buffer (0.3 M) pH 6.0 or 7*6
or iii) 0.05 ml ascorbate (0.08m ) - final conc. 2mM and
CHART 8.1. (continued)
O.A3 ml Tris-HCl buffer (0.3M) pH 6.0 or 7 
or iv) 0.02 ml methylene blue (1 mM) - final conc 
10~5M and 0.02 ml Tris-HCl buffer (0.3 M) 
pH 6.0/7.6.
Similarly, minor alterations v/ere made to the assay conditions 
for dimethylnitrosamine demethylation, so these consisted of:-
Tris-HCl buffer (0.3M), pH 6.0 or'pH 7-6 0.3 ml
Semicarbazide HC1 (2%), neutralised 0.2 ml
Dimethylnitrosamine (0.03 M in distilled water) 0.3 ml
Actuating system 1.0 ml
TOTAL 2.2 ml
This v/as incubated for 60 min at 37°C and the reaction v/as 
terminated and assayed for formaldehyde as previously described 
(p A5). V/here any variations in the above procedures have been 
used, these are indicated ‘in the results.
Mutagenicity assays: The Ames test v/as also adapted to incorporate
the various haemoglobin- and iron-based activating systems, using 
Salmonella typhimurium strain TA 100 and various concentrations 
of carcinogen (either dimethylnitrosamine dissolved in distilled 
water or 2-acetyl^aminofluorene dissolved in DMSO), using the 
preincubation variant (see p. 63). The viability of the bacteria 
before and after the incubation period was assessed as previously 
described. The exact composition of the incubation mixtures v/ill 
be found in the appropriate results tables.
RESULTS .
Plant and Yeast Cytochromes P-A30 •
The microsomes extracted from the Avocado pear mesocarp had
a specific cytochrome P-A50 content of 0.33 nmol/mg protein.
They v/ere found to bind several substrates, such as aniline
(Type II spectrum, K = 3*0 mM); perhydrofluorene (Type I, K = 3 0  mM)s s
and aminopyrine (Type I, K = 1.38 mM) (Mr. A. Delauney and .s
Miss T. Kingsland, personal communication). However, no binding 
or metabolism could be detected for ethylmorphine, benzphetamine 
or ethoxyresorufin even with enhanced substrate concentrations 
(results not shov/n). This was not due to a lack of reductase activity, 
and also there v/as a low, but detectable level of lauric acid 
hydroxylation (Miss T. Kingsland, personal communication) and a 
significant benzo(a)pyrene hydroxylation, v/ith a Km = 20 ^ uM and
V = 222 pmol 3~hydroxybenzo(a)pyrene/hour per nmol. P-A30
max
(Mr. A. Delauney, personal communication). It was for this 
reason that benzo(a)pyrene was chosen as the carcinogen in 
the Ames test. However, unfortunately, due to the extensive 
lipid nature of the preparation, it could not be filter 
sterilised through the usual 0.22^/0.43/a pore Millipore filters* 
and the 0.8^ul pore v/hich v/as used allowed contaminating bacteria 
to pass onto the plates and so nullify the results. Further 
investigation of the ability of Avocado pear cytochrome P-A30 to 
activate carcinogens awaits its purification from the microsomes 
in an active form.
The properties of the purified cytochrome P-AA8 from yeast, 
provided by Drs. D. J. King and M. R. Azari have been fully 
documented in a recent publication (King, Azari and V/iseman,
198A-), and have been shov/n to have several properties similar 
to the mammalian cytochrome P-AA8. However, in contrast to the 
mammalian enzyme, although it was shov/n to have a good, reconstituted 
activity in benzo(a)pyrene hydroxylase (332 pmol 3-hydroxybenzo(a)- 
pyrene/ hour per nmol. P-AA8, v/ith K = 33/J-M), no ethoxyresorufin 
O-deethylation activity could be measured in either microsomes or
purified reconstituted systems, using a wide range of both 
cytochrome and substrate concentrations, and assaying at both 
20° C and 37°C. The assay at 20°C v/as conducted as some yeast 
enzymes are not very stable at 37°C.
(Dr. M. Azari, personal communication). The results of the 
various Ames tests conducted using yeast preparations are summarised 
in Table 8.1. The main problems which were incurred were those 
related to effects on the viability of the bacteria (believed 
to be due predominantly to the presence of detergent in the 
preparations). The benzo(a)pyrene-induced preparations (i.e. nos.
3 and A) shov/ed some increase in the number of revertants in 
the presence of AO ;ug benzo(a)pyrene, although this aid not 
reach the doubling characteristically required to signify • 
a positive Ames tes't result. It does however appear that there may 
still be some contamination of inducer in these preparations which 
could contribute to the enhanced level of revertants in the 
background (DMF) plates.
Haemoglobin and Chemical Systems.
The ability of the addition of haemoglobin to microsomal 
supernatants to enhance their aniline hydroxylase activity is 
shown in Table 8.2., while it can be seen that haemoglobin 
on its own has a fairly limited activity. In addition, various 
haemoglobin- and iron-based systems were tested for their 
ability to p-hydroxylate aniline, using a further modification 
of the incubation mixture (Table 8.3). This activity v/as shown 
to be dependent on time, with a linear increase over 120 min 
(results not shown), so the activity v/as calculated at 60 min.
In addition, the ability of these various preparations to 
N-demethylate dime thy Ini trosamine v/as investigated (Table 8. A),, 
and with the erythrocyte suspension, the dependence of this activity 
on the substrate concentration v/as also investigated (Table 8.3 ). 
Before full Ames tests were carried out, the various haemoglobin- 
and chemical-based systems were tested for their effects on the
viability of the bacteria (Table 8.6). It can be seen that the 
haemoglobin-based systems only had marginal effects on bacterial 
viability, in contrast to the chemical systems, v/hich practically 
killed all the bacteria. The former were therefore investigated 
more fully, and the ability of both erythrocyte suspensions 
and haemolysates (in the presence/absence of various reducing 
agents etc) to activate'dimethylnitrosamine to mutagens was 
established using the Ames test (Table 8.7). In addition the 
abilit3r of various blood fractions to activate 2-acetylamino- 
fluorene to mutagens was tested (Table 8.8).
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TABLE 8»2«. Stimulation of microsomal aniline hydroxylation by
haemoglobin .
Each activity represents the means of duplicate assays on 
2 different microsomal supernatant fractions for each pretreatment 
group. Rats received i.p. injections of either 80 mg/kg pheno- 
barbitone or 20 mg/kg 3-methylcholanthrene daily for 3 days before 
killing. Haemoglobin (0.23 ml of 3 mg/ml suspension) replaced an 
equivalent volume of buffer in the appropriate incubations.
Preparation Aniline hydroxylase activity
nmol PAPa/min ^ nmol PAPa/min
per mg protein per nmol P-4-30
Control 0.12 0.23
Control + 0.26 0 .^ f82
haemoglobin (223%)C (208%)
Phenobarbitone 0.20 0.13
Phenobarbitone + 0.31 0.18
haemoglobin (136%) (1 -^2%)
3-methylcholanthrene 0.18 0.11
3-methylcholanthrene 0.31 0.23
+ haemoglobin (172%) (219%)
Haemoglobin alone -0.07d -
Notes a PAP = p-aminophenol
b protein content of microsomal supernatant 
c % activity in absence of haemoglobin 
d expressed per mg haemoglobin
Table 8.5. Aniline hydroxylation catalysed by haemoglobin- and
chemical-based systems.
In each case 1 ml of activating system (of composition as 
described in Chart 8.1), was substituted in the aniline hydroxylase 
assay. The results represent means of duplicate assays, carried out 
at pH 7*8 for 60 min. The concentration of haemoglobin in 
erythrocytes/haemolysates v/as approx. 1 JjIM.
Activating
system
nmol PAP/ 
min
nmol PAP/min per jxmol haemoglobin 
(tetramer)
Human erythrocytes 1.2 2.5
Erythrocytes + glucose 0.5 1.1
Erythrocytes + glucose + 
methylene blue
1.8 3.9 ..
Human haemolysate 0.5 1.0
Haemolysate + NADPH 0.5 1.0
Haemolysate + NADPH + 
methylene blue
• 3-5 6.5
Pure haemoglobin 0.2
Haemoglobin + ascorbate 2.0 52.9
Haemoglobin + FMN 0.2 kA
Haemoglobin + methylene blue 0.2 kA
nmol PAP/ 
min
nmol PAP/min per 
jUmol Fe
Udenfriend 1.3 0.7
Udenfriend + FMN 3.5 1.7
Fe-thiol nd nd
nd = not detectable
Table 8.4. Dimethylnitrosamine N-demethylation catalysed by
haemoglobin- and chemical-based systems*
In each case 1 ml of activating system (of composition as 
described in Chart 8.1), was substituted in the dimethylnitrosamine 
N-demethylase assay. The results represent means of duplicate 
assays, with a final concentration of dimethylnitrosamine in the 
incubation mixture of 0.01M and the rate calculated over 60 min.
Activating system yUmol. HCHO/min per■ yUmol
haemoglobin (tetramer)
pH = 7.8 pH = 6.0
Human erythrocytes 6.0 n.d.
Erythrocytes + glucose 5.6 n.d.
Erythrocytes + glucose + 
methylene blue
1.6 n.d.
Haemolysate 4.9 1.3
Haemolysate + NADPH 1.0 n.d.
Haemolysate + NADPH + 
methylene blue
• 0.4 n.d.
/Amol HCHO/min per yuimol Fe.
Udenfriend 6.0 4.5
Udenfriend + FMN 4.7 4.0
Fe-thiol o Co 0.8
n.d.■= not detectable
Table 8.5. Dimethylnitrosamine N-demethylase activity of goat
erythrocyte suspensions - effect of substrate concentration.
The dimethylnitrosamine N-demethylase assay was run as previously 
described for microsomes (see Chapter 7)i hut substituting a 
1 : 2 diluted erythrocyte suspension prepared from goat blood.
The results are the means of duplicate assays.
Substrate
concentration
(M)
Dimethylnitrosamine
N-demethylase
nmol HCHO/ 
min
nmol HCHO/min 
per ^ jmol haemo­
globin
0.005
0.010
0.020
0.100
0.500
1.000
n.d.
0.6
2.4
4.5 
16.8 
37.9
n.d.
1.5
6.0
11.3
42.0
95.0
Where n.d. = not detectable
Table 6.6. The effect of the haemoglobin- and chemical-based
activating systems on bacterial viability.
The activating systems were incubated with various concentrations 
of dimethylnitrosamine in a buffered system containing 100 jJI TA 100. 
Samples were removed at various time intervals and diluted to assess 
viability. Results are means of duplicate assays.
Preparation Viability (% of value in absence of 
activating system) in the presence 
of the following concentrations of 
dimethylnitrosamine
0 2500 5000 7500
pg/plate
1. 30 min. incubation 
a) Erythrocytes (goat)
0.05 ml 
0.10 ml 
0.20 ml
2. 60 min. incubation
a) Erythrocytes (human)
. 0,25 ml
b) Haemolysate
0.25 ml
c) Fe-thiol
0.25 ml
d) Udenfriend
0.25 ml
91
89
97
45
52
0 .4
22
52
67
2.4
14
72
52
1 .2
21
102
82
91
Table 6.7. Activation of dimethylnitrosamine to mutagens by 
various goat blood fractions .
Various concentrations of different blood preparations were incubated 
with dimethylnitrosamine (DMN-7,500 /Ag/plate) in the presence of 
100 pH TA100 (buffered) for 30 min. at 37°C. Results are means of 
duplicate assays.
Preparation No. revertants/plate 
in the presence of
0 jxg 7500 fig DMN
1. Buffer
2. Washed erythrocytes
a) 0.05 ml
b) 0.10 ml
c) 0.20 ml
d) 0.50 ml
3 . Haemolysate
a) 0.10 ml
b) 0.20 ml
c) O..3O ml
4. Plasma 
0.50 ml
5- Erythrocyte/plasma 
0.25/0.25 ml
6. Kaemolysate/plasma 
0.25/0.25 ml
207
210
173
173
185
297
242
236
178
183
227
198
190
224
207
333
249
316
377
321
263
192
Table 6.8. The activation of 2-acetylaminofluorene by various
goat blood fractions,
0.5 ml aliquots of the various blood fractions (or 50 • 50 
combinations of 2 fractions) were incubated at 37 C, for 30 min. 
in the presence of 100 p.1 TA100 plus 100 pi of either DMS0 or 
hOO yUg/ml solution of 2-acetylaminofiuorene (2AAF). The results 
are means of duplicate assays.
Preparation No. revertants/plate
in the presence of
0 ps hO ps 2-AAF
1. Washed erythrocytes 17^ 1o1
2. Haemolysate 166 199
3 . Plasma 193 503
A-. Erythrocyte/Plasma. 118 213
5* Haemolysate/plasma 1p0 183
DISCUSSION.
Plant and Yeast Cytochromes P-^fpO.
In many ways the plant microsomes showed similarities to
the cytochromes P-^4-8 from yeast and from 3-methylcholanthrene-
induced rat liver, with a high affinity for the 3-hydroxylation
of benzo(a)pyrene (plant - K = 20 juM, vrma;x; = 222 pmo 1/hour per
nmol P-4-50; yeast - K = 35 /uM, ^ x = 552 pmo 1/hour per nmol.
P_450). However, a noticeable difference between the mammalian
cytochrome P-*+48 and the Avocado pear and yeast cytochromes
was that only the former could deethylate ethoxyresorufin, with
no activity being detectable in the other preparations. Indeed
these tv/o activities were quite well correlated in rat hepatic
preparations (see Chapter 3)? although it v/as noted that the
aryl hydrocarbon hydroxylase activity v/as a less specific marker
for cytochrome P-V-f8 and v/as catalysed by other isoenzymes
(Guengerich et al, 19&2; Astrorn and DePierre, 1985)- The
plant microsomes were also poor at binding a range of other
xenobiotic substrates, as indicated by the high K values fors
aniline, aminopyrine and others. It should be noted, however,
that it is not always- possible to correlate the K and K valuess m
(as discussed in detail in Chapter k). Various suggestions 
have been made as to the physiolggical role of the mixed-function 
oxidase system in plant tissues (see Introduction to this chapter), 
and the low but detectable levels of lauric acid hydroxylase, 
in combination with the high levels of fatty acids in Avocado 
pears, suggests it could be involved in fatty acid metabolism. 
Progress in plant cytochrome P-^50 research has been severely 
impaired by the instability of the enzyme. Therefore, taking 
in account the inability to filter-sterilise the microsomal 
preparations for Ames testing, any real advance in.research in 
this area will av/ait the purification and stabilisation of the 
enzyme. Microsomal supernatants of other plant tissues, such 
as the Jerusalem artichoke, have been shown to hydroxylate benzo- 
(a)pyrene but this particular preparation appears to be fairly 
unique in its ability to activate benzo(a)pyrene to mutagens 
(Higashi et al, 1981).
In contrast to this, various yeast preparations have been 
shown to be able to activate carcinogens, although this depends 
021 their mixed-!unction oxidase activity, which in turn depends 
on their strain and growth phase (Callen and Philpot, 1977)•
Yeast and other fungi have been found to metabolically activate 
dimethylnitrosamine, aflatoxin B^j/j-naphthylamine (Callen and 
Philpot, 1977), 3-niethylcholanthrene, benzo(a)pyrene and a 
variety of other polycyclic aromatic hydrocarbons (Cerniglia,
Dodge and Gibson, 1982; Wackett and Gibson, 1982), and also to 
produce a range of Phase 2 metabolites. The genetically active 
products may be detected in the same cells through mitotic 
gene conversion and crossing over (Callen, 1978; Callen and 
Philpot, 1977). It has al so been suggested that yeast and other 
microorganisms (including mammalian microbial flora) may be 
'involved in both the oxidative (Haywood and Large, 1981) and 
reductive (Callen, 1978") metabolism of aromatic amines, 
depending on prevailing conditions.
Benzo(a)pyrene v/as chosen as the carcinogen in the Ames 
test, as the yeast cytochrome P-V+8 preparations had been shown 
to be efficient in the hydroxylation of this substrate, especially 
those preparations which had been induced by the presence of benzo(a)- 
pyrene in the incubation medium. The incorporation of the purified 
reconstituted yeast mixed-function'oxidase preparations in the 
Ames test initially caused problems related to bacterial killing 
(see Table 8.1), and this v/as traced to the presence of detergent 
(sodium cholate) in the preparations. This had been added during 
the purification procedure, and may not have been sufficiently 
removed. Later preparations were dialysed to avoid this problem, 
but instead led to difficulties in filter-sterilisation, as the 
proteins tended to clump together v/hen the detergent v/as removed.
The benzo(a)pyrene~induced preparation looked most promising 
with respect to activation of this substrate in the Ames test 
(Table 8.1), but the enhanced background revertant rate suggested 
that there could have been some contaminating levels of benzo(a)- 
pyrene remaining in the preparations. In the final preparation
used (no. *f on Table 8.1), a better solubilisation had been 
achieved through a long dialysis procedure and this begins 
to show some interesting trends, but in no case v/as a doubling 
of background achieved. These studies in yeast are in 
agreement with those in the rat, v/here aryl hydrocarbon 
hydroxylation does not necessarily correlate with benzo(a)- 
pyrene activation.
Haemoglobin and Chemical Systems: In agreement with the work
by Jonen, Kahl and Kahl, 1978, the addition of haemoglobin 
v/as found to stimulate the aniline hydroxylase activity of the 
microsomal supernatants (Table 8.2). It can also be noted that the 
type of induction had very little effect on this activity, which 
is probably because this reaction is catalysed equally well by 
both cytochrome P-*f50 and P-O+8 (Lu et al, 1972)* Haemoglobin 
on its ov/n had only a minimal activity, and the ability of various 
reducing systems to stimulate haemoglobin-catalysed aniline 
hydroxylation v/as also investigated (Table 8.3)? as it v/as 
believed that the reason for the low activity may have been 
because only about 25% of the purified haemoglobin would be in 
the active, reduced form. It is known that haemoglobin is 
rapidly autoxidised to methaemoglobin, probably through 
and 0^* release (Tomoaa, Yoneyama and Tsuji, 1981). It can 
be seen (Table 8.3) that ascorbate, but not FMN or methylene 
blue is able to stimulate the aniline hydroxylase activity of 
haemoglobin, and that the rate achieved by this combination 
is nearly equivalent to that catalysed by hepatic microsomal 
suspensions. The Udenfriend system v/as also able to catalyse 
this reaction at a reasonable rate and this v/as stimulated by the 
presence of FMN (Table 8.3). It appears therefore that reduction
3+of inorganic Fe , but not methaemoglobin may be catalysed by FMN, 
although a combination of FMN and NADPH has been shown to reduce 
the oxidised haem iron (Syrnms and Juchau, 197*0-■ Ascorbate, 
on the other hand, appears to be able to reduce both inorganic 
and haem ferric iron, although it cannot reduce cytochrome P-*f50 
(Omura and Sato, 196*0. It is possible, hov/ever, that the
stimulation of the haemoglobin reaction by ascorbate is not 
through reduction of the haemoprotein, but instead hydroxylation 
of aniline has occurred through the production of active oxygen 
species from either the ascorbate itself, or via autoxidation 
of the haemoglobin. No p-aminophenol v/as detectable after 
incubation of aniline with the Fe-cysteine system, even after 120 min. 
This disagreement with the results of Sakurai and Ogav/a, 1979 is 
probably because these authors used an aqueous acetone system, 
v/hich was believed to prevent OH* production, while in the 
present study, a buffered system, suitable for subsequent use 
in the Ames test was used.
The aniline hydroxylase activity of erythrocyte and haemo­
lysate suspensions v/as also measured. The results (Table 8.3 ) 
indicate that the activity of whole erythrocytes is greater than 
that of haemolysates, v/hich may be due to the latter oxidising 
more rapidly (the suspension visibly darkened), possibly,.... 
catalysed by 0^’, while the haemoglobin in intact erythrocytes 
was maintained as the reduced oxy-derivative. In agreement 
with the results of Blisard and Mieyal (1979)1 the aniline 
hydroxylase activity of erythrocytes v/as not stimulated by 
glucose alone, but v/as significantly raised if methylene blue 
v/as also present. The aniline hydroxylating capacity of the
 . . . . . . . . . . . . . .  - f
haemolysate v/as not altered by the inclusion of NADP and. 
glucose-6-phosphate in the medium, which may have been due to 
insufficient glucose-6-phosphate dehydrogenase activity. There 
is certainly a marked variation in this enzyme among human 
individuals and between animal species and strains, v/hich if 
low can lead to susceptibility to methaemoglobinaemia (Calabrese,
Moore and Ho, 1980). Methylene blue, however, notably stimulated 
the activity of the haemolysate, while its inability to raise 
the aniline hydroxylase activity of haemoglobin, suggests that it 
does not catalyse this reaction itself.
The activities of both haemoglobin-based (Mieyal et. al, 1976) 
and the iron-based systems (Sakurai and Ogawa, 1979; Udenfriend,
195*1-) have been reported to have lower pH optima. However, 
attempts to measure this activity at pH = 6.0 were unsuccessful, 
as it v/as found that known standards of p-aminophenoi could not be 
extracted from the incubation mixtures at this pH, possibly due 
to an ionized amino group preventing it from going into the ether 
phase. All the results presented in Table 8.3 are those activities 
obtained at pH 7*6. They have been calculated from the first 
60 min. of incubation, although the activity of the chemical 
systems at least continues up to 120 min (results not shown).
As Mailing, (1966) had shown the Udenfriend system capable 
of activating dirnethylnitrosamines to mutagens in Neurospora crassa, 
this carcinogen seemed to be a good starting point to investigate the 
activating ability of haemoglobin and chemical. ..systems. First of 
all, their ability to demethylate dimethylnitrosamine v/as studied 
(Table 8.*f), as this* assay is believed to be mediated via a hydroxy­
lation step when catajlysed by cytochrome P-*f-50. It can be seen in all 
cases that the activity v/as greater when the assay v/as carried out 
at pH = 7-6. This v/as most marked for the erythrocyte and haemo­
lysate suspensions, where the conditions for maximal activity were 
quite different from those for aniline hydroxylation. The rates 
of formaldehyde production v/ere decreased rather than increased by 
the presence of potential reducing systems. This v/as also true, 
to a lesser extent, for the Udenfriend system, and unlike aniline 
hydroxylation, the Fe-cyhteine system seemed to show the highest 
activity in this assay when expressed as nmol HCHO/min. However, 
further investigations revealed interference by an Fe-thiol- 
derived product v/hich reacted with'the Nash reagent to produce 
an intense absorption peak at about 3^5 am, the tail of v/hich 
interfered v/ith the absorbance of the 3 ?*f-diacetyl *? ,*f-dihydro - 
lutidine at *1-12 nrn. The true activity catalysed by this system 
v/as therefore difficult to estimate. It does however appear that 
a more potent oxidizing system is required to demethylate 
dimethylnitrosamine, v/hich may relate to the monoamine oxidase- 
type mechanism discussed in greater detail in Chapter 7-
Demethylation of dimethylnitrosamine by erythrocytes v/as studied 
in greater detail, and could be shown to be related to substrate 
concentration (Table 8.5). In this particular study, goats blood 
v/as used, and although it appears to have lower activity than 
the human blood, a strict comparison is not possible, as the assay 
conditions v/ere not identical.
Oxidation of several N,N-dialkylnitrosamines by chemical 
model systems have been investigated and several products 
v/ere formed from the diethyl- dipropyl, dibutyl- and dipentyl- 
derivatives and also N-nitrosopiperidine and N-nitrosomorpholine, 
principally catalysed by the Udenfriend system and to a lesser 
extent by the Fenton system (Hsiah et. al, 1976; Suzuki et. al,
1983 - and references therein). However, there is no known 
work on the metabolism of dimethylnitrosamine by these systems, 
and so the ability of both haemoglobin and non-haem iron systems 
to demethylate dimethylnitrosamine contrasts their published 
lack of ability to catalyse other demethylation reactions, such 
as that of ethylmorphine (Jonen, Kahl and Kahl, 1976) or amino- 
pyrine (Juchau and Syrnms, 197^ -).
Before the various haemoglobin and chemical-based systems 
were incorporated into the Ames test as activating systems, 
they were tested for their effect on bacterial viability and 
grov/th (Table 8.6). It v/as discovered that the erythrocyte 
and haemolysate suspensions prepared under the sterile conditions 
outlined in the methods did not provide a source of bacterial 
contamination, nor did they provide sufficient free histidine 
to increase the spontaneous mutation rate. Low levels of 
erythrocyte suspensions had a very limited effect of the viability 
of the Salmonella typhimurium strains, although some inhibition 
of colony growth v/as observed at 0.25 ml erythrocyte/haemolysate 
per plate, when incubated for a longer time interval (60 min).
A completely different situation v/as observed when the Udenfriend 
and Fe-eysteine systems were incorporated, as these resulted 
in a considerable reduction in bacterial viability (Table 8.6).
This v/as partidularly true of the Fe-thiol system, and did not
appear to be related to the concentration of dimethylnitrosamine
present and so v/as unlikely to be due to active metabolites formed
from the carcinogen. The bacteriocidal effect is believed to be
due to the production of active oxygen species from the chemical
systems. These may include peroxide, superoxide or hydroxyl
radicals, all of v/hich may be produced by autoxidation of ascorbate
(Arrigoni, Dipierro and Borraccino, 1981; Shikata, Obata and
2+
Tokuyama, 197o). An EDTA-Fe complex can also propagate lipid
peroxidation (Svingen et al, 1979), and the Fe-thiol complex
can produce active oxygen species (Rowley and Halliwell, 1982;
Sakurai and' Ogav/a, 1979) and initiate lipid peroxidation (Tien,
Bucher and Aust, 1982). In addition, the interaction of Fe(ll)
v/ith DNA'in the presence of can result in the production
- 2 2 J-
of hydroxyl radicals v/high may then be involved in both mutagenesis 
and toxicity (Floyd, 1981). Indeed, although Mailing (1966) v/as able 
to use the Udenfriend system to activate both dimethyl- and diethyl- 
nitrosamine to mutagens in Heurospora crassa, he also observed a 
problem v/ith toxicity. A further problem with using this system 
to metabolically activate dimethylnitrosamine to a mutagen, is 
that ascorbate in the presence of catalytic amounts of Fe(lll) 
has been shown to lower the mutagenicity of dimethylnitrosamine 
in a microsomal system, possibly through the deactivation of 
electrophilic alkylating metabolites (Guttenplan 1978). However, 
the Udenfriend system has been shown to activate diethylnitrosamine 
to alkylating intermediates (Archer and Eng, 1981).
In contrast to this, the haemoglobin-based systems do not 
release the peroxide or su.peroxide, and they have a reductase to 
transfer the electrons in 2 single electron steps (Blisard and 
Mieyal, 1979; Mieyal et_ al, 1976), v/hich probably explains their 
lack of effect on the viability of the bacteria. It v/as, therefore, 
these systems v/hich v/ere investigated further.
Some of the results achieved by incorporating various blood 
fractions in the Ames test v/ith dimethylnitrosamine as carcinogen 
are shown in Table 8.7. It can be seen that in the presence of 
0.5 ml washed goat erythrocytes, almost a doubling of the background 
v/as achieved in the presence of 7,^00 /Ug dimethylnitrosamine/plate. 
Similarly, as the quantity of haemolysate was increased, a trend 
toward activation v/as achieved. Surprisingly, the presence of plasma 
also demonstrated some activation of dimethylnitrosamine, although 
combinations of the different blood fractions diminished rather 
than enhanced the activation. Indeed when the various blood 
fractions v/ere investigated in more detail, there v/as a 
complicated dose-relationship (results not shown). Other 
preliminary studies (not shown) suggested that the activation 
of dimethylnitrosamine by haemolysate was not affected by the 
presence/absence of NADPH or FMN, although a slight stimulation 
was achieved by the presence of ascorbate, v/hich v/as in contrast to the 
effects on dimethylnitrosamine Ii-demethylation.
It has been suggested that erythrocytes could be the site 
of activation of aromatic amines (Golly and Hlavica, 19S3) and 
indeed reductive metabolism of N-hydroxy-2-aminofluorene by red 
blood corpuscles has been demonstrated (Eyer and Lierheimer,
1980). It is for this reason that some preliminary studies 
on the activation of 2-acetylaminofluorene by the various 
blood fractions have been carried out (Table 8.8 ). The plasma 
showed the greatest ability to enhance the number of revertants 
in the presence of 2-acetylaminofluorene, suggesting some 
activation, and it v/as also able to stimulate the activation 
of this carcinogen . by the erythrocyte preparation, suggesting 
that whole blood could be involved in metabolic activation.
The presence of added acetate did not enhance/decrease the 
activation of 2-acetylaminofluorene by these fractions (results 
not shown).
Model systems should simulate as closely as possible, the 
enzymic activation process for oxygen and the nature of the active 
oxygen species produced. The problem^that oxygen can be activated 
in a number of different ways, providing a large number of 
different.hydroxylating systems. In true mono-oxygenase stoi­
chiometry, all the oxygen incorporated in the substrate must 
originate from 0^, which needs to be activated by two electrons.
This active oxygen may then attack aromatic compounds in 
electron-rich positions, forming epoxides across double-bonds 
and subsequent migration of substituents. Aliphatic compounds
are best hydroxylated at tertiary -CH bonds. The oxygenated 
-iron intermediates of cytochrome P-k50, involved in its metabolic 
cycle are still the subject of considerable research (see 
reviews by Bonnett, 1981 and Sligar, Gelb and Heimbrook,
198k for current situation), although an oxenoid derivative 
is believed to be involved at some point, arising from 
polarization of the bonding between the oxygen atoms induced
3+
by the Fe . Therefore a model for cytochrome P-k30 should also form an
oxenoid species through tv/o electron reduction of 0^. It appears that
the main mechanism of the Udenfriend system is electrophilic
substitution by OH*, although there must be another hydroxylating
mechanism as it gives a different range of products to the Fenton
(Fe^V^C^) system (Sak'urai and Ogawa, 1979)* However, the 
2+
Fe /cysteine system is believed to be a good P-k50-rnodel in that 
the oxenoid derivative is formed at the right orientation (Smith,
Gaunt and Buzic, 1983)5 and this may also reflect the importance 
of the thiolate ligand of the P~k50 haem iron (Dawson, Anderson 
and Sono, 1982; Hahn et al, 1932). Other haemoproteins (including 
myoglobin and haemoglobin), v/hich have different 3th haem ligands, 
have different electron density and spin states of the iron, 
which can affect oxygen activation (Sono and Dawson, 1982). In 
addition to this, substrate binding position and its activation 
also affect metabolism, and so these v/ill vary according to the 
isoenzyme of cytochrome P-k30 (Bush and Trager, 1982; Sligar,
Gelb and Heimbrook, 198k). There have been several different
steps suggested in the chemical rearrangement around oxy-iron- 
substrate complex after the second reduction step of the P-k30 
cycle (e.g. Bonnett, 1981; MadDonald _et al, 1982; Smith and Sleath, 
1982) and similarly various metal-oxygen complexes, behaving like 
oxy-radicals or oxenoid intermediates have been suggested in the
various Fe(IIl) systems (Smith et. al, 1977)*
Cytochrome P-k^O-catalysed reactions may also be supported 
by peroxide or iodosobenzene, where the mechanisms are different 
from those supported by 02/NADPH (Heimbrook and Sligar, 1981).
In addition, hydroxylation by a haemin-based system may also be 
supported by either O^/NAfPH (Adams and Berman, 1982) or by 
peroxide (Adams et al, 1982), and furthermore, peroxide can 
support metmyoglobin-catalysed N-demethylation of aminopyrine 
(Griffin e_t al, 1980). The whole*'area becomes even more 
complicated, as some believe that the hydroxylation of aniline
and some other aromatic compounds and possibly ethanol may
be due to OH* resulting from the autoxidation of the oxy-cyto- 
chrome P-k^O complex (Ingelman-Sundberg and Ekstrom, 1982).
In addition, an alternative radical-intermediate pathway 
has been postulated for some demethylation reactions (Griffin 
et al, 1980), but this has been rejected by others (Kedderis 
et al, 1983).
These studies on haemoglobin- and chemical systems thus 
have a dual role, both in comparison v/ith cytochrome P~k30 
mechanisms and also to find out whether these could have any 
significance in vivo.
CONCLUSIONS.
The results presented in this chapter can only be considered 
to be preliminary steps in a wide and important area, which 
deserves attention in future research. There has been presented 
evidence for cytochrome P-kk8-type enzymes present in both yeast 
(Saccharomyces cerevisiae) and plant (Persea americana), v/hich 
can metabolise benzo(a)pyrene. The yeast enzyme showed some 
ability to activate this carcinogen in the Ames test, but further 
work on the plant enzyme awaits its purification and stabilization.
It appears that haemoglobin, particularly in combination .v/ith 
the reductases normally found in erythrocytes, is able to carry 
out various mono-oxygenase activities, including aniline 
hydroxylation, and dimethylnitrosamine demethylation and possibly 
its activation to mutagens in the Ames test. This activity, in 
addition to the presence of various plasma enzymes suggests that 
blood may have a more important role in metabolism of xenobiotics 
than.has been previously envisaged.
The Udenfriend and Fe-thiol systems were also able to hydroxyla 
but caused a high level of bacterial toxicity and so could not be 
incorporated in the Ames test. Still further research is needed 
to elucidate the mechanisms of hydroxylation catalysed by 
cytochrome P-k^O, haemoglobin and the inorganic iron-based systems.
C H A P T E R
CHAPTER 9- GENERAL DISCUSSION.
Cytochromes P-450 and P-448.
Much of the work presented in this thesis, and also current 
research from other sources, has emphasised the great disparity between 
cytochromes P-450 and P-448, such that they may be considered as two 
different families of enzymes rather than just isoenzymes , Although 
the peaks in their reduced-CO difference spectra were responsible for 
their original nomenclature, this is really the most minor difference 
between them. Also, although there are many substrates which cytochromes 
P-450 and P-448 can metabolise in common, their range of substrates 
differs, with cytochrome P-450 being able to metabolise a wide range 
of xenobiotics and possibly also lipids, while cytochrome P-448 acts 
on a much narrower range, particularly of endogenous substrates such 
as steroids and the Co-2 hydroxylation of prostaglandins. Cytochrome 
P-448 also differs from cytochrome P-450 in that it can metabolise 
substrates in sterically-hindered positions, so that they are not 
readily available for Phase 2 metabolism, and instead tend to bind to 
nucleophilic molecules. It is for this reason that cytochrome P-448 
tends to activate, while cytochrome P-450 tends to detoxify various 
chemicals, as has been discussed in detail for benzo(a)pyrene ( in 
Chapter 6). This suggests that cytochrome P-448 has a different sub­
strate binding site (discussed in more detail below) and possibly a 
different mechanism of hydroxylation. This is in contrast to most 
current understanding of the definition of isoenzymes (consider,for 
example, lactate dehydrogenase), which may have different Km and Vmax 
values, but catalyse the same reaction. The species and tissue dis­
tribution of cytochromes P-450 and P-448 also differ, with the former 
being found predominantly in the liver, while P-448 is mainly extra- 
hepatic in .distribution and uniquely present in the placenta. Cytochrome 
P-448 is found in a variety of organelles, including the nuclear mem­
brane, while cytochrome P-450 is more restricted to the endoplasmic 
reticulum. Also, as discussed in Chapter 8, cytochrome P-448 activity 
is found within plants, fungi and micro-organisms and is believed to
have arisen earlier on an evolutionary scale, and related to this 
appears earlier in embryonic development (Parke, 1984). In addition 
to this, cytochromes P-450 and P-448 are under completely different 
genetic control, with diverse mechanisms of regulation and dissimilar 
mRNA's. Substrates, inhibitors and inducers all have differing effects 
on cytochromes P-450 and P-448, with the latter having a capacity for 
much larger, planar chemicals.
Structurally, cytochromes P-450 and P-448 are very different, 
and studies on nucleotide and/or amino acid sequences have shown a 
degree of homology between different cytochromes P-450, and between 
different cytochromes P-448, but little homology between cytochromes 
of the two families ( Hanui jet al, 1984 » Sogawa et al. 1984* 1985-)- 
It is perhaps not surprising that the substrate binding site of cyto­
chrome P-450 (from both rat and. rabbit) was found to be different from 
that of cytochrome P-448 from both species (as discussed more fully 
in Chapter 4 ). In more recent studies (lewis,Ioannides and Parke, 19.86), 
it has been found that substrates, inhibitors and inducers of cytochrome 
P-450 tend to be small, globular molecules, while cytochrome P-448 tends 
to deal with large, flat, planar molecule?, which must be hydrophobic.
This helps to explain why 9-hydroxyellipticine was found to be such a 
good inhibitor/inducer, and 7-ethoxyresorufin a good substrate of 
cytochrome P-448, as these are all similarly-shaped molecules (see 
Chapters 3 & 4)* Much of the original confusion between cytochromes 
P-450 and P-448 was due to the use of non-specific assays, and in 
particular, the aryl hydrocarbon hydroxylase assay. As discussed in 
Chapter 3, ethoxyresorufin O-deethylation is a far more specific and 
sensitive ass,ay for cytochrome P-448, although there is still to be 
developed a truely specific assay for cytochrome P-450, as benzphetamine 
has severe limitations. The dealkylation of pentoxyresorufin may prove 
useful in determining the activity of the phenobarbitome-induced cyto­
chrome P-450.
Cytochrome P-448 converts aromatic amines, aromatic amides, 
heterocyclic amines and polycyclic aromatic hydrocarbons to reactive 
intermediates, while cytochrome P-450 primarily deactivates these compounds.
Another difference between the two types of cytochrome is that cytochrome 
•'P-448 may be induced by very small doses of the inducing agent (ie,50 yU#/kg 
benzo(a)pyrene - see Chapter 3), while much greater quantities of inducer 
are required to affect the levels of cytochrome P-450. Also, as mentioned 
in Chapters 1 & 4, cytochrome P-448 may have a completely different 
mechanism of hydroxylation to cytochrome P-450, which may involve the 
release of active oxygen species either from the cytochrome or the red­
uctase. In this respect, it would be far more like the chemical hydroxyl- 
ating systems of Chapter 8, and..it would be interesting to investigate 
the mechanisms of these further.
The Ames Test.
Chemical carcinogens provide a major cancer risk, and so it 
is important that there is a quick and reliable and inexpensive method 
for testing for them. Both mutagenicity and carcinogenicity are believed 
to be due to some kind of DNA damage, either directly or indirectly, and 
it is for reason that the Ames test was developed as a means of testing 
for chemical carcinogens. Its advantages and disadvantages have already 
been fully discussed in Chapter 1, so just a few of these points will now 
be taken and expanded upon, in relation to results obtained in this thesis.
One major criticism of the Ames test has been that metabolism 
of the chemicals is directed almost entirely towards oxidative, Phase 1 
reactions, due to the unphysiologically high levels of NADPH/02, and the 
almost complete lack of cofactors for Phase 2 reactions. These latter 
reactions may lead to either a lowering (eg. with the polycyclic aromatic 
hydrocarbons, see full discussion in Chapter 6) or an increase (eg. with 
the aromatic amines - Chapter 5) in the toxicity and/or carcinogenicity 
of the Phase 1 metabolites. Thus a distortion of the true metabolic pro­
file is obtained, which in many cases explains the disparity between 
the results obtained from in vitro mutagenicity assays and in vivo car­
cinogenicity tests in the same range of species.
Also, for general mutagenicity testing, an S9 mix prepared 
from Aroclor-induced rats is almost always used, on the assumption that 
it is the optimum activating system. In the present studies, where a
range of aromatic amines/amides, polycyclic aromatic, hydrocarbons, and 
nitrosamines have been tested in the presence of activating systems 
from a variety of species (of both sexes), the rat has appeared con­
sistently poor at activating most carcinogens. The hamster, on the 
other hand, was generally very efficient.at activating all. groups of 
carcinogens, particularly the. nitrosamines (see. Chapter. 7)• If* however, 
the 'best’ activating system is defined as that which most closely 
matches human preparations, it can be seen that this will vary according 
to the chemical structure, and thus the enzymes Involved in the activ­
ation process. Full extrapolation from an in vitro system of this nature 
to the situation in man awaits more basic research, not only on meta­
bolism, but also on absorption and distribution, the DNA target and its 
repair, promotion and other epigenetic phenomena, and immune surveillance 
etc. Many would suggest that, at the moment at least, there are far too 
many variables to be able to quantify chemical carcinogens with in vitro 
tests. It certainly seems important to measure a range of enzyme act­
ivities within the activating system used in the Ames test, which at 
present is rarely done. Cytochrome P-448 activity can be measured specif­
ically using the ethoxyresorufin O-deet.hylation assay, and it would 
also be commendable to measure cytochrome P-450 activity and that of its 
reductase. The FAD-monooxygenase (Ziegler enzyme) and also monoamine 
oxidase activities may also be significant with nitrogen-containing 
compounds, such as aromatic amines and amides and nitrosamines (see 
Chapters 5 & 7)» as could the levels of prostaglandin endoperoxide 
synthetase in extrahepatic tissues. Epoxide hydrolase and glutathione 
transferase activities should also be known, as was mentioned with 
respect to the polycyclic aromatic hydrocarbons (Chapter 6). However, 
this type of metabolic profiling should only be a start in rationalising 
the use of activation systems in assays such as the Ames test, as many 
carcinogens are activated by multicomponent pathways, and other, less 
well-characterised enzyme systems may be involved. Finally, in relation 
to the preliminary results of Chapter 8, the blood system should be 
acknowledged as another potential organ for the activation of chemical 
carcinogens.
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Summary
2-Acetylam inofluorene, 2-aminofluorene, 4-am inobiphenyl, 2-naphthylamine, 2- 
am inoanthracene and benzidine were assayed for m utagenicity in the A m es test in 
the presence of hepatic microsomal preparations derived from m ouse, hamster, rat, 
pig and man. Prior to each mutagenicity assay all activation system s were fully  
characterized with respect to m ono-oxygenase and m ixed-function amine oxidase 
activities. All com pounds were m etabolically activated to mutagens by all activation  
systems, but with markedly different efficiencies, hamster being the only species 
which readily activated all amines. The hamster also exhibited the highest ethoxyre- 
sorufin O-deethylase and dimethylaniline V -oxidase activities.
The use of the Am es Salm onella/m icrosom e test (Am es et al., 1975) is not 
confined to the screening o f chemicals for m utagenicity but also serves as a tool to 
further our understanding of the pathways of activation o f chem ical carcinogens. 
M etabolic activation of chemicals which are not direct-acting m utagens is usually  
achieved by incorporating a hepatic m icrosomal preparation (S9 mix) derived from  
rats pretreated with Aroclor 1254, a mixture o f polychlorinated biphenyls which  
induces a wide range of m ixed-function oxidases (Alvares et al., 1973).
During the last 5 years a number of workers have reported marked species 
differences in the activation o f som e carcinogens. For exam ple preparations from  
hamster liver were more effective than preparations from rat liver in the activation of  
nitrosamines (Prival et al., 1979), 2-acetylam inofluorene and 3-m ethylcholanthrene 
(Raineri et al., 1981). Furthermore, pretreatment o f animals with various m ono­
oxygenase inducers often resulted in decreased m utagenicity of carcinogens such as
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dimethylnitrosam ine (Hutton et al., 1979), whose activation does not appear to 
involve this enzym e system (Rowland et al., 1980; Phillipson et al., 1982; M asson et 
al., 1983). W e therefore embarked on a study to evaluate the ability of liver 
preparations from various animals to activate groups of chemical carcinogens and 
com pare it to that o f human hepatic preparations.
The aromatic amines comprise an important group of bladder carcinogens in 
animals and man which are used as dye intermediates in the rubber and plastics 
industries (Radom ski, 1979; Kriek, 1974). W e have previously reported a marked 
species variation in the activation of 2-acetylam inofluorene to mutagens, the rat 
being a very poor activator (Ioannides et al., 1981). In this paper we report the 
efficiency of various laboratory animals to activate six aromatic amines to mutagens 
and com pare it to that o f man. The pig has also been included in this study as this 
animal possesses high m ixed-function am ine oxidase activity (Ziegler and M itchell, 
1972), another m icrosomal enzym e system  involved in the activation o f aromatic 
amines (Pelroy and Gandolfi, 1980).
Materials and methods
Benzidine, 2-acetylam inofluorene, 2-aminoanthracene, 2-naphthylamine, dimeth- 
ylaniline and all cofactors (Sigma Co., Poole, Dorset), 2-am inofluorene (Aldrich  
Chemical Co., Gillingham, Dorset), 4-am inobiphenyl (Phase Separations Ltd., 
Queensferry, Flintshire) and ethoxyresorufin and resorufin (Pierce Chemicals, R ock­
ford, Illinois, U .S.A .) were purchased. Benzphetam ine was a generous gift o f  
U p joh n  Co. Ltd., Kalam azoo, Michigan, U .S.A .
M ale Wistar albino rats (150 -200  g) and male albino CD1 m ice (3 5 -4 0  g) were 
obtained from the Anim al Breeding Unit, University of Surrey, and male golden  
Syrian hamsters (100 -120  g) from Wrights of Essex, Essex, Great Britain. Fresh pig 
liver was obtained from the local abattoir and was kept frozen at — 80°C. The 
human liver sam ple was from a m ale killed in a traffic accident. The sample was also 
kept at — 80°C . ■
H epatic post-m itochondrial supernatant (9000 X g  supernatant, S9 fraction) and 
m icrosom al suspension (105 000 X  g pellet resuspended) were prepared as previously  
described (Ioannides and Parke, 1975). The following determinations were carried 
out on the post-m itochondrial supernatant: benzphetam ine A-dem ethylase (Lu et al.,
1972) and m ixed-function amine oxidase using dim ethylaniline as substrate (Ziegler 
and Pettit, 1964); and on the microsomal suspension: N A D PH -cytochrom e c 
reductase (W illiams and Kamin, 1962), ethoxyresorufin O-deethylase (Burke and 
Mayer, 1974), cytochrom e P-450 (Omura and Sato, 1964); protein was determined in 
both  fractions (Lowry et al., 1951).
Activation of the aromatic amines to mutagens in the Salmonella typhimurium  
strains TA1538 and TA 100 was carried out as described by Am es (Am es et al., 
1975), but em ploying double the amount of the S9 fraction in the S9 mix, i.e. 100 jul 
per plate. A ll carcinogens were dissolved in DM SO  so that less than 100 jul was 
added to each plate. Spontaneous reversion rates were in the range 1 4 -2 0  and 
6 5 -1 2 0  per plate for TA1538 and TA100 respectively.
TABLE 1
ENZYM E ACTIVITIES OF THE PREPARATIONS U SED  IN THE M UTAGENICITY ASSAYS
Mixed function oxidases and mixed function amine oxidase were determined in all activation systems 
prior to each mutagenicity assay. This table represents only a typical set of activities.
Animal
species
TV-Oxidation of 
dimethylaniline 
(nm oles/m in  
per mg pt)
A-Demethylation 
of benzphetamine 
(nmoles H C H O / 
min per mg pt)
O-Deethylation of 
ethoxyresorufin 
(pm oles/m in  
per mg pt)
N A D PH -cyto­
chrome c 
reductase 
(nm oles/m in  
per mg pt)
Cytochrome
P-450
(nm oles/m g pt)
M ouse a 8.2-21.4 1.52 26-87 51 1.03
Hamster 17.1 2.16 269 90 1.43
Rat 12.3 4.80 46 71 0.86
Pig 16.7 0.21 44 84 0.33
Human 4.5 0.84 68 50 0.37
a Marked variations were observed in the V-oxidation of dimethylaniline and O-deethylation of etho­
xyresorufin among mice.
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Fig. 1. M etabolic activation of 2-acetylaminofluorene to mutagens in Salmonella typhimurium  strain 
TA1538. Liver microsomal preparations were isolated from the mouse (□), hamster ( a ) ,  rat (O ), pig (■) 
and man ( • ) .  Each determination was carried out in triplicate.
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Results
Prior to each mutagenicity assay all activation systems were fully characterized 
with respect to m ono-oxygenases and m ixed-function amine oxidase. A  typical set o f 
activities is shown in Table 1. The human sample exhibited the lowest m ixed-func­
tion amine oxidase while the highest levels were observed in the pig and hamster. 
The latter species also had the highest content of cytochromes P-450 while low  levels 
were always observed in the human and pig hepatic microsomes. The cytochrome 
P-450-dependent TV-demethylation of benzphetam ine was low  in the human and pig 
liver while the rat exhibited the highest activity. The cytochrom e P-448-mediated  
O-deethylation o f ethoxyresorufin was markedly higher in the hamster (5-fold) than 
in any other animal species. The rate of N A D PH -dependent reduction of cyto­
chrome c was similar in all animal species.
Hepatic preparations from all animals activated all aromatic amines but at 
markedly different rates (Figs. 1 -6 ). The rat, in contrast to the other species, had a 
very limited capacity to convert 2-acetylam inofluorene to mutagens (Fig. 1). 2- 
Am inofluorene and 2-aminoanthracene were activated by all hepatic preparations 
with similar efficiency (Figs. 2 and 3). The activation of 2-naphthylamine was 
catalysed markedly more efficiently by the hamster than any of the other species
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Fig. 2. M etabolic activation of 2-aminofluorene to mutagens in Salmonella typhimurium  strain TA1538. 
Symbols as in Fig. 1.
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Fig. 3. Metabolic activation of 2-aminoanthracene to mutagens in Salmonella typhimurium  strain TA100. 
Symbols as in Fig. 1.
(Fig. 4). W hen the m utagenicity of 4-aminobiphenyl was investigated, the pig, in 
contrast to the other animal species, had poor capacity to activate this carcinogen  
(Fig. 5). Finally, only the hamster and mouse were effective activators o f benzidine 
(Fig. 6).
Discussion
The initial m etabolism  of aromatic amines involves N - and ring hydroxylations 
and iV-acetylation (Clayson and Garner, 1976; Tanaka et al., 1981; Brouns et al.,
330
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Fig. 4. M etabolic activation of 2-naphthylamine to mutagens in Salmonella typhimurium  strain TA100. 
Symbols as in Fig. 1.
1982). Ring hydroxylation is considered to be a deactivation pathway while iV-hy- 
droxylation is recognized as the first step in the activation of aromatic amines to 
their reactive intermediates (Weisburger and Weisburger, 1973; Miller et al., 1961; 
Sakai et al., 1978; Irving, 1979). The A-hydroxy derivatives serve only as proxim ate 
carcinogens and may undergo further m etabolism  through conjugation with 
glucuronic acid and sulphate, iV-deacetylation, JV-acetylation and N , O-acyl transfer 
(Sakai et al., 1978; Schut et al., 1978; Weeks et al., 1978; Wirth and Thorgeirsson,
1981).
The activation systems em ployed in the present m utagenicity studies lack acetylase 
activity (M cCann and Ames, 1977) and generally have very lim ited phase II enzym e
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Fig. 5. Metabolic activation of 4-aminobiphenyl to mutagens in Salmonella typhimurium strain TA1538. 
Symbols as in Fig. 1.
activity (Greim et al., 1980). Therefore under the present conditions only N - and 
ring-hydroxylated products are formed; since the latter are non-m utagenic (M asson  
et al., 1983a), m utagenicity can be assumed to be due to the TV-hydroxy m etabolites. 
Furthermore, the mutagenicity o f TV-hydroxy-4-aminobiphenyl was not enhanced in 
the presence of S9 demonstrating that it cannot be converted to the ultim ate 
carcinogen. Recently, it has been demonstrated that in the case o f 2-acetylam ino- 
fluorene activation could also be mediated by rat cytosolic preparations (Forster et 
al., 1981a and b). However, in the uninduced animal efficiency o f activation was 
very poor.
 ^ The N-hydroxylation of aromatic amines may be catalysed by (a) the cytochrom e
P-450-dependent m ono-oxygenases (Gutm ann and Bell, 1977; Thorgeirsson et al.,
1973), (b) the m ixed-function amine oxidase (Ziegler and M itchell, 1972; Pelroy and 
Gandolfi, 1980) and (c) by active forms of oxygen generated during the m etabolism  
o f arachidonic and by the prostaglandin endoperoxiide synthetase enzym e system
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Fig. 6. M etabolic activation of benzidine to mutagens in Salmonella typhimurium strain TA1538. Symbols 
as in Fig. 1.
present in extrahepatic tissues (Kadlubar et al., 1982). In the present study hepatic 
m ono-oxygenases and mixed function amine oxidase were determined prior to each 
m utagenicity assay to ensure the m etabolic integrity o f each activation system. The 
activities exhibited by the human activation system were always within the upper 
range reported in recent extensive studies (Jakobsson et al., 1982).
During our initial studies we observed marked species variations in the activation  
o f 2-acetylam inofluorene to mutagens, the rat being a very poor activator (Ioannides 
et al., 1981). This is confirmed in the present study and is com patible with previous 
reports-that the rat exhibits poor TV-hydroxylase activity (Razzouk and Roberfroid,
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1982). Similarly the rat was a poor activator o f 4-am inobiphenyl and 2-naphthyla- 
mine, but readily activated 2-am inofluorene and 2-aminoanthracene. In fact the last 
two com pounds were activated to the same extent by all animal and human  
preparations. The hamster was the only animal species which readily activated
2-naphthylamine. In general the hamster was the only animal species which effec­
tively activated all the com pounds studied.
In the standard Am es test em ploying an activating system derived from the 
Aroclor 1254-pretreated rat, benzidine is a weak mutagen (Garner, 1975; M cCann et 
al., 1975). In the present study the rat and all animal species, with the exception of 
the hamster, activated this carcinogen poorly. Pretreatment of animal with m ono­
oxygenase inducers failed to enhance the m utagenicity of this carcinogen suggesting  
that the major forms of cytochrome P-450 are not involved in its activation (Tucker 
and Tang, 1979). In addition, we were unable to dem onstrate activation o f this 
carcinogen to m utagens using highly purified preparations o f the major forms of 
cytochrom e P-450 induced in the rat by administration of phenobarbital and 
/?-naphthoflavone (H. M asson, G .G. G ibson and C. Ioannides, unpublished observa­
tions). However, chronic ethanol administration, which induces a specific form of 
cytochrom e P-450 involved in the production of hydroxy radicals (Ingelm an-Sund- 
berg and Hagbjork, 1982), also enhanced the m utagenicity of benzidine in both  
hamster and rat (C.M . Steele, C.E. Phillipson and C. Ioannides, unpublished  
observations). It is possible that this ethanol-induced isozym e and cytochrom e P-450 
(K oop et al., 1982) may also catalyse the activation of benzidine.
N o  correlation could be obtained in this study between the degree o f activation of 
the aromatic amines and either m ono-oxygenase or m ixed-function am ine oxidase 
activities. This is hardly surprising since the contribution o f these two system s in  
A-hydroxylation m ay vary am ong aromatic amines. 2-Am inothracene and 2- 
am inofluorene which were extensively activated by purified m ixed-function am ine 
oxidase (Pelroy and Gandolfi, 1980) were also activated by the pig, an animal 
possessing high m ixed-function amine oxidase activity but low  m ixed-function  
oxidase activity, while in contrast 2-acetylam inofluorene and 2-naphthylam ine were 
activated by neither the purified enzyme nor the pig.
It is o f interest that the hamster, the only animal species to readily activate all 
aromatic amines studied, always exhibited the highest cytochrom e P-448 activity, as 
exem plified by the O-deethylation of ethoxyresorufin, an enzym e catalysed exclu­
sively by this isozym e o f the cytochrome (Burke and Mayer, 1975; Ioannides et al.,
1983). Experimental evidence indicates that cytochrom e P-448 m ay facilitate the 
7V-hydroxylation o f aromatic amines more readily than the phenobarbital-induced  
cytochrome P-450 (Lotlikar and Zalesky, 1975; Norm an et al., 1979; Johnson et al., 
1980; Razzouk et al., 1982). Furthermore, the hamster also possessed the highest 
dim ethylaniline A -oxidase activity, being catalysed by cytochrom e P-448 in addition  
to the m ixed-function amine oxidase (Hlavica and Hiilsmann, 1979).
In conclusion we have demonstrated that the hamster exhibits higher capacity  
than the rat and other animals to activate aromatic amines to m utagens and the use 
o f this species in routine mutagenicity studies merits further investigation.
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SUM M ARY
Pretreatment o f  hamsters with phenobarbitone, 3-methylcholanthrene and Arochlor 1254 induced the 
hepatic microsomal mixed function oxidases, yet decreased the efficiency o f  activation o f  dimethyl­
nitrosamine (DM N) to intermediates mutagenic to the Salmonella typhim urium  strain TA-100. 
Furthermore, no correlation was obtained between cytochrome P-450 content, microsomal demethy- 
lation o f  DM N and its activation to mutagens. These results indicate that the demethylation o f DM N by 
the mixed-function oxidases is not the rate-limiting step in the metabolic activation o f  the carcinogen to 
mutagen(s), and that other microsomal or soluble enzymes may be involved.
INTRODUCTION
Nitrosam ines are potent carcinogens, inducing malignant tum ours in all animal 
species studied, and in m ost organs and tissues [1]. They require m etabolic 
activation to the ultim ate carcinogen(s), which interact(s) with cellular D N A . The 
bioactivation o f  D M N , the simplest member o f  this series, is considered to involve 
oxidative dem ethylation to the m onom ethyl nitrosam ine, which is unstable and 
breaks down to the m ethyldiazonium  ion, and eventually to the carbonium  ion  
which alkylates the D N A  [2]. The DM N-dem ethylase is associated with the 
m icrosom al fraction o f  the liver, and may be a cytochrom e P-450-dependent m ono­
oxygenase as it requires O2 and N A D P H  and is inhibited by CO [3]. H epatic 
cytochrom e P-450 exists in multiple form s, differing in structure, and substrate and 
product specificity [4], and evidence is accum ulating that these form s may play 
contrasting roles in the m etabolism  o f  carcinogens, som e directing m etabolism  
towards activation and others directing towards deactivation [5, 6].
Abbreviation: DM N, dimethylnitrosamine.
0378-4274/82/0000-0000/$02.75 ©  Elsevier Biomedical Press
96
Alternatively, it has been suggested that D M N  is activated by N -oxidation  [7] and 
m ay involve m onoam ine oxidase activity [8]. The present paper exam ines the role o f  
different cytochrom es P-450 o f  hamster liver in the m etabolic activation o f  D M N  to  
m utagens. The hamster was chosen as, unlike the rat, liver m icrosom al preparations 
from  this species readily m etabolise D M N  to m utagens, as determined by the Am es 
test [9].
M ATERIALS A N D  M ETHODS
D M N  (Ralph Em m anuel L td., W em bley, U .K .), 3-m ethylcholanthrene and 
enzym e cofactors (Sigm a, P oole , Dorset, U .K .), phenobarbital and organic solvents 
(BDH,. P oo le , D orset, U .K .), and ethoxyresorufin (Pierce Chem icals, R ockford, 
IL, U .S .A .) were purchased. A roclor 1254 was a gift o f  M onsanto Chemical C o., 
St. Louis, M I, U .S .A .
M ale G olden Syrian hamsters (1 0 0 -1 2 0  g) (Anim al Breeding U nit, University o f  
Surrey) were used. Induction o f  the liver m icrosom al enzym es was achieved by 
intraperitoneal adm inistration o f  either phenobarbitone (80 m g/k g),
3-m ethylcholanthrene (20 m g/k g) or A roclor 1254 (500 m g/k g) daily for 3 days. 
A nim als were killed 24 h after the last adm inistration.
The m icrosom al supernatant (9000 x  g  supernatant) and m icrosom al suspension  
(105000 x  g  pellet) were prepared as previously described [10]. DM N-dem ethylase  
activity was determined in the m icrosom al supernatant, at various substrate concen­
trations (2 -1 0 0  mM) by an adaptation o f  the m ethod described for ethylmorphine 
[11]. The follow ing determinations o f  enzym ic activities were carried out using the 
m icrosom al suspension: ethoxyresorufin O -deethylation [12], N A D PH -cytochrom e  
c  reductase [13], and cytochrom e P-450 [14]. M icrosom al protein content was deter­
m ined by the m ethod o f  Lowry [15]. A ctivation o f  D M N  to m utagens was deter­
m ined using the Am es test [16] but with double the am ount o f  S9 supernatant in the 
S9 m ix, i.e . 100 /d per plate.
RESULTS
A s expected, pretreatment with the different inducing agents resulted in an 
increase in the hepatic concentrations o f  cytochrom e P-450 (Table I). Ethoxy­
resorufin O-deethylation, a reaction catalysed by cytochrom e P-488 [17], was unaf­
fected by phenobarbitone pretreatment but was increased markedly follow ing  
adm inistration o f  3-m ethylcholanthrene and Aroclor 1254 (which induces both  
cytochrom e P-450 and cytochrom e P-448 activities). The N A D PH -dependent 
reduction o f  cytochrom e c  was stim ulated only by phenobarbitone and A roclor pre­
treatment.
Rat and m ouse hepatic D M N-dem ethylase, believed to catalyse the initial step in 
the bioactivation o f  D M N , exhibits different characteristics depending on substrate
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TABLE I
HAM STER LIVER M IXED FUNCTION O XID ASE ACTIVITIES FOLLOW ING PRETREATM ENT  
WITH VARIOUS INDUCING AGENTS
Treatment Ethoxyresorufin O- 
deethylase
(nm ol/m in/m g protein)
NADPH -cytochrom e 
c  reductase
(nm ol/m in /m g protein)
Cytochrome P-450 
(nm ol/m g protein)
Control 0.32 44 0.61
Phenobarbitone 0.26 63 1.29
3-Methylcholanthrene 1.99 45 1.53
Aroclor 1254 0.72 80 2.16
5  1 0  2 0
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Fig. 1. Liver microsomal DM N-demethylase activity o f  hamsters pretreated with various microsomal 
enzyme inducing agents: effect o f  substrate concentration. DM N-demethylase was determined in liver
microsomal supernatant preparations from untreated male hamsters ( • -----------------• ) ,  or from hamsters
pretreated with phenobarbitone ( ■ -----------------■ ) ,  3-methylcholanthrene (o----------------- o ), or Aroclor
( □ ---------- □ ) .  Results are expressed as (A) nmol HCHO form ed/m in/m g protein, and (B) nmol HCH O
form ed/m in/nm ol per cytochrome P-450.
concentrations (3, 18). DM N -dem ethylase I activity predom inates at low  substrate 
concentrations [ <  50 mM] and is inhibited by pretreatment o f  animals with m ixed- 
function oxidase inducers, while DM N-dem ethylase II activity predom inates at high  
substrate concentrations and the activity is increased follow ing pretreatment with  
mixed function oxidase inducers.
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Fig. 2. Activation o f  D M N  to mutagen(s) by liver microsomal preparations o f  hamsters pretreated with 
various microsomal inducing agents. Activation o f  DM N was determined by the increase in number o f  
revertants o f  Salmonella typhim urium  TA-100 in the Ames test using liver microsomal supernatants (S9
mix, 100 /xl/plate) from control male hamsters ( • ---------- • ) ,  or from hamsters pretreated with
phenobaribone ( ■ ---------- ■ ) ,  3-methylcholanthrene (o------------- o ), or Aroclor ( □ ---------- □ ) .  Results are
expressed as (A) number o f  revertants per plate, and (B) number o f  revertants/nmol o f  cytochrome P-450  
per plate.
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The present study shows that a similar situation exists in the hamster. A t low  
D M N  concentrations (2 m M ), pretreatment with the enzym e inducing agents led to  
inhibition o f  D M N -dem ethylase (type I), the effect being m ore pronounced with
3-m ethylcholanthrene and A roclor 1254, while at high substrate concentrations (100 
mM) all pretreatments increased D M N-dem ethylase activity (type II) (Fig. la ). 
H owever when D M N-dem ethylase is expressed per nm ol o f  cytochrom e P-450, all 
pretrehtments gave rise to inhibition o f  enzym e activity (Fig. lb ) indicating that 
D M N  dem ethylase activity may be associated preferentially with a specific form  o f  
cytochrom e P-450, which is not induced by any o f  the agents used.
Pretreatments o f  the hamsters with phenobarbitone, 3-m ethylcholanthrene or 
A roclor 1254 did not significantly alter the capacity o f  liver m icrosom es to activate 
D M N  to mutagenic interm ediates, as measured by the A m es’ test (Fig. 2a). 
However, when m utagenicity is expressed as the number o f  revertants/nm ol P-450, 
the liver m icrosom al preparations from  induced animals are far less effective  
activators o f  D M N  than are the preparations from control animals (Fig. 2b).
DISCUSSION
Studies using reconstituted systems o f  purified form s o f  cytochrom e P-450 isola­
ted from  livers o f  rats or rabbits, untreated or treated with phenobarbitone or
3-m ethylcholanthrene, have shown that cytochrom e P-450 can m etabolically  
dem ethylate D M N , the preparations from  the phenobarbitone-treated animals 
being the m ost efficient [3].
The role o f  two form s o f  the cytochrom e, namely P-450 and P-448, in the 
activation o f  D M N  to m utagens has now been investigated using hamster liver pre­
parations. Hamster liver was chosen, as rat liver preparations do not activate D M N  
to m utagens in the standard Am es system . G ood correlations have been reported  
between the tissue activities o f  DM N-dem ethylase and the ability to convert D M N  to  
mutagens [3, 19], and also between human liver cytochrom e P-450 content and the 
ability to generate m utagens [20]. The effects o f  enzym e-inducing agents in the 
present study show that they have little effect on hamster liver D M N -dem ethylase 
activity (Fig. lb ) or on the activation o f  D M N  to m utagens (Fig. 2a). The lack o f  
dependence o f  the activation o f  DM N on the concentration o f  cytochrom e P-450  
(Fig. 2a and b) is in contrast to observations with other carcinogens such as 
benzo(a)pyrene [5, 6]. In the present m utagenicity studies the D M N  concentrations 
(3 .7 5 -3 7 .5  mM) were well below 50 m M , i.e. were at the level where D M N - 
dem ethylase I predom inates. Lack o f  correlation between D M N  m etabolism  and 
m utagenesis has been reported by other workers [21].
The present observations indicate that (a) D M N  dem ethylase is not a typical 
m ixed-function oxidase enzyme; (b) D M N  dem ethylation is either not the rate- 
limiting step, or is not involved, in the m etabolic activation o f  D M N  to m utagens. 
Other m icrosom al or soluble enzymes may participate in the activation process o f
D M N  leading to the form ation o f  D N A  alkylating species. Indeed a large volum e o f  
experim ental evidence has accum ulated im plicating the involvem ent Of an N- 
oxidative step [7]. Furthermore, m onoam ine oxidase inhibitors have been shown  
to  inhibit the m utagenicity o f  D M N  but had no effects on the m utagenicity o f  
benzo(a)pyrene or aflatoxin  Bi [8].
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Studies on the substrate-binding sites of liver microsomal cytochrome P-448
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The interaction of substrates of the microsomal mixed-function oxidases with cyto­
chromes P-450 and P-448 was investigated by using liver microsomes from rats pre­
treated with phenobarbital or 3-methylcholanthrene, and with purified forms of the 
cytochromes isolated from rabbit liver. The two forms of the cytochrome have different 
substrate specificities; cytochrome P-450 has one type 1 substrate-binding site that can 
accommodate a large variety of substrates, but in contrast cytochrome P-448 may 
possess two type 1 substrate-binding sites, one of which is different to that of cyto­
chrome P-450 in that it shows a specificity for substrates such as safrole and 9-hydroxy- 
ellipticine. These findings explain why the two forms of the cytochrome have different 
substrate specificities and play contrasting roles in the activation and deactivation 
of xenobiotics.
The microsomal mixed-function oxidase system, 
which is involved in the detoxification and activation 
of exogenous chemicals, and in the turnover of many 
endogenous materials, is comprised essentially of 
three components, namely, cytochrome P-450, the 
flavoprotein cytochrome P-450 reductase and the 
membrane lipid electron coupler phosphatidylchol­
ine. Purified cytochrome P-450 and its reductase 
exist in several forms, and the isoenzymes of cyto­
chrome P-450 may be induced selectively by various 
substrates (Guengerich, 1979). One such form, 
namely cytochrome P-448, is preferentially induced 
by chemical carcinogens, and differs from the native 
cytochrome P-450 in its spectral, electrophoretic 
and immunological properties, amino acid composi­
tion and substrate and reaction specificity (Haugen 
et ah, 1975; Thomas et al., 1976a). Perhaps most 
important, cytochrome P-448 is able to effect 
oxygenation of molecules in sterically-hindered posi­
tions, a reaction not catalysed by other isoenzymes 
of cytochrome P-450 (Jerina & Daly, 1974; Levin 
et al., 1977). For example, cytochrome P-448, but 
not cytochrome P-450, catalyses the 2-hydroxylation 
of biphenyl, O-de-ethylation of ethoxyresorufin and 
the 9,10-epoxidation of benzo[a]pyrene (Creaven & 
Parke, 1966; Burke & Mayer, 1975; Levin et al.,
1977). Different forms of the cytochrome therefore
* Present address: Laboratoire de Chimie de l’Ecole 
Normale Superieure, 24 rue Lhomond, 75231 Paris- 
Cedex-05, France.
tend to play contrasting roles in the metabolism of 
toxic chemicals, cytochrome P-450 directing metab­
olism towards detoxification, whereas cytochrome 
P-448 promotes activation to electrophiles and 
mutagens (Ioannides & Parke, 1980). The activation 
of benzolalpyrene (Ioannides et al., 1981) and 
tryptophan pyrolysis products (Nebert et al., 1979) 
to mutagens, and the activation of paracetamol to 
covalently-bound intermediates (C. Ioannides, C. 
Steele & D. V. Parke, unpublished work) are all 
catalysed most readily by cytochrome P-448.
Recognition that cytochrome P-448, unlike cyto­
chrome P-450, may oxygenate substrates at steric- 
ally hindered positions, and that induced cyto­
chrome P-448 may contain traces of the inducing 
agent or its metabolite (Schenkman et al., 1969) has 
led to speculations concerning the substrate-binding 
site of cytochrome P-448 and the mechanism of 
oxygenation. Three major alternatives are possible, 
namely; (i) that the type 1 substrate-binding site of 
cytochrome P-448 is much larger than that of cyto­
chrome P-450; (ii) possibly because of bound induc­
ing agent, cytochrome P-448 is not able to accept 
another carbon substrate but activates 0 2 to 
superoxide or peroxide, which then hydroxylates 
the carbon substrate non-enzymically; or (iii) the 
cytochrome and reductase become decoupled and 
the reductase catalyses the oxygenation of the sub­
strate. The first of these possibilities is now investi­
gated, by means of spectral interaction studies of 
the cytochromes with different classes o f substrates, 
and by the effects of inhibitors.
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Materials and methods
Phenobarbital, hexobarbital, aniline hydrochloride 
(BDH Chemicals, Poole, Dorset, U.K.), 3-methyl­
cholanthrene (Sigma, Poole, Dorset, U.K.), per- 
hydrofluorene, 1-phenylhexane (Aldrich Chemical 
Co., Milwaukee, WI, U.S.A.), safrole (Hopkin and 
Williams, Chadwell Heath, Essex, U.K.) and pento­
barbital (May and Baker, Dagenham, Essex, U.K.) 
were all purchased from the respective suppliers. 
9-Hydroxyellipticine and benzphetamine were gifts 
from P. Lesca Laboratoire de Pharmacologie et de 
Toxicologie Fondamental du CNRS, Toulouse, 
France, and Upjohn Co., Kalamazoo, MI, U.S.A., 
respectively.
Male Wistar albino rats (170-200 g) from the 
Animal Breeding Unit, University of Surrey, were 
used in all experiments. Induction of the mixed- 
function oxidases was achieved by intraperitoneal 
administration of either phenobarbital (80 mg/kg 
body wt.) or 3-methylcholanthrene (20 mg/kg body 
wt.) for 3 days. 9-Hydroxyellipticine was admini­
stered intraperitoneally (20 mg/kg body wt.) lh  
before killing. Animals were killed 24 h after the last 
administration of the inducer, and the livers were 
immediately excised and washed. Microsomes were 
prepared as previously described (Ioannides & Parke, 
1975) and stored until use (Delaforge et a l ,  1980a). 
Rabbit LM2 (cytochrome P-450) and LM4 (cyto­
chrome P-448) preparations from phenobarbital- 
and /?-naphthoflavone-induced animals respectively 
were prepared as previously described (Coon et al.,
1978).
Substrate binding to cytochromes P-450 and 
P-448 with type I and type II substrates was studied 
by using a Varian Cary double-beam spectrophoto­
meter coupled with automatic base-line correction 
(Schenkman et al., 1967).
R e su lts
The type II substrate aniline (0.5-10mM) gave a 
typical type II spectrum with liver microsomal prep­
arations from both phenobarbital-induced and 3- 
methylcholanthrene-induced rats, and with LM2 and 
LM4 purified cytochromes. Similarly, the type I sub­
strates pentobarbital (l-10m M ), benzphetamine 
(0 .05-0 .10mM), hexobarbital (0.5-2.0mM), per- 
hydrofluorene (1 //l) and 1-phenylhexane (1//1) inter­
acted with the microsomal preparation from pheno­
barbital-induced rats and with the LM2 (cyto­
chrome P-450) purified cytochrome, eliciting type I 
spectra, but none of the type I substrates interacted 
with the microsomes from 3-methylcholanthrene- 
treated rats, or with the LM4 (cytochrome P-448) 
cytochrome to give a type I spectral change.
In contrast, safrole interacted with both cyto­
chromes P-450 and P-448, as well as with both puri-
0.010
0.005
Wavelength (nm)
450400
-0.005
0.005
Wavelength (nm)
A
-0.005 -
Fig. 1. In teractions o f  safrole with phenobarbita l- and  
3-m ethylcholanthrene-induced m icrosom es a n d  with L M 2 
ind L M 4 rabbit p repara tion s before a n d  a fter sa turation  
o f  the type I  substrate-b inding site  with perhydrofluorene
( a ) ---------- , Both cuvettes contained m icrosom es
from 3-methylcholanthrene-pretreated rats, but saf­
role (0.2 mM) w as only added to the test cuvette.
—  Perhydrofluorene (1 //l) and m icrosom es 
from 3-methylcholanthrene-pretreated animals were 
added to both reference and test cuvettes and safrole
(0.2 mM) in the test cu v ette . , M icrosom es from
phenobarbital-pretreated animals were added in both 
cuvettes and safrole (0.2 mM) in the test cuvette only.
 , M icrosom es from phenobarbital-pretreated
rats and perhydrofluorene (1 //I) were added in both  
cuvettes. Safrole (0 .2  mM) w as added only in the test ^
cuvette. (b)  L M 4 w as added in both cuvettes
and safrole (0.2 mM) in the test cuvette on ly .—
L M 4 and perhydrofluorene (1 //l) were added in both |
cuvettes and safrole (0.2 mM) in the test cuvette only. *
 , L M 2 w as added in both cuvettes and safrole
(0.2 mM) in the test cuvette o n ly .  , L M 2 and
perhydrofluorene (l/z l) w as added in both cuvettes 
and safrole (0.2 mM) in the test cuvette only. 
Phenobarbital-induced m icrosom es (1.2 nmol o f  
cytochrom e P -450/m l), 3-methylcholanthrene- 
induced m icrosom es (0.7 nm ol o f  cytochrom e P- 
450 /m l), L M 2 and L M 4 ( ln m o l o f  cytochrom e  
P -450 /m l) were all suspended in O.lM -phosphate 
buffer, pH  7.4.
fied rabbit cytochromes, to give typical type I 
spectral changes (Fig. 1). When perhydrofluorene 
was added to both reference and test cuvettes at
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Fig. 2. In teraction  o f  9-hvdroxyellip ticine with m icro­
som es fro m  ph enobarbita l- a n d  3-m ethylcholanthrene- 
induced ra ts a n d  with L M 2 a n d  L M 4 rabbit prepara tion s
( a ) -------- , Interaction o f  9-hydroxyellipticine (1/zm)
with m icrosom es from 3-methylcholanthrene-pre- 
treated r a t s .  , Interaction o f  9-hydroxy­
ellipticine (1 p M )  with m icrosom es from pheno-
barbitone-pretreated rats. (b) --------, Interaction o f
9-hydroxyellipticine (5 //m) with LM 4 preparation.
 , Interaction o f  9-hydroxyellipticine (5 //m)
with L M 2 preparation. M icrosom es (0.7 nmol o f  
cytochrom e P -450/m l) and solubilized preparations 
(l.O nm ol o f  cytochrom e P -450 /m l) were suspended  
> in 0.1 M-phosphate buffer, pH  7.4.
concentrations that saturate the type I binding site, 
microsomal preparations from phenobarbital- 
induced animals, or the LM2 purified cytochrome, 
showed greatly decreased type I binding spectra 
with safrole; in contrast the microsomal preparation 
from 3-methylcholanthrene-induced animals, and the 
LM4 preparation, showed little change (Fig. 1).
9-Hydroxyellipticine interacts with liver micro­
somes from both 3-methylcholanthrene- and pheno­
barbital-induced rats to give a type II spectral change 
having an asymmetric trough (Fig. 2). Similar inter­
actions were observed with purified cytochromes
+0.015
+0.010
+0.005
A
400 450
Wavelength (nm)
-0.005
- 0.010
+0.015
+ 0.010
A +0.005
400/ I 450
Wavelength (nm)
-0.005
Fig. 3. In teractions o f  9-hydroxyellip tic ine with m ic­
rosom es fro m  phenobarb ita l-induced  ra ts  an d  rabb it L M 2 
prepara tion s before an d  a fter sa tu ra tion  o f  type I  
substrate-b inding site  with benzphetam ine a n d  p erh y d ro ­
fluoren e respectively
( a ) --------, Both cuvettes contained m icrosom es from
phenobarbital-pretreated rats but 9-hydroxy­
ellipticine (5 p m ) w as added only to the test cuvette.
 , Both cuvettes contained m icrosom es from
phenobarbital-pretreated rats and benzphetam ine 
(0.1 mM), and 9-hydroxyellipticine (5pM ) w as added
only to the test cuvette. (b) --------, Both cuvettes
contained the L M 2 preparation and 9-hydroxy­
ellipticine (5//m ) w as added only to the test cuvette. 
 , Both cuvettes contained the L M 2 prep­
aration and perhydrofluorene (l/z l), but 9-hydroxy­
ellipticine (5 pm) was only added to the test cuvette. 
M icrosom es and solubilized preparations were sus­
pended in buffer as described in the legend to  Fig. 1.
P-450 (LM2) and P-448 (LM4) isolated from rabbits 
pretreated with phenobarbital and /?-naphthoflavone 
respectively (Fig. 2). Addition of the type I substrate
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Fig. 4. In teractions o f  9 -hydroxyellip ticine with m icro­
som es fro m  3-m ethylcholanthrene-induced ra ts an d  rabb it 
L M 4p repara tion s before a n d  a fter sa turation  o f  the type I  
substrate-b inding site  with safrole
(a) --------, Both cuvettes contained m icrosom es from
3-methylcholanthrene-pretreated rats, but 9-hydroxy­
ellipticine (5//m ) was added only to the test cuvette.
 , Both cuvettes contained m icrosom es from 3-
m ethylcholanthrene-pretreated rats and safrole (0 .2  mM), 
but 9-hydroxyellipticine (5 gM) w as added only to the test
cuvette. (b) ------- , Both cuvettes contained the L M 4
preparation but 9-hydroxyellipticine (5 p u )  was only
added to the test cu v e tte . , Both cuvettes contained
the L M 4 preparation and safrole (0 .2 mM) but 9-hydroxy­
ellipticine (5//m ) w as only added to the test cuvette. 
M icrosom es and solubilized preparations were suspended 
in buffer as described in the legend to  Fig. 1.
benzphetamine (0.1 mM) to both reference and test 
cuvettes to saturate the type I binding site resulted 
in an increase in the spectral interaction of 9- 
hydroxyellipticine with the liver microsomes from 
phenobarbital-induced rats, which was accompanied 
by disappearance of the asymmetry and a shift of 
the spectrum to lower wavelengths (Fig. 3); however,
30
20
-25 -20 -15 10 100 1555
1/IS] (m M )-1
50
100
50
-10 5 10 15-5 0
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Fig. 5. E ffect o f  9 -hydroxyellip ticine adm in istra tion  on 
the spectra l interaction o f  safrole with hepatic m icro­
som es fro m  ra ts p re tre a te d  with phenobarb ita l o r  3- 
m ethylcholanthrene  
(a) O ,  Phenobarbital; □ , phenobarbital +  9- 
hydroxyellipticine. (b) # ,  3-M ethylcholanthrene; ■ ,  
3-m ethylcholanthrene +  9-hydroxyellipticine. M icro­
som es were suspended ( lm g  o f  protein/m l) in 
0.1 M-phosphate buffer, pH  7.4.
no similar changes in the spectra were seen when 
microsomes form the 3-methylcholanthrene-pre- 
treated rats were used. When the solubilized cyto­
chromes from LM2 and LM4 preparations, isolated 
from rabbit liver, were used, similar results were 
obtained; perhydrofluorene augmented the 9- 
hydroxyellipticine spectrum, eliminated the asym­
metry and shifted the spectrum with LM2 but not 
with LM4 (Fig. 3).
In contrast, when safrole (0.2 mM) instead of 
perhydrofluorene was added to both test and refer­
ence cuvettes, there was an increase in the spectral 
interaction of 9-hydroxyellipticine, a shift to lower 
wavelengths and loss of spectral asymmetry, with 
the liver microsomes from 3-methylcholanthrene- 
induced rats (Fig. 4), but this time no similar effect 
was seen with microsomes from phenobarbital-pre­
treated animals. With the purified rabbit hepatic 
LM2 and LM4 preparations, similar results were 
obtained.
Administration of 9-hydroxyellipticine 1 h before 
killing the animals resulted in competitive inhibition 
of the binding of safrole to the microsomes from 
3-methylcholanthrene-induced rats but had very
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little effect on the binding to the microsomes from 
phenobarbital-induced animals (Fig. 5).
D isc u ss io n
In the present study we examined the binding of 
\  various substrates to rat and rabbit liver cyto-
* chromes P-450 and P-448. Type I substrates hexo­
barbital, benzphetamine, pentobarbital, perhydro- 
> fluorene and 1-phenylhexane gave the expected type
f I spectral interactions with rat and rabbit cyto­
chrome P-450, but none elicited any spectral inter­
action with cytochrome P-448. The decrease or 
absence of type I spectral changes with cytochrome 
P-448 have been reported by a number of workers 
(Schenkman et a l ,  1969; Remmer et a l ,  1969; 
Shoeman et a l ,  1969). These observations indicate 
that either cytochrome P-448 has no typical type I 
binding site or the binding site is occupied by the 
inducing chemical and/or a metabolite. The binding 
to cytochrome P-448 of radioactivity associated 
with the inducing chemical (3-methylcholanthrene) 
lends support to the latter possibility (Schenkman 
et a l ,  1969; Jefcoate & Gaylor, 1969). However, 
the binding of some product of the inducer at an 
allosteric site, preventing the interaction of type I 
substrates, cannot be excluded.
In contrast, safrole interacts with both cyto­
chrome P-450 and P-448, yielding typical type I 
spectral changes (Fig. 1), indicating that safrole 
binds to a type I site of cytochrome P-448 to which 
other type I substrates do not bind, or that safrole 
can displace the inducer or its metabolite bound on 
the normal type I site of this cytochrome. The latter 
possibility is unlikely, as safrole does not have a 
high affinity for cytochrome P-448 (&s =  0.13mM; 
Delaforge et a l ,  19806). Furthermore, when the 
type I site is blocked with perhydrofluorene, safrole 
elicits an unchanged type I spectrum with cyto- 
r  chrome P-448, whereas the spectral change with 
cytochrome P-450 is greatly decreased by perhydro- 
T. fluorene (Fig. 1). This indicates that the type I site of
\ cytochrome P-450 accommodates safrole and other
type I substrates, whereas cytochrome P-448 prob­
ably has two distinct and independent ‘type I’ bind­
ing sites, one of which interacts preferentially with 
safrole.
9-Hydroxyellipticine, a potent inhibitor of cyto­
chrome P-448 (Delaforge et al., 1980a), interacts 
with both cytochrome P-450 and P-448 to give type 
II spectral changes (Fig. 2) (Lesca et a l ,  1978; 
Sautereau & Lesca, 1979). The asymmetry of these 
spectra, as in the case of aniline (Schenkman, 1970), 
disappeared and the spectrum shifted to lower wave­
lengths when the type I binding site was blocked 
(Figs. 2 and 3), indicating that the spectrum of 9- 
hydroxyellipticine has a type I component. 9- 
Hydroxyellipticine is displaced by benzphetamine or
perhydrofluorene from the type I site of cytochrome 
P-450 (Fig. 3), but no displacement occurs with 
cytochrome P-448 (result not shown). In contrast, 
safrole displaces 9-hydroxyellipticine from cyto­
chrome P-448 with loss of spectral asymmetry (Fig. 
4), but not from cytochrome P-450 (result 
not shown), thus providing further evidence that 
cytochrome P-448 has a type I binding site, but 
different from that of cytochrome P-450, the former 
being shared by safrole and 9-hydroxyellipticine. 
Administration of 9-hydroxyellipticine to rats inhi­
bited competitively the binding of safrole to cyto­
chrome P-448, confirming that these two compounds 
interact with the same type I binding site of cyto­
chrome P-448 (Fig. 5). However, 9-hydroxyellipticine 
administered to phenobarbital-pretreated animals 
had little effect on the binding of safrole to cyto­
chrome P-450 (Fig. 5), which does not accord fully 
with 9-hydroxyellipticine and safrole, together with 
other substrates, binding at the same type I site of 
cytochrome P-450. This may be due to the poor 
affinity of 9-hydroxyellipticine for cytochrome P-450 
(Delaforge et a l ,  1980a) as 9-hydroxyellipticine 
(10//m ) inhibited competitively the type I interaction 
of safrole with cytochrome P-450 in vitro (M. 
Delaforge, C. Ioannides & D. V. Parke, unpublished 
work).
Previous studies demonstrated that cytochromes 
P-450 from rat and rabbit have different properties 
(Thomas et a l ,  19766). In the present study the 
rabbit solubilized preparations and the crude micro­
somal preparations from induced rats exhibited the 
same specificity towards the various compounds 
investigated, indicating that the rabbit and rat forms 
of the cytochrome may have similar substrate-bind­
ing sites. The observations presented here indicate 
that the different substrate specificities of cyto­
chromes P-450 and P-448 may be due, at least 
partly, to the presence of different type I binding 
sites. It appears that cytochrome P-450 has only one 
type I substrate-binding site, which can accommo­
date various substrates of different chemical struc­
ture and molecular dimensions. However, with cyto­
chrome P-448 this substrate binding site is either 
absent or occupied by the inducing agent or its 
metabolite, but a second type I substrate-binding 
site, distinct from that of cytochrome P-450, is also 
present. Possibly the binding of the inducing agent, 
or its metabolite, to cytochrome P-450 produces 
a conformational change in the normal type I site so 
that its substrate specificity and site of substrate 
oxygenation are changed to that characteristic of 
cytochrome P-448.
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Abstract— 1. The O -deethylation o f ethoxyresorufin and the m etabolic activation of benzo[a]pyrene to 
m utagens were determ ined in hepatic microsomal preparations from control and induced animals.
2. A n excellent direct correlation (r =  0.95) has been observed betw een ethoxyresorufin O -deethylase 
and the m etabolic activation o f benzo[a]pyrene to mutagens when the fraction o f cytochrom es P-450 pre­
sent as cytochrom e P-448 was altered by the administration o f phenobarbitone and 3-methylcholanthrene 
alone or in com bination with 9-hydroxyellipticine.
3. The correlation between these activities was maintained follow ing treatment o f animals with 
Arochlor 1254, benzo[a]pyrene, benzo[e]pyrene, 7,12-dim ethylbenzo[a]anthracene, 2-anthramine and 2- 
naphthylamine.
INTRODUCTION
It is now well-known that many toxic chemicals are 
metabolically converted into reactive species by the 
action of the microsomal mixed function oxidases 
(Ioannides and Parke, 1980). This enzyme system 
requires oxygen and reduced NADP and comprises 
cytochrome P-450 reductase and the haemoprotein 
cytochrome P-450 which acts as the terminal 
oxygenase. Cytochrome P-450 exists in many forms 
or isoenzymes which differ from each other in struc­
ture, physicochemical and immunological proper­
ties, substrate specificity, and in their reaction 
mechanisms and kinetics (Guengerich et al., 1982; 
Phillipson etal., 1982). A  closely related microsomal 
cytochrome but a different enzyme (Ioannides et al. , 
1984), namely, cytochrome P-448, is preferentially 
induced by many carcinogens and is also involved in 
their activation (Levin et al., 1977; Ioannides et al., 
1981), as well as in the activation of certain drugs such 
as paracetamol to reactive intermediates responsible 
for their toxicity (Ioannides et al. , 1983; Steele et al. , 
1983). In contrast, the phenobarbital-induced form 
of the haemoprotein (cytochrome P-450) directs 
metabolism primarily towards detoxication (Ioan­
nides and Parke, 1980). It is thus evident that the 
response of a tissue to a toxic chemical may be influ­
enced, not only by the amount of cytochrome it con­
tains, but also by the nature of the cytochromes pre­
sent, and it is imperative that techniques are availa­
ble, capable of determining individual forms of the 
cytochromes in the presence of others in biological 
tissues.
The existence of various forms of cytochrome 
P-450 and P-448 in different tissues has been 
unequivocally demonstrated by isolating and purify­
ing these to homogeneity (Guengerich et al., 1982). 
This is a long and cumbersome procedure with poor
* Author to whom correspondence should be addressed.
yields which does not allow the typing of the different 
cytochrome forms in individual animals. In most 
cases the amounts of a particular form of the cyto­
chrome were markedly increased by prior treatment 
of the animals with a specific inducer. Isolation of the 
microsomal cytochromes from untreated animals has 
proved more problematic. The isolation procedure is 
also likely to prove difficult when studying 
extrahepatic tissues having low contents of micro­
somal cytochromes. Another approach has been to 
characterize these forms in crude mixtures by the use 
of specific antibodies, inhibiting differentially the 
metabolism of substrates by microsomes. It should be 
emphasized however that although specific, these 
antibodies may show cross-reactivity towards other 
forms of the microsomal cytochromes (Dus, 1982). 
Furthermore, recent work has demonstrated that 
forms of cytochrome P-450 may be immunologically 
identical although they have different molecular 
weights and different primary structures as shown by 
peptide mapping (Sagami and Watanabe, 1983). 
Alternatively, individual forms of the microsomal 
cytochromes in crude preparations may be distin­
guished and quantified by their substrate specificity. 
Studies with the highly purified forms of these cyto­
chromes have confirmed that each form has its own, 
but frequently overlapping, substrate specificity indi­
cating that it would be unlikely that a single substrate 
could be used to characterize any one form of the 
cytochromes.
The two most extensively studied forms of the 
microsomal cytochromes are the phenobarbital- 
induced cytochrome P-450 and the polycyclic aroma­
tic hydrocarbon-induced cytochrome P-448, because 
these exhibit markedly different substrate 
specificities. Cytochrome P-450 activity is commonly 
determined using benzphetamine or ethylmorphine 
as substrates and measuring the amount of formal­
dehyde released following their oxidative demethyla­
tion (Lu et al., 1972). The activity of cytochrome P- 
448 may be determined using substrates and reac­
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tions which are exclusively catalysed by this form of 
the! cytochrome, such as the 2-hydroxylation of 
biphenyl, the O-deethylation of ethoxyresorufin 
(Biirke and Mayer, 1975) and the activation of 
benzo[n]pyrene to mutagens (Levin et al., 1977; 
Ioannides et al., 1981). The aryl hydrocarbon hyd­
roxylase, fluorimetric assay, commonly employed by 
many workers cannot be included in this category 
because of its lack of specificity and the technical 
problems still associated with this method (Hansen 
and Fouts, 1972; DePierre and Ernster, 1978; Yang 
et al., 1978). Studies conducted using immunoglobu­
lins raised in goat and rabbit have shown that cytoc­
hrome Pr 450 and not cytochrome P-448 is the most 
active form of the cytochromes catalysing polycyclic 
aromatic hydrocarbon-induced aryl hydrocarbon 
hydroxylase activity (Negishi and Nebert, 1979; 
Chen et al., 1982). In the present study, 3-methyl- 
cholanthrene-induced cytochrome P-448 activity has 
been characterized by determination of 
ethoxyresorufin O-deethylase activity and by the 
activation of benzo[o]pyrene to mutagens, and the 
ratio of these two activities calculated. Although 
more than one form of microsomal cytochromes may 
metabolize one or both of these substrates, a constant 
ratio of the two activities is likely to be characteristic 
of only one form, especially when different inducing 
agents are employed.
Cytochrome P-448 may exist in different forms in 
rat and mouse livers, having different substrate 
specificities (Atlas et al., 1977; Lang and Nebert, 
1981; Chen et al., 1982; Goldstein et al., 1982). The 
present study was therefore undertaken to determine 
if different forms of cytochrome P-448 are present in 
rat liver following pretreatment with various induc­
ers.
MATERIALS AND METHODS
3-M ethylcholanthrene, 2-anthramine, benzo[«]pyrene, 
benzo[e]pyrene, cytochrom e c, and all cofactors (Sigma 
C o., P oole, D orset, U .K .) , phenobarbitone (B D H , P oole, 
D orset, U .K .) , ethylmorphine (May & Baker, Dagenham , 
E ssex, U .K .) , and resorufin and ethoxyresorufin (Pierce 
Chem icals, Rockford, Illinois, U .S .A .)  were all purchased.
2-Naphthylamine was a sample from that used in the inter­
national programme for the evaluation o f short-term tests 
for carcinogenicity. 9-Hydroxyellipticine was generously 
donated by D r P. Lesca, Laboratoire de Pharmacologie et 
de T oxicologie Fondam entable du C N R S, France, 
benzphetam ine by U pjohn  Co. Ltd, Kalamanzoo, M ichi­
gan, U .S .A ., Arochlor 1254 by M onsanto Chemical C o ., St 
Louis, M issouri, U .S .A ., and 7,12-dim ethylbenzo[a]an- 
thracenene by IIT Institute, Chicago, Illinois, U .S .A .
M ale Wistar albino rats (150-200 g) (Anim al Breeding 
U nit, University o f Surrey) w ere used in all experiments. 
Induction of the hepatic m icrosomal mixed function  
oxidases was achieved by single daily intraperitoneal 
administration o f either phenobarbitone (80 mg/kg) or 3- 
m ethylcholanthrene (20 mg/kg) for three days. Som e o f the 
animals received in addition a single intraperitoneal dose of 
9-hydroxyellipticine (20 m g/kg), 1 hr before killing the ani­
m als, i.e . 23 hr after the administration o f  the last dose of 
inducing agent. In the experim ent using various inducing 
agents and chemical carcinogens, animals received a single 
intraperitoneal dose (50 mg/kg) for three days o f 3-methyl­
cholanthrene, benzo[a]pyrene, benzo[e]pyrene, 2- 
anthramine, 2-acetam idofluorene, 2-naphthylamine, 7,12- 
dimethylbenzo[fl]anthracene, or phenobarbitone. A ll ani­
mals were killed 24 hr after the injection. Furthermore, 
som e animals were pretreated with a single dose of 
A rochlor 1254 (500 mg/kg) and killed 5 days later as 
described by A m es et al. (1975) for the preparation o f hepa­
tic activation systems for use in the mammalian/Salmonella  
typhim urium  mutagenicity assay.
H epatic microsomal supernatant (9000 gsupernatant, S9) 
and m icrosom es (105,000 g  pellet resuspended in 1.15%  
KC1) were prepared as previously described (Ioannides et 
al., 1975). The A-dem ethylation o f benzphetam ine (Lu et 
a l., 1972) and ethylmorphine (Holtzm an et a l., 1968) were 
determ ined using the m icrosomal supernatant; the O- 
deethylation o f ethoxyresorufin (Burke and M ayer, 1974), 
cytochrom e P-450 concentration (Omura and Sato, 1964), 
N A D PH -cytochrom e c reductase (Williams and Kamin, 
1962) and microsomal protein (Lowry et a l., 1951) were 
determ ined using resuspended microsom es. The activation 
o f benzo[a]pyrene to mutagens in the T A  100 strain o f Sal­
m onella typhimurin  (A m es et a l., 1975) was investigated 
using S9 preparations from the variously pretreated ani­
mals. Prior to each mutagenicity study the various S9 prep­
arations w ere fully characterized with respect to mixed func­
tion oxidase activities and cytochrom e P-450 levels.
Statistical analysis was carried out using simple linear 
regression.
RESULTS
As expected, pretreatment of animals with 3- 
methylcholanthrene stimulated the activity of the 
cytochrome P-488-mediated O-deethylation of 
ethoxyresorufin, while phenobarbitone pretreat­
ment diminished this enzyme activity (Table 1). Both 
inducers caused increases in the concentration of 
microsomal cytochromes, and phenobarbitone, but 
not 3-methylcholanthrene, produced an increase in 
NADPH cytochrome c reductase activity. Co­
administration of 9-hydroxyellipticine 1 hr before kil­
ling the rats resulted in almost complete inhibition of 
cytochrome P-448-dependent ethoxyresorufin O- 
deethylase activity, but had no effect on the cytoc­
hrome P-450-dependent enzyme activity (ethylmor­
phine A-demethylase). Similarly, 3-methylcholan­
threne administration stimulated the activation of 
benzo[a]pyrene to mutagens, while phenobarbitone 
administration significantly decreased activation 
(Fig. 1). Furthermore, the 3-methylcholanthrene- 
induced activation of benzo[a]pyrene was prevented 
by administration of the cytochrome P-448 inhibitor, 
9-hydroxyellipticine, to these animals 1 hr before kil­
ling (Fig. 1). An excellent direct relationship (r =  
+0.95) has been demonstrated between 
ethoxyresorufin O-deethylase activity (P-448) and 
the activation of benzo[a]pyrene to mutagens by liver 
microsomal preparations from rats pretreated with 
various inducing agents (Fig. 2). Similarly an excel­
lent, but inverse correlation (r =  —0.89) has been 
demonstrated between ethylmorphine N- 
demethylase (P-450) and benzo[a]pyrene activation 
to mutagens (not shown).
The hepatic microsomal activities of 
benzphetamine N-demethylase (cytochrome P-450), 
ethoxyresorufin O-deethylase (cytochrome P-448) 
and concentrations of total microsomal cytochrome, 
following the administration of various inducing 
agents and chemical carcinogens, are shown in Table
2. As expected, animals pretreated with Arochlor 
1254 and phenobarbitone exhibited the highest levels 
of total microsomal cytochromes, and the latter
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Table 1. Typical mixed-function oxidase activities of the hepatic microsomal preparations used in the Ames test to activate benzo[a]pyrene
Pretreatment
Ethylmorphine 
/V-demethylase 
(nmol HCHO/min per mg protein)
Ethoxyresorufin 
O-deethylase 
(nmol/min per mg protein)
NADPH-cytochrome c 
reductase 
(nmol/min per mg protein)
Microsomal 
cytochromes 
(nmol/mg protein)
Control 1.5 0.72 34 0.61
Phenobarbitone 2.2 0.14 53 1.40
Phenobarbitone +
9-hydroxyellipticine 2.1 0.10 47 1.48
3-Methylcholanthrene 1.3 2.56 27 1.44
3-Methylcholanthrene +
9-hydroxyellipticine 1.8 0.21 33 0.95
Animals (3 per group) were given single daily intraperitoneal doses o f either phenobarbitone (80 mg/kg) or 3-methylcholanthrene (20 mg/kg) 
for three days and were killed 24 hr after the last injection. Some of the animals received in addition a single intraperitoneal administration 
of 9-hydroxyellipticine (20 mg/kg) 1 hr before death. Mixed function oxidases were always determined in each liver preparation prior to 
its use for activation in the Ames test. Results given are typical and are for a single liver preparation.
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Fig. 1. Effects o f different liver microsomal preparations on 
the mutagenicity o f benzo(a)pyrene in the A m es test. The 
A m es test was carried out using the Salmonella 
typhim urium  T A  100 strain. Activation systems were 
derived from control rats ( • ) ;  and rats pretreated with 3- 
methylcholanthrene (A );  3-methylcholanthrene +  9-hyd­
roxyellipticine (A); phenobarbitone (□ );  and phenobar­
bitone +  9-hydroxyellipticine (■ ) . Three animals were used  
for each pretreatment. Results shown are typical, and are 
for one animal. Each point represents the mean o f three 
plates which did not differ from each other by more than 
15%. Spontaneous revertants have been subtracted.
Fig. 2. Correlation betw een ethoxyresorufin O -deethyla­
tion and activation o f  benzo[a]pyrene to mutagens in the 
A m es test by liver m icrosomal preparations from rats pre­
treated with 3-methylcholanthrene or phenobarbitone. 
Benzo[o]pyrene activation is taken as the number o f rever- 
tants/plate at a concentration o f 15 pig benzo[a]pyrene. 
Liver microsomal preparations for activation w ere obtained  
from control rats ( • ) ;  and rats pretreated with 3-methyl- 
cholanthrene (A );  phenobarbitone (□ );  3-m ethylcholan­
threne +  9-hydroxyellipticine (A); and phenobarbitone +  
9-hydroxyellipticine (■ ) .
Table 2. Typical mixed-function oxidase activities and cytochrome P-450 contents of liver microsomal preparations derived from rats 
pretreated with various inducing agents and used to activate benzo[a]pyrene to mutagens in the Ames test
Pretreatment
Benzphatamine A-demethylase 
(nmol HCHO/min per mg protein)
Ethoxyresorufin O-deethylase 
(nmol/min per mg protein)
Total microsomal 
cytochromes 
(nmol/mg protein)
Control 3.4 0.27 0.23
Arochlor 1254 4.7 2.14 0.90
3-Methylcholanthrene 3.3 2.03 0.45
Benzo[a]pyrene 1.9 1.73 0.31
7,12-Dimethylbenzo[a]anthracene 4.8 0.66 0.27
2-Anthramine 4.7 0.46 0.17
2-Naphthylamine 0.8 0.23 0.22
Benzo[e]pyrene 4.6 0.20 0.20
Phenobarbitone 10.1 0.14 0.87
Animals (2 per group) received a single daily intraperitoneal dose (50 mg/kg) for three days o f each inducing agent, except for Arochlor 1254 
which was given by single administration (500 mg/kg) and animals were killed 5 days later. All other animals were killed 24 hr after last 
administration. Mixed function oxidases were always determined in each liver preparation prior to its use for activation in the Am es test. 
Results shown are typical, and are for a single liver preparation.
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animals also exhibited the highest benzphetamine N -  
demethylase activity (P-450). Ethoxyresorufin O- 
deethylase, on the other hand, was highest in the 
Arochlor 1254-, 3-methylcholanthrene-, and 
benzo[a]pyrene-pretreated animals and lowest in the 
benzojejpyrene- and phenobarbitone-pretreated ani­
mals. All preparations activated benzo[a]pyrene to 
mutagens, the most efficient being those from the 
animals pretreated with 3-methylcholanthrene, 
Arochlor 1254 and benzo[<z]pyrene (Fig. 3). Once 
again, ethoxyresorufin O-deethylase activity exhi­
bited an excellent direct relationship (r =  +0.95) 
with the activation of benzo(a)pyrene to mutagens 
(Fig. 4). In contrast, no correlation was observed 
(r =  -0 .1 4 ) between benzphetamine A-demethylase 
activity and benzo[a]pyrene activation (not shown).
DISCUSSION
The two most extensively studied forms of liver 
microsomal haemoprotein are the phenobarbital- 
and 3-methylcholanthrene-induced cytochromes P- 
450 and P-448, respectively. These have been iso­
lated and purified, from a number of animals, and 
have been shown to possess different substrate bind­
ing sites (Phillipson et al., 1982; Dus, 1982) and to 
exhibit different substrate specificities and reaction 
kinetics (Guengerich et al., 1982), so that these may 
be considered as distinctly different enzymes. They 
often play contrasting roles in the activation/deacti­
vation of drugs and carcinogens (Parke and Ioan­
nides, 1982); for example cytochrome P-448 prefe­
rentially catalyses the biotransformation of 
benzo[a]pyrene to its ultimate carcinogen (Levin et 
al., 1977; Ioannides et al., 1981) and of paracetamol 
to the reactive intermediate responsible for the acute 
hepatotoxicity of the drug at high doses (Ioannides et 
al., 1983; Steele etal.,  1983), and is twice more effec­
tive than cytochrome P-450 in activating 4- 
aminobiphenyl to mutagenic intermediates (Masson 
etal.,  1983).
Two reactions which are preferentially catalysed 
by cytochrome P-448 are the O-deethylation of 
ethoxyresorufin (Burke and Mayer, 1975) and the 
oxidative activation of benzo[a]pyrene (Ioannides et 
al., 1981). Both were significantly induced by pre­
treatment with 3-methylcholanthrene and inhibited 
by 9-hydroxyellipticine, a specific inhibitor of cyto­
chrome P-448 (Lesca et al., 1978; Delaforge et al., 
1980, 1982). The greater inhibition of ethoxyresoru­
fin O-deethylase activity (90%) than of 
benzo[a]pyrene activation (50%) by 9-hydroxyellip­
ticine shows the greater specificity of the former sub­
strate for this particular form of cytochrome. The 
inhibition by 9-hydroxyellipticine of the 3-metnyi- 
cholanthrene-induced increase in benzo[a]pyrene 
mutagenicity (see Fig. 1), confirms similar previous 
studies carried out in vitro (Lesca et al., 1979).
An excellent direct correlation (r =  +0.95) has 
been observed between ethoxyresorufin O-deeth- 
ylase and the metabolic activation of benzo[a]pyrene 
to mutagens (Fig. 2) indicating that both assays mea­
sure the same enzyme activity. The relative activities 
of these two enzyme systems remained constant 
when the fraction of the cytochrome present as cyto­
chrome P-448 was altered by the administration of
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Fig. 3. Activation o f benzo[a]pyrene to m utagens in the 
A m es test by liver preparations derived from rats pretreated  
with mixed-function oxidase inducers. The A m es test was 
carried out using the Salm onella typhim urium  T A  100 
strain. A ctivation systems w ere derived from rats pre­
treated with benzo[a]pyrene ( • ) ;  benzo[e]pyrene (A); 3- 
methylcholanthrene (□ );  7,12-dim ethylbenzo[a]an- 
thracene (O); Arochlor 1254 (■ );  2-anthramine (O); 2- 
naphthylamine ( ♦ ) ;  and phenobarbitone (A ) .  Each point 
represents the m ean o f three plates which did not differ 
from each other by more than 15%. Spontaneous revertants 
have been subtracted.
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Fig. 4. Correlation betw een ethoxyresorufin O -deethyla­
tion and activation o f benzo[a]pyrene to mutagens by liver 
miscrosomal preparations from rats pretreated with various 
mixed-function oxidase inducers. Benzo[a]pyrene activa­
tion was as taken as the number o f revertants/plate at a con­
centration of 10 |xg benzo[fl]pyrene. Activation systems 
w ere from rats pretreated with benzo[a]pyrene 
benzo[e]pyrene (A); 3-methylcholanthrene (□ );  7,12- 
dimethylbenz[fl]anthracene (O); Arochlor 1254 (■ );  2- 
anthramine (<0); 2-naphthylamine ( ♦ ) ;  and phenobar­
bitone ( A ) .
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phenobarbitone and 3-methylcholanthrene alone or 
in combination with 9-hydroxyellipticine. These 
observations indicate that: (a) the form of cyto­
chrome P-448 induced by 3-methylcholanthrene 
administration is similar to that present in small 
amounts in control and phenobarbital-treated ani­
mals; (b) the constant ratio between the O-deethyla­
tion of ethoxyresorufin and activation of 
benzo[u]pyrene to mutagens may be used to define 
this form. The possibility that an additional form of 
the cytochrome may exist having similar substrate 
specificity and reaction kinetics towards these sub­
strates although unlikely, cannot be totally excluded. 
A good correlation between ethoxyresorufin O- 
deethylase and benzo[a]pyrene hydroxylase (aryl 
hydrocarbon hydroxylase, AHH) activities has also 
been reported (Lang et al., 1981). This latter study 
was conducted with mice and the enzyme activities 
were determined at different times following pre­
treatment with 3-methylcholanthrene; the assay used 
for benzo[a]pyrene hydroxylase determines princi­
pally the 3- and 9-hydroxy derivatives of the substrate 
(Holder et al. , 1975) while the Ames’ test used in the 
present study reflects primarily the formation of 
arene oxides and possibly quinones of 
benzo[a]pyrene (Wood et al., 1975,1976; Wislocki et 
al., 1976). However, the lack of specificity associated 
with the AHH assay, as previously mentioned, 
makes it unsuitable for the determination of a single, 
specific form of cytochrome P-450.
Interestingly an excellent, but inverse relationship, 
has now also been observed between the activation of 
benzo[a]pyrene to mutagens and the cytochrome P- 
450-dependent TV-demethylation of ethylmorphine, 
demonstrating that this form of the cytochrome plays 
no role in the ultimate metabolic activation of 
benzo[u]pyrene to mutagens.
The presence of two forms of cytochrome 
P-448 inducible by 3-methylcholanthrene and 
3,4,5,3',4',5'-hexachlorobiphenyl has been demos- 
trated in rat liver microsomes (Goldstein etal., 1982; 
Luster et al., 1983). In the present studies, following 
pretreatment of rats with various carcinogens and 
microsomal enzyme inducing agents, ethoxyresoru­
fin deethylase activity showed an excellent and 
constant correlation with the activation of 
benzo[a]pyrene to mutagens as measured in the 
Ames’ test (r =  +0.95) (see Fig. 4), indicating that 
the inducing agents all probably increase the synth­
esis of the same isozyme of cytochrome P-448. These 
findings are in agreement with the work of Luster et 
al. (1983) who showed, using a double-antibody 
immunoassay procedure, that treatment of rats with 
Archlor 1254 induces a form of cytochrome P-448, 
similar to that induced by 3-methylcholanthrene pre­
treatment, both of which catalyse the O-deethylation 
of ethoxyresorufin (Goldstein et al., 1982).
In conclusion our studies indicate that the O- 
deethylation of ethoxyresorufin and the activation of 
benzo[a]pyrene to mutagens are both catalysed by 
the same form of rat liver cytochrome P-448 induced 
by 3-methylcholanthrene administration; this form of 
cytochrome P-448 is also induced by pretreatment 
with Arochlor-1254 or benzofojpyrene, and is pre­
sent in small amounts in control animals and also in 
animals treated by other mixed-function oxidase
inducers and chemical carcinogens.
SUMMARY
The mixed function oxidases and the metabolic 
activation of benzo[a]pyrene to mutagens in the 
Ames test were determined in liver microsomal prep­
arations from rats pretreated with phenobarbitone or 
3-methylcholanthrene, either alone or in combina­
tion with 9-hydroxyellipticine, a specific cytochrome 
P-488 inhibitor. Co-administration of 9-hydroxyel- 
lipticine inhibited the 3-methylcholanthrene-induced 
O-deethylation of ethoxy resorufin and the activation 
of benzo[o]pyrene to mutagens. A  positive correla­
tion was observed between the O-deethylation of 
ethoxyresorufin and activation of benzo[a]pyrene by 
liver microsomal preparations from these animals, 
indicating that both assays measure the same activity.
Liver microsomal preparations from rats pre­
treated with various inducing agents and chemical 
carcinogens all activated benzo[a]pyrene to muta­
gens. The most effective were those from the animals 
pretreated with 3-methylcholanthrene, Arochlor 
1254 and benzo[a]pyrene, which also exhibited the 
highest ethoxyresorufin O-deethylase activities. The 
O-deethylation of ethoxyresorufin exhibited an 
excellent direct correlation with the activation of 
benzo[a]pyrene to mutagens in the induced prepara­
tions. It is concluded that the 3-methylcholanthrene- 
induced cytochrome P-448 is also induced by other 
chemical carcinogens and is present in small amounts 
in untreated animals.
Acknow ledgem ents— The authors wish to thank Mrs S. A . 
Smith and M iss C. M. Steele for technical assistance and the 
M RC for financial support.
REFERENCES
A m es B . N ., McCann J. and Yamasaki E . (1975) M ethods 
for detecting carcinogens and m utagens with the 
Salmonella/m amm alian-m icrosom e m utagenicity test. 
M utat, Res. 31, 347-364.
A tlas S. A .,  Boobis A . R ., Felton J. S ., Thorgeirsson S.S. 
and N ebert D . W . (1977) O ntogenic expression of  
polycyclic aromatic com pound-inducible m ono­
oxygenase activities and forms o f cytochrom e P-450 in 
rabbit. J. biol. Chem. 252, 4712-4721.
Burke M . D . and M ayer R . T. (1974) Ethoxyresorufin: 
D irect fluorimetric assay o f a microsomal O -dealkylation  
which is preferentially inducible by 3-m ethylcholan­
threne. D rug M etab. D ispos. 2 , 583-588.
Burke M . D . and M ayer R . T. (1975) Inherent specificities 
o f  purified cytochrom es P-450 and P-448 toward  
biphenyl hydroxylation and ethoxyresorufin deethyla- 
tion. D rug M etab. D ispos. 3 , 245-253.
Chen Y . T ., Lang M. A ., Jensen N . M ., N egishi M ., Tukey  
R . H ., Sidransky E ., G uenther T. M . and N ebert D . W .
(1982) Similarities between m ouse and rat-liver 
microsomal cytochrom e P-450 induced by 3-m ethyl­
cholanthrene. Eur. J. Biochem. 122, 361-368.
D elaforge M ., Ioannides C. and Parke D . V . (1980) 
Inhibition of cytochrom e P-448 mixed function oxidase  
activity follow ing administration o f  9-hydroxyellipticine 
to rats. Chem. Biol. Interact. 3 2 ,101-110 .
D elaforge M ., Ioannides C. and Parke D . V . (1982) 
Selective inhibition o f the safrole-induced m ixed- 
function oxidase activities by 9-hydroxyellipticine.
42 C a r o lin e  E. P hillipson  et al.
Chem. Biol. Interact. 42, 279-289.
D ePierre J. W . and Ernster L. (1978) The m etabolism  of  
polycyclic hydrocarbons and its relationship to cancer. 
Biochem. biophys. A cta  473 ,149-186 .
D us K. M. (1982) Insights into the active site o f the 
cytochrom e P-450 haem oprotein family —  a unifying 
concept based on structural considerations. Xenobiotica  
12, 745-772.
G oldstein J. A .,  Linko P ., Luster M . I. and Sundheimer 
D . W . (1982) Purification and characterization o f  a 
second form o f hepatic cytochrom e P-448 from rats 
treated with a pure polychlorinated biphenyl isomer. 
J. biol. Chem. 257 ,2702-2707.
Guengerich F. P ., Dannans G. A ., Wright S. T ., Martin 
M. V. and Kaminsky L. S. (1982) Purification and 
characterization o f microsomal cytochrom e P-450’s. 
X enobiotica  11, 701-716.
H ansen A . R . and Fouts J. R . (1972) Som e problem s in 
M ichaelis-M enten kinetic analysis o f  benzpyrene 
hydroxylase in hepatic m icrosom es from polycyclic 
hydrocarbon-pretreated animals. Chem. Biol. Interact. 
5 ,1 6 7 -1 8 2 .
H older G ., Yagi H ., Levin W ., Lu A . Y . H . and Jerina 
D . M . (1975) M etabolism o f  benzo(o)pyrene III. An  
evaluation of the fluorescence assay. Biochem . biophys. 
Res. Com m un. 65 ,1363-1370.
Holtzm an J. L ., Gram T. E ., Gigon P. L. and G illette J. R .
(1968) The distribution o f the com ponents o f mixed- 
function oxidase betw een the rough and sm ooth
/e n d o p la sm ic  reticulum o f liver cells. Biochem . J. 110, 
407-412.
Ioannides C. and Parke D . V . (1975) M echanism of  
induction o f hepatic microsomal drug metabolising  
enzym es by a series o f barbiturates. J. Pharm. Pharmac. 
27 ,739-746 .
Ioannides C. and Parke D . V . (1982) The metabolic 
activation and detoxication o f m utagens and carcinogens. 
Chem. Ind. 22, 854-859.
Ioannides C ., Parkinson C. and Parke D . V . (1981) 
Activation o f benzo(a)pyrene and 2-acetamidofluorene  
to mutagens by microsomal preparations from different 
animal species: role o f cytochrom es P-450 and P-448. 
Xenobiotica  10, 701-708.
Ioannides C ., Steele C. M . and Parke D . V . (1983) Species 
variation in the m etabolic activation o f  paracetamol to 
toxic intermediates: role o f cytochrom es P-450 and 
P-448. Toxic. Lett. 16, 55-61.
Ioannides C ., Lum P. Y . and Parke D . V . (1984) 
Cytochrome P-448 and the activation of toxic chemicals 
and carcinogens. X enobiotica. 14, 119-137.
Lang M. A . and N ebert D . W . (1981) Structural gene 
products o f the A h locus. J. biol. Chem. 256, 12058- 
12067.
L angM . A ., G ielen J. E . and N ebert D . W . (1981) G enetic 
evidence for many unique liver microsomal P-450- 
m ediated m ono-oxygenase activities in heterogeneic  
stock m ice. J. biol. Chem. 256,12068-12075.
Lesca P ., Lecointe P ., Paoletti C. and M ansuy D . (1978) 
Ellipticines as potent inhibitors o f arylhydrocarbon 
hydroxylase: their binding to microsomal cytochrome 
P-450 and protective effects against benzo(a)pyrene  
mutagenicity. Biochem: Pharmac. 27 ,1203-1209.
Lesca P ., Lecointe P ., Paoletti C. and M ansuy D . (1979) 
Ellipticines as potent inhibitors o f  microsomes- 
dependent chemical m utagenesis. Chem. Biol. Interact. 
25 ,279-287 .
Levin W ., W ood A . W „ Lu A . Y . H ., Ryan D ., W est S ., 
Conney A . H .,T h a k k erD . R ., Y a g iH . and JerinaD . M.
(1977) R ole o f purified cytochrom e P-448 and epoxide  
hydrase in the activation and detoxication of  
benzo(fl)pyrene. In D rug M etabolism  Concepts (Edited  
by D . M . Jerina) pp. 99-126. A C S Symposium Series 
N o. 44.
Lowry O . H ., Rosebrough N . J ., Farr A . L. and Randall 
A . J. (1951) Protein m easurem ent with the Folin phenol 
reagents. J. biol. Chem. 193, 265-275.
Lu A .  Y . H ., Kuntzman R ., W est S ., Jacobson M . and 
Conney A . H . (1972) Reconstituted liver microsomal 
enzym e system that hydroxylates drugs, other foreign  
com pounds and endogenous substrates II. R ole o f the  
cytochrom e P-450 and P-448 fractions in drug and steroid  
hydroxylations. J. biol. Chem. 247,1727-1734.
Luster M. I ., Lawson L. D ., Linko P. and G oldstein J. A .
(1983) Immunochemical evidence for two 3-methyl- 
cholanthrene-inducible forms o f  cytochrome P448 in rat 
liver m icrosom es using a double-antibody radio­
immunoassay procedure. Molec. Pharmac. 23 ,252-257 .
M asson H . A .,  Ioannides C ., Gorrod J. W . and Gibson
G . G. (1983) The role o f highly purified cytochrome 
P-450 isozymes in the activation o f 4-aminobiphenyl to  
m utagenic products in the A m es test. Carcinogenesis 
4 ,1583-1586 .
Negishi M . and N ebert D . W . (1979) Structural gene  
products o f the A h locus. J. biol. Chem. 254, 11015— 
11023.
Omura T. and Sato R . (1964) The carbon m onoxide  
pigment o f liver m icrosom es I. Evidence for its 
haem oprotein nature. J. biol. Chem. 239, 2370-2378.
Parke D . V. and Ioannides C. (1982) R ole o f mixed function  
oxidases in the formation o f biological reactive inter­
m ediates. A d v . exp. M ed. Biol. 136A, 23-38.
Phillipson C. E ., Ioannides C ., D elaforge M . and Parke 
D . V . (1982) Studies on the substrate-binding sites of 
liver microsomal cytochrom e P-448. Biochem. J. 207, 
51-56.
Sagami I. and W atanabe M. (1983) Purification and 
characterization o f pulmonary cytochrome P-450 from
- 3-methylcholanthrene-treated rats. J. Biochem. 93, 
1499-1508.
Steele C. M ., Masson H . A .,  Battershill J. M ., Gibson G .G . 
and Ioannides C. (1983) M etabolic activation o f paracet­
amol by highly purified forms of cytochrome P-450. 
Res. Com m un. Chem. Pathol. Pharmac. 40, 109-120.
W illiams C. H . Jr and Kamin H . (1962) Microsomal 
triphosphopyridine nucleotide cytochrome c reductase 
of liver. J. biol. Chem. 237, 587-595.
W islocki P. G ., W ood A . W ., Chang R . L ., Levin W ., Yagi
H ., Hernandez O ., D ansette P. M ., Jerina D . M. and 
Conney A . H . (1976) M utagenicity and cytotoxicity of 
benzo(a)pyrene arene oxides, phenols, quinones and 
dihydrodiols in bacterial and mammalian cells. Cancer 
Res. 36, 3350-3357.
W ood A . W ., G oode R . L ., Chang R . L ., Levin W ., 
Conney A . H ., Yagi H ., D ansette P. M . and Jerina D . M. 
(1975) M utagenic and cytotoxic activity of 
benzo(o)pyrene 4 ,5-, 7,8- and 9,10-oxides and the six 
corresponding phenols. Proc. natn. A cad. Sci. U .S.A. 
72,3176-3180 .
W ood A . W ., Levin W ., Lu A . Y . H „  Yagi H ., Hernandez
O ., Jerina D . M . and Conney A . H . (1976) Metabolism  
o f benzo(a)pyrene and benzo(a)pyrene derivatives to 
mutagenic products by highly purified hepatic 
microsomal enzym es. J. biol. Chem. 251, 4882-4890.
Y ang C. S ., Strickhart F. S. and Kicha P. L. (1978) 
A nalysis o f the aryl hydrocarbon hydroxylase assay. 
Biochem . Pharmac. 27 ,2321-2326 .
Biochemical Pharmacology, Vol. 34, No. 3, pp. 441-442, 1985. 
Printed in Great Britain.
0006-2952/85 $3.00 + 0.00 
©  1985 Pergamon Press Ltd.
METABOLIC .ACTIVATION OF NITROSAM INES TO M UTAGENS BY  
VARIOUS ANIM AL SPECIES IN CLUDING  M AN
C a ro lin e  E . P h illip son  and C o sta s  Ioann ides
\
-> B io ch em istry  D ep a rtm e n t, U n iv ers ity  o f  Surrey,
G uildford , Surrey, G U 2 5X H , U .K .
IN TRO DUCTIO N
The n itr o sa m in e s  co m p rise  a ub iqu itous group o f  p o te n t  c h e m ic a l c a rc in o g en s w h ich , su rp risin g ly , w hen  
in corp orated  in to  th e  S a lm o n e lla /m ic r o so m e  m u ta g e n ic ity  t e s t  m ay e ith e r  ex h ib it  a very  w eak  m u ta g e n ic  resp o n se  
or no m u ta g e n ic ity  a t a ll (1 ,2 ). T he n itr o sa m in e s are in d ir e c t-a c t in g  c a rc in o g en s requ iring m e ta b o lic  a c t iv a t io n  
and it  is  c o n c e iv a b le  th a t  th e ir  poor m u ta g en ic  resp on se  is th e  resu lt  o f  th e  ra t being  an in ap p rop ria te  an im al 
sp e c ie s  to  u se  a s th e  so u rce  o f  th e  a c t iv a tio n  sy s te m . M arked sp e c ie s  d if fe r e n c e s  in th e  b io a c t iv a t io n  o f  
c a rc in o g en s to  m uta g en s in th e  A m es te s t  has a lread y  b een  rep orted  for a ro m a tic  am in es w h ere  th e  h a m ste r , in  
c o n tr a st  to  th e  r a t , w as a v ery  e f f ic ie n t  a c t iv a to r  (3). In th e  p r e se n t  p ap er w e  rep ort th e  b io a c t iv a t io n  o f  f iv e  
n itr o sa m in e s to  m u ta g en s by various an im al sp e c ie s  includ ing m an.
METHODS
M ale go ld en  Syrian h a m sters (1 0 0 -1 2 0  g), m a le  W istar a lb ino ra ts (1 3 0 -2 0 0  g) and m a le  C D 1 m ic e  w e r e  u sed . 
T he hum an liv e r  sa m p le  w as from  a m a le , a t r a f f ic  a c c id e n t  v ic t im , and fresh  p ig  liv e r  w a s ob ta in ed  from  th e  
lo c a l a b a tto ir , b oth  sa m p les b ein g  stored  a t - 8 0 ° C . H e p a tic  p o st-m ito c h o n d r ia l su p ern a ta n t (S9 fr a c t io n )  and 
m icro so m a l su sp en sion  w ere  prepared  and th e  fo llo w in g  d e te r m in a tio n s  w ere  carried  ou t in th e  p o s t -  
m itoch ron d ria l su p ern atan t: kynuram ine o x id a se  (4), d im e th y la n ilin e  N -o x id a s e  (5) and b en z p h e ta m in e
N -d e m e th y la s e  (6); in th e  m icro so m a l su sp en sion , e th o x y reso r u fin  O -d e e th y la s e  (7), N A D P H -c y to c h r o m e  c  
r e d u c ta se  (8) and c y to c h r o m e  P -4 5 0  (9); p ro te in  w as d eterm in ed  in both  fr a c t io n s  (10). E f f ic ie n c y  o f  a c t iv a t io n  
to  m u ta g en s w as d e term in ed  using th e  A m es t e s t  and em p lo y in g  S a lm o n ella  typhim urium  stra in  TA 100 (11). 
D ou b le  th e  usual am oun t o f  S9 fr a c t io n  w as used in th e  S9 m ix , i .e .  100 pi p er  p la te , and e a c h  n itr o sa m in e  a t  f iv e  
c o n c e n tr a t io n s  (2 5 0 -2 0 0 0  p g /p la te )  w as p rein cu b ated  w ith  th e  a c t iv a t io n  sy s te m  and b a c te r ia  fo r  30 m in u tes  a t  
37 °C .
RESULTS A N D  DISC USSIO N
T h ree e n z y m e  s y s te m s  h a v e  b een  im p lica ted  in. th e  b io a c t iv a t io n  o f n itro sa m in es; th e  c y tr o c h r o m e  P -4 5 0  
d ep en d en t m ix e d -fu n c tio n  o x id a se s , th e  m ix ed -fu n c tio n  a m in e  o x id a se  and m onoam in e o x id a se . N o t  a ll th r e e
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e n zy m e sy s te m s co n tr ib u te  to  the a c t iv a tio n  o f  all n itr o sa m in e s . F or ex a m p le  th e  c y to c h r o m e  P -4 5 0  en zy m e  
sy s te m  appears not to  p a r t ic ip a te  in th e  a c t iv a tio n  o f  d im e th y ln itro sa m in e  to  m u ta g en s (1 2 ,1 3 ), w hich m ay be  
c a ta ly se d  by a m icro so m a l m onoam in e o x id a se  (14). N e ith e r  o f  th e se  e n z y m e  sy s te m s  is in volved  in the  
b io a c t iv a t io n  o f n itr osom orp h o lin e  (15). A ll a c t iv a tio n  sy s te m s  em p loyed  in th e  p r e se n t  study w ere  fully  
c h a ra c ter ised  w ith  r e s p e c t  to  th e se  e n zy m e sy s te m s  (T ab le 1).
TABLE 1 CH ARA C TER ISA TIO N  OF ACTIVATION SYSTEMS U SED  IN THE AMES TEST
M ouse H a m ster R a t P ig H um an
4 -H y d ro x y la tio n  o f  kynuram ine  
(n m o l/m in  p er  100 pi o f S 9 .fr a c tio n ) 0 .15 0 .16 0 .26 0 .58 0 .5 4
N -o x id a tio n  o f  d im e th y la n ilin e  
(p m o l/m in  p er  100 pi o f  S9 fra c tio n ) 4 1 .8 4 4 .8 27.1 4 7 .5 12.3
N -D e m e th y la t io n  o f  b en zp h eta m in e  
(n m o l/m in  p er  100 pi o f  S9 fr a c tio n ) 6 .41 11 .50 4 .25 2 .99 4 .9 4
O -D e e th y la t io n  o f  e th o x y reso r u fin  
(p m o l/m in  p er  100 pi o f  S9 fra c tio n ) 20 53 40 17 16
C y to ch ro m e P -4 5 0  
(n m o l/1 0 0  pi o f  S9 fr a c tio n ) 0 .46 0 .69 0 .4 4 0 .18 0 .1 4
P ro te in
(m g /1 0 0  pi o f  S9 fr a c tio n ) 2.2 2 .0 2.2 3.1 2.7
TABLE 2 BIOACTIVATION OF NITROSAM INES TO M UTAGENS BY VARIOUS ANIM AL SPECIES A N !
R e su lts  are p resen ted  as th e  a v era g e  o f  tr ip lic a te  p la te s  from  w hich  th e  sp o n tan eou s rev er sio n  r a te  (44 
has b een  su b tr a c te d . T r ip lic a te s  did not d iffe r  from  each  o th er  by m ore than 15% . R e su lts  for  on ly on  
ca rc in o g en  co n c e n tr a tio n  are show n.
C arc in o g en  C o n cen tra tio n
I n n  /r-» 1 n  f- r» i
H istid in e  R e v e r ta n ts /p la te
M ouse H a m ster R a t P ig H um an
D im eth y ln itro sa m in e  1000 70 123 19 13 16
M eth y le th y ln itro sa m in e  1000 69 151 47 31 10
D ip rop y ln itro sa m in e  250 53 1 0 i 32 14 36
N itro so p ip er id in e  1000 1033 1706 80 126 219
N itro so p y rro lid in e  1000 64 1329 8 152 1257
T he s im p le st  a n a logu e d im e th y ln itro sa m in e  w as a c t iv a te d  by th e  h am ster  w ith  th e  m ouse a lso  ex h ib itin g  a 
d oubling o f  th e  sp o n tan eou s rev ersio n  r a te  (T able 2); none o f  th e  o th e r  a c t iv a tio n  sy s te m s  produced  a p o s it iv e  
m u ta g e n ic  r esp o n se . E sse n tia lly  th e  sa m e  p ic tu r e  em e r g e s  w ith  th e  o th e r  tw o  a lip h a tic  n itr o sa m in e s , th e  
m eth y le th y l-a n d  d ip ro p y l-a n a lo g u es. The c y c lic  n itrosam in e n itroso p ip er id in e  w as m e ta b o lic a lly  co n v er ted  to  
m u ta g en s by all a c t iv a tio n  sy s te m s , b ut w ith  m arked ly  d if fe r e n t  e f f ic ie n c ie s ,  th e  h a m ster  being o n c e  aga in  th e  
m o st e f f ic ie n t  fo llo w ed  by th e  m ouse (T able 2). A ll an im al s p e c ie s ,  w ith  th e  e x c e p tio n  o f  th e  ra t, could  
b io a c t iv a te  n itro so p y rro lid in e , th e  h a m ster  and hum an p rep a ra tio n s b ein g  by far  th e  m o st e f f e c t iv e  (T ab le 2). N o  
co r r e la tio n  w as ev id en t b e tw e e n  th e  e f f ic ie n c y  o f a c t iv a tio n  o f  th e  n itro sa m in es by th e  various sp e c ie s  and any o f
th e  e n z y m e  sy s te m s  stu d ied  su g g e s tin g  th a t  e ith e r  th e se  are n o t in volved  in th e  a c t iv a tio n  p r o c e s s  or do n o t
c a ta ly s e  th e  r a te - lim itin g  s te p .
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Dimethylnitrosamine, dipropylnitrosamine, methylethyl- 
nitrosamine, nitrosopiperidine and nitrosopyrrolidine were 
assayed for mutagenicity in the Ames test in the presence of 
hepatic postmitochondrial preparations isolated from the 
mouse, rat, hamster, pig and man. Prior to each mutagenicity 
assay all activation systems were fully characterised with re­
spect to monoamine oxidase, mixed-function amine oxidase 
and mixed-function oxidase activities. The hamster was the 
most efficient activator for all nitrosamines followed by the 
mouse. The latter species, however, activated nitrosopyrrol­
idine only weakly which was the only carcinogen readily ac­
tivated by the human preparation. None of the aliphatic 
nitrosamines was activated by the rat or pig. No correlation 
was observed between efficiency of activation and any of the 
enzyme activities studied.
Introduction
In the Ames Salmonella/microsome test (1) metabolic ac­
tivation of chemicals which are not direct acting mutagens is 
achieved by incorporating a hepatic postmitochondrial prep­
aration from rats pretreated with Arochlor 1254, a mixture of 
polychlorinated biphenyls which induces a wide range of 
mixed-function oxidases (2). Using this system the demon­
stration of a positive mutagenic response for some nitro­
samines has proved problematic, presumably because the 
metabolic activation of this group of carcinogens appears not 
to involve the cytochrome P-450-dependent mixed-function 
oxidase system (3 — 5).
Occasionally higher mutagenicities have been reported for 
some nitrosamines when the activation system was isolated 
from the hamster or mouse instead of the rat (6 — 10). Species 
variations in metabolic activation have already been reported 
for other groups of carcinogens, such as the aromatic amines 
(11) where the hamster was markedly the most efficient acti­
vator. It is thus conceivable that the sensitivity of mutagen­
icity tests to some chemicals may be enhanced by incorpor­
ating activation systems from animals other than the rat.
In the present paper we report the results of a comparative 
study of the metabolic activation of five nitrosamines to 
mutagens in the Ames test by hepatic preparations isolated 
from the rat, mouse, hamster, pig and man.
Materials and methods
Dimethyl-, dipropyl- and methylethyl-nitrosamines, nitrosopiperidine, nitro­
sopyrrolidine, dimethylaniline and all cofactors (Sigma Co., Poole, Dorset), 
resorufin and ethoxyresorufin (Pierce Chemicals, Rockford, IL) were pur­
chased. Benzphetamine was a generous gift o f  Upjohn Co. Ltd., Kalamazoo, 
MI.
Male golden Syrian hamsters (100—120 g) were purchased from Wrights o f
Essex, Essex, Great Britain, male Wistar albino rats (150 — 200 g) and male 
CD1 mice (35—40 g) from the Animal Breeding Unit, University o f  Surrey. 
The human liver sample was from a male traffic accident victim, and fresh pig 
liver was obtained from the local abbatoir. Both samples were maintained at 
-  80°C. None o f the animal species was pretreated with inducing agents.
Hepatic post-mitochondrial supernatant (S9 fraction) and microsomal 
suspensions (105 000 g  pellet resuspended) were prepared as previously de­
scribed (12). The following determinations were carried out on the post­
mitochondrial supernatant: benzphetamine N-demethylase (13), dimethyl­
aniline N-oxidase (14) and kynuramine oxidase (15); on the microsomal 
suspension: ethoxyresorufin O-deethylase (16), NADPH-cytochrome c re­
ductase (17) and cytochromes P-450 (18); protein was determined in both 
fractions (19).
Metabolic activation o f  nitrosamines to mutagenic intermediates was deter­
mined using the Ames test and employing Salmonella typhimurium  strain 
TA  100. Prior to each experiment the bacterial strain was tested to ensure that 
it retained its characteristics (1). Activation was caried out by using 100 /d o f  
the S9 fraction in the S9 mix, i.e., double the amount routinely employed in 
the Ames test. Dimethylnitrosamine, methylethylnitrosamine and nitroso­
piperidine were dissolved in water. Nitrosopyrrolidine and dipropylnitros­
amine were dissolved in DMSO; the concentration o f  DMSO never exceeded 
100 /il/plate. Each nitrosamine was preincubated with the activation system 
and the bacteria for 30 min at 37°C in a shaking water bath. The same acti­
vation systems were employed in all mutagenicity studies so as to allow direct 
comparison. Spontaneous reversion rate was in the range o f 44 —75 revertants 
per plate.
Results
All activation systems used in the mutagenicity assays were 
fully characterised with respect to microsomal mixed-func­
tion oxidases, mixed-function amine oxidase and monoamine 
oxidase (Table I). The mouse and hamster exhibited the 
highest mixed function amine oxidase activities determined 
using dimethylaniline as substrate, while the pig and human 
hepatic preparations exhibited the highest monoamine oxi­
dase activities when determined using kynuramine as sub­
strate. The cytochrome P-450-catalysed N-demethylation of 
benzphetamine was highest in the hamster and lowest in the 
pig, while the cytochrome P-448-dependent O-deethylation of 
ethoxyresorufin was highest in the hamster and rat. Micro­
somal cytochromes P-450 content was highest in the hamster 
and lowest in the human and pig livers. The rate of NADPH- 
dependent reduction of cytochrome c was similar in all 
species, except the hamster which showed higher activity 
(Table I).
A marked species difference was observed in the metabolic 
activation of the various nitrosamines into intermediates 
mutagenic in the Ames test. The hamster was the only species 
which activated all nitrosamines studied (Figures 1—5). The 
mouse activated readily only nitrosopiperidine (Figure 5), and 
weak mutagenic responses were seen with the acyclic nitros­
amines. The human hepatic microsomal system was an effec­
tive activator of nitrosopyrrolidine (Figure 4) and a weak 
mutagenic response was also observed with the other cyclic 
nitrosamine, nitrosopiperidine (Figure 5). The rat and pig 
hepatic preparations could only weakly activate the cyclic 
nitrosamines but not the other nitrosamines studied (Figures
1 -5 ) .
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Table I. Enzyme activities o f activation systems used in the Ames test. 
Mixed function oxidases, mixed function amine oxidase and monoamine 
oxidase were determined in all activation systems prior to each 
mutagenicity assay.
Mouse Rat Hamster Pig Human
N-oxidation o f  dimethylaniline 21.4 
(nm ol/m in/m g protein)
12.3 21.9 15.5 4.5
4-Hydroxylation o f  kynuramine 68 
(pm ol/m in/m g protein)
120 80 190 200
N-Demethylation o f  benzphetamine 2.85 
(nm ol/m in/m g protein)
1.93 5.61 0.96 1.81
O-Deethylation o f  ethoxyresorufin 26 
(pm ol/m in/m g protein)
60 60 21 36
NADPH-Cytochrome c reductase 31 
(nm ol/m in/m g protein)
39 64 47 36
Cytochrome P-450 0.60 0.66 0.78 0.21 0.32
(nm ol/m g protein)
150
100
50
200015001000500
Dimethylnitrosamine (ug/plate)
Fig. 1. Metabolic activation o f  dimethylnitrosamine to mutagens in 
Salmonella typhimurium  strain TA 100. Liver microsomal preparations 
were isolated from the mouse (O), hamster (A), rat (A), pig ( • )  and man 
( □ ) .  Each point represents the mean o f triplicate plates.
Discussion
The nitrosamines comprise a group of potent carcinogens 
inducing malignant tumours in all animals studied (20). The 
metabolic activation of both cyclic and acyclic nitrosamines 
is believed to proceed through a single hydroxylation of the a- 
carbon to yield to a-hydroxynitrosamine which subsequently 
decomposes generating the electrophilic species (21). The 
cytochrome P-450-dependent mixed-function oxidase system 
is responsible for the initial hydroxylation (5). However, a 
number of studies failed to demonstrate a relationship be­
tween a-hydroxylation of nitrosamines such as dimethylni­
trosamine, and their mutagenicity/carcinogenicity or between 
mixed-function oxidase activity and hydroxylation of the 
nitrosamines (4,22 — 24). Furthermore, using reconstituted 
systems employing highly purified proteins we have demon­
strated that both the phenobarbital-induced and /3-naphtho- 
flavone-induced cytochromes P-450 and P-448, respectively, 
could not activate dimethylnitrosamine to mutagens although 
they could facilitate its a-hydroxylation as evidenced by the
150
100
50
Methyl ethylnitrosamine (pg/plate)
Fig. 2. Metabolic activation o f methylethylnitrosamine to mutagens in 
Salmonella typhimurium  strain TA 100. Symbols as in Figure 1.
°100
Dipropylnitrosamine (ug/plate)
Fig. 3. Metabolic activation o f dipropylnitrosamine to mutagens in 
Salmonella typhimurium  strain TA 100. Symbols as in Figure 1.
generation of formaldehyde (5), confirming the suggestion 
that oxidative demethylation may not be the prerequisite step 
in the activation of nitrosamines (25). Indeed, it has been sug­
gested that an N-oxidative step, catalysed by the monoamine 
oxidase system, may be involved in the activation of di­
methylnitrosamine (3,26), but not of nitrosopyrrolidine (27).
In the present study prior to each mutagenicity assay all ac­
tivation systems were characterised with respect to mixed- 
function oxidases using benzphetamine (cytochrome P-450) 
and ethoxyresorufin (cytochrome P-448) as substrates, mono­
amine oxidase using kynuramine as substrate and the 
N-oxidation of dimethylaniline served as a measure of the 
mixed-function amine oxidase system. Although the latter 
substrate may also be metabolised by cytochrome P-448 (28), 
this isozyme is present in very small amounts in untreated ani­
mals (29). The activities exhibited by the human activation 
system were always within the range recently reported in 
extensive studies (30).
The hamster was the most efficient activator of all nitros-
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Fig. 4. Metabolic activation o f  nitrosopyrrolidine to mutagens in 
Salmonella typhimurium  strain TA 100. Symbols as in Figure 1.
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1000
500
N i t r o s o p i p e r i d i n e  ( p g / p l a t e )
Fig. 5. Metabolic activation o f nitrosopiperidine to mutagens in Salmonella 
typhimurium  strain TA 100. Symbols as in Figure 1.
amines studied, followed by the mouse. The latter species, 
however, could only weakly activate nitrosopyrrolidine which 
was the only carcinogen readily activated by the human 
> microsomal preparation. None of the aliphatic nitrosamines 
J studied could be activated either by the rat or pig.
No correlation was evident between the efficiency of acti- 
\  vation of nitrosamines and mixed-function oxidase, mixed- 
function amine oxidase or monoamine oxidase activities indi­
cating that these enzyme systems are either not involved in the 
activation process of these carcinogens or they do not catalyse 
the rate limiting step. There is substantial experimental evi­
dence implicating other NADH- and NADPH-dependent, 
both oxidative and reductive pathways in the metabolism and 
activation of nitrosamines to mutagens (31 —34). The exact 
role of these pathways in the bioactivation of nitrosamines re­
mains largely unclear.
In conclusion we have demonstrated that, as previously 
shown with other chemical carcinogens (7,8,11), the hamster 
exhibits higher capacity than other animals and man in acti­
vating nitrosamines to mutagens, and the use of this species in 
routine mutagenicity studies merits serious consideration.
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Abstract
Administration of a single dose of the inhibitor of the hepatic 
mixed function oxidases, 9-hydroxyellipticine (9-OHE), 
resulted in a marked increase in the cytochrome P-448 cata­
lysed activities of ethoxyresorufin O-deethylase, biphenyl 
2-hydroxylase and activation of benzo[a]pyrene to mutagens. 
In contrast there was no effect on the cytochrome P-450 
catalysed benzphetamine N-demethylase activity. The induc­
tive effect was prevented by simultaneous administration of 
the protein synthesis inhibitors cycloheximide and actinomy- 
cin D. It is concluded that 9-OHE may also act as an inducer 
of the hepatic microsomal mixed function oxidases, selective­
ly inducing the synthesis of cy tochrome P-448. Therefore, 
9-OHE, like other inhibitors of this enzyme system, exhibits a 
biphasic effect, its inhibitory phase being followed by one of 
enzyme induction. 9-OHE was a direct mutagen in the 
Salmonella typhimurium strains TA 98 and TA 100.
Introduction
Ellipticine (5,ll-dimethyl-6H-pyrido 4-3,b-carbazole) and 
its derivatives comprise a group of plant alkaloids isolated 
from many species of Ochrosia and Aspidoderma (1,2), and 
exhibit strong antineoplastic activity towards a number o f ex­
perimental tumours and human malignancies (3 —6). Ellipti­
cine is a substrate of the microsomal mixed function oxidase 
system being hydroxylated primarily at the 9-position, which 
is excreted as sulphate and glucuronide, and to a lesser extent 
at the 7-position (7 — 11). The 9-hydroxylated derivative of 
ellipticine exhibits the highest antineoplastic activity (4,12).
Preliminary studies showed that 9-hydroxyellipticine 
(9-OHE)* acts as a direct mutagen towards TA 98 and 
TA 1538 strains of Salmonella typhimurium, but requires 
metabolism to express its mutagenicity towards TA 100 (13). 
Ellipticine, and especially its 9-hydroxy derivative, are strong 
inhibitors, both in vivo and in vitro, of the microsomal mixed 
function oxidases of liver and lung (14—17). 9-OHE presum­
ably prevents the hydroxylation o f substrates, because o f its 
interaction with the sixth ligand o f cytochrome P-450 (14). 
The high affinity of 9-OHE for cytochrome P-448, the major 
form of cytochrome P-450 selectively induced by many car­
cinogens, makes it a useful tool for studying the heterogeneity 
of the microsomal monooxygenases. A single dose of 9-OHE 
to rats pretreated with 3-methylcholanthrene gave rise to 
marked inhibition of the cytochrome P-488-catalysed activi­
ties of ethoxyresorufin O-deethylase and biphenyl
2-hydroxylase (17).
JTo whom all correspondence should be addressed.
‘ Abbreviation: 9-OHE, 9-hydroxyelliptidne.
Many inhibitors of the mixed function oxidase, such as 
SKF 525 A, are characterised by a biphasic effect, in that the 
inhibitory phase is followed by a phase o f enzyme induction 
(18). In such a case the time the animal is killed following ad­
ministration of the compound is critical if the inhibitory or in­
ductive effect is to be manifested. In the present study the 
possible inductive effect o f 9-OHE on the hepatic microsomal 
mixed function oxidases has been investigated in the rat.
Materials and Methods
3-Methylcholanthrene, benzo[a]pyrene, cycloheximide and all cofactors 
(Sigma, Poole, Dorset, UK), biphenyl and its hydroxy derivatives (BDH, 
Poole, Dorset, UK), actinomycin D  (Boehringer Mannheim GmbH, FRG) 
and resorufin and ethoxyresorufin (Pierce Chemicals, Rockford, IL, USA) 
were purchased. 9-OHE was kindly donated by Dr. P.Lesca, Laboratoire de 
Pharmacologie et de Toxicologie Fondamentale du CNRS, France. Arochlor 
1254 and benzphetamine were generous gifts from Monsanto C o., St. Louis, 
M O, U SA  and Upjohn Co. Ltd., Kalamazoo, MI, U SA , respectively.
Male Wistar albino rats (150 — 200 g) (Animal Breeding Unit, University o f 
Surrey) received either a single i.p . dose (20 m g/kg) o f  9-OHE dissolved in 
olive oil (20 m g/kg) or single daily doses for 3 days. In the study with the in­
hibitors o f  protein synthesis the animals received a single i.p . dose o f  9-OHE 
(20 m g/kg) together with actinomycin D  24 h before (0.5 m g/kg) and 16 h 
before (0.25 m g/kg) killing and preparation o f liver microsomal fractions, or 
cycloheximide 24 h before (2 m g/kg) and 16 h before (1 m g/kg) preparation 
o f  liver microsomal fractions. Two groups o f animals received olive oil, the 
vehicle for 9-OHE, and either actinomycin D  or cycloheximide. In all cases 
animals were killed 24 h after the last administration o f 9-OHE or olive oil, 
and hepatic microsomal fractions were prepared as previously described (19). 
The following determinations were carried out, on the microsomal super­
natant (9000 g  supernatant, S9): benzphetamine N-demethylase (20), and 
on the microsomal suspension (105 000 g  pellet resuspended): the 2- and
4-hydroxylation o f  biphenyl (21), NADPH-cytochrome c reductase (22), 
ethoxyresorufin O-deethylase (23) and cytochromes P450 and b 5 (24). Protein 
was measured by the method o f  Lowiy, et al. (25). The efficiency o f  the 
various S9 preparations in activating benzo[a]pyrene to intermediates 
mutagenic to the T A  100 strain o f  Salmonella typhimurium  was also in­
vestigated (26). Similarly the mutagenicity o f  9-OHE to strains TA 98 and 
T A  100 was determined in the absence and in the presence o f  an activating 
system derived from an Arochlor pretreated animal (26).
Results
Twenty four hours after the administration of a single dose 
of 9-OHE a marked increase was seen in ethoxyresorufin 
O-deethylase activity (10-fold) and in the 2-hydroxylation o f 
biphenyl (40-fold) (Table I). In contrast there were no 
changes in the 4-hydroxylation of biphenyl, N-demethylation 
o f benzphetamine or NADPH-dependent reduction o f cyto­
chrome c. The microsomal levels o f cytochrome P-450 and b5 
were unchanged. However, the ellipticine-pretreated animals 
were much more efficient in activating benzo[a]pyrene to 
mutagens in Salmonella typhimurium (TA 100), than were 
control animals (Figure 1A). In the absence of benzo[a]- 
pyrene there was no increase in the number of histidine rever- 
tants,above the spontaneous rate indicating that residual 
amounts o f 9-OHE, itself a weak mutagen, were not present 
in the S9 mix (data not shown).
Repeated administration of 9-OHE resulted in small, 
statistically non-significant increases in ethoxyresorufin 
O-deethylase and biphenyl 2-hydroxylase activities (Table II). 
There were no changes in biphenyl 4-hydroxylase, NADPH- 
cytochrome c reductase activities, but benzphetamine
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N-demethylase was slightly inhibited. Similarly there were no 
changes in cytochrome P-450 and b5 levels. Microsomal 
preparations from 9-OHE pretreated animals were more effi­
cient than controls in activating benzo[a]pyrene to mutagens 
(Figure IB) but the effect was less pronounced than that 
observed following a single administration.
Administration of the protein synthesis inhibitors cyclo­
heximide and actinomycin D prevented the enhancement o f 
ethoxyresorufin O-deethylase following a single i.p. dose of 
9-OHE, but had little effect on the demethylation o f benz­
phetamine (Table III). In addition the same inhibitors o f pro­
tein synthesis prevented the increase in the efficiency o f ac­
tivation o f benzo[a]pyrene to mutagens in Salmonella typhi­
murium (TA 100) following a single administration o f 
9-OHE (Figure 2).
9-OHE is a weak direct mutagen to both TA 98 and
Table I. Effect o f  a single administration o f  9-OHE on the rat hepatic 
microsomal mixed function oxidases.
Control Test
Biphenyl 4-hydroxylase 
(nm ol/m in/m g protein)
0.82 ±  0.10 0.87 ±  0.18
Biphenyl 2-hydroxylase 
(pm ol/m in/m g protein)
0.86 ±  1.59b 38 ±  1.9*
Benzphetamine N-demethylase 
(nmol H C H O /m in/m g protein)
5.2 ±  1.3 6.1 ±  2.1
Ethoxyresofurin O-deethylase 
(pm ol/m in/m g protein)
40 ±  17 398 ±  25a
NADPH-cytochrome c reductase 
(nm ol/m in/m g protein)
43 ±  5 48 ±  7
Cytochrome P-450 
(nm ol/m g protein)
0.69 ±  0.08 0.75 ±  0.10
Cytochrome b 5 
(nm ol/m g protein)
0.40 ±  0.02 0.44 ±  0.04
Animals received a single i.p. dose o f  9-OHE (20 m g/kg). Results are 
presented as means ±  S .D . for five animals. ap  < 0 .001. bN o  activity was 
detected in three o f the animals.
TA 100 strains o f Salmonella typhimurium at the concentra­
tions studied (Figure 3). At higher concentrations 9-OHE was 
cytotoxic.
Discussion
Compounds act as inducers o f the microsomal mixed func­
tion oxidases apparently by saturating the active sites o f this 
enzyme system, so that slowly metabolised compounds are 
good inducers, and vice versa (19). Preliminary studies have 
shown that 9-OHE is metabolised by conjugation reactions 
and appears not to be a substrate of the mixed function ox­
idases (10). Furthermore, 9-OHE interacts with hepatic 
microsomal cytochrome P-450 to give a type II spectral 
change, characteristic of compounds interacting with the 
haem moiety o f cytochrome P-450 (14). However, studies 
performed in our own laboratory showed that the type II 
spectral change elicited by 9-OHE contains also a type I com­
ponent, demonstrating that the compound may also act as a 
substrate of the mixed function oxidases (Phillipson, Ioan- 
nides, Delaforge and Parke, unpublished observations).
Administration o f a single dose o f 9-OHE gave rise to 
marked induction o f the cytochrome P-448-catalysed activi­
ties o f ethoxyresorufin O-deethylase and biphenyl 2-hyd­
roxylase, but had no effect on the cytochrome P-450- 
catalysed benzphetamine N-demethylase. In addition, micro­
somal preparations from the 9-OHE pretreated animals were 
better activators o f benzo[a]pyrene to mutagens, a chemical 
carcinogen whose activation is catalysed primarily by cyto­
chrome P-448 (27). 9-OHE administration had no effect on 
the microsomal levels o f cytochrome P-450 and b5 and, like 
its parent compound ellipticine (28), had no effect on 
NADPH-cytochrome c reductase. The enhancement of 
ethoxyresorufin O-deethylase following administration of 
9-OHE was prevented by co-administration of the inhibitors 
o f protein synthesis, actinomycin D and cycloheximide, in­
dicating that 9-OHE induces the formation o f new enzymic 
protein.
With repeated administration the inductive effect of
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Fig. 1. Effect o f  9-OHE on the activation o f benzo[a]pyrene to mutagens by hepatic post-mitochondrial supernatant. A . Single administration; ( □ ------□ )  control,
( ■ — - ■ )  9-OHE treated. B . Repeated administration; (O  -O) control, ( • — —• )  9-OHE treated. Spontaneous reversion rates have been subtracted from
each value.
Mutagenicity of 9-hydroxyelIiptidne
Table II. Effect o f  repeated administration o f  9-OHE on the rat hepatic 
microsomal mixed function oxidases. '
Control Test
Biphenyl 4-hydroxylase 
(nm ol/m in/m g protein)
0.66 ±  0.08 0.66 ±  0.12
Biphenyl 2-hydroxylase 
(pm ol/m in/m g protein)
35 ±  15 50 ±  5
Benzphetamine N-demethylase 
(nmol H C H O /m in/m g protein)
4.3 ±  0.2 3.5 ±  0.4
Ethoxyresorufin O-deethylase 
(pm ol/m in/m g protein)
113 ±  102 136 ±  82
NADPH-cytochrome c reductase 
(nm ol/m in/m g protein)
50 ±  6 44 ±  5
Cytochrome P-450 
(nm ol/m g protein)
0.85 ±  0.06 0.79 ±  0.13
Cytochrome b5 0.46 ±  0.06 0.39 ±  0.02
(nm ol/m g protein)
Animals received single daily i.p . administrations o f 9-OHE (20 m g/kg) for 
three days. Results are presented as means ±  S.D . for five animals.
Table III. Effect o f  inhibitors o f  protein synthesis on the enhancement o f  
hepatic mixed-function oxidases by 9-OHE.
Pretreatment Ethoxyresorufin
O-deethylase
(pm ol/m in/m g
protein)
Benzphetamine 
N-demethylase 
(nmol H C H O /m in/m g  
protein)
Control 250 ± 40 1 9 ± 0.4
9-OHE 640 ± 30 1 9 ± 0.2
Cycloheximide 290 ± 66 1 7 ± 0.3
9-OHE +  cycloheximide 98 ± 4a 1 8 ± 0.4
Actinomycin D 180 ± 27 1 9 ± 0.2
9-OHE +  actinomycin D 91 ± 12a 1 8 ± 0.4
Results are presented as means ±  S.D . for five animals. ap  <  0.001 when 
compared to animals receiving 9-OHE only.
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Fig. 2. Effect o f  inhibitors o f  protein synthesis on the 9-OHE induced activa­
tion o f  benzo[a]pyrene to mutagens. (O O) Control; ( • -------• )  9-OHE;
(A A) cycloheximide; (A  A) cycloheximide +  9-OHE; ( □ ------ □ )
actinomycin D; ( ■ ------ ■ )  actinomycin D  +  9-OHE. Spontaneous reversion
rates have been subtracted from each value.
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Fig. 3. Mutagenicity o f  9-OHE in the presence and absence o f  an activating 
enzyme system. A  =  TA 100; B =  TA 98. Spontaneous reversion rates have 
been subtracted from each value. The activation system was derived from  
Arochlor 1254 pretreated rats (26).
9-OHE was decreased. As 9-OHE is metabolised by conjuga­
tion (10), induction of the mixed function oxidases should not 
be accompanied by faster elimination o f the compound, 
which might therefore accumulate on repeated administration 
and inhibit cytochrome P-448 activity.
9-OHE was a direct mutagen to both TA 98 and TA 100 
strains o f Salmonella typhimurium. This is in contrast to a 
previous study where the compound was shown to be a direct 
mutagen only to the TA 98 and TA 1538 strains and required 
metabolism to exert its mutagenic effect on TA 100 (13), 
although enhanced mutagenic activity was observed with 
TA 100 at 5 /ig/plate when an S9 mix was present (Figure 3).
From the present studies it is clear that 9-OHE selectively 
induces cytochrome P-448, the form o f cytochrome P-450
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selectively induced by many chemical carcinogens. This is 
compatible with its high affinity for this form of the haemo- 
protein (17). There is no direct evidence that 9-OHE is a car­
cinogen, but it must be bome in mind that many cytotoxic 
agents are known carcinogens (29).
9-OHE is the major metabolite of ellipticine and this reac­
tion appears to be catalysed by cytochrome P-448, since ellip­
ticine hydroxylase activity is enhanced following pretreatment 
with benzo[a]pyrene but not by phenobarbitone (7). The 
mutagenicity o f ellipticine is increased in the presence o f an 
activating system derived from Arochlor 1254 pretreated 
animals (14). In addition, ellipticine itself is an inducer of 
cytochrome P-448 activity (30). All these observations in­
dicate that 9-OHE is responsible for the mutagenicity and 
inductive effects of the parent compound ellipticine, and may 
also contribute, at least partly, to its antineoplastic activity, 
since 9-OHE exhibits the highest degree of antineoplastic ac­
tivity o f the ellipticines (4,12).
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